data_2k16_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k16 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . 0.456 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 55.1 m-85 . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 122.103 0.954 . . . . 0.0 109.13 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 51.5 t -136.68 114.3 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.225 -174.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 39.5 mt -124.69 154.61 32.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -98.83 134.7 41.34 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.53 0.681 . . . . 0.0 110.076 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -71.93 172.23 10.33 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.962 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -63.12 -34.65 78.07 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 123.207 0.603 . . . . 0.0 110.468 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -88.67 -14.4 37.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.895 0.855 . . . . 0.0 108.994 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 105.31 10.51 31.48 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.077 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -68.96 164.0 23.27 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -88.36 121.06 30.32 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.632 0.73 . . . . 0.0 110.89 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 39.2 mm -91.51 112.45 25.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 173.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -88.47 130.84 35.1 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.424 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 32.8 mt -100.51 104.13 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.398 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 44.7 t -54.73 112.42 4.0 Favored Pre-proline 0 N--CA 1.429 -1.519 0 CA-C-N 113.734 -1.575 . . . . 0.0 108.997 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -71.93 3.58 3.79 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.005 1.803 . . . . 0.0 112.216 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -83.74 -36.67 13.16 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 22.3 p -114.97 -27.75 7.26 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 122.507 -0.408 . . . . 0.0 111.122 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 82.29 24.0 0.2 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.298 1.839 . . . . 0.0 110.309 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.545 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 41.2 mttm -102.86 144.43 28.6 Favored Pre-proline 0 N--CA 1.467 0.408 0 C-N-CA 123.393 0.677 . . . . 0.0 111.255 174.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -80.42 174.09 11.66 Favored 'Trans proline' 0 C--O 1.242 0.683 0 C-N-CA 123.094 2.53 . . . . 0.0 108.479 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 15.4 t70 -69.31 102.11 1.66 Allowed 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.222 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -94.97 5.06 52.99 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.438 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 119.31 55.81 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 17.7 m -134.25 163.1 53.59 Favored Pre-proline 0 N--CA 1.417 -2.108 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -75.3 137.67 21.35 Favored 'Trans proline' 0 C--O 1.264 1.777 0 C-N-CA 122.459 2.106 . . . . 0.0 108.581 172.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.505 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 58.1 mtp -117.03 152.78 33.93 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.961 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.9 tt -134.41 134.2 54.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -99.21 160.31 19.95 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.737 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.87 166.74 15.76 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.573 0.702 . . . . 0.0 110.869 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -92.88 -22.77 19.06 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.631 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -101.55 -37.64 8.31 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.246 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . 0.25 16.2 p -103.21 169.64 8.43 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.961 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.2 -21.04 19.31 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.503 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -87.1 163.59 16.91 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.897 -171.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -110.2 142.6 41.53 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.503 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -112.79 -178.05 3.29 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 125.014 1.326 . . . . 0.0 108.468 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.869 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 59.2 m80 -110.84 160.26 16.92 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -60.17 -54.1 58.55 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.24 -26.59 77.6 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 122.281 1.987 . . . . 0.0 114.071 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.869 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 5.8 m -69.31 -36.81 77.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.947 0.88 . . . . 0.0 111.772 -176.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.452 HG21 HG12 ' A' ' 899' ' ' ILE . 28.2 m -107.11 -17.87 7.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.36 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 93.3 48.94 2.7 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 121.224 -0.512 . . . . 0.0 113.139 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.452 HG12 HG21 ' A' ' 897' ' ' VAL . 44.0 mm -88.56 125.17 41.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 69.1 mtm -91.65 -37.26 13.16 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.127 0.489 . . . . 0.0 109.69 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -156.61 158.93 37.94 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -55.2 113.81 6.1 Favored Pre-proline 0 C--N 1.32 -0.717 0 O-C-N 124.093 0.871 . . . . 0.0 111.984 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 CA--C 1.548 1.181 0 C-N-CA 123.346 2.698 . . . . 0.0 112.724 -179.711 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 . . . . . 0 N--CA 1.418 -2.05 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -106.45 132.17 52.78 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -127.97 137.35 52.21 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 5.8 p -69.82 168.45 17.57 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 123.996 0.918 . . . . 0.0 109.695 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.24 -20.3 10.87 Favored 'Trans proline' 0 CA--C 1.552 1.409 0 C-N-CA 123.195 2.597 . . . . 0.0 112.429 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -79.29 -56.27 4.47 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.478 0.711 . . . . 0.0 109.195 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 71.5 m -79.03 -17.51 55.16 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 918' ' ' ILE . . . -67.06 -31.22 71.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.334 1.064 . . . . 0.0 108.645 172.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -73.42 -22.99 60.07 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.45 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -74.49 -36.59 63.27 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 172.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 915' ' ' ALA . 50.5 mm . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 172.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . 0.448 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 88.7 m-85 . . . . . 0 C--O 1.244 0.798 0 CA-C-O 120.792 0.329 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 90.9 t -132.56 116.83 29.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.855 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 35.2 mt -120.2 157.26 22.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -102.01 131.64 48.32 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.035 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.77 173.5 8.11 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.853 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.95 -37.78 80.52 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.767 0.827 . . . . 0.0 111.143 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . 0.491 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 75.9 m95 -91.15 1.45 57.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.557 0.694 . . . . 0.0 110.626 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.08 14.19 56.51 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.761 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.491 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 58.8 m-80 -73.84 155.65 38.57 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.73 113.17 24.01 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.678 0.751 . . . . 0.0 112.006 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 37.1 mm -80.41 118.47 28.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 175.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -92.16 138.22 31.71 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.329 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 33.5 mt -104.07 127.34 58.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 42.9 t -79.38 112.82 31.58 Favored Pre-proline 0 N--CA 1.423 -1.815 0 C-N-CA 124.348 1.059 . . . . 0.0 108.719 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 31.9 Cg_exo -60.79 -6.06 5.43 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 123.883 3.056 . . . . 0.0 113.664 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -85.53 -23.5 46.84 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.785 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 18.9 p -123.92 -33.89 3.07 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 82.5 21.86 0.23 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.943 1.697 . . . . 0.0 109.706 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -103.66 139.52 20.19 Favored Pre-proline 0 C--O 1.25 1.107 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.934 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.59 153.93 49.54 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.845 2.363 . . . . 0.0 110.644 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 29.2 t70 -79.53 146.17 32.79 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.139 0.495 . . . . 0.0 111.845 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -108.79 -0.62 19.82 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.247 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 106.13 51.78 0.81 Allowed Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -172.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 1.3 m -109.02 164.35 14.91 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.04 114.92 3.36 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 121.745 1.63 . . . . 0.0 108.886 172.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 68.7 mtp -115.06 167.58 10.69 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.2 tt -132.22 143.83 38.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -101.23 147.15 17.63 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 43.7 t -80.34 170.67 16.08 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.022 0.529 . . . . 0.0 110.009 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . 0.433 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 26.8 t70 -88.99 -24.83 22.29 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -100.67 -31.8 11.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.323 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 22.4 m -104.71 149.09 25.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -92.45 -9.99 39.53 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.57 150.43 49.0 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.844 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -101.29 135.44 42.77 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.786 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -115.85 150.73 36.54 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.646 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 43.2 m80 -79.11 139.94 37.94 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.916 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 31.4 m0 -52.34 -52.03 66.84 Favored Pre-proline 0 CA--C 1.551 1.014 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.59 -9.3 22.08 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.951 1.767 . . . . 0.0 113.309 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -93.52 -17.84 22.94 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.453 0.644 . . . . 0.0 111.074 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 893' ' ' HIS . 31.5 m -118.48 7.67 6.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.927 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 70.72 37.61 66.92 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.723 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 49.0 mt -108.48 124.28 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-O 121.73 0.776 . . . . 0.0 110.848 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -105.0 -21.15 13.33 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.518 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -155.76 146.9 22.47 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -55.8 114.95 8.34 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 124.848 1.343 . . . . 0.0 112.133 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 N--CA 1.454 -0.818 0 C-N-CA 121.966 1.778 . . . . 0.0 109.784 173.883 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 92.9 t90 -134.35 138.09 44.64 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.697 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 97.5 m-85 -135.56 136.36 41.06 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 11.5 p -62.55 165.7 8.76 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 124.081 0.952 . . . . 0.0 110.24 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.15 -10.26 5.83 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.014 2.476 . . . . 0.0 112.291 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 28.9 mmmt -83.28 -54.11 5.25 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 72.0 m -81.49 -21.37 38.72 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.32 -27.55 67.99 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -78.5 -5.39 52.46 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.635 0.731 . . . . 0.0 110.273 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -83.82 -34.97 24.57 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 68.9 mt . . . . . 0 C--N 1.308 -1.21 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.3 -179.55 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 . . . . . 0 N--CA 1.424 -1.774 0 CA-C-O 122.296 1.046 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.32 115.57 18.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 113.902 -1.499 . . . . 0.0 107.516 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 56.5 mt -108.1 152.21 9.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -108.09 135.09 50.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.09 174.09 11.92 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.261 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.81 -24.42 63.47 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.247 0.546 . . . . 0.0 111.029 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -88.26 4.87 44.3 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.333 0.587 . . . . 0.0 110.412 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 74.73 22.06 77.66 Favored Glycine 0 CA--C 1.502 -0.738 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.598 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -86.21 154.57 21.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -86.67 130.69 34.39 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.796 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 41.6 mm -103.14 105.61 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.744 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.2 m-90 -83.95 136.86 33.91 Favored 'General case' 0 C--N 1.252 -3.639 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.609 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.5 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 53.3 mt -102.71 129.0 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.348 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 43.6 t -80.65 109.13 11.85 Favored Pre-proline 0 N--CA 1.416 -2.162 0 C-N-CA 125.612 1.565 . . . . 0.0 107.387 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 32.5 Cg_exo -62.17 -0.81 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.335 2.69 . . . . 0.0 113.624 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.81 -49.04 9.25 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 3.9 p -107.74 -20.22 13.29 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 122.593 0.357 . . . . 0.0 111.113 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 78.68 23.05 0.64 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.745 1.618 . . . . 0.0 108.786 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -101.16 141.97 23.69 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.566 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.93 174.15 12.84 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.661 2.241 . . . . 0.0 109.226 170.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.434 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 17.2 t0 -60.8 109.78 1.14 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.835 0.826 . . . . 0.0 110.501 174.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -101.67 13.71 34.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.292 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 102.82 49.1 1.2 Allowed Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 21.2 m -130.03 157.01 78.28 Favored Pre-proline 0 N--CA 1.412 -2.369 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.18 135.32 16.84 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 121.973 1.782 . . . . 0.0 108.447 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 65.0 mtp -115.71 142.32 46.91 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.696 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.5 tt -123.05 136.42 59.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -119.59 152.26 17.21 Favored Glycine 0 CA--C 1.483 -1.926 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.734 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 888' ' ' CYS . 42.3 t -58.62 160.1 5.89 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.651 0.78 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -88.11 -27.25 22.04 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.54 -39.59 18.61 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.675 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 885' ' ' CYS . 8.5 p -138.17 167.12 22.49 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.031 0.444 . . . . 0.0 110.981 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -90.04 68.33 7.19 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.799 0.809 . . . . 0.0 109.755 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -112.02 97.47 6.69 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.7 -2.334 . . . . 0.0 104.7 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -96.39 128.78 43.63 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.439 -171.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . 0.491 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 36.5 m-85 -122.55 169.3 11.16 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.744 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.567 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.5 m80 -89.36 149.79 22.85 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.087 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -49.6 -56.33 17.4 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.44 -11.16 29.07 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.324 2.016 . . . . 0.0 113.94 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 62.8 m -89.18 -29.8 19.04 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.479 HG22 HG12 ' A' ' 899' ' ' ILE . 17.2 m -113.45 3.55 8.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -175.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.06 5.73 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.576 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.479 HG12 HG22 ' A' ' 897' ' ' VAL . 24.5 mm -105.15 114.6 45.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 90.2 mmm -95.61 -21.86 17.97 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.324 0.583 . . . . 0.0 110.204 -177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -165.52 163.07 19.52 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -45.81 111.57 1.44 Allowed Pre-proline 0 C--O 1.241 0.609 0 O-C-N 124.579 1.174 . . . . 0.0 111.419 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--O 1.243 0.736 0 C-N-CA 122.873 2.382 . . . . 0.0 111.396 179.869 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 . . . . . 0 N--CA 1.427 -1.605 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -129.1 139.17 52.09 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -130.26 147.04 51.94 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 20.0 p -61.06 160.04 24.11 Favored Pre-proline 0 C--N 1.317 -0.806 0 O-C-N 123.871 0.732 . . . . 0.0 110.388 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.16 -15.13 13.45 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.863 2.375 . . . . 0.0 112.604 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 18.4 mtmm -82.3 -50.93 8.4 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.81 -31.52 66.64 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.74 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -65.8 -25.52 67.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.114 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.21 -37.41 57.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.48 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -60.16 -44.08 95.27 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 74.4 mt . . . . . 0 N--CA 1.447 -0.596 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.713 179.444 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 . . . . . 0 CA--C 1.505 -0.78 0 CA-C-O 121.375 0.607 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 59.1 t -111.05 106.69 21.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 34.6 mt -108.67 131.67 58.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -85.4 117.9 24.6 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 862' ' ' GLU . 24.9 t70 -69.11 177.54 2.66 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.36 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . 0.411 ' H ' ' CG ' ' A' ' 861' ' ' ASP . 27.5 mt-10 -66.82 -30.91 71.22 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 124.686 1.194 . . . . 0.0 109.941 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . 0.6 ' HB3' ' ND2' ' A' ' 865' ' ' ASN . 72.5 t-105 -89.14 -3.19 58.71 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.899 0.856 . . . . 0.0 109.024 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.32 9.98 71.88 Favored Glycine 0 CA--C 1.502 -0.762 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.496 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.6 ' ND2' ' HB3' ' A' ' 863' ' ' TRP . 47.9 m-80 -62.2 148.89 43.23 Favored 'General case' 0 C--O 1.249 1.027 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -85.89 101.36 12.79 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.997 0.903 . . . . 0.0 109.774 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 49.8 mm -89.54 115.22 28.78 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.593 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -103.08 126.32 50.2 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.526 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.534 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 27.6 mt -87.87 124.32 40.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.422 ' C ' ' H ' ' A' ' 872' ' ' GLY . 42.9 t -79.36 106.5 4.69 Favored Pre-proline 0 N--CA 1.415 -2.191 0 C-N-CA 125.325 1.45 . . . . 0.0 107.412 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 21.6 Cg_exo -67.39 13.6 0.16 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.665 2.91 . . . . 0.0 113.247 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 870' ' ' CYS . . . -92.25 -40.21 5.19 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 174.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 11.0 p -111.96 -25.55 9.34 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.084 0.469 . . . . 0.0 110.325 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 79.9 18.66 0.67 Allowed 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.459 1.904 . . . . 0.0 110.916 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -94.74 138.51 22.19 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.491 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -72.52 148.4 47.89 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.159 2.572 . . . . 0.0 111.695 174.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.28 141.15 54.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -85.93 -34.1 21.0 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.512 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 127.83 46.46 0.19 Allowed Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 106.336 -2.706 . . . . 0.0 106.336 -171.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 20.9 p -114.11 165.41 13.7 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 114.387 -0.907 . . . . 0.0 109.697 -173.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.76 124.13 13.97 Favored 'Trans proline' 0 C--O 1.255 1.353 0 C-N-CA 122.082 1.855 . . . . 0.0 111.442 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.8 mtp -124.66 161.72 25.68 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.862 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.8 tt -130.68 138.06 54.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -108.36 152.32 16.98 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.965 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 47.4 t -77.84 167.28 21.77 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.378 0.609 . . . . 0.0 110.363 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -104.41 -23.09 13.22 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.127 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -84.94 -40.9 16.44 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.434 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.7 p -105.55 -95.06 0.35 Allowed 'General case' 0 N--CA 1.427 -1.577 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.468 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 37.3 t70 174.62 -20.46 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.022 0.929 . . . . 0.0 109.778 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -55.69 141.94 36.1 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -176.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -104.1 131.64 51.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.518 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 911' ' ' CYS . 10.6 m-85 -117.74 155.43 30.01 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.167 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.658 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 36.6 m80 -80.93 143.29 32.74 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.404 ' N ' ' HD2' ' A' ' 895' ' ' PRO . 29.2 m0 -52.59 -51.7 70.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 30.4 Cg_endo -61.2 -20.35 67.58 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.321 2.014 . . . . 0.0 113.405 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 61.6 m -80.47 -26.01 38.51 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.088 0.47 . . . . 0.0 111.641 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 11.8 m -114.0 8.25 7.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.449 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 73.04 48.79 18.83 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.7 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 58.6 mt -119.85 133.7 65.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 122.636 -0.332 . . . . 0.0 110.619 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.3 ptp -128.37 -2.88 5.57 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.265 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -164.39 130.62 2.98 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -44.64 96.35 0.11 Allowed Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 127.002 2.121 . . . . 0.0 113.83 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 0.4 OUTLIER . . . . . 0 CA--C 1.556 1.58 0 C-N-CA 123.553 2.835 . . . . 0.0 116.346 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 . . . . . 0 C--O 1.242 0.669 0 CA-C-O 121.152 0.501 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -107.98 124.37 50.06 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.582 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.37 145.94 46.66 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 892' ' ' TYR . 27.3 p -66.18 163.55 37.59 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.769 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.55 -23.65 26.07 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.695 2.263 . . . . 0.0 111.904 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -79.17 -50.87 10.3 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.721 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 917' ' ' LYS . 98.0 m -82.89 -25.2 32.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.49 65.39 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -74.36 -19.6 60.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.256 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 49.2 mtmt -86.1 -30.56 22.46 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 46.3 mm . . . . . 0 C--N 1.33 -0.274 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 176.632 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 CA--C 1.513 -0.465 0 CA-C-O 121.591 0.71 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 44.4 t -135.04 118.12 23.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.2 mt -131.92 165.39 32.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -117.91 147.93 42.64 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.42 -175.82 5.85 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.08 -27.53 67.44 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.796 0.331 . . . . 0.0 111.828 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -78.04 -48.16 16.76 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.977 0.418 . . . . 0.0 110.208 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 129.34 28.04 0.79 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.968 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -88.05 155.93 19.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -83.08 130.04 35.08 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-O 121.328 0.585 . . . . 0.0 109.455 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 50.7 mm -92.43 102.83 13.99 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 -75.51 114.34 13.96 Favored 'General case' 0 C--N 1.267 -2.997 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.436 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 50.1 mt -98.52 113.03 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.467 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 43.4 t -63.46 112.94 8.1 Favored Pre-proline 0 N--CA 1.422 -1.872 0 O-C-N 124.784 1.303 . . . . 0.0 109.068 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . 0.482 ' HD2' ' CE1' ' A' ' 892' ' ' TYR . 53.1 Cg_exo -58.82 -15.94 29.1 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.631 2.887 . . . . 0.0 113.098 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -70.59 -43.52 60.38 Favored Glycine 0 N--CA 1.433 -1.504 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.927 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 7.4 p -109.0 -26.51 10.15 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.952 0.406 . . . . 0.0 110.653 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 13.9 m120 77.95 25.02 0.67 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.772 1.629 . . . . 0.0 109.507 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.76 139.51 20.94 Favored Pre-proline 0 C--O 1.247 0.936 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.324 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.43 173.86 11.76 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 123.649 2.899 . . . . 0.0 112.931 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.81 112.42 1.64 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.595 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -103.22 -6.56 21.98 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.926 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 117.97 -17.82 11.67 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.07 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 64.2 m -68.17 156.27 90.31 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-N 116.674 0.237 . . . . 0.0 110.773 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.16 133.71 36.47 Favored 'Trans proline' 0 C--O 1.253 1.26 0 C-N-CA 122.785 2.323 . . . . 0.0 111.784 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.0 mtp -119.0 154.43 33.08 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.1 tt -124.61 145.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -102.98 155.21 18.2 Favored Glycine 0 C--O 1.248 0.999 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 886' ' ' ASP . 43.4 t -79.96 175.12 10.92 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.739 0.78 . . . . 0.0 110.749 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . 0.41 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 19.2 t70 -99.04 -24.47 14.89 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . 0.425 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 10.6 t70 -91.85 -39.08 11.94 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.571 0.7 . . . . 0.0 109.623 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 5.3 p -120.04 172.42 7.76 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.208 0.528 . . . . 0.0 112.371 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -104.26 11.22 35.13 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.926 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -80.17 149.86 30.36 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.226 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -110.83 134.47 52.49 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.902 0.382 . . . . 0.0 111.879 -173.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . 0.482 ' CE1' ' HD2' ' A' ' 871' ' ' PRO . 90.5 m-85 -123.58 147.89 46.87 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.75 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 53.6 m80 -76.47 145.01 39.5 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.413 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.416 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 35.9 m0 -54.58 -51.85 74.95 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 174.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 33.3 Cg_endo -63.36 -12.53 31.01 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.525 2.15 . . . . 0.0 113.162 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 73.6 m -85.34 -29.91 24.11 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.199 0.524 . . . . 0.0 110.834 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 16.7 m -107.89 -4.6 10.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.469 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 86.31 32.69 15.93 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.566 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 52.1 mt -98.28 123.92 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-O 121.365 0.602 . . . . 0.0 109.93 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -106.7 -19.78 13.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.073 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -151.83 150.47 30.16 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -53.97 111.48 2.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.653 1.221 . . . . 0.0 111.385 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.489 2.126 . . . . 0.0 110.816 179.352 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 . . . . . 0 N--CA 1.439 -1.009 0 CA-C-O 121.223 0.535 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -139.76 131.84 27.97 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -125.13 140.53 52.79 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 24.8 p -71.33 164.57 56.23 Favored Pre-proline 0 N--CA 1.424 -1.745 0 O-C-N 123.855 0.722 . . . . 0.0 110.524 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -59.92 -9.97 11.12 Favored 'Trans proline' 0 CA--C 1.552 1.409 0 C-N-CA 122.895 2.397 . . . . 0.0 112.704 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -87.26 -46.32 9.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 122.252 -0.28 . . . . 0.0 110.289 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 92.2 m -76.4 -27.81 56.45 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.218 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -68.77 -24.73 64.47 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.437 0.637 . . . . 0.0 109.67 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -68.37 -37.69 80.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -60.94 -38.43 85.8 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.432 0.634 . . . . 0.0 109.845 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 50.4 mm . . . . . 0 C--N 1.317 -0.846 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.415 -178.874 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . 0.496 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 65.0 m-85 . . . . . 0 CA--C 1.505 -0.776 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.57 128.59 60.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 45.3 mt -137.13 162.26 34.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -102.89 140.78 36.71 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 119.071 0.85 . . . . 0.0 110.966 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -76.71 173.67 11.35 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.681 173.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -70.66 -26.76 63.59 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . 0.534 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 96.2 m95 -88.61 -6.57 57.44 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.193 0.521 . . . . 0.0 109.926 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 94.32 13.71 53.27 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.942 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.534 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 51.6 m-80 -72.9 158.88 34.65 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -91.72 127.99 37.39 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 121.982 0.896 . . . . 0.0 111.726 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 46.3 mm -99.62 125.96 53.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.592 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -108.08 152.71 24.15 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.496 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 31.9 mt -112.69 133.0 59.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 O-C-N 123.579 0.55 . . . . 0.0 109.823 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 45.3 t -80.54 111.39 22.44 Favored Pre-proline 0 N--CA 1.421 -1.886 0 C-N-CA 124.911 1.284 . . . . 0.0 109.24 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 32.6 Cg_exo -63.3 2.88 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.315 0 C-N-CA 123.894 3.063 . . . . 0.0 113.498 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -90.04 -19.38 47.06 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.743 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 7.0 p -137.97 -25.29 0.98 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 17.1 t30 78.92 20.43 0.75 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.671 1.589 . . . . 0.0 109.257 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.413 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 99.3 mttt -92.43 139.12 23.83 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.731 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . 0.406 ' HA ' HG12 ' A' ' 869' ' ' ILE . 57.8 Cg_endo -77.59 163.7 29.12 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.546 2.831 . . . . 0.0 112.487 174.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.465 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 12.8 t70 -59.1 125.95 25.69 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.525 0.73 . . . . 0.0 111.831 175.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -99.02 19.5 15.01 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.655 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 84.11 42.5 7.53 Favored Glycine 0 CA--C 1.488 -1.639 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 -172.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 9.1 p -115.48 150.79 45.2 Favored Pre-proline 0 N--CA 1.409 -2.508 0 CA-C-N 113.77 -1.215 . . . . 0.0 111.565 -170.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.77 123.0 9.95 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 122.072 1.848 . . . . 0.0 108.72 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.465 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 92.4 mtp -120.27 157.18 29.7 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.9 tt -119.19 134.96 61.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.15 157.5 21.55 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 886' ' ' ASP . 52.3 t -80.64 170.77 15.89 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.5 0.667 . . . . 0.0 110.503 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . 0.409 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 22.2 t70 -93.82 -24.1 17.89 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . 0.413 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 16.0 t70 -99.86 -48.1 4.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.796 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.7 p -98.65 165.3 11.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.354 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -88.32 -16.19 33.71 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.158 0.983 . . . . 0.0 110.521 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.66 152.29 45.54 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.757 -174.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -105.42 133.64 49.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.512 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -115.4 146.77 41.28 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.69 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.3 m80 -76.88 141.07 40.74 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -50.31 -51.62 61.87 Favored Pre-proline 0 CA--C 1.555 1.161 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.78 -22.53 74.58 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.402 2.068 . . . . 0.0 114.176 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 60.9 m -81.02 -26.9 36.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.529 0.681 . . . . 0.0 111.652 -175.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.495 HG21 HG12 ' A' ' 899' ' ' ILE . 15.1 m -112.68 -5.47 11.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.087 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 85.65 41.81 7.12 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.365 175.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.495 HG12 HG21 ' A' ' 897' ' ' VAL . 39.9 mm -90.98 108.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.7 ptm -87.19 -23.93 24.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.735 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -162.68 149.36 12.95 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -49.66 110.6 1.65 Allowed Pre-proline 0 C--O 1.241 0.619 0 O-C-N 124.508 1.13 . . . . 0.0 111.8 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 122.979 2.452 . . . . 0.0 112.107 -179.456 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 N--CA 1.441 -0.902 0 CA-C-O 121.183 0.516 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -130.09 131.98 45.96 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -133.45 137.78 45.88 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.246 0.546 . . . . 0.0 110.132 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.665 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 7.5 p -73.48 172.12 9.01 Favored Pre-proline 0 C--N 1.296 -1.723 0 C-N-CA 124.862 1.265 . . . . 0.0 110.641 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.71 -16.17 23.86 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 123.002 2.468 . . . . 0.0 111.665 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.665 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 11.7 mmmm -80.56 -55.02 5.14 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.26 0.624 . . . . 0.0 110.849 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.425 ' O ' HG12 ' A' ' 918' ' ' ILE . 71.6 m -85.59 -22.82 27.86 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.65 -22.18 61.72 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 913' ' ' LYS . 3.4 t-20 -66.96 -36.13 81.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.741 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -66.05 -49.14 68.69 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.404 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 914' ' ' CYS . 32.5 mm . . . . . 0 C--O 1.244 0.765 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.078 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . 0.411 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 49.7 m-85 . . . . . 0 N--CA 1.425 -1.693 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.61 118.06 37.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.517 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . 0.43 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 54.5 mt -117.07 162.78 14.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -96.63 134.33 40.01 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 119.313 0.96 . . . . 0.0 110.108 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -75.86 174.4 9.94 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.99 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -68.47 -30.04 68.8 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 123.666 0.786 . . . . 0.0 110.784 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -79.95 -15.58 56.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.885 0.85 . . . . 0.0 108.895 176.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 96.93 18.56 29.17 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -81.6 178.24 8.46 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -95.88 129.0 43.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.073 0.463 . . . . 0.0 110.317 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.43 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 28.2 mm -92.1 122.27 43.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -90.84 148.61 22.39 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 124.22 0.95 . . . . 0.0 111.208 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.438 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 50.7 mt -122.17 136.44 59.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.471 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.85 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 50.0 t -77.59 106.98 4.38 Favored Pre-proline 0 N--CA 1.426 -1.668 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . 0.503 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 57.5 Cg_endo -78.14 15.19 1.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.018 1.812 . . . . 0.0 111.977 -177.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -87.52 -32.0 14.62 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 9.4 p -115.13 -32.37 5.72 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.582 -0.309 . . . . 0.0 110.475 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 87.55 26.26 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.828 2.051 . . . . 0.0 109.864 -175.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.464 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 25.6 mtpp -110.23 139.07 21.08 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.553 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.6 Cg_endo -76.51 169.95 20.89 Favored 'Trans proline' 0 C--O 1.249 1.051 0 C-N-CA 123.426 2.751 . . . . 0.0 112.98 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -51.99 113.45 1.01 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.538 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -107.64 18.18 21.74 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.58 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 83.72 27.75 37.51 Favored Glycine 0 CA--C 1.492 -1.366 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 10.7 p -106.02 167.59 9.44 Favored Pre-proline 0 N--CA 1.42 -1.935 0 C-N-CA 123.82 0.848 . . . . 0.0 110.043 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.75 123.84 9.29 Favored 'Trans proline' 0 N--CA 1.437 -1.811 0 C-N-CA 121.368 1.379 . . . . 0.0 109.762 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 78.1 mtp -122.44 150.51 42.39 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.668 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . 0.49 ' HB ' ' NE1' ' A' ' 894' ' ' TRP . 19.0 tt -117.36 148.67 19.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -109.87 157.45 15.06 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.596 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.51 ' HB3' ' OD2' ' A' ' 890' ' ' ASP . 42.2 t -91.73 -170.83 2.69 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 126.037 1.735 . . . . 0.0 108.016 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -120.54 -23.34 6.11 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.965 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . 0.437 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 3.4 t70 -102.52 -25.09 13.72 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -167.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 890' ' ' ASP . 22.6 p -119.12 -143.93 0.36 Allowed 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -174.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -130.04 87.04 2.47 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . 0.51 ' OD2' ' HB3' ' A' ' 885' ' ' CYS . 1.4 p30 -128.78 157.62 40.94 Favored 'General case' 0 C--N 1.256 -3.494 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -159.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -161.09 117.3 2.22 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 127.85 2.46 . . . . 0.0 106.409 161.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . 0.503 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 62.8 m-85 -120.02 147.98 44.12 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.718 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 53.4 m80 -76.69 140.2 40.79 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.899 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.49 ' NE1' ' HB ' ' A' ' 883' ' ' ILE . 24.2 m0 -53.51 -51.2 78.11 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.08 -9.42 25.01 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.039 1.826 . . . . 0.0 113.919 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 74.3 m -86.51 -39.7 15.99 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.293 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.492 HG22 HG12 ' A' ' 899' ' ' ILE . 30.5 m -104.57 -4.07 9.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.205 -175.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 87.1 53.0 2.93 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.519 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.492 HG12 HG22 ' A' ' 897' ' ' VAL . 16.7 mm -114.02 136.05 51.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.2 ptp -121.08 -15.59 8.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.605 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -162.61 135.48 5.77 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -39.21 96.7 0.12 Allowed Pre-proline 0 N--CA 1.494 1.746 0 C-N-CA 126.169 1.788 . . . . 0.0 113.833 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 12.0 Cg_endo . . . . . 0 CA--C 1.551 1.365 0 C-N-CA 123.553 2.835 . . . . 0.0 118.113 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . 0.459 ' HB2' ' CE2' ' A' ' 910' ' ' PHE . 38.2 mt-30 . . . . . 0 C--O 1.238 0.48 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -101.12 131.38 47.08 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' A' ' 908' ' ' GLN . 92.0 m-85 -128.76 139.34 52.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 27.4 p -66.43 166.99 14.23 Favored Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 124.226 0.954 . . . . 0.0 110.944 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -48.78 -24.48 7.03 Favored 'Trans proline' 0 CA--C 1.552 1.405 0 C-N-CA 123.841 3.028 . . . . 0.0 113.075 175.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -87.01 -41.31 13.98 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.725 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 90.8 m -85.7 -17.94 34.53 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.65 74.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 122.127 0.965 . . . . 0.0 108.654 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.78 -29.19 70.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.897 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -70.4 -35.49 73.5 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.173 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.411 HD12 ' CD2' ' A' ' 910' ' ' PHE . 70.8 mt . . . . . 0 C--N 1.327 -0.397 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 . . . . . 0 CA--C 1.509 -0.611 0 CA-C-O 122.526 1.155 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 92.3 t -131.91 120.74 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 113.717 -1.583 . . . . 0.0 108.969 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . 0.426 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 45.6 mt -119.75 152.28 22.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -102.97 137.69 40.83 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.161 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.65 172.65 10.27 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.569 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.8 -28.05 66.41 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 122.613 0.365 . . . . 0.0 110.758 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 -74.72 -23.85 58.65 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 107.62 3.82 34.69 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.164 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -69.69 149.0 48.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.977 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -84.62 127.05 33.87 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.737 0.78 . . . . 0.0 112.096 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.426 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 47.0 mm -98.75 117.55 43.97 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -94.24 135.88 35.14 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.742 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.55 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 51.1 mt -105.77 128.35 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 25.7 t -82.75 107.97 10.87 Favored Pre-proline 0 N--CA 1.414 -2.234 0 C-N-CA 125.04 1.336 . . . . 0.0 108.833 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 36.2 Cg_exo -63.17 0.25 1.81 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.459 2.772 . . . . 0.0 113.014 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.3 -33.61 35.05 Favored Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 20.3 p -119.6 -28.43 5.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.816 0.341 . . . . 0.0 110.719 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.0 t30 80.63 29.51 0.21 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.032 2.133 . . . . 0.0 109.04 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -113.05 141.4 25.55 Favored Pre-proline 0 C--O 1.243 0.732 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.038 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -74.43 155.84 45.67 Favored 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 123.324 2.682 . . . . 0.0 112.691 174.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.441 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 19.5 t70 -77.35 145.72 37.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.81 176.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -133.89 5.66 3.63 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.972 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 118.73 40.66 0.65 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.723 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 37.8 m -105.07 166.08 12.07 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -69.35 123.07 9.86 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.636 1.557 . . . . 0.0 109.778 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 53.2 mtp -120.42 161.06 21.86 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.608 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.9 tt -138.26 148.15 25.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -121.14 149.16 17.4 Favored Glycine 0 C--O 1.252 1.224 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.502 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 52.2 t -64.69 160.76 19.22 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.64 1.176 . . . . 0.0 110.995 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.78 -12.34 53.89 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -106.71 -39.41 5.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.586 ' HB2' ' OD1' ' A' ' 890' ' ' ASP . 22.9 m -85.85 -160.87 0.57 Allowed 'General case' 0 CA--C 1.569 1.691 0 CA-C-O 121.849 0.833 . . . . 0.0 113.159 -174.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -133.55 29.63 3.88 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . 0.586 ' OD1' ' HB2' ' A' ' 888' ' ' CYS . 11.7 p-10 -89.28 176.97 6.73 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 112.068 -2.333 . . . . 0.0 112.399 -170.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -152.72 116.94 4.91 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.43 -1.714 . . . . 0.0 106.859 170.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . 0.445 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 26.6 m-85 -107.46 158.67 17.0 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.711 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 42.2 m80 -86.81 144.5 27.01 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.615 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 29.2 m0 -51.9 -54.11 44.09 Favored Pre-proline 0 CA--C 1.552 1.022 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.58 -23.33 64.51 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.158 1.905 . . . . 0.0 113.202 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.711 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 53.5 m -79.73 -21.89 43.96 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.252 0.549 . . . . 0.0 111.531 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 12.6 m -116.46 9.92 7.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.43 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 70.8 38.23 66.08 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 114.928 -1.033 . . . . 0.0 113.199 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.615 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 51.0 mt -111.07 127.05 68.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 120.993 0.425 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 92.7 mmm -123.54 -6.48 8.11 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.133 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -145.16 138.12 26.34 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -59.95 112.69 5.76 Favored Pre-proline 0 C--N 1.317 -0.822 0 O-C-N 124.442 1.089 . . . . 0.0 110.992 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo . . . . . 0 C--O 1.25 1.108 0 C-N-CA 122.679 2.253 . . . . 0.0 111.184 179.252 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 . . . . . 0 N--CA 1.437 -1.124 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -126.99 134.52 50.34 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -124.45 140.17 53.2 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.307 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 892' ' ' TYR . 25.4 p -64.16 163.87 21.7 Favored Pre-proline 0 N--CA 1.424 -1.755 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.682 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.43 -10.54 6.83 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 122.806 2.337 . . . . 0.0 112.434 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 913' ' ' LYS . 74.4 mmtt -87.81 -57.95 2.75 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.431 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 75.1 m -69.25 -25.99 64.56 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.32 68.64 Favored 'General case' 0 C--O 1.198 -1.633 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.5 -5.01 58.46 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -87.77 -44.14 11.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 67.0 mt . . . . . 0 C--O 1.242 0.692 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.777 178.366 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 C--O 1.225 -0.2 0 CA-C-O 121.395 0.616 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.83 109.18 18.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 56.4 mt -102.84 148.58 7.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -96.88 122.87 40.32 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.421 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.21 165.52 11.31 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.75 -29.58 70.22 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -94.46 3.67 54.85 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.3 1.048 . . . . 0.0 109.776 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.06 22.22 46.27 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.486 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -76.71 147.73 37.22 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -80.09 113.6 18.38 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.174 0.512 . . . . 0.0 111.765 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 45.8 mm -97.92 118.67 44.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 175.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -99.98 147.0 26.06 Favored 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.334 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.463 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 37.4 mt -113.49 132.49 62.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.898 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 53.8 t -86.81 107.15 12.85 Favored Pre-proline 0 N--CA 1.405 -2.686 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 24.6 Cg_exo -65.01 1.35 1.94 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.14 2.56 . . . . 0.0 113.852 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -77.44 -50.4 6.68 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 4.4 p -102.24 -19.26 15.13 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 123.093 0.557 . . . . 0.0 110.288 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 77.56 19.39 1.21 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.557 1.543 . . . . 0.0 109.857 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -103.07 140.61 21.21 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.153 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 48.1 Cg_endo -74.85 173.02 15.16 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 123.269 2.646 . . . . 0.0 112.067 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.38 129.18 40.64 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.516 0.674 . . . . 0.0 111.101 174.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -118.06 34.36 5.21 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 73.54 44.1 34.36 Favored Glycine 0 CA--C 1.493 -1.287 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -173.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.5 p -120.23 151.04 52.71 Favored Pre-proline 0 N--CA 1.412 -2.338 0 CA-C-N 113.871 -1.164 . . . . 0.0 111.526 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.75 120.18 6.28 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 121.88 1.72 . . . . 0.0 109.995 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 76.3 mtp -115.94 150.28 37.4 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.839 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.6 tt -123.27 140.0 48.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -107.08 144.63 15.91 Favored Glycine 0 C--O 1.247 0.937 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.284 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.44 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 44.5 t -70.05 147.73 49.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.351 0.596 . . . . 0.0 112.08 -178.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -81.9 -24.22 35.81 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.249 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.2 -51.79 9.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 120.989 0.424 . . . . 0.0 110.002 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 10.5 p -107.7 -92.86 0.41 Allowed 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.1 t70 179.62 -30.78 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.325 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -50.72 134.33 24.97 Favored 'General case' 0 C--O 1.247 0.947 0 O-C-N 124.703 1.252 . . . . 0.0 112.384 -172.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -101.9 133.16 47.11 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.333 -172.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -117.84 155.55 29.91 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.411 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.3 m80 -77.21 143.57 38.91 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.487 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 27.7 m0 -49.8 -53.78 38.7 Favored Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.14 -19.02 65.1 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.228 1.952 . . . . 0.0 113.795 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 79.3 m -84.11 -23.7 30.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.003 0.43 . . . . 0.0 111.925 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 893' ' ' HIS . 12.5 m -114.98 5.98 7.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.934 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 75.64 44.8 19.6 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.837 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.487 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 7.7 mm -110.32 109.7 29.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 mmt -109.61 -2.29 17.61 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.182 0.515 . . . . 0.0 110.43 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -154.32 143.62 21.32 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -58.1 116.76 15.75 Favored Pre-proline 0 N--CA 1.438 -1.058 0 O-C-N 124.225 0.953 . . . . 0.0 110.673 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.45 -1.085 0 C-N-CA 122.262 1.975 . . . . 0.0 110.632 176.01 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -123.84 129.46 51.05 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.907 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.44 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 55.3 m-85 -120.13 142.44 48.92 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 25.7 p -63.9 160.21 48.23 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -51.53 -23.56 14.9 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.883 2.388 . . . . 0.0 112.529 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.567 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 33.3 mmtp -68.36 -55.19 12.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.37 0.668 . . . . 0.0 109.578 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.508 ' SG ' ' HE2' ' A' ' 917' ' ' LYS . 78.7 m -77.57 -22.09 51.5 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.493 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -63.56 -35.66 81.24 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.443 1.116 . . . . 0.0 108.585 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -76.72 -17.5 59.05 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.165 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.508 ' HE2' ' SG ' ' A' ' 914' ' ' CYS . 43.7 mtmt -85.76 -16.39 39.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 49.9 mm . . . . . 0 C--O 1.22 -0.467 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.052 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.965 0.888 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.05 110.61 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.864 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 58.8 mt -117.15 160.88 16.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -115.18 136.89 52.63 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.754 0.706 . . . . 0.0 110.544 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.17 176.73 7.04 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 124.831 1.252 . . . . 0.0 109.065 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.58 -26.81 62.76 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.248 0.619 . . . . 0.0 110.209 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.61 -3.34 50.04 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.317 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.69 -2.95 86.29 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 116.161 -0.472 . . . . 0.0 113.056 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -71.24 153.22 42.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 123.611 0.242 . . . . 0.0 111.019 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -71.26 146.72 48.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.557 0.694 . . . . 0.0 111.75 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 31.3 mm -120.79 126.88 75.75 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' A' ' 876' ' ' PRO . 26.1 m-90 -100.47 153.89 18.98 Favored 'General case' 0 C--N 1.285 -2.199 0 O-C-N 123.643 0.589 . . . . 0.0 111.235 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 39.8 mt -118.15 117.48 54.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.745 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 38.4 t -73.81 111.65 13.15 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.28 7.97 2.74 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.984 1.79 . . . . 0.0 112.5 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.65 -27.11 43.75 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 8.4 p -121.52 -32.95 3.73 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.727 0.775 . . . . 0.0 109.411 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 80.45 39.78 0.08 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 126.745 2.018 . . . . 0.0 109.944 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -118.33 143.69 33.6 Favored Pre-proline 0 N--CA 1.446 -0.674 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.305 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 868' ' ' TRP . 50.7 Cg_endo -74.59 173.98 13.41 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 123.398 2.732 . . . . 0.0 113.018 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.42 138.93 2.21 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.071 0.949 . . . . 0.0 111.889 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -118.04 -22.97 7.6 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.144 0.974 . . . . 0.0 109.356 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 116.01 -10.49 17.97 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -171.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 11.9 p -65.05 153.0 90.04 Favored Pre-proline 0 N--CA 1.433 -1.301 0 C-N-CA 125.569 1.548 . . . . 0.0 111.193 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.54 137.37 46.17 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 122.278 1.985 . . . . 0.0 109.834 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 83.8 mtp -125.5 149.61 48.13 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.2 tt -118.84 150.75 21.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -113.76 144.92 18.33 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.418 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 49.2 t -76.72 154.69 33.88 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.58 -9.97 36.31 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.155 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.96 -64.13 1.2 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 1.6 p -94.57 -49.27 5.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.101 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 14.1 t70 80.01 79.54 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.471 1.508 . . . . 0.0 113.489 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -129.74 177.77 6.99 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -99.63 123.56 44.01 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 119.339 0.972 . . . . 0.0 112.819 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -116.82 148.69 41.0 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.748 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 49.1 m80 -76.85 144.08 39.27 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.219 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -52.77 -57.8 14.55 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.03 -11.21 30.08 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.77 1.647 . . . . 0.0 113.672 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.748 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -84.11 -37.05 22.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.285 0.564 . . . . 0.0 111.855 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.504 HG21 HG12 ' A' ' 899' ' ' ILE . 27.0 m -102.03 -8.63 9.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.772 -176.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 95.96 56.31 1.23 Allowed Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.592 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.504 HG12 HG21 ' A' ' 897' ' ' VAL . 9.0 mm -130.47 125.8 59.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 87.6 mtp -127.02 8.12 6.69 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.738 0.78 . . . . 0.0 110.411 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . 0.731 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -173.95 145.81 1.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -66.18 103.02 0.4 Allowed Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.7 1.2 . . . . 0.0 112.877 -174.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . 0.731 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 25.5 Cg_endo . . . . . 0 N--CA 1.448 -1.165 0 C-N-CA 124.019 3.146 . . . . 0.0 115.998 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 . . . . . 0 C--O 1.24 0.605 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -108.85 137.5 46.68 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.464 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -126.02 138.25 53.71 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 27.4 p -69.33 163.44 58.19 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.037 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.06 -23.47 22.03 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 123.847 3.031 . . . . 0.0 112.492 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.486 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 29.9 mmmt -69.04 -44.02 73.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 73.6 m -89.01 -27.42 20.88 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.004 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.6 -24.91 61.98 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 120.777 0.322 . . . . 0.0 110.379 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.31 -13.84 59.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.606 0.717 . . . . 0.0 109.792 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -73.39 -29.58 62.7 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 54.4 mt . . . . . 0 N--CA 1.443 -0.794 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.382 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . 0.442 ' CE1' ' HA ' ' A' ' 871' ' ' PRO . 54.9 m-85 . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 121.576 0.703 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.35 121.08 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.749 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 59.0 mt -124.83 154.22 32.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -91.82 125.52 36.56 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.925 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -71.01 171.58 10.6 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.293 -1.322 . . . . 0.0 109.043 172.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.39 -29.15 69.25 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 122.602 0.361 . . . . 0.0 111.884 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . 0.49 ' HB3' ' ND2' ' A' ' 865' ' ' ASN . 44.2 t-105 -87.92 -11.93 46.18 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 97.95 15.05 37.64 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.812 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.49 ' ND2' ' HB3' ' A' ' 863' ' ' TRP . 45.9 m-80 -71.36 151.85 43.73 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -78.05 116.21 18.36 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 25.2 mm -64.15 114.59 2.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 122.172 0.987 . . . . 0.0 111.518 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.66 105.64 0.32 Allowed 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 111.478 -2.601 . . . . 0.0 110.988 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.501 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 40.4 mt -127.07 131.04 71.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 891' ' ' TRP . 52.6 t -85.81 110.23 28.57 Favored Pre-proline 0 N--CA 1.418 -2.055 0 O-C-N 124.164 0.915 . . . . 0.0 108.849 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 50.6 Cg_exo -57.0 -20.34 36.54 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.394 2.729 . . . . 0.0 113.028 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -68.97 -36.04 80.43 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.539 -0.362 . . . . 0.0 112.962 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 12.3 p -118.51 -13.54 9.71 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.806 0.303 . . . . 0.0 111.289 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 72.36 24.18 3.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.25 1.42 . . . . 0.0 109.692 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -113.6 138.41 22.58 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 121.771 -0.58 . . . . 0.0 112.071 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 57.1 Cg_endo -73.22 174.03 12.74 Favored 'Trans proline' 0 C--O 1.253 1.228 0 C-N-CA 124.154 3.236 . . . . 0.0 113.328 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.09 137.09 57.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.676 176.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -122.57 25.21 8.9 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.597 1.189 . . . . 0.0 107.856 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 81.52 52.47 4.18 Favored Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 106.438 -2.665 . . . . 0.0 106.438 -171.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 3.7 p -124.0 152.57 66.94 Favored Pre-proline 0 N--CA 1.413 -2.278 0 CA-C-N 113.861 -1.17 . . . . 0.0 112.239 -170.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -72.23 112.58 3.47 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.032 1.822 . . . . 0.0 110.048 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 79.3 mtp -122.15 144.16 49.12 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.762 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 15.9 tt -117.19 152.18 19.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.779 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -110.17 156.38 15.61 Favored Glycine 0 CA--C 1.538 1.518 0 O-C-N 123.206 0.316 . . . . 0.0 113.441 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.473 ' H ' ' CG ' ' A' ' 890' ' ' ASP . 43.8 t -84.92 -170.26 3.04 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 126.31 1.844 . . . . 0.0 109.157 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -123.08 -11.54 8.04 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -107.91 -54.63 2.47 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -173.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 15.7 p -99.57 -134.79 0.28 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -165.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -128.74 89.48 2.89 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 885' ' ' CYS . 2.6 p30 -128.06 148.69 50.56 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -158.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . 0.497 ' O ' ' HA ' ' A' ' 870' ' ' CYS . 68.2 m95 -161.52 117.66 2.13 Favored 'General case' 0 C--O 1.208 -1.129 0 C-N-CA 128.058 2.543 . . . . 0.0 106.929 160.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -124.54 148.73 47.59 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.462 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.674 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 57.9 m80 -80.8 144.86 31.77 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -53.53 -52.68 64.66 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.2 -11.59 32.79 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.998 1.799 . . . . 0.0 113.122 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.674 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 87.6 m -84.66 -32.14 23.79 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.648 0.737 . . . . 0.0 110.928 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 893' ' ' HIS . 20.9 m -101.52 -27.46 3.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.934 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 104.22 52.99 0.85 Allowed Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.052 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.79 136.64 58.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.026 0.441 . . . . 0.0 110.854 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.8 ptp -128.37 -1.11 5.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.849 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -150.4 141.72 23.27 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -71.91 112.34 13.96 Favored Pre-proline 0 C--N 1.311 -1.089 0 C-N-CA 123.039 0.536 . . . . 0.0 111.912 -176.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 41.0 Cg_endo . . . . . 0 N--CA 1.446 -1.293 0 C-N-CA 122.506 2.137 . . . . 0.0 111.029 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 . . . . . 0 N--CA 1.426 -1.675 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -118.5 140.37 49.97 Favored 'General case' 0 C--N 1.26 -3.287 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -129.53 136.41 49.81 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 9.0 p -73.85 167.25 37.02 Favored Pre-proline 0 N--CA 1.415 -2.207 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.183 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.05 -19.7 21.05 Favored 'Trans proline' 0 CA--C 1.551 1.331 0 C-N-CA 122.976 2.451 . . . . 0.0 112.41 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -81.16 -37.02 29.45 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 110.285 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 97.3 m -89.1 -30.02 18.95 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.808 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.13 68.17 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.05 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -73.05 -19.43 61.18 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.281 0.562 . . . . 0.0 111.562 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -101.05 -27.68 13.14 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.201 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 C--N 1.309 -1.186 0 CA-C-O 121.249 0.547 . . . . 0.0 109.53 174.522 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 122.179 0.99 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 8.1 p -143.42 130.36 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.684 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . 0.428 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 44.2 mt -124.39 150.75 29.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -94.75 125.06 39.16 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.622 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.02 172.37 11.13 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.157 174.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.93 -30.39 71.48 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 123.644 0.778 . . . . 0.0 111.188 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -85.53 -0.67 55.67 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.435 0.636 . . . . 0.0 110.465 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 84.01 3.76 88.91 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.213 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -73.01 149.65 43.08 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -78.96 128.17 32.93 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.532 0.682 . . . . 0.0 111.371 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 858' ' ' VAL . 32.4 mm -96.02 121.61 46.73 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 23.4 m-90 -99.76 139.35 35.55 Favored 'General case' 0 C--N 1.264 -3.121 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.597 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 31.6 mt -103.97 119.16 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.404 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.501 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 50.7 t -61.89 108.83 1.76 Allowed Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 125.143 1.377 . . . . 0.0 108.222 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 52.6 Cg_exo -57.7 -16.99 27.05 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.735 2.957 . . . . 0.0 113.22 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -70.88 -46.43 45.35 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.246 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 17.0 p -106.75 -28.01 10.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 63.4 t30 81.25 27.84 0.19 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.714 1.606 . . . . 0.0 109.221 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.53 139.33 20.0 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.182 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -76.17 162.73 33.77 Favored 'Trans proline' 0 C--O 1.251 1.173 0 C-N-CA 123.08 2.52 . . . . 0.0 112.583 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.413 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 17.5 t70 -65.96 141.38 58.22 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.46 14.59 8.23 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 122.781 1.277 . . . . 0.0 107.965 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 85.29 52.66 3.33 Favored Glycine 0 N--CA 1.423 -2.186 0 N-CA-C 105.828 -2.909 . . . . 0.0 105.828 -170.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 11.4 p -119.69 153.54 54.44 Favored Pre-proline 0 N--CA 1.418 -2.034 0 CA-C-N 113.927 -1.137 . . . . 0.0 111.091 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.97 118.67 5.69 Favored 'Trans proline' 0 C--O 1.257 1.429 0 C-N-CA 122.24 1.96 . . . . 0.0 109.951 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.413 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 77.0 mtp -125.32 142.32 51.57 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.074 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.3 tt -110.73 144.88 17.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -110.99 163.52 12.25 Favored Glycine 0 C--N 1.301 -1.395 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.078 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.436 ' H ' ' CG ' ' A' ' 890' ' ' ASP . 51.2 t -88.99 -164.33 1.12 Allowed 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 126.027 1.731 . . . . 0.0 108.551 -177.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -131.34 -8.96 3.74 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.637 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -109.0 -46.93 3.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.4 p -104.29 -126.73 0.23 Allowed 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -166.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -136.02 88.54 2.4 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 885' ' ' CYS . 3.1 p30 -127.74 146.89 50.43 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 113.085 -1.87 . . . . 0.0 115.238 -161.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -162.39 117.62 1.88 Allowed 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 128.046 2.538 . . . . 0.0 106.349 158.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . 0.42 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 44.8 m-85 -123.25 148.97 45.32 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.752 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.8 m80 -77.91 145.85 35.91 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.505 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 31.6 m0 -51.95 -55.63 28.87 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 175.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.28 -12.68 34.04 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.426 2.084 . . . . 0.0 113.99 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.752 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.3 m -86.49 -21.88 26.74 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.027 0.442 . . . . 0.0 111.069 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.471 HG22 HG12 ' A' ' 899' ' ' ILE . 14.4 m -120.52 5.79 6.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.144 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 84.15 23.4 51.95 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.712 175.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.505 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 16.9 mm -91.04 121.6 41.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 18.3 ptm -118.29 -6.14 10.83 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.281 0.562 . . . . 0.0 110.568 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.1 149.81 21.57 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -60.32 112.95 6.28 Favored Pre-proline 0 C--N 1.314 -0.977 0 O-C-N 124.172 0.92 . . . . 0.0 111.004 -177.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 C--O 1.248 0.993 0 C-N-CA 123.155 2.57 . . . . 0.0 111.111 179.828 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 . . . . . 0 N--CA 1.432 -1.352 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -136.4 135.71 38.98 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -126.52 139.18 53.42 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 16.9 p -64.7 167.15 9.64 Favored Pre-proline 0 C--N 1.29 -2.003 0 O-C-N 124.2 0.937 . . . . 0.0 111.892 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -56.17 -13.4 9.52 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 123.074 2.516 . . . . 0.0 112.128 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 31.6 mmmt -84.34 -60.57 2.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 92.5 m -73.04 -27.41 61.74 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.78 78.22 Favored 'General case' 0 C--O 1.201 -1.481 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -72.42 -22.81 61.05 Favored 'General case' 0 C--O 1.211 -0.924 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -72.06 -46.44 56.9 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 70.2 mt . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.465 -180.0 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . 0.43 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 97.0 m-85 . . . . . 0 C--O 1.24 0.571 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 14.0 p -143.62 118.89 4.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.635 0.731 . . . . 0.0 112.231 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 47.5 mt -114.84 160.87 13.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -103.78 130.65 51.34 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.233 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.83 175.29 2.5 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 125.623 1.569 . . . . 0.0 111.123 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -58.32 -40.17 81.37 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 124.937 1.295 . . . . 0.0 111.107 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . 0.47 ' HB3' ' ND2' ' A' ' 865' ' ' ASN . 66.9 t-105 -80.12 -25.92 39.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.369 0.604 . . . . 0.0 110.037 177.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 117.6 7.21 12.25 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.47 ' ND2' ' HB3' ' A' ' 863' ' ' TRP . 46.0 m-80 -64.25 159.9 19.8 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -85.24 117.4 24.16 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.332 0.587 . . . . 0.0 109.954 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 42.4 mm -90.76 114.02 27.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -86.13 128.07 34.82 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.847 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 33.3 mt -100.9 123.7 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.15 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 41.1 t -77.71 117.2 64.15 Favored Pre-proline 0 N--CA 1.408 -2.533 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.152 -176.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . 0.536 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 58.6 Cg_exo -56.5 -17.82 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.656 2.904 . . . . 0.0 113.32 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.75 -21.42 76.79 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 121.314 -0.469 . . . . 0.0 113.295 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 10.8 p -138.21 -10.6 1.48 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.301 0.551 . . . . 0.0 112.231 -177.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.257 2.3 p-10 61.15 25.44 15.44 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.299 1.84 . . . . 0.0 111.129 -173.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -106.33 140.21 21.07 Favored Pre-proline 0 N--CA 1.435 -1.222 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.3 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.73 173.65 14.15 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 123.347 2.698 . . . . 0.0 112.336 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.96 138.7 42.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.616 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -119.58 -6.1 10.22 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.895 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 89.66 21.12 41.34 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -172.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.6 t -100.89 161.32 24.13 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.36 113.62 1.76 Allowed 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.732 2.288 . . . . 0.0 111.649 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 85.6 mtp -109.92 156.83 19.92 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.02 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.6 tt -126.6 142.73 42.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.92 152.39 19.66 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.579 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 48.8 t -85.15 169.89 13.43 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.649 0.738 . . . . 0.0 110.325 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.65 -32.96 16.01 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . 0.478 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 14.4 t70 -100.88 -38.31 8.29 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.529 -174.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 60.5 m -89.42 158.49 17.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.148 0.499 . . . . 0.0 110.255 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.64 -0.28 43.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -86.84 159.34 19.11 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.461 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -117.0 142.4 47.0 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.156 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . 0.536 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 64.4 m-85 -114.69 171.33 7.7 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.757 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 65.2 m80 -99.12 151.93 20.43 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -54.35 -53.29 61.04 Favored Pre-proline 0 CA--C 1.553 1.094 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.65 -29.75 90.55 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.75 1.633 . . . . 0.0 113.011 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.757 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 28.5 m -70.41 -21.68 62.81 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.859 0.837 . . . . 0.0 111.901 -175.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.25 10.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.198 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 71.79 46.61 37.15 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.243 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.14 136.37 58.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 62.3 mtt -128.19 -4.92 5.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.52 156.43 30.23 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . 0.439 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -44.0 114.24 1.79 Allowed Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 125.206 1.566 . . . . 0.0 112.149 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 11.4 Cg_endo . . . . . 0 CA--C 1.57 2.302 0 C-N-CA 123.913 3.075 . . . . 0.0 113.066 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 . . . . . 0 C--O 1.248 1.012 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -116.95 133.43 56.02 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.985 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -127.47 141.98 51.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 7.6 p -75.43 168.63 25.88 Favored Pre-proline 0 N--CA 1.421 -1.922 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.972 178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.72 -24.15 29.11 Favored 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 123.075 2.517 . . . . 0.0 111.803 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 0.0 OUTLIER -70.1 -58.5 3.74 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.98 176.767 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 87.2 m -72.91 -21.48 60.9 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.29 -20.2 65.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.51 -34.84 27.81 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.417 ' NZ ' ' SG ' ' A' ' 914' ' ' CYS . 22.5 mtmm -67.5 -43.18 81.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.508 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 72.0 mt . . . . . 0 C--O 1.241 0.647 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.49 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 . . . . . 0 N--CA 1.443 -0.788 0 CA-C-O 122.394 1.092 . . . . 0.0 108.269 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 42.5 t -130.79 101.08 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 112.672 -2.058 . . . . 0.0 105.483 172.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 40.0 mt -103.58 154.24 5.77 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -102.22 125.14 48.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.514 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . 0.431 ' HB3' ' H ' ' A' ' 865' ' ' ASN . 17.6 t70 -67.19 177.24 1.87 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.663 176.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -72.99 -25.11 60.87 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.357 0.599 . . . . 0.0 110.298 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -87.69 -12.64 44.77 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.157 0.98 . . . . 0.0 108.7 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 93.57 19.53 34.69 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.933 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.431 ' H ' ' HB3' ' A' ' 861' ' ' ASP . 63.8 m-20 -72.78 150.95 42.34 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -77.93 110.42 12.82 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 121.61 0.719 . . . . 0.0 110.696 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 46.3 mm -94.82 115.39 33.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -103.6 145.55 29.88 Favored 'General case' 0 C--N 1.255 -3.529 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.217 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.87 120.49 52.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.406 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.7 t -78.59 119.66 78.12 Favored Pre-proline 0 N--CA 1.404 -2.737 0 C-N-CA 125.0 1.32 . . . . 0.0 108.316 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.4 -4.58 13.17 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.63 2.22 . . . . 0.0 111.629 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -72.02 -43.5 48.64 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 5.7 p -114.49 -24.32 8.89 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.7 t30 78.75 24.66 0.55 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.824 1.65 . . . . 0.0 108.235 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -110.25 139.63 21.63 Favored Pre-proline 0 C--O 1.244 0.783 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.983 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.81 165.52 32.53 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.182 2.588 . . . . 0.0 112.361 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.437 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 16.6 t0 -60.49 117.33 5.15 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.634 0.731 . . . . 0.0 112.375 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.81 6.42 46.87 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.661 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 105.66 40.08 2.09 Favored Glycine 0 N--CA 1.435 -1.413 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 49.1 m -123.82 159.23 56.96 Favored Pre-proline 0 N--CA 1.428 -1.549 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.14 133.62 25.3 Favored 'Trans proline' 0 C--O 1.252 1.204 0 C-N-CA 122.405 2.07 . . . . 0.0 110.896 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.407 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 64.6 mtp -123.11 163.11 21.17 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.872 -178.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . 0.452 ' HB ' ' HE1' ' A' ' 894' ' ' TRP . 17.6 tt -141.28 143.23 28.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.95 151.96 17.29 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.629 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 53.8 t -76.09 150.97 37.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.094 0.473 . . . . 0.0 110.481 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -82.55 -25.56 33.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.748 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -97.33 -40.33 8.78 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.309 -0.556 . . . . 0.0 112.343 -173.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 32.0 p -98.49 -106.13 0.2 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 117.879 -1.528 . . . . 0.0 114.11 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -158.79 -41.79 0.06 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.985 -170.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.77 161.12 30.42 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -170.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -112.26 133.76 54.19 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.345 -1.752 . . . . 0.0 108.384 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -117.22 159.17 23.08 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.579 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 56.2 m80 -82.93 144.74 29.81 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.145 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.452 ' HE1' ' HB ' ' A' ' 883' ' ' ILE . 38.2 m0 -53.52 -48.95 91.17 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 177.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 28.4 Cg_endo -63.71 -13.97 40.02 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.275 1.983 . . . . 0.0 113.088 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -89.37 -26.67 20.93 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.241 0.543 . . . . 0.0 111.803 -176.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 893' ' ' HIS . 18.8 m -110.11 -4.93 10.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.443 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 83.67 48.17 5.35 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.723 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 46.1 mt -112.89 121.87 65.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.605 0.717 . . . . 0.0 111.517 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 96.2 mmm -92.7 -31.19 15.19 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.345 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.74 159.67 35.49 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -48.26 109.58 1.19 Allowed Pre-proline 0 C--N 1.323 -0.554 0 O-C-N 124.73 1.268 . . . . 0.0 111.659 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo . . . . . 0 C--O 1.244 0.784 0 C-N-CA 123.236 2.624 . . . . 0.0 112.406 -177.978 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 . . . . . 0 N--CA 1.427 -1.607 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -104.5 124.81 49.93 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.121 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -124.9 142.61 51.34 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 28.6 p -66.95 166.2 21.17 Favored Pre-proline 0 C--N 1.294 -1.817 0 O-C-N 123.609 0.568 . . . . 0.0 111.5 -176.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -49.54 -27.28 14.03 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.431 2.754 . . . . 0.0 112.509 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -82.04 -47.93 12.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.341 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 917' ' ' LYS . 92.5 m -78.38 -32.61 48.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.1 -32.03 73.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.51 -35.78 76.79 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.186 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.431 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 27.3 mtmt -70.77 -18.18 62.77 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.102 0.561 . . . . 0.0 110.656 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 51.0 mt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 121.758 0.79 . . . . 0.0 109.771 -178.054 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 64.4 t -138.73 121.09 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 113.316 -1.765 . . . . 0.0 108.267 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 55.7 mt -127.48 148.92 32.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 41.3 mtt180 -95.02 125.06 39.42 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 121.734 0.778 . . . . 0.0 110.891 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.93 171.73 3.32 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.629 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -60.86 -36.38 79.02 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 124.024 0.929 . . . . 0.0 110.6 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . 0.505 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 92.8 m95 -87.0 -10.15 53.84 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.376 0.608 . . . . 0.0 111.05 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 100.34 8.44 49.89 Favored Glycine 0 CA--C 1.5 -0.883 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.357 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.505 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 37.1 m-80 -71.79 160.94 31.72 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . 0.448 ' OE1' ' HA ' ' A' ' 866' ' ' GLN . 14.4 mm-40 -90.81 133.35 35.27 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 122.124 0.964 . . . . 0.0 112.159 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 858' ' ' VAL . 45.8 mm -110.63 121.81 64.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 113.532 -1.667 . . . . 0.0 108.114 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -101.35 140.12 36.08 Favored 'General case' 0 C--N 1.271 -2.808 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.565 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.501 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 36.4 mt -106.08 124.31 61.27 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.461 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 42.2 t -78.2 113.91 37.79 Favored Pre-proline 0 N--CA 1.404 -2.762 0 O-C-N 124.442 1.089 . . . . 0.0 108.743 -178.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . 0.539 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 37.6 Cg_exo -61.19 -2.47 2.38 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.282 2.655 . . . . 0.0 113.309 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.06 -39.69 19.02 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 7.5 p -114.98 -25.81 8.0 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.349 0.66 . . . . 0.0 111.554 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 76.48 26.52 0.88 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.886 1.675 . . . . 0.0 110.085 -173.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -108.03 138.82 20.21 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.466 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 44.5 Cg_endo -72.83 170.71 19.0 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.369 2.713 . . . . 0.0 113.749 176.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -64.31 133.28 52.39 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.097 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -123.44 6.73 8.97 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.903 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 93.65 22.86 25.15 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 2.7 p -96.31 155.85 37.58 Favored Pre-proline 0 C--N 1.296 -1.722 0 C-N-CA 123.35 0.66 . . . . 0.0 110.408 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.43 118.09 4.93 Favored 'Trans proline' 0 C--O 1.257 1.456 0 C-N-CA 122.069 1.846 . . . . 0.0 111.568 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.6 mtp -113.4 162.92 15.51 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.569 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.5 tt -130.64 145.29 35.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -108.95 151.02 17.14 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 42.6 t -80.74 178.85 8.1 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.513 0.673 . . . . 0.0 110.929 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . 0.42 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 28.9 t70 -110.48 -18.44 13.21 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.941 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . 0.418 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 16.4 t70 -95.93 -46.96 6.32 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 25.4 p -101.87 -179.07 3.9 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -117.81 17.64 14.23 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.349 1.071 . . . . 0.0 109.45 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -102.62 163.35 12.27 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.184 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -112.19 141.83 45.41 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.875 0.369 . . . . 0.0 111.854 -174.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . 0.539 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 10.9 m-85 -120.94 169.39 10.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.698 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 56.6 m80 -96.02 150.39 20.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 118.692 0.678 . . . . 0.0 111.341 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -56.1 -53.89 58.54 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.46 -19.22 67.47 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.165 1.91 . . . . 0.0 113.799 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 45.3 m -80.84 -31.21 35.57 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.34 0.59 . . . . 0.0 111.742 -176.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.474 HG22 HG12 ' A' ' 899' ' ' ILE . 24.0 m -108.86 -22.66 4.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.824 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 104.31 55.08 0.77 Allowed Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.168 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.474 HG12 HG22 ' A' ' 897' ' ' VAL . 30.5 mm -113.06 117.78 56.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 86.9 mtp -87.72 -40.34 14.2 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -144.49 154.63 43.11 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -54.51 110.09 1.94 Allowed Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 124.799 1.312 . . . . 0.0 112.431 -176.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 25.3 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.516 2.144 . . . . 0.0 111.067 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 . . . . . 0 N--CA 1.425 -1.678 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -125.84 138.9 53.84 Favored 'General case' 0 C--N 1.248 -3.811 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.42 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 84.2 m-85 -125.55 137.36 53.93 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 18.7 p -77.26 166.6 43.14 Favored Pre-proline 0 C--N 1.28 -2.421 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.344 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -49.02 -30.99 19.38 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.228 2.619 . . . . 0.0 112.465 176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.556 ' HA ' ' HE2' ' A' ' 913' ' ' LYS . 7.8 mmpt? -81.02 -42.95 20.3 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 92.4 m -78.4 -20.18 51.69 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.084 177.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -70.22 -23.24 62.9 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -79.48 -10.89 59.89 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.964 0.411 . . . . 0.0 110.539 175.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -87.31 -57.73 2.85 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 C--O 1.239 0.546 0 CA-C-N 114.673 -1.148 . . . . 0.0 111.045 -177.052 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . 0.427 ' HA ' HD12 ' A' ' 869' ' ' ILE . 4.4 m-85 . . . . . 0 CA--C 1.494 -1.201 0 CA-C-O 123.124 1.44 . . . . 0.0 108.125 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.2 108.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.397 -3.108 0 CA-C-N 111.493 -2.594 . . . . 0.0 106.638 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . 0.463 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 30.9 mt -117.73 154.41 19.63 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.724 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -100.76 137.25 39.4 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.399 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 862' ' ' GLU . 32.1 t70 -78.07 179.31 6.9 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.75 176.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . 0.407 ' H ' ' CG ' ' A' ' 861' ' ' ASP . 10.2 pt-20 -71.29 -29.89 65.59 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.946 0.403 . . . . 0.0 110.266 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -80.04 -10.9 59.8 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.821 0.819 . . . . 0.0 109.546 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.82 18.34 40.99 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -78.72 155.15 29.53 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -85.07 118.72 24.81 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.992 0.901 . . . . 0.0 110.876 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.463 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 37.0 mm -91.14 114.4 28.4 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -100.34 147.21 26.05 Favored 'General case' 0 C--N 1.264 -3.114 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.771 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 857' ' ' TYR . 26.9 mt -102.19 109.24 25.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-O 121.223 0.535 . . . . 0.0 110.626 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 49.4 t -56.29 115.43 9.88 Favored Pre-proline 0 N--CA 1.438 -1.074 0 C-N-CA 126.217 1.807 . . . . 0.0 110.32 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -59.81 -13.4 22.19 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.633 2.889 . . . . 0.0 112.869 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.46 -38.06 34.16 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.212 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 9.1 p -120.99 -15.96 8.16 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 117.218 0.509 . . . . 0.0 112.25 -175.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 72.39 21.54 3.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.315 1.446 . . . . 0.0 108.707 -176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.408 ' HZ2' ' HB3' ' A' ' 875' ' ' LYS . 7.1 mtpm? -101.93 141.78 23.25 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.3 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -73.32 158.33 48.61 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.637 2.224 . . . . 0.0 110.931 173.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.59 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 10.3 t0 -48.74 123.33 6.73 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.469 0.652 . . . . 0.0 111.696 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -90.47 6.1 44.86 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.473 -175.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 91.81 36.73 6.31 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 108.281 -1.927 . . . . 0.0 108.281 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 22.8 m -122.37 161.58 42.52 Favored Pre-proline 0 N--CA 1.418 -2.029 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.37 133.34 32.22 Favored 'Trans proline' 0 C--O 1.254 1.285 0 C-N-CA 121.576 1.517 . . . . 0.0 110.306 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.59 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 75.8 mtp -112.05 154.52 25.26 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.52 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.1 tt -124.75 138.23 54.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.14 158.52 16.75 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.57 169.56 17.86 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.366 0.603 . . . . 0.0 110.315 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -91.42 -26.03 19.06 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -98.54 -49.33 4.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.277 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 17.6 p -99.7 179.2 4.61 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.595 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -110.2 11.61 23.58 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.809 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -81.99 151.97 26.91 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.951 0.405 . . . . 0.0 111.236 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -114.45 139.18 49.74 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.951 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -119.23 162.42 18.72 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.294 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.6 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 65.4 m80 -83.45 144.14 29.78 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.401 ' N ' ' HD2' ' A' ' 895' ' ' PRO . 26.3 m0 -51.24 -49.49 81.37 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 175.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 893' ' ' HIS . 28.5 Cg_endo -63.93 -23.6 68.03 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.659 2.24 . . . . 0.0 114.053 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 61.2 m -76.81 -25.7 53.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.56 0.695 . . . . 0.0 111.563 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.49 HG22 HG12 ' A' ' 899' ' ' ILE . 9.0 m -114.14 -2.59 10.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.712 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 73.19 45.08 32.65 Favored Glycine 0 CA--C 1.504 -0.606 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.202 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.49 HG12 HG22 ' A' ' 897' ' ' VAL . 45.4 mm -80.02 -67.9 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.391 1.091 . . . . 0.0 110.457 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.9 mtt 66.63 -14.94 0.15 Allowed 'General case' 0 C--N 1.264 -3.117 0 C-N-CA 128.398 2.679 . . . . 0.0 114.74 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.11 147.13 19.31 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -51.88 110.16 1.74 Allowed Pre-proline 0 C--O 1.239 0.517 0 O-C-N 124.491 1.119 . . . . 0.0 112.186 -175.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo . . . . . 0 N--CA 1.457 -0.676 0 C-N-CA 122.908 2.405 . . . . 0.0 112.104 -177.92 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 . . . . . 0 N--CA 1.425 -1.679 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 73.0 t90 -125.42 119.95 29.68 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.525 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.47 138.63 53.7 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 30.8 p -66.39 161.84 54.54 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 123.754 0.658 . . . . 0.0 111.55 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.45 -16.12 22.22 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.207 2.605 . . . . 0.0 112.916 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.463 ' CE ' ' HA ' ' A' ' 913' ' ' LYS . 3.9 mmpt? -84.26 -48.5 9.69 Favored 'General case' 0 N--CA 1.44 -0.963 0 O-C-N 122.145 -0.347 . . . . 0.0 110.177 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.462 ' O ' HG13 ' A' ' 918' ' ' ILE . 84.7 m -68.49 -39.96 81.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.05 176.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.09 71.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.203 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -64.11 -43.65 94.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.26 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -79.62 -33.3 41.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.522 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 914' ' ' CYS . 85.4 mt . . . . . 0 C--O 1.246 0.879 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 . . . . . 0 CA--C 1.507 -0.684 0 CA-C-O 121.436 0.636 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 57.5 t -125.08 129.11 73.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.718 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 58.0 mt -125.56 144.58 35.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -92.05 117.03 29.44 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.452 175.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -71.31 176.07 4.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.72 -22.88 59.76 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.437 0.637 . . . . 0.0 109.452 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -85.99 -0.43 55.47 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.168 0.985 . . . . 0.0 108.687 173.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 75.69 16.5 80.61 Favored Glycine 0 CA--C 1.5 -0.878 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.868 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -68.35 134.01 49.61 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -82.04 81.34 8.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.51 0.672 . . . . 0.0 109.274 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 858' ' ' VAL . 46.5 mm -53.14 135.88 14.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 113.198 -1.819 . . . . 0.0 112.287 -174.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -103.07 132.63 49.18 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 124.186 0.929 . . . . 0.0 109.877 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 40.8 mt -102.43 116.96 47.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.524 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.0 111.34 3.55 Favored Pre-proline 0 N--CA 1.443 -0.806 0 C-N-CA 125.255 1.422 . . . . 0.0 110.532 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -65.31 3.73 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.851 3.034 . . . . 0.0 113.613 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -86.16 -46.03 5.44 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 14.1 p -116.4 -22.03 8.97 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.528 0.68 . . . . 0.0 110.456 -176.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.274 2.8 m-20 70.75 56.0 0.24 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 125.765 1.626 . . . . 0.0 111.563 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.3 140.01 37.13 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.151 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -74.19 173.99 13.22 Favored 'Trans proline' 0 C--O 1.257 1.427 0 C-N-CA 123.359 2.706 . . . . 0.0 112.624 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.4 ' HA ' ' SD ' ' A' ' 882' ' ' MET . 3.4 m-20 -48.51 106.11 0.09 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.744 0.818 . . . . 0.0 108.929 172.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -102.57 -15.05 16.52 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.957 0.408 . . . . 0.0 110.868 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 127.09 -21.21 5.84 Favored Glycine 0 N--CA 1.437 -1.252 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 50.0 m -70.99 157.06 91.16 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.293 -0.454 . . . . 0.0 109.807 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -65.97 137.91 50.57 Favored 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.707 2.271 . . . . 0.0 111.468 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.4 ' SD ' ' HA ' ' A' ' 877' ' ' ASP . 91.7 mtp -128.71 148.31 50.82 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.481 -175.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.5 tt -129.49 148.06 33.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -111.69 146.89 17.97 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.812 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.43 ' HB3' ' SG ' ' A' ' 888' ' ' CYS . 52.8 t -70.37 155.78 40.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -86.98 -24.0 24.85 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.568 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -92.02 -45.42 8.33 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.882 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 885' ' ' CYS . 29.8 p -100.44 -178.27 3.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.485 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -112.62 14.89 20.16 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 122.712 1.244 . . . . 0.0 109.431 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.95 153.03 21.62 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.056 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 26.8 m95 -118.93 138.79 52.53 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.35 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -124.29 161.46 25.8 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.099 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.712 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 56.8 m80 -86.67 146.47 26.29 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -49.93 -53.5 42.24 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.65 -10.54 29.08 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 122.224 1.949 . . . . 0.0 113.792 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 62.4 m -87.07 -33.72 19.4 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.593 0.711 . . . . 0.0 111.023 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.5 HG23 HG12 ' A' ' 899' ' ' ILE . 19.2 m -104.75 -15.62 8.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.797 -176.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 96.0 47.36 2.46 Favored Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.855 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.5 HG12 HG23 ' A' ' 897' ' ' VAL . 48.3 mm -95.39 105.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.8 ptm -87.11 -19.5 28.44 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.234 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -170.5 151.35 3.64 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -45.56 111.53 1.39 Allowed Pre-proline 0 C--O 1.243 0.719 0 O-C-N 124.673 1.233 . . . . 0.0 110.754 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--O 1.244 0.822 0 C-N-CA 122.903 2.402 . . . . 0.0 112.196 -177.53 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 . . . . . 0 CA--C 1.5 -0.96 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -117.39 128.65 55.23 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.561 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -131.23 146.32 52.27 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 20.8 p -76.65 164.88 56.75 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.39 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.59 -24.11 21.62 Favored 'Trans proline' 0 CA--C 1.551 1.366 0 C-N-CA 123.355 2.703 . . . . 0.0 112.275 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -78.54 -53.8 6.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.498 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.51 ' O ' HG12 ' A' ' 918' ' ' ILE . 85.7 m -78.54 -26.72 45.78 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.72 69.93 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -74.57 -35.54 63.05 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.053 0.93 . . . . 0.0 110.066 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -71.71 -15.62 62.21 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.005 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 914' ' ' CYS . 44.6 mm . . . . . 0 C--N 1.325 -0.473 0 C-N-CA 123.512 0.725 . . . . 0.0 111.661 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.46 0.043 0 CA-C-O 121.655 0.741 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.76 121.71 66.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.333 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 51.2 mt -126.85 138.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 173.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -98.59 122.15 41.43 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.182 0.992 . . . . 0.0 112.435 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.89 173.19 1.91 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 113.185 -1.825 . . . . 0.0 109.69 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.57 -28.86 70.17 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.783 0.833 . . . . 0.0 110.884 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . 0.47 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 76.3 m95 -98.24 10.68 40.06 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.076 0.465 . . . . 0.0 111.317 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.46 1.69 83.31 Favored Glycine 0 CA--C 1.508 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.144 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.47 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 45.4 m-80 -65.37 137.56 57.58 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.18 126.87 33.54 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.68 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 48.7 mm -91.49 129.13 42.68 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.622 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -77.69 145.95 36.32 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.852 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 52.6 mt -129.99 128.2 64.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.84 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.5 t -72.43 117.36 58.17 Favored Pre-proline 0 N--CA 1.419 -2.015 0 C-N-CA 125.165 1.386 . . . . 0.0 108.711 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.88 -1.13 6.35 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.565 2.176 . . . . 0.0 112.817 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.93 -48.16 10.42 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.562 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 5.8 p -113.28 -19.28 11.83 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 122.684 0.394 . . . . 0.0 111.489 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.4 t30 81.01 19.79 0.44 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.475 1.51 . . . . 0.0 109.228 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -97.73 138.81 21.06 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.918 176.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.6 Cg_endo -73.88 174.21 12.71 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.34 2.693 . . . . 0.0 110.534 173.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -59.48 119.98 8.52 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.368 0.604 . . . . 0.0 109.38 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -104.26 23.92 12.34 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 76.77 51.68 6.28 Favored Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 105.654 -2.978 . . . . 0.0 105.654 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 7.7 p -125.87 159.38 61.78 Favored Pre-proline 0 N--CA 1.42 -1.943 0 CA-C-N 113.981 -1.109 . . . . 0.0 112.888 -166.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -77.22 108.13 2.56 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 121.988 1.792 . . . . 0.0 109.563 174.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 81.9 mtp -116.24 164.76 14.02 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.839 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.5 tt -133.6 134.62 56.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.69 154.73 20.7 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 53.8 t -80.81 167.84 19.48 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.444 0.64 . . . . 0.0 110.265 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -92.86 -31.63 14.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . 0.423 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 27.5 t70 -91.45 -36.91 13.5 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.863 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 55.7 m -97.51 168.32 10.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.65 10.99 26.84 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -94.25 175.08 6.83 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.336 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -132.03 140.14 48.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.121 0.486 . . . . 0.0 112.082 -172.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -119.22 158.33 26.21 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.219 1.008 . . . . 0.0 108.285 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.658 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 73.3 m80 -84.26 149.13 26.3 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.365 176.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 33.3 m0 -53.0 -54.52 43.2 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.53 -16.44 52.31 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.274 1.983 . . . . 0.0 113.444 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 81.8 m -81.28 -27.25 35.19 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.149 0.499 . . . . 0.0 110.85 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 893' ' ' HIS . 21.1 m -115.42 14.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.109 -176.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 71.2 35.42 64.03 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.837 -1.074 . . . . 0.0 114.231 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 57.6 mt -105.61 127.58 60.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.466 0.65 . . . . 0.0 111.024 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.7 mmt -105.17 -25.12 12.61 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.231 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -152.66 154.71 35.87 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . 0.446 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -49.68 112.92 2.91 Favored Pre-proline 0 C--O 1.241 0.628 0 O-C-N 124.779 1.299 . . . . 0.0 112.366 -177.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 19.3 Cg_endo . . . . . 0 C--O 1.254 1.296 0 C-N-CA 122.998 2.466 . . . . 0.0 112.202 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 . . . . . 0 N--CA 1.439 -0.993 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -117.81 141.61 48.23 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 120.594 -0.443 . . . . 0.0 109.815 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -132.45 137.59 47.32 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 17.1 p -66.98 165.06 29.45 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 123.992 0.917 . . . . 0.0 110.102 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -56.01 -18.86 24.06 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.595 2.197 . . . . 0.0 112.045 174.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.575 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 74.9 mmtt -74.49 -48.49 26.92 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.542 ' O ' HG12 ' A' ' 918' ' ' ILE . 68.8 m -76.63 -29.77 56.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.99 -11.24 60.68 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 120.698 0.285 . . . . 0.0 110.931 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.04 -29.71 35.0 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 172.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.464 ' CE ' ' HA ' ' A' ' 914' ' ' CYS . 53.3 mtmt -80.52 -36.74 32.78 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.912 176.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 914' ' ' CYS . 40.1 mm . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.702 0.287 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 90.9 t -134.75 118.64 26.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 37.6 mt -122.58 166.45 17.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -108.6 131.97 54.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 119.548 1.067 . . . . 0.0 109.501 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.35 175.21 8.62 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 123.697 0.799 . . . . 0.0 108.917 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -68.09 -27.95 66.93 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 123.716 0.806 . . . . 0.0 111.013 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -81.78 -15.4 54.38 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 102.3 -8.93 55.77 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.897 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -66.76 146.82 54.03 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.53 144.88 43.88 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 121.832 0.825 . . . . 0.0 111.502 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 858' ' ' VAL . 39.3 mm -105.32 121.63 57.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -90.02 143.57 26.67 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 123.975 0.797 . . . . 0.0 109.425 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 40.8 mt -107.7 123.4 63.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 892' ' ' TYR . 41.6 t -75.2 114.46 35.57 Favored Pre-proline 0 N--CA 1.409 -2.486 0 O-C-N 124.593 1.183 . . . . 0.0 108.67 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.4 -1.72 6.99 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.147 2.565 . . . . 0.0 112.011 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -78.27 -40.74 18.98 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 6.9 p -118.38 -15.37 9.7 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 57.8 t30 71.49 32.41 2.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.417 1.087 . . . . 0.0 108.285 -175.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -116.0 140.43 26.27 Favored Pre-proline 0 C--O 1.241 0.636 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.639 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 40.2 Cg_endo -72.47 167.27 27.46 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 123.317 2.678 . . . . 0.0 112.699 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.485 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 21.7 t70 -65.84 138.42 57.88 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.239 172.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -124.52 33.41 5.25 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 74.82 47.38 14.58 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 107.487 -2.245 . . . . 0.0 107.487 -173.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 6.2 p -120.45 149.32 49.67 Favored Pre-proline 0 N--CA 1.423 -1.807 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.027 -171.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.89 126.25 16.23 Favored 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 122.037 1.825 . . . . 0.0 110.384 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.485 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 88.9 mtp -128.3 157.79 39.97 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.869 -177.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.69 138.07 52.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -105.46 155.09 17.04 Favored Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.871 ' SG ' ' HB2' ' A' ' 888' ' ' CYS . 1.7 p -74.04 135.74 43.07 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.801 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.9 -48.94 72.39 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.699 -174.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . 0.575 ' HB2' ' CE1' ' A' ' 910' ' ' PHE . 14.9 t70 -80.65 -49.41 11.27 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-O 122.704 1.24 . . . . 0.0 109.12 -175.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.871 ' HB2' ' SG ' ' A' ' 885' ' ' CYS . 0.0 OUTLIER -73.6 -103.73 0.01 OUTLIER 'General case' 0 N--CA 1.38 -3.95 0 N-CA-C 118.929 2.937 . . . . 0.0 118.929 -162.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -178.3 -25.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -166.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . 0.436 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 22.7 m-20 -90.93 173.46 7.96 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.45 0.643 . . . . 0.0 111.94 -170.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -132.81 127.39 34.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.116 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . 0.43 ' HA ' ' SG ' ' A' ' 870' ' ' CYS . 82.6 m-85 -122.67 162.51 21.82 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.672 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.597 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 54.6 m80 -84.17 151.76 24.67 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.468 ' CG ' ' HB ' ' A' ' 899' ' ' ILE . 25.9 m0 -53.12 -56.37 24.53 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.52 -13.62 40.75 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.206 1.938 . . . . 0.0 114.043 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 76.5 m -77.75 -40.86 39.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.492 0.663 . . . . 0.0 111.109 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.462 HG22 HG12 ' A' ' 899' ' ' ILE . 27.1 m -99.57 -26.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.669 -175.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 110.17 35.42 2.14 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.214 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.468 ' HB ' ' CG ' ' A' ' 894' ' ' TRP . 42.2 mm -90.16 106.73 17.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 91.3 mmm -91.93 -25.64 18.8 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.244 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -151.74 147.84 27.18 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -57.57 114.36 8.17 Favored Pre-proline 0 C--N 1.319 -0.718 0 O-C-N 124.415 1.072 . . . . 0.0 111.891 -176.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 N--CA 1.46 -0.467 0 C-N-CA 122.905 2.403 . . . . 0.0 111.028 177.033 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 . . . . . 0 N--CA 1.439 -0.988 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -127.81 125.09 39.16 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.403 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 887' ' ' ASP . 22.0 m-85 -118.16 147.04 43.73 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.767 ' SG ' ' HB2' ' A' ' 914' ' ' CYS 0.254 1.8 p -80.49 164.58 51.02 Favored Pre-proline 0 C--N 1.271 -2.839 0 C-N-CA 124.478 1.111 . . . . 0.0 111.176 -174.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.56 -12.86 30.12 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.685 2.257 . . . . 0.0 112.296 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 32.4 mmtp -88.21 -62.11 1.56 Allowed 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.443 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.767 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 96.3 m -74.35 -27.76 60.82 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -175.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 910' ' ' PHE . . . -72.55 -25.95 61.56 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.322 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -89.47 -4.55 57.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.754 0.788 . . . . 0.0 110.164 -177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 913' ' ' LYS . 35.8 mmtp -83.69 -47.64 10.99 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 171.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 CA--C 1.519 -0.232 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.227 178.129 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 C--O 1.215 -0.719 0 CA-C-O 121.655 0.74 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.68 128.17 74.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.17 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 46.9 mt -126.0 166.02 22.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 177.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -116.58 140.71 49.08 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.93 -168.06 1.65 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.176 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.53 -34.02 77.28 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.006 0.922 . . . . 0.0 110.714 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -87.35 -33.51 19.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.783 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 122.57 16.64 3.72 Favored Glycine 0 C--N 1.308 -1.015 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.204 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -83.52 151.18 25.54 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -79.31 135.77 36.83 Favored 'General case' 0 N--CA 1.396 -3.133 0 CA-C-O 122.02 0.914 . . . . 0.0 110.181 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 27.4 mm -103.34 129.56 55.03 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.05 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.887 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -92.67 142.71 27.07 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.898 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 39.8 mt -111.41 122.92 66.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.113 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.5 t -65.66 112.53 8.9 Favored Pre-proline 0 N--CA 1.431 -1.404 0 C-N-CA 124.769 1.228 . . . . 0.0 108.817 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.69 -5.18 8.28 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.713 2.942 . . . . 0.0 112.961 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.95 -39.2 28.64 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 121.119 -0.562 . . . . 0.0 111.967 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 9.6 p -124.44 -10.32 7.44 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 122.79 0.436 . . . . 0.0 111.629 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.336 9.5 p30 60.12 32.39 20.93 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 126.022 1.729 . . . . 0.0 112.258 -172.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -103.59 138.96 19.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.095 173.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.9 Cg_endo -74.08 171.09 18.65 Favored 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 123.38 2.72 . . . . 0.0 113.888 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.92 145.24 42.8 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.551 174.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -115.83 -0.62 12.82 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 99.92 39.54 3.32 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 107.341 -2.304 . . . . 0.0 107.341 -172.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 14.3 m -106.44 168.67 7.81 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 114.607 -0.797 . . . . 0.0 110.527 -171.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -74.51 115.62 4.36 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 121.316 1.344 . . . . 0.0 108.901 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 83.4 mtp -122.57 162.3 22.09 Favored 'General case' 0 N--CA 1.407 -2.605 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . 0.486 ' HB ' ' HE1' ' A' ' 894' ' ' TRP . 18.0 tt -122.31 133.44 68.57 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-O 120.713 0.292 . . . . 0.0 110.44 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.08 143.77 16.87 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 52.7 t -71.94 167.95 19.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.551 0.691 . . . . 0.0 110.272 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . 0.407 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 24.6 t70 -84.97 -26.29 27.23 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 174.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -95.36 -47.96 6.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.119 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 10.1 m -83.79 146.63 28.04 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.97 17.12 23.12 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.279 1.038 . . . . 0.0 108.51 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -108.77 168.4 9.37 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.383 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -115.43 150.44 36.43 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -168.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -123.37 149.68 44.65 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.68 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 44.2 m80 -75.42 142.06 43.1 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.186 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.486 ' HE1' ' HB ' ' A' ' 883' ' ' ILE . 21.1 m0 -55.85 -49.47 92.76 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 20.3 Cg_endo -61.47 -19.08 63.04 Favored 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 122.154 1.903 . . . . 0.0 113.105 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 74.0 m -83.41 -21.22 33.06 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.401 0.62 . . . . 0.0 111.519 -177.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 893' ' ' HIS . 15.9 m -118.43 12.58 7.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.877 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 62.49 48.8 79.26 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.097 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 57.7 mt -118.59 136.58 55.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 122.582 -0.364 . . . . 0.0 111.108 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 61.5 mtt -121.9 -11.6 8.52 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.229 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . 0.526 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -156.54 137.29 13.33 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -50.77 100.78 0.24 Allowed Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 125.263 1.425 . . . . 0.0 113.686 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 14.4 Cg_endo . . . . . 0 CA--C 1.544 0.985 0 C-N-CA 123.715 2.943 . . . . 0.0 116.46 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 121.499 0.666 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -100.4 131.67 46.2 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.191 -173.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 84.9 m-85 -126.83 139.33 53.18 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 15.5 p -70.26 167.43 25.84 Favored Pre-proline 0 N--CA 1.426 -1.644 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.787 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.84 -20.64 18.15 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 123.08 2.52 . . . . 0.0 111.886 173.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.436 ' HA ' ' HE2' ' A' ' 913' ' ' LYS . 8.9 mmpt? -81.03 -51.47 8.46 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.21 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.484 ' O ' HG12 ' A' ' 918' ' ' ILE . 91.4 m -75.08 -29.66 60.73 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.7 66.31 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.19 0.519 . . . . 0.0 110.334 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -68.37 -28.79 67.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.354 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -79.15 -39.13 34.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.891 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 914' ' ' CYS . 47.8 mm . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.232 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.286 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 16.2 m -75.72 113.29 13.01 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 117.16 0.48 . . . . 0.0 110.316 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -86.35 -42.03 14.02 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -93.08 171.79 8.72 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.308 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 76.53 12.31 2.56 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.858 1.263 . . . . 0.0 110.859 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 23.3 mmt -87.13 -23.96 24.68 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.896 0.855 . . . . 0.0 109.037 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . 0.407 ' O ' HG22 ' A' ' 858' ' ' VAL . . . -100.28 -174.35 2.65 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.152 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . 0.456 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 55.1 m-85 68.22 12.34 8.72 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 122.103 0.954 . . . . 0.0 109.13 -172.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 856' ' ' ALA . 51.5 t -136.68 114.3 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.225 -174.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 39.5 mt -124.69 154.61 32.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -98.83 134.7 41.34 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.53 0.681 . . . . 0.0 110.076 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -71.93 172.23 10.33 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.962 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -63.12 -34.65 78.07 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 123.207 0.603 . . . . 0.0 110.468 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -88.67 -14.4 37.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.895 0.855 . . . . 0.0 108.994 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 105.31 10.51 31.48 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.077 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -68.96 164.0 23.27 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -88.36 121.06 30.32 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.632 0.73 . . . . 0.0 110.89 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 39.2 mm -91.51 112.45 25.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 173.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -88.47 130.84 35.1 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.424 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 32.8 mt -100.51 104.13 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.398 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 44.7 t -54.73 112.42 4.0 Favored Pre-proline 0 N--CA 1.429 -1.519 0 CA-C-N 113.734 -1.575 . . . . 0.0 108.997 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -71.93 3.58 3.79 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.005 1.803 . . . . 0.0 112.216 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -83.74 -36.67 13.16 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 22.3 p -114.97 -27.75 7.26 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 122.507 -0.408 . . . . 0.0 111.122 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 82.29 24.0 0.2 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.298 1.839 . . . . 0.0 110.309 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.545 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 41.2 mttm -102.86 144.43 28.6 Favored Pre-proline 0 N--CA 1.467 0.408 0 C-N-CA 123.393 0.677 . . . . 0.0 111.255 174.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -80.42 174.09 11.66 Favored 'Trans proline' 0 C--O 1.242 0.683 0 C-N-CA 123.094 2.53 . . . . 0.0 108.479 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 15.4 t70 -69.31 102.11 1.66 Allowed 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.222 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -94.97 5.06 52.99 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.438 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 119.31 55.81 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 17.7 m -134.25 163.1 53.59 Favored Pre-proline 0 N--CA 1.417 -2.108 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -75.3 137.67 21.35 Favored 'Trans proline' 0 C--O 1.264 1.777 0 C-N-CA 122.459 2.106 . . . . 0.0 108.581 172.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.505 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 58.1 mtp -117.03 152.78 33.93 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.961 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.9 tt -134.41 134.2 54.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -99.21 160.31 19.95 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.737 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.87 166.74 15.76 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.573 0.702 . . . . 0.0 110.869 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -92.88 -22.77 19.06 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.631 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -101.55 -37.64 8.31 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.246 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . 0.25 16.2 p -103.21 169.64 8.43 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.961 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.2 -21.04 19.31 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.503 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -87.1 163.59 16.91 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.897 -171.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -110.2 142.6 41.53 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.503 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -112.79 -178.05 3.29 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 125.014 1.326 . . . . 0.0 108.468 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.869 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 59.2 m80 -110.84 160.26 16.92 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -60.17 -54.1 58.55 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.24 -26.59 77.6 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 122.281 1.987 . . . . 0.0 114.071 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.869 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 5.8 m -69.31 -36.81 77.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.947 0.88 . . . . 0.0 111.772 -176.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.452 HG21 HG12 ' A' ' 899' ' ' ILE . 28.2 m -107.11 -17.87 7.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.36 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 93.3 48.94 2.7 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 121.224 -0.512 . . . . 0.0 113.139 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.452 HG12 HG21 ' A' ' 897' ' ' VAL . 44.0 mm -88.56 125.17 41.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 69.1 mtm -91.65 -37.26 13.16 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.127 0.489 . . . . 0.0 109.69 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -156.61 158.93 37.94 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -55.2 113.81 6.1 Favored Pre-proline 0 C--N 1.32 -0.717 0 O-C-N 124.093 0.871 . . . . 0.0 111.984 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.19 165.93 28.64 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 123.346 2.698 . . . . 0.0 112.724 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.51 151.1 80.31 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.716 2.277 . . . . 0.0 112.267 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 0.2 OUTLIER -85.14 -21.9 29.05 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.709 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.71 -27.08 62.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.827 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 23.1 ttt -79.33 143.94 34.7 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -97.0 121.44 38.89 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -106.45 132.17 52.78 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -127.97 137.35 52.21 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 5.8 p -69.82 168.45 17.57 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 123.996 0.918 . . . . 0.0 109.695 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.24 -20.3 10.87 Favored 'Trans proline' 0 CA--C 1.552 1.409 0 C-N-CA 123.195 2.597 . . . . 0.0 112.429 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -79.29 -56.27 4.47 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.478 0.711 . . . . 0.0 109.195 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 71.5 m -79.03 -17.51 55.16 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 918' ' ' ILE . . . -67.06 -31.22 71.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.334 1.064 . . . . 0.0 108.645 172.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -73.42 -22.99 60.07 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.45 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -74.49 -36.59 63.27 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 172.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 915' ' ' ALA . 50.5 mm -60.79 -43.02 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 172.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 80.2 tttt 71.4 -68.76 0.21 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.541 1.937 . . . . 0.0 113.581 169.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -176.91 -50.96 0.01 OUTLIER 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -92.56 91.86 7.78 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.308 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -96.51 140.65 30.83 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.531 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -115.7 10.23 15.41 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-O 121.721 0.772 . . . . 0.0 111.189 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 69.4 t60 . . . . . 0 N--CA 1.424 -1.75 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 175.41 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.651 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 22.6 t -84.57 85.15 7.45 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -125.89 168.52 13.76 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.437 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 59.9 ttp -117.6 124.15 47.93 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -138.55 128.01 24.61 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.708 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 65.8 mtt -137.4 135.35 36.87 Favored 'General case' 0 C--O 1.249 1.029 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 175.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . 0.49 ' O ' HD13 ' A' ' 869' ' ' ILE . . . 60.37 -150.72 0.41 Allowed 'General case' 0 N--CA 1.469 0.502 0 O-C-N 124.368 1.042 . . . . 0.0 109.765 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . 0.448 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 88.7 m-85 -119.58 9.65 11.55 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.016 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 90.9 t -132.56 116.83 29.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.855 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 35.2 mt -120.2 157.26 22.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -102.01 131.64 48.32 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.035 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.77 173.5 8.11 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.853 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.95 -37.78 80.52 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.767 0.827 . . . . 0.0 111.143 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . 0.491 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 75.9 m95 -91.15 1.45 57.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.557 0.694 . . . . 0.0 110.626 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.08 14.19 56.51 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.761 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.491 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 58.8 m-80 -73.84 155.65 38.57 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.73 113.17 24.01 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.678 0.751 . . . . 0.0 112.006 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 37.1 mm -80.41 118.47 28.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 175.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -92.16 138.22 31.71 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.329 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.49 HD13 ' O ' ' A' ' 856' ' ' ALA . 33.5 mt -104.07 127.34 58.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.38 112.82 31.58 Favored Pre-proline 0 N--CA 1.423 -1.815 0 C-N-CA 124.348 1.059 . . . . 0.0 108.719 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 31.9 Cg_exo -60.79 -6.06 5.43 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 123.883 3.056 . . . . 0.0 113.664 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -85.53 -23.5 46.84 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.785 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 18.9 p -123.92 -33.89 3.07 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -177.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 82.5 21.86 0.23 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.943 1.697 . . . . 0.0 109.706 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -103.66 139.52 20.19 Favored Pre-proline 0 C--O 1.25 1.107 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.934 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.59 153.93 49.54 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.845 2.363 . . . . 0.0 110.644 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 29.2 t70 -79.53 146.17 32.79 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.139 0.495 . . . . 0.0 111.845 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -108.79 -0.62 19.82 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.247 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 106.13 51.78 0.81 Allowed Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -172.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 1.3 m -109.02 164.35 14.91 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.04 114.92 3.36 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 121.745 1.63 . . . . 0.0 108.886 172.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 68.7 mtp -115.06 167.58 10.69 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.2 tt -132.22 143.83 38.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -101.23 147.15 17.63 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 43.7 t -80.34 170.67 16.08 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.022 0.529 . . . . 0.0 110.009 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . 0.433 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 26.8 t70 -88.99 -24.83 22.29 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -100.67 -31.8 11.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.323 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 22.4 m -104.71 149.09 25.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -92.45 -9.99 39.53 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.57 150.43 49.0 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.844 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -101.29 135.44 42.77 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.786 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -115.85 150.73 36.54 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.646 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 43.2 m80 -79.11 139.94 37.94 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.916 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 31.4 m0 -52.34 -52.03 66.84 Favored Pre-proline 0 CA--C 1.551 1.014 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.59 -9.3 22.08 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.951 1.767 . . . . 0.0 113.309 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -93.52 -17.84 22.94 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.453 0.644 . . . . 0.0 111.074 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 893' ' ' HIS . 31.5 m -118.48 7.67 6.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.927 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 70.72 37.61 66.92 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.723 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 49.0 mt -108.48 124.28 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-O 121.73 0.776 . . . . 0.0 110.848 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -105.0 -21.15 13.33 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.518 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -155.76 146.9 22.47 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -55.8 114.95 8.34 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 124.848 1.343 . . . . 0.0 112.133 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -68.53 155.52 68.74 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.966 1.778 . . . . 0.0 109.784 173.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.07 146.16 88.97 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.27 1.98 . . . . 0.0 112.411 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -64.59 -32.95 74.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.999 0.904 . . . . 0.0 109.667 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -78.81 1.48 23.15 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.163 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 21.0 ttt -97.85 133.19 42.69 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -81.46 137.22 35.65 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.036 -1.065 . . . . 0.0 108.484 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 92.9 t90 -134.35 138.09 44.64 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.697 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 97.5 m-85 -135.56 136.36 41.06 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 11.5 p -62.55 165.7 8.76 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 124.081 0.952 . . . . 0.0 110.24 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.15 -10.26 5.83 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.014 2.476 . . . . 0.0 112.291 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 28.9 mmmt -83.28 -54.11 5.25 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 72.0 m -81.49 -21.37 38.72 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.32 -27.55 67.99 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 919' ' ' LYS . 2.9 t-20 -78.5 -5.39 52.46 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.635 0.731 . . . . 0.0 110.273 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -83.82 -34.97 24.57 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 68.9 mt -86.58 -50.6 13.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.3 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 916' ' ' ASN . 63.3 tttm -108.88 94.9 5.3 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -69.36 -32.55 71.69 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.695 -173.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 71.02 134.68 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.107 1.363 . . . . 0.0 111.857 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -142.5 -176.54 4.89 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.12 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -151.11 147.46 27.09 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 C--N 1.296 -1.741 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 177.41 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.071 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 21.4 t -82.69 90.34 6.84 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 117.542 0.671 . . . . 0.0 110.205 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -166.57 103.18 0.6 Allowed 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -114.6 134.27 55.18 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -87.65 149.97 23.94 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 24.4 mmt -92.71 -53.75 4.05 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -125.57 156.92 38.34 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -108.53 64.25 0.61 Allowed 'General case' 0 C--N 1.283 -2.316 0 CA-C-O 122.296 1.046 . . . . 0.0 111.096 -170.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.32 115.57 18.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 113.902 -1.499 . . . . 0.0 107.516 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 56.5 mt -108.1 152.21 9.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -108.09 135.09 50.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.09 174.09 11.92 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.261 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.81 -24.42 63.47 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.247 0.546 . . . . 0.0 111.029 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -88.26 4.87 44.3 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.333 0.587 . . . . 0.0 110.412 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 74.73 22.06 77.66 Favored Glycine 0 CA--C 1.502 -0.738 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.598 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -86.21 154.57 21.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -86.67 130.69 34.39 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.796 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 41.6 mm -103.14 105.61 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.744 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.2 m-90 -83.95 136.86 33.91 Favored 'General case' 0 C--N 1.252 -3.639 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.609 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.5 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 53.3 mt -102.71 129.0 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.348 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 43.6 t -80.65 109.13 11.85 Favored Pre-proline 0 N--CA 1.416 -2.162 0 C-N-CA 125.612 1.565 . . . . 0.0 107.387 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 32.5 Cg_exo -62.17 -0.81 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.335 2.69 . . . . 0.0 113.624 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.81 -49.04 9.25 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 3.9 p -107.74 -20.22 13.29 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 122.593 0.357 . . . . 0.0 111.113 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 78.68 23.05 0.64 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.745 1.618 . . . . 0.0 108.786 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -101.16 141.97 23.69 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.566 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.93 174.15 12.84 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.661 2.241 . . . . 0.0 109.226 170.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.434 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 17.2 t0 -60.8 109.78 1.14 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.835 0.826 . . . . 0.0 110.501 174.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -101.67 13.71 34.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.292 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 102.82 49.1 1.2 Allowed Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 21.2 m -130.03 157.01 78.28 Favored Pre-proline 0 N--CA 1.412 -2.369 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.18 135.32 16.84 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 121.973 1.782 . . . . 0.0 108.447 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 65.0 mtp -115.71 142.32 46.91 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.696 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.5 tt -123.05 136.42 59.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -119.59 152.26 17.21 Favored Glycine 0 CA--C 1.483 -1.926 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.734 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 888' ' ' CYS . 42.3 t -58.62 160.1 5.89 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.651 0.78 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -88.11 -27.25 22.04 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.54 -39.59 18.61 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.675 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 885' ' ' CYS . 8.5 p -138.17 167.12 22.49 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.031 0.444 . . . . 0.0 110.981 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -90.04 68.33 7.19 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.799 0.809 . . . . 0.0 109.755 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -112.02 97.47 6.69 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.7 -2.334 . . . . 0.0 104.7 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -96.39 128.78 43.63 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.439 -171.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . 0.491 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 36.5 m-85 -122.55 169.3 11.16 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.744 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.567 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.5 m80 -89.36 149.79 22.85 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.087 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -49.6 -56.33 17.4 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.44 -11.16 29.07 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.324 2.016 . . . . 0.0 113.94 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 62.8 m -89.18 -29.8 19.04 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.479 HG22 HG12 ' A' ' 899' ' ' ILE . 17.2 m -113.45 3.55 8.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -175.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.06 5.73 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.576 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.479 HG12 HG22 ' A' ' 897' ' ' VAL . 24.5 mm -105.15 114.6 45.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 90.2 mmm -95.61 -21.86 17.97 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.324 0.583 . . . . 0.0 110.204 -177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -165.52 163.07 19.52 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -45.81 111.57 1.44 Allowed Pre-proline 0 C--O 1.241 0.609 0 O-C-N 124.579 1.174 . . . . 0.0 111.419 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.91 160.74 39.71 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.873 2.382 . . . . 0.0 111.396 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.43 141.62 89.62 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.25 1.967 . . . . 0.0 111.328 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -78.34 -11.97 59.97 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.105 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.66 -10.2 41.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.561 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 21.2 ttt -80.69 130.55 35.16 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.007 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -89.39 134.91 33.87 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -129.1 139.17 52.09 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -130.26 147.04 51.94 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 20.0 p -61.06 160.04 24.11 Favored Pre-proline 0 C--N 1.317 -0.806 0 O-C-N 123.871 0.732 . . . . 0.0 110.388 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.16 -15.13 13.45 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.863 2.375 . . . . 0.0 112.604 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 18.4 mtmm -82.3 -50.93 8.4 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.81 -31.52 66.64 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.74 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . 0.401 ' HB3' ' NZ ' ' A' ' 919' ' ' LYS . . . -65.8 -25.52 67.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.114 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.21 -37.41 57.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.48 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -60.16 -44.08 95.27 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 74.4 mt -68.93 -54.21 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.713 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . 0.401 ' NZ ' ' HB3' ' A' ' 915' ' ' ALA . 32.4 mtmm -100.04 84.11 2.81 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.857 0.836 . . . . 0.0 109.604 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -97.88 -40.97 8.24 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.599 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 67.75 -83.1 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.925 1.29 . . . . 0.0 110.695 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -173.63 170.55 4.04 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -86.59 123.5 31.84 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 . . . . . 0 C--O 1.256 1.395 0 C-N-CA 123.701 0.801 . . . . 0.0 109.982 -179.599 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.892 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 68.4 p 43.21 83.63 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -166.23 169.65 14.05 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 67.6 mtt -102.5 39.12 1.56 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 70.65 12.85 7.31 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.628 1.171 . . . . 0.0 112.655 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 26.2 mmt -92.33 79.19 5.03 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.135 0.493 . . . . 0.0 110.758 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -118.68 -176.22 3.05 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -95.67 -5.74 41.6 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.375 0.607 . . . . 0.0 111.261 -175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 59.1 t -111.05 106.69 21.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 34.6 mt -108.67 131.67 58.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -85.4 117.9 24.6 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 862' ' ' GLU . 24.9 t70 -69.11 177.54 2.66 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.36 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . 0.411 ' H ' ' CG ' ' A' ' 861' ' ' ASP . 27.5 mt-10 -66.82 -30.91 71.22 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 124.686 1.194 . . . . 0.0 109.941 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . 0.6 ' HB3' ' ND2' ' A' ' 865' ' ' ASN . 72.5 t-105 -89.14 -3.19 58.71 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.899 0.856 . . . . 0.0 109.024 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.32 9.98 71.88 Favored Glycine 0 CA--C 1.502 -0.762 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.496 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.6 ' ND2' ' HB3' ' A' ' 863' ' ' TRP . 47.9 m-80 -62.2 148.89 43.23 Favored 'General case' 0 C--O 1.249 1.027 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -85.89 101.36 12.79 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.997 0.903 . . . . 0.0 109.774 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 49.8 mm -89.54 115.22 28.78 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.593 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -103.08 126.32 50.2 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.526 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.534 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 27.6 mt -87.87 124.32 40.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . 0.422 ' C ' ' H ' ' A' ' 872' ' ' GLY . 42.9 t -79.36 106.5 4.69 Favored Pre-proline 0 N--CA 1.415 -2.191 0 C-N-CA 125.325 1.45 . . . . 0.0 107.412 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 21.6 Cg_exo -67.39 13.6 0.16 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.665 2.91 . . . . 0.0 113.247 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 870' ' ' CYS . . . -92.25 -40.21 5.19 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 174.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 11.0 p -111.96 -25.55 9.34 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.084 0.469 . . . . 0.0 110.325 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 79.9 18.66 0.67 Allowed 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.459 1.904 . . . . 0.0 110.916 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -94.74 138.51 22.19 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.491 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -72.52 148.4 47.89 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.159 2.572 . . . . 0.0 111.695 174.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.28 141.15 54.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -85.93 -34.1 21.0 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.512 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 127.83 46.46 0.19 Allowed Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 106.336 -2.706 . . . . 0.0 106.336 -171.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 20.9 p -114.11 165.41 13.7 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 114.387 -0.907 . . . . 0.0 109.697 -173.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.76 124.13 13.97 Favored 'Trans proline' 0 C--O 1.255 1.353 0 C-N-CA 122.082 1.855 . . . . 0.0 111.442 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.8 mtp -124.66 161.72 25.68 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.862 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.8 tt -130.68 138.06 54.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -108.36 152.32 16.98 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.965 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 47.4 t -77.84 167.28 21.77 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.378 0.609 . . . . 0.0 110.363 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -104.41 -23.09 13.22 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.127 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -84.94 -40.9 16.44 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.434 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.7 p -105.55 -95.06 0.35 Allowed 'General case' 0 N--CA 1.427 -1.577 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.468 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 37.3 t70 174.62 -20.46 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.022 0.929 . . . . 0.0 109.778 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -55.69 141.94 36.1 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -176.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -104.1 131.64 51.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.518 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 911' ' ' CYS . 10.6 m-85 -117.74 155.43 30.01 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.167 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.658 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 36.6 m80 -80.93 143.29 32.74 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.404 ' N ' ' HD2' ' A' ' 895' ' ' PRO . 29.2 m0 -52.59 -51.7 70.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 30.4 Cg_endo -61.2 -20.35 67.58 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.321 2.014 . . . . 0.0 113.405 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 61.6 m -80.47 -26.01 38.51 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.088 0.47 . . . . 0.0 111.641 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 11.8 m -114.0 8.25 7.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.449 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 73.04 48.79 18.83 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.7 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 58.6 mt -119.85 133.7 65.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 122.636 -0.332 . . . . 0.0 110.619 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.3 ptp -128.37 -2.88 5.57 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.265 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -164.39 130.62 2.98 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -44.64 96.35 0.11 Allowed Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 127.002 2.121 . . . . 0.0 113.83 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 0.4 OUTLIER -114.08 156.03 0.04 OUTLIER 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 123.553 2.835 . . . . 0.0 116.346 -176.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -97.04 172.37 0.78 Allowed 'Trans proline' 0 N--CA 1.439 -1.681 0 N-CA-C 105.617 -2.493 . . . . 0.0 105.617 157.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . 0.443 ' HG3' ' H ' ' A' ' 907' ' ' MET . 8.3 pt-20 -86.43 -29.51 22.79 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 115.983 -2.287 . . . . 0.0 109.767 174.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 148.65 -20.24 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 130.518 3.527 . . . . 0.0 103.657 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 907' ' ' MET . . . . . 0.443 ' H ' ' HG3' ' A' ' 905' ' ' GLU . 56.3 ttp -126.23 170.25 12.04 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 111.544 -2.571 . . . . 0.0 105.703 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -46.98 152.52 0.51 Allowed 'General case' 0 C--O 1.242 0.669 0 O-C-N 124.537 1.148 . . . . 0.0 110.929 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -107.98 124.37 50.06 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.582 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.37 145.94 46.66 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 892' ' ' TYR . 27.3 p -66.18 163.55 37.59 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.769 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.55 -23.65 26.07 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.695 2.263 . . . . 0.0 111.904 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -79.17 -50.87 10.3 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.721 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 917' ' ' LYS . 98.0 m -82.89 -25.2 32.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.49 65.39 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -74.36 -19.6 60.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.256 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 49.2 mtmt -86.1 -30.56 22.46 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 46.3 mm -68.61 -61.27 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -94.08 95.17 8.83 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . 0.431 ' HB3' ' NZ ' ' A' ' 920' ' ' LYS . 4.7 ttpm? -146.16 -45.78 0.2 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.567 -166.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.26 135.56 44.21 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -168.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -86.15 146.27 26.65 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.689 -1.596 . . . . 0.0 107.519 177.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -85.23 -0.89 56.08 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.653 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 . . . . . 0 C--N 1.29 -2.021 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 174.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.915 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 4.7 p -102.14 -57.77 2.0 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 116.943 0.371 . . . . 0.0 110.069 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 64.1 m80 65.41 -70.11 0.1 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.289 1.436 . . . . 0.0 113.303 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 88.8 mtp -84.63 82.65 8.32 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -167.4 -163.38 0.51 Allowed 'General case' 0 C--N 1.307 -1.283 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 95.2 mmm -113.98 17.48 17.84 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -68.15 -88.52 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -124.76 1.18 8.13 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.591 0.71 . . . . 0.0 111.026 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 44.4 t -135.04 118.12 23.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.2 mt -131.92 165.39 32.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -117.91 147.93 42.64 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.42 -175.82 5.85 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.08 -27.53 67.44 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.796 0.331 . . . . 0.0 111.828 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -78.04 -48.16 16.76 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.977 0.418 . . . . 0.0 110.208 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 129.34 28.04 0.79 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.968 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -88.05 155.93 19.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -83.08 130.04 35.08 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-O 121.328 0.585 . . . . 0.0 109.455 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 50.7 mm -92.43 102.83 13.99 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 -75.51 114.34 13.96 Favored 'General case' 0 C--N 1.267 -2.997 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.436 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 50.1 mt -98.52 113.03 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 43.4 t -63.46 112.94 8.1 Favored Pre-proline 0 N--CA 1.422 -1.872 0 O-C-N 124.784 1.303 . . . . 0.0 109.068 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . 0.482 ' HD2' ' CE1' ' A' ' 892' ' ' TYR . 53.1 Cg_exo -58.82 -15.94 29.1 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.631 2.887 . . . . 0.0 113.098 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -70.59 -43.52 60.38 Favored Glycine 0 N--CA 1.433 -1.504 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.927 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.4 p -109.0 -26.51 10.15 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.952 0.406 . . . . 0.0 110.653 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 13.9 m120 77.95 25.02 0.67 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.772 1.629 . . . . 0.0 109.507 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.76 139.51 20.94 Favored Pre-proline 0 C--O 1.247 0.936 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.324 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.43 173.86 11.76 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 123.649 2.899 . . . . 0.0 112.931 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.81 112.42 1.64 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.595 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -103.22 -6.56 21.98 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.926 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 117.97 -17.82 11.67 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.07 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 64.2 m -68.17 156.27 90.31 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-N 116.674 0.237 . . . . 0.0 110.773 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.16 133.71 36.47 Favored 'Trans proline' 0 C--O 1.253 1.26 0 C-N-CA 122.785 2.323 . . . . 0.0 111.784 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.0 mtp -119.0 154.43 33.08 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.1 tt -124.61 145.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -102.98 155.21 18.2 Favored Glycine 0 C--O 1.248 0.999 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 886' ' ' ASP . 43.4 t -79.96 175.12 10.92 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.739 0.78 . . . . 0.0 110.749 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . 0.41 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 19.2 t70 -99.04 -24.47 14.89 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . 0.425 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 10.6 t70 -91.85 -39.08 11.94 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.571 0.7 . . . . 0.0 109.623 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 5.3 p -120.04 172.42 7.76 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.208 0.528 . . . . 0.0 112.371 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -104.26 11.22 35.13 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.926 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -80.17 149.86 30.36 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.226 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -110.83 134.47 52.49 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.902 0.382 . . . . 0.0 111.879 -173.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . 0.482 ' CE1' ' HD2' ' A' ' 871' ' ' PRO . 90.5 m-85 -123.58 147.89 46.87 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.75 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 53.6 m80 -76.47 145.01 39.5 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.413 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.416 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 35.9 m0 -54.58 -51.85 74.95 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 174.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 33.3 Cg_endo -63.36 -12.53 31.01 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.525 2.15 . . . . 0.0 113.162 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 73.6 m -85.34 -29.91 24.11 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.199 0.524 . . . . 0.0 110.834 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 16.7 m -107.89 -4.6 10.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.469 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 86.31 32.69 15.93 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.566 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 52.1 mt -98.28 123.92 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-O 121.365 0.602 . . . . 0.0 109.93 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -106.7 -19.78 13.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.073 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -151.83 150.47 30.16 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -53.97 111.48 2.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.653 1.221 . . . . 0.0 111.385 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.6 149.19 67.6 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.489 2.126 . . . . 0.0 110.816 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.23 126.57 22.51 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.601 2.2 . . . . 0.0 111.679 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.77 -9.24 58.43 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.525 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.52 -20.22 63.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.386 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 52.1 tpp -102.72 149.77 24.13 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.278 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -85.38 149.05 25.7 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.223 0.535 . . . . 0.0 109.825 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -139.76 131.84 27.97 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -125.13 140.53 52.79 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 24.8 p -71.33 164.57 56.23 Favored Pre-proline 0 N--CA 1.424 -1.745 0 O-C-N 123.855 0.722 . . . . 0.0 110.524 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -59.92 -9.97 11.12 Favored 'Trans proline' 0 CA--C 1.552 1.409 0 C-N-CA 122.895 2.397 . . . . 0.0 112.704 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -87.26 -46.32 9.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 122.252 -0.28 . . . . 0.0 110.289 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 92.2 m -76.4 -27.81 56.45 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.218 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -68.77 -24.73 64.47 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.437 0.637 . . . . 0.0 109.67 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -68.37 -37.69 80.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -60.94 -38.43 85.8 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.432 0.634 . . . . 0.0 109.845 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 50.4 mm -63.26 -35.6 72.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.415 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -100.09 -3.52 31.72 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -173.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 923' ' ' LYS . 19.9 mtmm -86.87 97.88 10.9 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 118.141 -1.424 . . . . 0.0 109.097 176.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -86.73 -23.66 25.42 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.403 0.621 . . . . 0.0 109.854 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -73.09 -44.16 60.83 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.041 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . 0.404 ' O ' ' HE2' ' A' ' 920' ' ' LYS . 22.3 ttmm -154.5 158.62 40.16 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 . . . . . 0 C--N 1.311 -1.073 0 CA-C-O 118.546 -0.74 . . . . 0.0 110.294 178.561 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.771 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 16.7 m -81.42 155.14 26.04 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -152.32 177.21 10.81 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -155.59 34.96 0.36 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 174.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -72.83 125.58 27.89 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.562 -1.654 . . . . 0.0 110.456 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 26.2 ptm -134.52 134.36 41.34 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . 0.455 ' O ' HD13 ' A' ' 869' ' ' ILE . . . -142.91 -178.26 5.73 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . 0.496 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 65.0 m-85 -121.61 7.79 10.04 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.792 -174.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.57 128.59 60.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 45.3 mt -137.13 162.26 34.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -102.89 140.78 36.71 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 119.071 0.85 . . . . 0.0 110.966 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -76.71 173.67 11.35 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.681 173.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -70.66 -26.76 63.59 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . 0.534 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 96.2 m95 -88.61 -6.57 57.44 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.193 0.521 . . . . 0.0 109.926 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 94.32 13.71 53.27 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.942 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.534 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 51.6 m-80 -72.9 158.88 34.65 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -91.72 127.99 37.39 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 121.982 0.896 . . . . 0.0 111.726 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 46.3 mm -99.62 125.96 53.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.592 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -108.08 152.71 24.15 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.496 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 31.9 mt -112.69 133.0 59.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 O-C-N 123.579 0.55 . . . . 0.0 109.823 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 45.3 t -80.54 111.39 22.44 Favored Pre-proline 0 N--CA 1.421 -1.886 0 C-N-CA 124.911 1.284 . . . . 0.0 109.24 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 32.6 Cg_exo -63.3 2.88 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.315 0 C-N-CA 123.894 3.063 . . . . 0.0 113.498 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -90.04 -19.38 47.06 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.743 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 7.0 p -137.97 -25.29 0.98 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 17.1 t30 78.92 20.43 0.75 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.671 1.589 . . . . 0.0 109.257 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.413 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 99.3 mttt -92.43 139.12 23.83 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.731 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . 0.406 ' HA ' HG12 ' A' ' 869' ' ' ILE . 57.8 Cg_endo -77.59 163.7 29.12 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.546 2.831 . . . . 0.0 112.487 174.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.465 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 12.8 t70 -59.1 125.95 25.69 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.525 0.73 . . . . 0.0 111.831 175.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -99.02 19.5 15.01 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.655 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 84.11 42.5 7.53 Favored Glycine 0 CA--C 1.488 -1.639 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 -172.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 9.1 p -115.48 150.79 45.2 Favored Pre-proline 0 N--CA 1.409 -2.508 0 CA-C-N 113.77 -1.215 . . . . 0.0 111.565 -170.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.77 123.0 9.95 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 122.072 1.848 . . . . 0.0 108.72 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.465 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 92.4 mtp -120.27 157.18 29.7 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.9 tt -119.19 134.96 61.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.15 157.5 21.55 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 886' ' ' ASP . 52.3 t -80.64 170.77 15.89 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.5 0.667 . . . . 0.0 110.503 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . 0.409 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 22.2 t70 -93.82 -24.1 17.89 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . 0.413 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 16.0 t70 -99.86 -48.1 4.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.796 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.7 p -98.65 165.3 11.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.354 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -88.32 -16.19 33.71 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.158 0.983 . . . . 0.0 110.521 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.66 152.29 45.54 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.757 -174.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -105.42 133.64 49.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.512 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -115.4 146.77 41.28 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.69 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.3 m80 -76.88 141.07 40.74 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -50.31 -51.62 61.87 Favored Pre-proline 0 CA--C 1.555 1.161 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.78 -22.53 74.58 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.402 2.068 . . . . 0.0 114.176 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 60.9 m -81.02 -26.9 36.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.529 0.681 . . . . 0.0 111.652 -175.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.495 HG21 HG12 ' A' ' 899' ' ' ILE . 15.1 m -112.68 -5.47 11.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.087 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 85.65 41.81 7.12 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.365 175.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.495 HG12 HG21 ' A' ' 897' ' ' VAL . 39.9 mm -90.98 108.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.7 ptm -87.19 -23.93 24.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.735 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -162.68 149.36 12.95 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -49.66 110.6 1.65 Allowed Pre-proline 0 C--O 1.241 0.619 0 O-C-N 124.508 1.13 . . . . 0.0 111.8 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.74 157.76 51.5 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.979 2.452 . . . . 0.0 112.107 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -68.96 130.17 19.82 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.399 2.066 . . . . 0.0 110.522 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -76.6 -5.36 47.44 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.339 0.59 . . . . 0.0 110.672 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -68.67 -21.72 64.42 Favored 'General case' 0 N--CA 1.391 -3.409 0 C-N-CA 125.729 1.612 . . . . 0.0 108.985 172.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 46.9 ttm -103.71 136.61 43.09 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.77 144.53 47.54 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.183 0.516 . . . . 0.0 110.435 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -130.09 131.98 45.96 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -133.45 137.78 45.88 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.246 0.546 . . . . 0.0 110.132 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.665 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 7.5 p -73.48 172.12 9.01 Favored Pre-proline 0 C--N 1.296 -1.723 0 C-N-CA 124.862 1.265 . . . . 0.0 110.641 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.71 -16.17 23.86 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 123.002 2.468 . . . . 0.0 111.665 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.665 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 11.7 mmmm -80.56 -55.02 5.14 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.26 0.624 . . . . 0.0 110.849 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.425 ' O ' HG12 ' A' ' 918' ' ' ILE . 71.6 m -85.59 -22.82 27.86 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.65 -22.18 61.72 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 913' ' ' LYS . 3.4 t-20 -66.96 -36.13 81.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.741 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -66.05 -49.14 68.69 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.404 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 914' ' ' CYS . 32.5 mm -61.12 -39.87 83.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.078 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp 70.09 81.47 0.17 Allowed 'General case' 0 N--CA 1.408 -2.544 0 C-N-CA 126.273 1.829 . . . . 0.0 109.829 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -73.98 -38.15 64.23 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 28.0 t70 59.98 86.86 0.09 Allowed 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 113.619 -1.628 . . . . 0.0 111.42 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.74 79.96 9.29 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.58 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -154.51 139.18 17.0 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.216 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 . . . . . 0 C--N 1.287 -2.135 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 172.285 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.536 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 851' ' ' SER . . . . . 0.776 ' HA ' ' SD ' ' A' ' 855' ' ' MET . 78.7 p -149.11 13.75 0.88 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 117.592 0.696 . . . . 0.0 111.581 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -79.03 -84.48 0.08 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.169 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 66.6 mtt -123.39 -45.76 2.07 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 122.207 1.003 . . . . 0.0 109.215 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -81.93 81.57 7.87 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.604 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 855' ' ' MET . . . . . 0.776 ' SD ' ' HA ' ' A' ' 851' ' ' SER . 25.5 ptt? -147.94 24.71 1.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 122.139 0.971 . . . . 0.0 109.856 175.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -93.04 17.05 11.43 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.842 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . 0.411 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 49.7 m-85 -91.73 77.92 5.53 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.61 118.06 37.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.517 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . 0.43 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 54.5 mt -117.07 162.78 14.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -96.63 134.33 40.01 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 119.313 0.96 . . . . 0.0 110.108 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -75.86 174.4 9.94 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.99 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -68.47 -30.04 68.8 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 123.666 0.786 . . . . 0.0 110.784 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -79.95 -15.58 56.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.885 0.85 . . . . 0.0 108.895 176.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 96.93 18.56 29.17 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -81.6 178.24 8.46 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -95.88 129.0 43.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.073 0.463 . . . . 0.0 110.317 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.43 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 28.2 mm -92.1 122.27 43.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -90.84 148.61 22.39 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 124.22 0.95 . . . . 0.0 111.208 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.438 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 50.7 mt -122.17 136.44 59.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.471 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.85 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 50.0 t -77.59 106.98 4.38 Favored Pre-proline 0 N--CA 1.426 -1.668 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . 0.503 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 57.5 Cg_endo -78.14 15.19 1.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.018 1.812 . . . . 0.0 111.977 -177.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -87.52 -32.0 14.62 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 9.4 p -115.13 -32.37 5.72 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.582 -0.309 . . . . 0.0 110.475 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 87.55 26.26 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.828 2.051 . . . . 0.0 109.864 -175.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.464 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 25.6 mtpp -110.23 139.07 21.08 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.553 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.6 Cg_endo -76.51 169.95 20.89 Favored 'Trans proline' 0 C--O 1.249 1.051 0 C-N-CA 123.426 2.751 . . . . 0.0 112.98 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -51.99 113.45 1.01 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.538 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -107.64 18.18 21.74 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.58 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 83.72 27.75 37.51 Favored Glycine 0 CA--C 1.492 -1.366 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 10.7 p -106.02 167.59 9.44 Favored Pre-proline 0 N--CA 1.42 -1.935 0 C-N-CA 123.82 0.848 . . . . 0.0 110.043 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.75 123.84 9.29 Favored 'Trans proline' 0 N--CA 1.437 -1.811 0 C-N-CA 121.368 1.379 . . . . 0.0 109.762 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 78.1 mtp -122.44 150.51 42.39 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.668 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . 0.49 ' HB ' ' NE1' ' A' ' 894' ' ' TRP . 19.0 tt -117.36 148.67 19.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -109.87 157.45 15.06 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.596 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.51 ' HB3' ' OD2' ' A' ' 890' ' ' ASP . 42.2 t -91.73 -170.83 2.69 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 126.037 1.735 . . . . 0.0 108.016 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -120.54 -23.34 6.11 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.965 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . 0.437 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 3.4 t70 -102.52 -25.09 13.72 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -167.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 890' ' ' ASP . 22.6 p -119.12 -143.93 0.36 Allowed 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -174.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -130.04 87.04 2.47 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . 0.51 ' OD2' ' HB3' ' A' ' 885' ' ' CYS . 1.4 p30 -128.78 157.62 40.94 Favored 'General case' 0 C--N 1.256 -3.494 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -159.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -161.09 117.3 2.22 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 127.85 2.46 . . . . 0.0 106.409 161.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . 0.503 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 62.8 m-85 -120.02 147.98 44.12 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.718 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 53.4 m80 -76.69 140.2 40.79 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.899 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.49 ' NE1' ' HB ' ' A' ' 883' ' ' ILE . 24.2 m0 -53.51 -51.2 78.11 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.08 -9.42 25.01 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.039 1.826 . . . . 0.0 113.919 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 74.3 m -86.51 -39.7 15.99 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.293 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.492 HG22 HG12 ' A' ' 899' ' ' ILE . 30.5 m -104.57 -4.07 9.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.205 -175.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 87.1 53.0 2.93 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.519 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.492 HG12 HG22 ' A' ' 897' ' ' VAL . 16.7 mm -114.02 136.05 51.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.2 ptp -121.08 -15.59 8.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.605 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -162.61 135.48 5.77 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -39.21 96.7 0.12 Allowed Pre-proline 0 N--CA 1.494 1.746 0 C-N-CA 126.169 1.788 . . . . 0.0 113.833 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 12.0 Cg_endo -109.92 139.55 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 123.553 2.835 . . . . 0.0 118.113 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -101.58 158.27 0.37 Allowed 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 123.388 2.726 . . . . 0.0 108.327 160.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -87.92 -31.0 19.66 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 117.896 -1.522 . . . . 0.0 109.803 174.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 150.92 -20.47 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 129.621 3.168 . . . . 0.0 103.555 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 25.8 ttt -117.8 166.53 12.35 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 111.708 -2.496 . . . . 0.0 106.757 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . 0.459 ' HB2' ' CE2' ' A' ' 910' ' ' PHE . 38.2 mt-30 -56.42 160.02 3.35 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 124.528 1.142 . . . . 0.0 109.446 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -101.12 131.38 47.08 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' A' ' 908' ' ' GLN . 92.0 m-85 -128.76 139.34 52.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 27.4 p -66.43 166.99 14.23 Favored Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 124.226 0.954 . . . . 0.0 110.944 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -48.78 -24.48 7.03 Favored 'Trans proline' 0 CA--C 1.552 1.405 0 C-N-CA 123.841 3.028 . . . . 0.0 113.075 175.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -87.01 -41.31 13.98 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.725 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 90.8 m -85.7 -17.94 34.53 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.65 74.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 122.127 0.965 . . . . 0.0 108.654 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.78 -29.19 70.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.897 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.484 ' HA ' ' CB ' ' A' ' 921' ' ' ASP . 91.1 mttt -70.4 -35.49 73.5 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.173 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.411 HD12 ' CD2' ' A' ' 910' ' ' PHE . 70.8 mt -64.28 -39.37 85.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -64.75 -75.19 0.09 Allowed 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.1 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -173.92 108.14 0.14 Allowed 'General case' 0 N--CA 1.41 -2.469 0 C-N-CA 125.464 1.505 . . . . 0.0 109.694 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . 0.484 ' CB ' ' HA ' ' A' ' 917' ' ' LYS . 36.6 t70 -129.48 37.51 3.99 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.673 1.225 . . . . 0.0 108.672 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -79.85 101.8 8.74 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.28 172.5 17.24 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.069 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 9.4 p80 . . . . . 0 C--N 1.309 -1.186 0 C-N-CA 125.127 1.371 . . . . 0.0 108.985 172.551 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.675 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 5.3 p -83.59 176.91 8.67 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.027 0.531 . . . . 0.0 110.93 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -76.08 -49.6 17.01 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.287 0.565 . . . . 0.0 110.25 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 21.0 mmt -123.42 160.36 27.01 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.474 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 66.02 19.58 11.21 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.035 0.934 . . . . 0.0 110.989 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -84.74 -12.9 52.78 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.645 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -159.97 -173.11 3.91 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 67.93 30.1 6.25 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.526 1.155 . . . . 0.0 108.15 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 92.3 t -131.91 120.74 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 113.717 -1.583 . . . . 0.0 108.969 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . 0.426 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 45.6 mt -119.75 152.28 22.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -102.97 137.69 40.83 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.161 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.65 172.65 10.27 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.569 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.8 -28.05 66.41 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 122.613 0.365 . . . . 0.0 110.758 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 -74.72 -23.85 58.65 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 107.62 3.82 34.69 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.164 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -69.69 149.0 48.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.977 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -84.62 127.05 33.87 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.737 0.78 . . . . 0.0 112.096 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.426 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 47.0 mm -98.75 117.55 43.97 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -94.24 135.88 35.14 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.742 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.55 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 51.1 mt -105.77 128.35 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 25.7 t -82.75 107.97 10.87 Favored Pre-proline 0 N--CA 1.414 -2.234 0 C-N-CA 125.04 1.336 . . . . 0.0 108.833 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 36.2 Cg_exo -63.17 0.25 1.81 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.459 2.772 . . . . 0.0 113.014 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.3 -33.61 35.05 Favored Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 20.3 p -119.6 -28.43 5.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.816 0.341 . . . . 0.0 110.719 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.0 t30 80.63 29.51 0.21 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.032 2.133 . . . . 0.0 109.04 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -113.05 141.4 25.55 Favored Pre-proline 0 C--O 1.243 0.732 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.038 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -74.43 155.84 45.67 Favored 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 123.324 2.682 . . . . 0.0 112.691 174.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.441 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 19.5 t70 -77.35 145.72 37.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.81 176.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -133.89 5.66 3.63 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.972 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 118.73 40.66 0.65 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.723 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 37.8 m -105.07 166.08 12.07 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -69.35 123.07 9.86 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.636 1.557 . . . . 0.0 109.778 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 53.2 mtp -120.42 161.06 21.86 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.608 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.9 tt -138.26 148.15 25.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -121.14 149.16 17.4 Favored Glycine 0 C--O 1.252 1.224 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.502 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 52.2 t -64.69 160.76 19.22 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.64 1.176 . . . . 0.0 110.995 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.78 -12.34 53.89 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -106.71 -39.41 5.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.586 ' HB2' ' OD1' ' A' ' 890' ' ' ASP . 22.9 m -85.85 -160.87 0.57 Allowed 'General case' 0 CA--C 1.569 1.691 0 CA-C-O 121.849 0.833 . . . . 0.0 113.159 -174.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -133.55 29.63 3.88 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . 0.586 ' OD1' ' HB2' ' A' ' 888' ' ' CYS . 11.7 p-10 -89.28 176.97 6.73 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 112.068 -2.333 . . . . 0.0 112.399 -170.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -152.72 116.94 4.91 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.43 -1.714 . . . . 0.0 106.859 170.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . 0.445 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 26.6 m-85 -107.46 158.67 17.0 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.711 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 42.2 m80 -86.81 144.5 27.01 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.615 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 29.2 m0 -51.9 -54.11 44.09 Favored Pre-proline 0 CA--C 1.552 1.022 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.58 -23.33 64.51 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.158 1.905 . . . . 0.0 113.202 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.711 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 53.5 m -79.73 -21.89 43.96 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.252 0.549 . . . . 0.0 111.531 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 12.6 m -116.46 9.92 7.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.43 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 70.8 38.23 66.08 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 114.928 -1.033 . . . . 0.0 113.199 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.615 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 51.0 mt -111.07 127.05 68.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 120.993 0.425 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 92.7 mmm -123.54 -6.48 8.11 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.133 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -145.16 138.12 26.34 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -59.95 112.69 5.76 Favored Pre-proline 0 C--N 1.317 -0.822 0 O-C-N 124.442 1.089 . . . . 0.0 110.992 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.24 164.49 33.83 Favored 'Trans proline' 0 C--O 1.25 1.108 0 C-N-CA 122.679 2.253 . . . . 0.0 111.184 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.53 126.64 22.95 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.24 1.96 . . . . 0.0 111.98 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 0.5 OUTLIER -82.3 -6.81 59.5 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.724 -178.272 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.43 8.23 39.53 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.815 -1.539 . . . . 0.0 108.882 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 23.0 ttt -122.52 139.62 53.68 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -75.92 137.99 40.73 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -126.99 134.52 50.34 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -124.45 140.17 53.2 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.307 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 892' ' ' TYR . 25.4 p -64.16 163.87 21.7 Favored Pre-proline 0 N--CA 1.424 -1.755 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.682 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.43 -10.54 6.83 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 122.806 2.337 . . . . 0.0 112.434 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 913' ' ' LYS . 74.4 mmtt -87.81 -57.95 2.75 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.431 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 75.1 m -69.25 -25.99 64.56 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.32 68.64 Favored 'General case' 0 C--O 1.198 -1.633 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.5 -5.01 58.46 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -87.77 -44.14 11.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 67.0 mt -72.41 -50.89 32.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.777 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -89.91 79.96 6.52 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -139.16 -59.33 0.59 Allowed 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 37.4 t70 48.37 82.64 0.04 OUTLIER 'General case' 0 C--O 1.243 0.757 0 O-C-N 125.191 1.557 . . . . 0.0 112.789 173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.17 160.55 14.27 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.079 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -151.62 153.7 34.97 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 69.1 t60 . . . . . 0 C--N 1.303 -1.427 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.774 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.129 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 10.8 p -97.48 -50.08 4.65 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 116.686 0.243 . . . . 0.0 111.162 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 57.52 35.73 26.14 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 122.442 1.115 . . . . 0.0 108.638 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 55.3 ttp -71.69 132.21 44.24 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.575 -174.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -84.92 8.15 18.58 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.694 0.759 . . . . 0.0 112.274 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 97.5 mmm -91.32 80.8 5.51 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -154.51 -162.25 1.36 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.379 -175.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -85.38 10.0 13.97 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.395 0.616 . . . . 0.0 110.716 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.83 109.18 18.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 56.4 mt -102.84 148.58 7.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -96.88 122.87 40.32 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.421 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.21 165.52 11.31 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.75 -29.58 70.22 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -94.46 3.67 54.85 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.3 1.048 . . . . 0.0 109.776 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.06 22.22 46.27 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.486 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -76.71 147.73 37.22 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -80.09 113.6 18.38 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.174 0.512 . . . . 0.0 111.765 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 45.8 mm -97.92 118.67 44.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 175.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -99.98 147.0 26.06 Favored 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.334 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.463 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 37.4 mt -113.49 132.49 62.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.898 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 53.8 t -86.81 107.15 12.85 Favored Pre-proline 0 N--CA 1.405 -2.686 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 24.6 Cg_exo -65.01 1.35 1.94 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.14 2.56 . . . . 0.0 113.852 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -77.44 -50.4 6.68 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 4.4 p -102.24 -19.26 15.13 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 123.093 0.557 . . . . 0.0 110.288 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 77.56 19.39 1.21 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.557 1.543 . . . . 0.0 109.857 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -103.07 140.61 21.21 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.153 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 48.1 Cg_endo -74.85 173.02 15.16 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 123.269 2.646 . . . . 0.0 112.067 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.38 129.18 40.64 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.516 0.674 . . . . 0.0 111.101 174.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -118.06 34.36 5.21 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 73.54 44.1 34.36 Favored Glycine 0 CA--C 1.493 -1.287 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -173.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.5 p -120.23 151.04 52.71 Favored Pre-proline 0 N--CA 1.412 -2.338 0 CA-C-N 113.871 -1.164 . . . . 0.0 111.526 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.75 120.18 6.28 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 121.88 1.72 . . . . 0.0 109.995 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 76.3 mtp -115.94 150.28 37.4 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.839 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.6 tt -123.27 140.0 48.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -107.08 144.63 15.91 Favored Glycine 0 C--O 1.247 0.937 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.284 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.44 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 44.5 t -70.05 147.73 49.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.351 0.596 . . . . 0.0 112.08 -178.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -81.9 -24.22 35.81 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.249 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.2 -51.79 9.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 120.989 0.424 . . . . 0.0 110.002 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 10.5 p -107.7 -92.86 0.41 Allowed 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.1 t70 179.62 -30.78 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.325 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -50.72 134.33 24.97 Favored 'General case' 0 C--O 1.247 0.947 0 O-C-N 124.703 1.252 . . . . 0.0 112.384 -172.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -101.9 133.16 47.11 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.333 -172.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -117.84 155.55 29.91 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.411 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.3 m80 -77.21 143.57 38.91 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.487 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 27.7 m0 -49.8 -53.78 38.7 Favored Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.14 -19.02 65.1 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.228 1.952 . . . . 0.0 113.795 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 79.3 m -84.11 -23.7 30.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.003 0.43 . . . . 0.0 111.925 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 893' ' ' HIS . 12.5 m -114.98 5.98 7.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.934 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 75.64 44.8 19.6 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.837 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.487 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 7.7 mm -110.32 109.7 29.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 mmt -109.61 -2.29 17.61 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.182 0.515 . . . . 0.0 110.43 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -154.32 143.62 21.32 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -58.1 116.76 15.75 Favored Pre-proline 0 N--CA 1.438 -1.058 0 O-C-N 124.225 0.953 . . . . 0.0 110.673 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -68.19 140.33 48.85 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.262 1.975 . . . . 0.0 110.632 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.11 152.84 56.35 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.571 2.181 . . . . 0.0 112.261 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 1.0 OUTLIER -73.67 -5.51 41.01 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.216 -178.064 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.37 -10.91 47.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.691 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 24.0 ttt -95.35 125.76 40.19 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.64 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -84.49 126.78 33.59 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -123.84 129.46 51.05 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.907 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.44 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 55.3 m-85 -120.13 142.44 48.92 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 25.7 p -63.9 160.21 48.23 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -51.53 -23.56 14.9 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.883 2.388 . . . . 0.0 112.529 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.567 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 33.3 mmtp -68.36 -55.19 12.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.37 0.668 . . . . 0.0 109.578 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.508 ' SG ' ' HE2' ' A' ' 917' ' ' LYS . 78.7 m -77.57 -22.09 51.5 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.493 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -63.56 -35.66 81.24 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.443 1.116 . . . . 0.0 108.585 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -76.72 -17.5 59.05 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.165 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.508 ' HE2' ' SG ' ' A' ' 914' ' ' CYS . 43.7 mtmt -85.76 -16.39 39.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 49.9 mm -67.54 -32.05 55.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp 52.76 118.77 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 127.211 2.204 . . . . 0.0 115.601 176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -83.13 73.19 10.1 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 122.551 1.167 . . . . 0.0 108.416 173.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -93.43 -33.15 13.94 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 113.619 -1.628 . . . . 0.0 107.578 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -99.09 -174.25 2.71 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . 0.424 ' HB2' ' HZ1' ' A' ' 923' ' ' LYS . 3.1 ttmp? -80.01 156.76 27.0 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.264 0.554 . . . . 0.0 110.647 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 76.4 t60 . . . . . 0 C--N 1.305 -1.352 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.698 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.17 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 51.6 m 61.82 -174.2 0.14 Allowed 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.409 0.684 . . . . 0.0 111.464 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . 0.436 ' HE1' ' OD1' ' A' ' 874' ' ' ASN . 60.7 t60 -87.9 87.24 7.29 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 60.2 mtt -94.92 84.71 4.21 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 121.709 0.766 . . . . 0.0 111.14 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -143.6 119.1 10.34 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 26.1 mmt -82.91 -31.4 27.81 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -159.17 179.0 9.41 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -108.5 11.9 26.5 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.965 0.888 . . . . 0.0 109.647 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.05 110.61 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.864 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 58.8 mt -117.15 160.88 16.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -115.18 136.89 52.63 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.754 0.706 . . . . 0.0 110.544 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.17 176.73 7.04 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 124.831 1.252 . . . . 0.0 109.065 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.58 -26.81 62.76 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.248 0.619 . . . . 0.0 110.209 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.61 -3.34 50.04 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.317 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.69 -2.95 86.29 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 116.161 -0.472 . . . . 0.0 113.056 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -71.24 153.22 42.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 123.611 0.242 . . . . 0.0 111.019 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -71.26 146.72 48.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.557 0.694 . . . . 0.0 111.75 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 31.3 mm -120.79 126.88 75.75 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' A' ' 876' ' ' PRO . 26.1 m-90 -100.47 153.89 18.98 Favored 'General case' 0 C--N 1.285 -2.199 0 O-C-N 123.643 0.589 . . . . 0.0 111.235 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 39.8 mt -118.15 117.48 54.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.745 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 38.4 t -73.81 111.65 13.15 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.28 7.97 2.74 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.984 1.79 . . . . 0.0 112.5 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.65 -27.11 43.75 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 8.4 p -121.52 -32.95 3.73 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.727 0.775 . . . . 0.0 109.411 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . 0.436 ' OD1' ' HE1' ' A' ' 852' ' ' HIS . 55.8 m-80 80.45 39.78 0.08 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 126.745 2.018 . . . . 0.0 109.944 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -118.33 143.69 33.6 Favored Pre-proline 0 N--CA 1.446 -0.674 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.305 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 868' ' ' TRP . 50.7 Cg_endo -74.59 173.98 13.41 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 123.398 2.732 . . . . 0.0 113.018 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.42 138.93 2.21 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.071 0.949 . . . . 0.0 111.889 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -118.04 -22.97 7.6 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.144 0.974 . . . . 0.0 109.356 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 116.01 -10.49 17.97 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -171.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 11.9 p -65.05 153.0 90.04 Favored Pre-proline 0 N--CA 1.433 -1.301 0 C-N-CA 125.569 1.548 . . . . 0.0 111.193 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.54 137.37 46.17 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 122.278 1.985 . . . . 0.0 109.834 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 83.8 mtp -125.5 149.61 48.13 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.2 tt -118.84 150.75 21.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -113.76 144.92 18.33 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.418 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 49.2 t -76.72 154.69 33.88 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.58 -9.97 36.31 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.155 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.96 -64.13 1.2 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 1.6 p -94.57 -49.27 5.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.101 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 14.1 t70 80.01 79.54 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.471 1.508 . . . . 0.0 113.489 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -129.74 177.77 6.99 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -99.63 123.56 44.01 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 119.339 0.972 . . . . 0.0 112.819 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -116.82 148.69 41.0 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.748 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 49.1 m80 -76.85 144.08 39.27 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.219 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -52.77 -57.8 14.55 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.03 -11.21 30.08 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.77 1.647 . . . . 0.0 113.672 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.748 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -84.11 -37.05 22.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.285 0.564 . . . . 0.0 111.855 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.504 HG21 HG12 ' A' ' 899' ' ' ILE . 27.0 m -102.03 -8.63 9.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.772 -176.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 95.96 56.31 1.23 Allowed Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.592 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.504 HG12 HG21 ' A' ' 897' ' ' VAL . 9.0 mm -130.47 125.8 59.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 87.6 mtp -127.02 8.12 6.69 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.738 0.78 . . . . 0.0 110.411 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . 0.731 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -173.95 145.81 1.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -66.18 103.02 0.4 Allowed Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.7 1.2 . . . . 0.0 112.877 -174.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . 0.731 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 25.5 Cg_endo -105.69 131.0 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 124.019 3.146 . . . . 0.0 115.998 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -100.01 148.78 0.45 Allowed 'Trans proline' 0 N--CA 1.43 -2.221 0 C-N-CA 122.745 2.297 . . . . 0.0 109.481 164.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -70.03 -46.98 63.89 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 149.8 -11.41 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 130.221 3.408 . . . . 0.0 103.516 -172.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 23.5 ttt -135.29 169.39 17.55 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 112.309 -2.223 . . . . 0.0 105.747 -175.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -45.7 157.99 0.09 Allowed 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.813 1.645 . . . . 0.0 113.421 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -108.85 137.5 46.68 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.464 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -126.02 138.25 53.71 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 27.4 p -69.33 163.44 58.19 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.037 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.06 -23.47 22.03 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 123.847 3.031 . . . . 0.0 112.492 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.486 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 29.9 mmmt -69.04 -44.02 73.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 73.6 m -89.01 -27.42 20.88 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.004 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.6 -24.91 61.98 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 120.777 0.322 . . . . 0.0 110.379 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.31 -13.84 59.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.606 0.717 . . . . 0.0 109.792 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -73.39 -29.58 62.7 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 54.4 mt -94.72 -60.62 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.382 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -96.03 147.28 23.87 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.208 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -123.98 85.07 2.36 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.38 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -105.14 -13.67 15.64 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -141.3 159.23 42.66 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.599 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.61 8.77 0.69 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.634 0.73 . . . . 0.0 111.434 176.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 . . . . . 0 C--N 1.302 -1.461 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -178.961 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.532 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 47.0 t -166.49 158.68 13.77 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -74.28 -18.77 60.67 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 173.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 71.8 mtm 66.0 31.97 8.73 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.35 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -77.6 70.84 4.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.185 0.993 . . . . 0.0 109.325 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 53.7 mtm -138.76 20.88 2.68 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -94.56 -177.53 4.26 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.971 -174.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . 0.442 ' CE1' ' HA ' ' A' ' 871' ' ' PRO . 54.9 m-85 -86.87 19.37 3.02 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.576 0.703 . . . . 0.0 110.123 -175.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.35 121.08 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.749 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 59.0 mt -124.83 154.22 32.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -91.82 125.52 36.56 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.925 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -71.01 171.58 10.6 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.293 -1.322 . . . . 0.0 109.043 172.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.39 -29.15 69.25 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 122.602 0.361 . . . . 0.0 111.884 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . 0.49 ' HB3' ' ND2' ' A' ' 865' ' ' ASN . 44.2 t-105 -87.92 -11.93 46.18 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 97.95 15.05 37.64 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.812 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.49 ' ND2' ' HB3' ' A' ' 863' ' ' TRP . 45.9 m-80 -71.36 151.85 43.73 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -78.05 116.21 18.36 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 25.2 mm -64.15 114.59 2.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 122.172 0.987 . . . . 0.0 111.518 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.66 105.64 0.32 Allowed 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 111.478 -2.601 . . . . 0.0 110.988 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.501 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 40.4 mt -127.07 131.04 71.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 891' ' ' TRP . 52.6 t -85.81 110.23 28.57 Favored Pre-proline 0 N--CA 1.418 -2.055 0 O-C-N 124.164 0.915 . . . . 0.0 108.849 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 50.6 Cg_exo -57.0 -20.34 36.54 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.394 2.729 . . . . 0.0 113.028 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -68.97 -36.04 80.43 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.539 -0.362 . . . . 0.0 112.962 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 12.3 p -118.51 -13.54 9.71 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.806 0.303 . . . . 0.0 111.289 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 72.36 24.18 3.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.25 1.42 . . . . 0.0 109.692 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -113.6 138.41 22.58 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 121.771 -0.58 . . . . 0.0 112.071 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 57.1 Cg_endo -73.22 174.03 12.74 Favored 'Trans proline' 0 C--O 1.253 1.228 0 C-N-CA 124.154 3.236 . . . . 0.0 113.328 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.09 137.09 57.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.676 176.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -122.57 25.21 8.9 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.597 1.189 . . . . 0.0 107.856 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 81.52 52.47 4.18 Favored Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 106.438 -2.665 . . . . 0.0 106.438 -171.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 3.7 p -124.0 152.57 66.94 Favored Pre-proline 0 N--CA 1.413 -2.278 0 CA-C-N 113.861 -1.17 . . . . 0.0 112.239 -170.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -72.23 112.58 3.47 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.032 1.822 . . . . 0.0 110.048 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 79.3 mtp -122.15 144.16 49.12 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.762 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 15.9 tt -117.19 152.18 19.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.779 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -110.17 156.38 15.61 Favored Glycine 0 CA--C 1.538 1.518 0 O-C-N 123.206 0.316 . . . . 0.0 113.441 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.473 ' H ' ' CG ' ' A' ' 890' ' ' ASP . 43.8 t -84.92 -170.26 3.04 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 126.31 1.844 . . . . 0.0 109.157 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -123.08 -11.54 8.04 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -107.91 -54.63 2.47 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -173.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 15.7 p -99.57 -134.79 0.28 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -165.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -128.74 89.48 2.89 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 885' ' ' CYS . 2.6 p30 -128.06 148.69 50.56 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -158.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . 0.497 ' O ' ' HA ' ' A' ' 870' ' ' CYS . 68.2 m95 -161.52 117.66 2.13 Favored 'General case' 0 C--O 1.208 -1.129 0 C-N-CA 128.058 2.543 . . . . 0.0 106.929 160.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -124.54 148.73 47.59 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.462 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.674 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 57.9 m80 -80.8 144.86 31.77 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -53.53 -52.68 64.66 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.2 -11.59 32.79 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.998 1.799 . . . . 0.0 113.122 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.674 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 87.6 m -84.66 -32.14 23.79 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.648 0.737 . . . . 0.0 110.928 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 893' ' ' HIS . 20.9 m -101.52 -27.46 3.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.934 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 104.22 52.99 0.85 Allowed Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.052 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.79 136.64 58.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.026 0.441 . . . . 0.0 110.854 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.8 ptp -128.37 -1.11 5.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.849 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -150.4 141.72 23.27 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -71.91 112.34 13.96 Favored Pre-proline 0 C--N 1.311 -1.089 0 C-N-CA 123.039 0.536 . . . . 0.0 111.912 -176.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 41.0 Cg_endo -75.43 129.81 12.29 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.506 2.137 . . . . 0.0 111.029 175.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . 0.458 ' HB2' ' HG2' ' A' ' 906' ' ' GLU . 35.9 Cg_exo -60.39 143.76 99.49 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.661 2.241 . . . . 0.0 111.73 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -71.08 -2.9 17.14 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 904' ' ' PRO . 9.1 pt-20 -69.46 -18.6 63.73 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.322 0.582 . . . . 0.0 109.488 171.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 51.3 ttm -100.41 128.82 46.37 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -77.21 128.7 34.84 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -118.5 140.37 49.97 Favored 'General case' 0 C--N 1.26 -3.287 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -129.53 136.41 49.81 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 9.0 p -73.85 167.25 37.02 Favored Pre-proline 0 N--CA 1.415 -2.207 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.183 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.05 -19.7 21.05 Favored 'Trans proline' 0 CA--C 1.551 1.331 0 C-N-CA 122.976 2.451 . . . . 0.0 112.41 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -81.16 -37.02 29.45 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 110.285 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 97.3 m -89.1 -30.02 18.95 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.808 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.13 68.17 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.05 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -73.05 -19.43 61.18 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.281 0.562 . . . . 0.0 111.562 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -101.05 -27.68 13.14 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.201 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 72.7 mt -76.57 -54.79 12.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 121.249 0.547 . . . . 0.0 109.53 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -100.04 -176.95 3.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt 54.31 -157.25 0.2 Allowed 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.393 1.077 . . . . 0.0 111.729 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -122.37 159.77 26.81 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -79.14 171.88 14.58 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 125.195 1.398 . . . . 0.0 111.522 -175.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -147.1 150.98 36.08 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 36.8 m80 . . . . . 0 C--N 1.31 -1.127 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 170.579 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.384 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 51.5 m -77.57 130.45 36.93 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.105 0.453 . . . . 0.0 109.804 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 74.28 81.0 0.12 Allowed 'General case' 0 CA--C 1.511 -0.519 0 C-N-CA 124.282 1.033 . . . . 0.0 111.486 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 95.9 mmm -98.37 115.05 27.64 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.895 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 67.61 13.3 9.23 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.407 1.083 . . . . 0.0 110.589 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 65.4 mtt -100.24 98.68 9.33 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -116.89 -159.14 0.72 Allowed 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -90.03 19.73 4.74 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 122.179 0.99 . . . . 0.0 109.261 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 8.1 p -143.42 130.36 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.684 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . 0.428 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 44.2 mt -124.39 150.75 29.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -94.75 125.06 39.16 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.622 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.02 172.37 11.13 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.157 174.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.93 -30.39 71.48 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 123.644 0.778 . . . . 0.0 111.188 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -85.53 -0.67 55.67 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.435 0.636 . . . . 0.0 110.465 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 84.01 3.76 88.91 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.213 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -73.01 149.65 43.08 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -78.96 128.17 32.93 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.532 0.682 . . . . 0.0 111.371 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 858' ' ' VAL . 32.4 mm -96.02 121.61 46.73 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 23.4 m-90 -99.76 139.35 35.55 Favored 'General case' 0 C--N 1.264 -3.121 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.597 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 31.6 mt -103.97 119.16 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.404 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 50.7 t -61.89 108.83 1.76 Allowed Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 125.143 1.377 . . . . 0.0 108.222 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 52.6 Cg_exo -57.7 -16.99 27.05 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.735 2.957 . . . . 0.0 113.22 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -70.88 -46.43 45.35 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.246 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 17.0 p -106.75 -28.01 10.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -173.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 63.4 t30 81.25 27.84 0.19 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.714 1.606 . . . . 0.0 109.221 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.53 139.33 20.0 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.182 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -76.17 162.73 33.77 Favored 'Trans proline' 0 C--O 1.251 1.173 0 C-N-CA 123.08 2.52 . . . . 0.0 112.583 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.413 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 17.5 t70 -65.96 141.38 58.22 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.46 14.59 8.23 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 122.781 1.277 . . . . 0.0 107.965 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 85.29 52.66 3.33 Favored Glycine 0 N--CA 1.423 -2.186 0 N-CA-C 105.828 -2.909 . . . . 0.0 105.828 -170.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 11.4 p -119.69 153.54 54.44 Favored Pre-proline 0 N--CA 1.418 -2.034 0 CA-C-N 113.927 -1.137 . . . . 0.0 111.091 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.97 118.67 5.69 Favored 'Trans proline' 0 C--O 1.257 1.429 0 C-N-CA 122.24 1.96 . . . . 0.0 109.951 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.413 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 77.0 mtp -125.32 142.32 51.57 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.074 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.3 tt -110.73 144.88 17.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -110.99 163.52 12.25 Favored Glycine 0 C--N 1.301 -1.395 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.078 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.436 ' H ' ' CG ' ' A' ' 890' ' ' ASP . 51.2 t -88.99 -164.33 1.12 Allowed 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 126.027 1.731 . . . . 0.0 108.551 -177.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -131.34 -8.96 3.74 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.637 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -109.0 -46.93 3.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.4 p -104.29 -126.73 0.23 Allowed 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -166.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -136.02 88.54 2.4 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 885' ' ' CYS . 3.1 p30 -127.74 146.89 50.43 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 113.085 -1.87 . . . . 0.0 115.238 -161.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -162.39 117.62 1.88 Allowed 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 128.046 2.538 . . . . 0.0 106.349 158.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . 0.42 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 44.8 m-85 -123.25 148.97 45.32 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.752 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.8 m80 -77.91 145.85 35.91 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.505 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 31.6 m0 -51.95 -55.63 28.87 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 175.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.28 -12.68 34.04 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.426 2.084 . . . . 0.0 113.99 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.752 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.3 m -86.49 -21.88 26.74 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.027 0.442 . . . . 0.0 111.069 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.471 HG22 HG12 ' A' ' 899' ' ' ILE . 14.4 m -120.52 5.79 6.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.144 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 84.15 23.4 51.95 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.712 175.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.505 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 16.9 mm -91.04 121.6 41.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 18.3 ptm -118.29 -6.14 10.83 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.281 0.562 . . . . 0.0 110.568 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.1 149.81 21.57 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -60.32 112.95 6.28 Favored Pre-proline 0 C--N 1.314 -0.977 0 O-C-N 124.172 0.92 . . . . 0.0 111.004 -177.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -72.8 162.5 40.97 Favored 'Trans proline' 0 C--O 1.248 0.993 0 C-N-CA 123.155 2.57 . . . . 0.0 111.111 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.77 123.3 13.53 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.568 2.179 . . . . 0.0 111.682 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.42 -17.66 63.99 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.173 -0.922 . . . . 0.0 113.281 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -87.38 -9.42 54.82 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.919 0.39 . . . . 0.0 110.757 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 48.2 ttm -80.47 133.14 35.81 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -77.02 135.42 38.66 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -136.4 135.71 38.98 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -126.52 139.18 53.42 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 16.9 p -64.7 167.15 9.64 Favored Pre-proline 0 C--N 1.29 -2.003 0 O-C-N 124.2 0.937 . . . . 0.0 111.892 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -56.17 -13.4 9.52 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 123.074 2.516 . . . . 0.0 112.128 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 31.6 mmmt -84.34 -60.57 2.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 92.5 m -73.04 -27.41 61.74 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.78 78.22 Favored 'General case' 0 C--O 1.201 -1.481 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -72.42 -22.81 61.05 Favored 'General case' 0 C--O 1.211 -0.924 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -72.06 -46.44 56.9 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.42 -43.71 77.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.465 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -94.46 28.33 2.63 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 123.664 0.785 . . . . 0.0 109.787 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -66.7 -33.26 75.25 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.662 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -142.5 107.08 4.82 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.365 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -73.13 100.77 3.14 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 170.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -83.85 147.61 27.45 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.176 -169.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 61.0 m80 . . . . . 0 C--N 1.299 -1.628 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.604 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.79 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 18.9 m -105.53 24.61 11.9 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.612 0.72 . . . . 0.0 109.247 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -93.96 28.08 2.56 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.2 -65.49 0.67 Allowed 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.329 -176.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 57.61 27.09 13.69 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.642 1.177 . . . . 0.0 110.793 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 21.3 ptp -134.19 -163.27 1.34 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.598 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . 0.43 ' O ' HD13 ' A' ' 869' ' ' ILE . . . 70.01 -150.56 0.11 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -175.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . 0.43 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 97.0 m-85 -86.77 16.49 4.75 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 118.568 0.622 . . . . 0.0 112.318 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 14.0 p -143.62 118.89 4.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.635 0.731 . . . . 0.0 112.231 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 47.5 mt -114.84 160.87 13.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -103.78 130.65 51.34 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.233 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.83 175.29 2.5 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 125.623 1.569 . . . . 0.0 111.123 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -58.32 -40.17 81.37 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 124.937 1.295 . . . . 0.0 111.107 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . 0.47 ' HB3' ' ND2' ' A' ' 865' ' ' ASN . 66.9 t-105 -80.12 -25.92 39.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.369 0.604 . . . . 0.0 110.037 177.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 117.6 7.21 12.25 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.47 ' ND2' ' HB3' ' A' ' 863' ' ' TRP . 46.0 m-80 -64.25 159.9 19.8 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -85.24 117.4 24.16 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.332 0.587 . . . . 0.0 109.954 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 42.4 mm -90.76 114.02 27.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -86.13 128.07 34.82 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.847 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 33.3 mt -100.9 123.7 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.15 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.1 t -77.71 117.2 64.15 Favored Pre-proline 0 N--CA 1.408 -2.533 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.152 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . 0.536 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 58.6 Cg_exo -56.5 -17.82 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.656 2.904 . . . . 0.0 113.32 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.75 -21.42 76.79 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 121.314 -0.469 . . . . 0.0 113.295 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 10.8 p -138.21 -10.6 1.48 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.301 0.551 . . . . 0.0 112.231 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.257 2.3 p-10 61.15 25.44 15.44 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.299 1.84 . . . . 0.0 111.129 -173.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -106.33 140.21 21.07 Favored Pre-proline 0 N--CA 1.435 -1.222 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.3 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.73 173.65 14.15 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 123.347 2.698 . . . . 0.0 112.336 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.96 138.7 42.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.616 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -119.58 -6.1 10.22 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.895 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 89.66 21.12 41.34 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -172.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.6 t -100.89 161.32 24.13 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.36 113.62 1.76 Allowed 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.732 2.288 . . . . 0.0 111.649 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 85.6 mtp -109.92 156.83 19.92 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.02 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.6 tt -126.6 142.73 42.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.92 152.39 19.66 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.579 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 48.8 t -85.15 169.89 13.43 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.649 0.738 . . . . 0.0 110.325 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.65 -32.96 16.01 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . 0.478 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 14.4 t70 -100.88 -38.31 8.29 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.529 -174.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 60.5 m -89.42 158.49 17.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.148 0.499 . . . . 0.0 110.255 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.64 -0.28 43.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -86.84 159.34 19.11 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.461 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -117.0 142.4 47.0 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.156 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . 0.536 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 64.4 m-85 -114.69 171.33 7.7 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.757 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 65.2 m80 -99.12 151.93 20.43 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -54.35 -53.29 61.04 Favored Pre-proline 0 CA--C 1.553 1.094 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.65 -29.75 90.55 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.75 1.633 . . . . 0.0 113.011 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.757 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 28.5 m -70.41 -21.68 62.81 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.859 0.837 . . . . 0.0 111.901 -175.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.25 10.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.198 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 71.79 46.61 37.15 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.243 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.14 136.37 58.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 62.3 mtt -128.19 -4.92 5.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.52 156.43 30.23 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . 0.439 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -44.0 114.24 1.79 Allowed Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 125.206 1.566 . . . . 0.0 112.149 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 11.4 Cg_endo -57.09 177.58 0.18 Allowed 'Trans proline' 0 CA--C 1.57 2.302 0 C-N-CA 123.913 3.075 . . . . 0.0 113.066 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 906' ' ' GLU . 22.5 Cg_exo -46.62 -165.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 125.254 3.97 . . . . 0.0 117.937 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -63.8 37.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 127.839 2.456 . . . . 0.0 113.94 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.462 ' H ' ' C ' ' A' ' 904' ' ' PRO 0.269 2.4 pt-20 50.08 26.99 2.3 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 126.783 2.033 . . . . 0.0 112.915 -177.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.4 tpt -61.47 145.93 50.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 170.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -44.97 126.03 5.57 Favored 'General case' 0 C--O 1.248 1.012 0 O-C-N 124.477 1.111 . . . . 0.0 113.879 -170.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -116.95 133.43 56.02 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.985 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -127.47 141.98 51.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 7.6 p -75.43 168.63 25.88 Favored Pre-proline 0 N--CA 1.421 -1.922 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.972 178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.72 -24.15 29.11 Favored 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 123.075 2.517 . . . . 0.0 111.803 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 0.0 OUTLIER -70.1 -58.5 3.74 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.98 176.767 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 87.2 m -72.91 -21.48 60.9 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.29 -20.2 65.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.51 -34.84 27.81 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.417 ' NZ ' ' SG ' ' A' ' 914' ' ' CYS . 22.5 mtmm -67.5 -43.18 81.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.508 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 72.0 mt -66.68 -36.18 76.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt 76.55 132.28 0.05 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.914 1.686 . . . . 0.0 111.662 174.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -84.95 -24.37 28.37 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . 0.469 ' CG ' ' H ' ' A' ' 922' ' ' LYS . 17.0 t70 61.89 -161.74 0.29 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.665 1.186 . . . . 0.0 110.277 172.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . 0.469 ' H ' ' CG ' ' A' ' 921' ' ' ASP . 28.2 mtpp -85.64 63.07 7.85 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -56.44 130.49 45.1 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.865 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 40.3 m80 . . . . . 0 N--CA 1.418 -2.067 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 173.904 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.644 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 22.8 t -75.29 144.59 42.4 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -77.13 75.01 3.7 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.846 0.831 . . . . 0.0 111.881 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 66.7 mtt -119.1 -53.67 2.25 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.086 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -102.31 13.1 35.53 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.257 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 86.3 mtp -121.22 108.33 13.62 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -149.21 172.8 14.25 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.734 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -107.26 0.18 23.02 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.394 1.092 . . . . 0.0 108.269 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 42.5 t -130.79 101.08 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 112.672 -2.058 . . . . 0.0 105.483 172.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 40.0 mt -103.58 154.24 5.77 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -102.22 125.14 48.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.514 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . 0.431 ' HB3' ' H ' ' A' ' 865' ' ' ASN . 17.6 t70 -67.19 177.24 1.87 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.663 176.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -72.99 -25.11 60.87 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.357 0.599 . . . . 0.0 110.298 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -87.69 -12.64 44.77 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.157 0.98 . . . . 0.0 108.7 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 93.57 19.53 34.69 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.933 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.431 ' H ' ' HB3' ' A' ' 861' ' ' ASP . 63.8 m-20 -72.78 150.95 42.34 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -77.93 110.42 12.82 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 121.61 0.719 . . . . 0.0 110.696 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 46.3 mm -94.82 115.39 33.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -103.6 145.55 29.88 Favored 'General case' 0 C--N 1.255 -3.529 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.217 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.87 120.49 52.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . 0.406 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.7 t -78.59 119.66 78.12 Favored Pre-proline 0 N--CA 1.404 -2.737 0 C-N-CA 125.0 1.32 . . . . 0.0 108.316 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.4 -4.58 13.17 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.63 2.22 . . . . 0.0 111.629 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -72.02 -43.5 48.64 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 5.7 p -114.49 -24.32 8.89 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.7 t30 78.75 24.66 0.55 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.824 1.65 . . . . 0.0 108.235 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -110.25 139.63 21.63 Favored Pre-proline 0 C--O 1.244 0.783 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.983 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.81 165.52 32.53 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.182 2.588 . . . . 0.0 112.361 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.437 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 16.6 t0 -60.49 117.33 5.15 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.634 0.731 . . . . 0.0 112.375 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.81 6.42 46.87 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.661 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 105.66 40.08 2.09 Favored Glycine 0 N--CA 1.435 -1.413 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 49.1 m -123.82 159.23 56.96 Favored Pre-proline 0 N--CA 1.428 -1.549 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.14 133.62 25.3 Favored 'Trans proline' 0 C--O 1.252 1.204 0 C-N-CA 122.405 2.07 . . . . 0.0 110.896 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.407 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 64.6 mtp -123.11 163.11 21.17 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.872 -178.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . 0.452 ' HB ' ' HE1' ' A' ' 894' ' ' TRP . 17.6 tt -141.28 143.23 28.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.95 151.96 17.29 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.629 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 53.8 t -76.09 150.97 37.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.094 0.473 . . . . 0.0 110.481 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -82.55 -25.56 33.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.748 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -97.33 -40.33 8.78 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.309 -0.556 . . . . 0.0 112.343 -173.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 32.0 p -98.49 -106.13 0.2 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 117.879 -1.528 . . . . 0.0 114.11 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -158.79 -41.79 0.06 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.985 -170.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.77 161.12 30.42 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -170.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -112.26 133.76 54.19 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.345 -1.752 . . . . 0.0 108.384 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -117.22 159.17 23.08 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.579 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 56.2 m80 -82.93 144.74 29.81 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.145 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.452 ' HE1' ' HB ' ' A' ' 883' ' ' ILE . 38.2 m0 -53.52 -48.95 91.17 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 177.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 28.4 Cg_endo -63.71 -13.97 40.02 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.275 1.983 . . . . 0.0 113.088 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -89.37 -26.67 20.93 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.241 0.543 . . . . 0.0 111.803 -176.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 893' ' ' HIS . 18.8 m -110.11 -4.93 10.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.443 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 83.67 48.17 5.35 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.723 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 46.1 mt -112.89 121.87 65.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.605 0.717 . . . . 0.0 111.517 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 96.2 mmm -92.7 -31.19 15.19 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.345 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.74 159.67 35.49 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -48.26 109.58 1.19 Allowed Pre-proline 0 C--N 1.323 -0.554 0 O-C-N 124.73 1.268 . . . . 0.0 111.659 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.25 147.02 95.16 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 123.236 2.624 . . . . 0.0 112.406 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.19 136.12 54.23 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.493 2.129 . . . . 0.0 110.803 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.56 1.44 16.76 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.53 -9.62 59.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.917 0.865 . . . . 0.0 108.819 173.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 36.4 ttm -113.51 121.79 45.31 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -76.28 131.15 39.07 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -104.5 124.81 49.93 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.121 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -124.9 142.61 51.34 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 28.6 p -66.95 166.2 21.17 Favored Pre-proline 0 C--N 1.294 -1.817 0 O-C-N 123.609 0.568 . . . . 0.0 111.5 -176.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -49.54 -27.28 14.03 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.431 2.754 . . . . 0.0 112.509 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -82.04 -47.93 12.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.341 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 917' ' ' LYS . 92.5 m -78.38 -32.61 48.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . 0.499 ' O ' ' HG2' ' A' ' 919' ' ' LYS . . . -66.1 -32.03 73.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.51 -35.78 76.79 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.186 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.431 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 27.3 mtmt -70.77 -18.18 62.77 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.102 0.561 . . . . 0.0 110.656 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 51.0 mt -97.24 -33.18 4.3 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 CA-C-O 121.758 0.79 . . . . 0.0 109.771 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 915' ' ' ALA . 29.3 mmmt -86.4 -31.11 21.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.687 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -83.11 135.04 34.96 Favored 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.821 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 4.4 t70 68.65 -168.12 0.18 Allowed 'General case' 0 C--N 1.32 -0.686 0 O-C-N 124.647 1.217 . . . . 0.0 109.94 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . 0.473 ' HB3' ' HZ1' ' A' ' 922' ' ' LYS . 0.3 OUTLIER -114.88 -8.03 12.57 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -140.37 -172.4 3.42 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 . . . . . 0 C--N 1.297 -1.695 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.054 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.216 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 4.4 p -141.31 77.17 1.58 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.863 0.84 . . . . 0.0 111.343 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -178.29 -74.17 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.693 -1.594 . . . . 0.0 107.496 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 36.7 tpp 51.07 89.7 0.02 OUTLIER 'General case' 0 C--O 1.243 0.755 0 C-N-CA 125.286 1.435 . . . . 0.0 113.193 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -84.93 127.67 34.28 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.066 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 69.9 mtm -78.32 80.72 4.71 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.398 0.618 . . . . 0.0 109.428 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -132.54 178.73 6.61 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 67.4 27.84 7.97 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -174.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 64.4 t -138.73 121.09 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 113.316 -1.765 . . . . 0.0 108.267 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 55.7 mt -127.48 148.92 32.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 41.3 mtt180 -95.02 125.06 39.42 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 121.734 0.778 . . . . 0.0 110.891 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.93 171.73 3.32 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.629 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -60.86 -36.38 79.02 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 124.024 0.929 . . . . 0.0 110.6 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . 0.505 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 92.8 m95 -87.0 -10.15 53.84 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.376 0.608 . . . . 0.0 111.05 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 100.34 8.44 49.89 Favored Glycine 0 CA--C 1.5 -0.883 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.357 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.505 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 37.1 m-80 -71.79 160.94 31.72 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . 0.448 ' OE1' ' HA ' ' A' ' 866' ' ' GLN . 14.4 mm-40 -90.81 133.35 35.27 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 122.124 0.964 . . . . 0.0 112.159 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 858' ' ' VAL . 45.8 mm -110.63 121.81 64.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 113.532 -1.667 . . . . 0.0 108.114 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -101.35 140.12 36.08 Favored 'General case' 0 C--N 1.271 -2.808 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.565 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.501 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 36.4 mt -106.08 124.31 61.27 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 42.2 t -78.2 113.91 37.79 Favored Pre-proline 0 N--CA 1.404 -2.762 0 O-C-N 124.442 1.089 . . . . 0.0 108.743 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . 0.539 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 37.6 Cg_exo -61.19 -2.47 2.38 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.282 2.655 . . . . 0.0 113.309 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.06 -39.69 19.02 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.5 p -114.98 -25.81 8.0 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.349 0.66 . . . . 0.0 111.554 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 76.48 26.52 0.88 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.886 1.675 . . . . 0.0 110.085 -173.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -108.03 138.82 20.21 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.466 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 44.5 Cg_endo -72.83 170.71 19.0 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.369 2.713 . . . . 0.0 113.749 176.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -64.31 133.28 52.39 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.097 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -123.44 6.73 8.97 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.903 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 93.65 22.86 25.15 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 2.7 p -96.31 155.85 37.58 Favored Pre-proline 0 C--N 1.296 -1.722 0 C-N-CA 123.35 0.66 . . . . 0.0 110.408 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.43 118.09 4.93 Favored 'Trans proline' 0 C--O 1.257 1.456 0 C-N-CA 122.069 1.846 . . . . 0.0 111.568 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.6 mtp -113.4 162.92 15.51 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.569 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.5 tt -130.64 145.29 35.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -108.95 151.02 17.14 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 42.6 t -80.74 178.85 8.1 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.513 0.673 . . . . 0.0 110.929 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . 0.42 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 28.9 t70 -110.48 -18.44 13.21 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.941 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . 0.418 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 16.4 t70 -95.93 -46.96 6.32 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 25.4 p -101.87 -179.07 3.9 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -117.81 17.64 14.23 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.349 1.071 . . . . 0.0 109.45 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -102.62 163.35 12.27 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.184 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -112.19 141.83 45.41 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.875 0.369 . . . . 0.0 111.854 -174.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . 0.539 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 10.9 m-85 -120.94 169.39 10.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.698 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 56.6 m80 -96.02 150.39 20.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 118.692 0.678 . . . . 0.0 111.341 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -56.1 -53.89 58.54 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.46 -19.22 67.47 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.165 1.91 . . . . 0.0 113.799 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 45.3 m -80.84 -31.21 35.57 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.34 0.59 . . . . 0.0 111.742 -176.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.474 HG22 HG12 ' A' ' 899' ' ' ILE . 24.0 m -108.86 -22.66 4.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.824 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 104.31 55.08 0.77 Allowed Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.168 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.474 HG12 HG22 ' A' ' 897' ' ' VAL . 30.5 mm -113.06 117.78 56.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 86.9 mtp -87.72 -40.34 14.2 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -144.49 154.63 43.11 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -54.51 110.09 1.94 Allowed Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 124.799 1.312 . . . . 0.0 112.431 -176.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 25.3 Cg_endo -66.15 152.24 81.68 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 122.516 2.144 . . . . 0.0 111.067 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.65 147.8 38.31 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.706 2.271 . . . . 0.0 112.632 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -25.14 65.62 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.928 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -77.04 -14.07 59.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.706 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 25.4 ttt -82.92 121.62 27.21 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.082 0.468 . . . . 0.0 110.934 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -80.65 127.94 33.05 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -125.84 138.9 53.84 Favored 'General case' 0 C--N 1.248 -3.811 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.42 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 84.2 m-85 -125.55 137.36 53.93 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 18.7 p -77.26 166.6 43.14 Favored Pre-proline 0 C--N 1.28 -2.421 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.344 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -49.02 -30.99 19.38 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.228 2.619 . . . . 0.0 112.465 176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.556 ' HA ' ' HE2' ' A' ' 913' ' ' LYS . 7.8 mmpt? -81.02 -42.95 20.3 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 92.4 m -78.4 -20.18 51.69 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.084 177.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -70.22 -23.24 62.9 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -79.48 -10.89 59.89 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.964 0.411 . . . . 0.0 110.539 175.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -87.31 -57.73 2.85 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 68.5 mt -66.01 -53.88 32.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 114.673 -1.148 . . . . 0.0 111.045 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm 58.63 -179.01 0.07 Allowed 'General case' 0 N--CA 1.425 -1.7 0 C-N-CA 125.898 1.679 . . . . 0.0 111.197 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -114.21 -43.58 3.21 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 21.8 t70 70.43 132.9 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.404 1.482 . . . . 0.0 113.924 173.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 36.5 tttp 71.47 148.55 0.08 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.526 1.13 . . . . 0.0 111.941 173.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . 0.505 ' H ' ' HD3' ' A' ' 923' ' ' LYS . 0.0 OUTLIER -89.24 71.8 8.22 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.352 1.072 . . . . 0.0 110.338 176.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 . . . . . 0 C--N 1.293 -1.872 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -177.744 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.056 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 11.7 p -66.51 -41.7 88.44 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 173.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -105.63 158.22 16.85 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 66.1 mtt 68.81 179.04 0.24 Allowed 'General case' 0 C--O 1.244 0.811 0 O-C-N 124.195 0.934 . . . . 0.0 109.505 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -89.69 -164.23 1.12 Allowed 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 23.9 mmt -72.48 -23.15 61.0 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -169.74 -150.66 0.08 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.75 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . 0.427 ' HA ' HD12 ' A' ' 869' ' ' ILE . 4.4 m-85 77.39 22.28 0.96 Allowed 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 123.124 1.44 . . . . 0.0 108.125 -171.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.2 108.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.397 -3.108 0 CA-C-N 111.493 -2.594 . . . . 0.0 106.638 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . 0.463 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 30.9 mt -117.73 154.41 19.63 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.724 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -100.76 137.25 39.4 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.399 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 862' ' ' GLU . 32.1 t70 -78.07 179.31 6.9 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.75 176.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . 0.407 ' H ' ' CG ' ' A' ' 861' ' ' ASP . 10.2 pt-20 -71.29 -29.89 65.59 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.946 0.403 . . . . 0.0 110.266 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -80.04 -10.9 59.8 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.821 0.819 . . . . 0.0 109.546 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.82 18.34 40.99 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -78.72 155.15 29.53 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -85.07 118.72 24.81 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.992 0.901 . . . . 0.0 110.876 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.463 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 37.0 mm -91.14 114.4 28.4 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -100.34 147.21 26.05 Favored 'General case' 0 C--N 1.264 -3.114 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.771 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 857' ' ' TYR . 26.9 mt -102.19 109.24 25.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-O 121.223 0.535 . . . . 0.0 110.626 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 49.4 t -56.29 115.43 9.88 Favored Pre-proline 0 N--CA 1.438 -1.074 0 C-N-CA 126.217 1.807 . . . . 0.0 110.32 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -59.81 -13.4 22.19 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.633 2.889 . . . . 0.0 112.869 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.46 -38.06 34.16 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.212 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 9.1 p -120.99 -15.96 8.16 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 117.218 0.509 . . . . 0.0 112.25 -175.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 72.39 21.54 3.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.315 1.446 . . . . 0.0 108.707 -176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.408 ' HZ2' ' HB3' ' A' ' 875' ' ' LYS . 7.1 mtpm? -101.93 141.78 23.25 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.3 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -73.32 158.33 48.61 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.637 2.224 . . . . 0.0 110.931 173.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.59 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 10.3 t0 -48.74 123.33 6.73 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.469 0.652 . . . . 0.0 111.696 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -90.47 6.1 44.86 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.473 -175.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 91.81 36.73 6.31 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 108.281 -1.927 . . . . 0.0 108.281 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 22.8 m -122.37 161.58 42.52 Favored Pre-proline 0 N--CA 1.418 -2.029 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.37 133.34 32.22 Favored 'Trans proline' 0 C--O 1.254 1.285 0 C-N-CA 121.576 1.517 . . . . 0.0 110.306 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.59 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 75.8 mtp -112.05 154.52 25.26 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.52 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.1 tt -124.75 138.23 54.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.14 158.52 16.75 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.57 169.56 17.86 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.366 0.603 . . . . 0.0 110.315 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -91.42 -26.03 19.06 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -98.54 -49.33 4.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.277 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 17.6 p -99.7 179.2 4.61 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.595 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -110.2 11.61 23.58 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.809 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -81.99 151.97 26.91 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.951 0.405 . . . . 0.0 111.236 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -114.45 139.18 49.74 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.951 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -119.23 162.42 18.72 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.294 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.6 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 65.4 m80 -83.45 144.14 29.78 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.401 ' N ' ' HD2' ' A' ' 895' ' ' PRO . 26.3 m0 -51.24 -49.49 81.37 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 175.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 893' ' ' HIS . 28.5 Cg_endo -63.93 -23.6 68.03 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.659 2.24 . . . . 0.0 114.053 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 61.2 m -76.81 -25.7 53.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.56 0.695 . . . . 0.0 111.563 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.49 HG22 HG12 ' A' ' 899' ' ' ILE . 9.0 m -114.14 -2.59 10.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.712 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 73.19 45.08 32.65 Favored Glycine 0 CA--C 1.504 -0.606 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.202 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.49 HG12 HG22 ' A' ' 897' ' ' VAL . 45.4 mm -80.02 -67.9 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.391 1.091 . . . . 0.0 110.457 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.9 mtt 66.63 -14.94 0.15 Allowed 'General case' 0 C--N 1.264 -3.117 0 C-N-CA 128.398 2.679 . . . . 0.0 114.74 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.11 147.13 19.31 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -51.88 110.16 1.74 Allowed Pre-proline 0 C--O 1.239 0.517 0 O-C-N 124.491 1.119 . . . . 0.0 112.186 -175.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.01 133.14 32.31 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.908 2.405 . . . . 0.0 112.104 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . 0.423 ' HB2' ' HG2' ' A' ' 906' ' ' GLU . 33.0 Cg_exo -63.53 140.25 74.57 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.347 2.032 . . . . 0.0 110.758 176.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.92 0.73 14.71 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 904' ' ' PRO . 10.9 pt-20 -69.16 -19.97 64.01 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 173.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 46.9 ttp -104.12 127.34 51.7 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 115.234 -0.893 . . . . 0.0 108.919 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -83.54 140.46 32.25 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 172.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 73.0 t90 -125.42 119.95 29.68 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.525 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.47 138.63 53.7 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 30.8 p -66.39 161.84 54.54 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 123.754 0.658 . . . . 0.0 111.55 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.45 -16.12 22.22 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.207 2.605 . . . . 0.0 112.916 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.463 ' CE ' ' HA ' ' A' ' 913' ' ' LYS . 3.9 mmpt? -84.26 -48.5 9.69 Favored 'General case' 0 N--CA 1.44 -0.963 0 O-C-N 122.145 -0.347 . . . . 0.0 110.177 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.462 ' O ' HG13 ' A' ' 918' ' ' ILE . 84.7 m -68.49 -39.96 81.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.05 176.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.09 71.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.203 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -64.11 -43.65 94.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.26 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -79.62 -33.3 41.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.522 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 914' ' ' CYS . 85.4 mt -62.09 -47.39 93.37 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 174.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . 0.43 ' HG2' ' H ' ' A' ' 920' ' ' LYS . 44.2 tttm 57.31 -151.14 0.43 Allowed 'General case' 0 N--CA 1.418 -2.051 0 C-N-CA 125.622 1.569 . . . . 0.0 110.196 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . 0.43 ' H ' ' HG2' ' A' ' 919' ' ' LYS . 67.0 mttm 53.73 27.04 6.47 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 124.282 1.033 . . . . 0.0 111.833 -172.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.75 117.04 21.74 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 113.85 -1.523 . . . . 0.0 107.599 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.97 -34.84 0.72 Allowed 'General case' 0 N--CA 1.405 -2.693 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.522 -178.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -151.16 151.49 32.0 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.258 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 84.6 t60 . . . . . 0 C--N 1.302 -1.485 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.792 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.813 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 17.2 p -93.58 -32.49 14.1 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 122.553 -0.381 . . . . 0.0 111.571 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -116.72 -24.59 7.66 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.156 0.503 . . . . 0.0 111.692 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 48.6 tpp -104.12 27.05 8.05 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.604 0.716 . . . . 0.0 109.432 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 69.39 166.13 0.27 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.005 1.322 . . . . 0.0 112.469 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 64.4 mtt -99.29 111.45 23.82 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.132 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -164.04 -179.97 6.57 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -112.43 -7.86 13.92 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.436 0.636 . . . . 0.0 110.199 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 57.5 t -125.08 129.11 73.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.718 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 58.0 mt -125.56 144.58 35.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -92.05 117.03 29.44 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.452 175.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -71.31 176.07 4.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.72 -22.88 59.76 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.437 0.637 . . . . 0.0 109.452 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -85.99 -0.43 55.47 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.168 0.985 . . . . 0.0 108.687 173.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 75.69 16.5 80.61 Favored Glycine 0 CA--C 1.5 -0.878 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.868 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -68.35 134.01 49.61 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -82.04 81.34 8.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.51 0.672 . . . . 0.0 109.274 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 858' ' ' VAL . 46.5 mm -53.14 135.88 14.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 113.198 -1.819 . . . . 0.0 112.287 -174.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -103.07 132.63 49.18 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 124.186 0.929 . . . . 0.0 109.877 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 40.8 mt -102.43 116.96 47.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.524 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.0 111.34 3.55 Favored Pre-proline 0 N--CA 1.443 -0.806 0 C-N-CA 125.255 1.422 . . . . 0.0 110.532 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -65.31 3.73 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.851 3.034 . . . . 0.0 113.613 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -86.16 -46.03 5.44 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 14.1 p -116.4 -22.03 8.97 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.528 0.68 . . . . 0.0 110.456 -176.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.274 2.8 m-20 70.75 56.0 0.24 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 125.765 1.626 . . . . 0.0 111.563 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.3 140.01 37.13 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.151 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -74.19 173.99 13.22 Favored 'Trans proline' 0 C--O 1.257 1.427 0 C-N-CA 123.359 2.706 . . . . 0.0 112.624 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.4 ' HA ' ' SD ' ' A' ' 882' ' ' MET . 3.4 m-20 -48.51 106.11 0.09 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.744 0.818 . . . . 0.0 108.929 172.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -102.57 -15.05 16.52 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.957 0.408 . . . . 0.0 110.868 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 127.09 -21.21 5.84 Favored Glycine 0 N--CA 1.437 -1.252 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 50.0 m -70.99 157.06 91.16 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.293 -0.454 . . . . 0.0 109.807 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -65.97 137.91 50.57 Favored 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.707 2.271 . . . . 0.0 111.468 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.4 ' SD ' ' HA ' ' A' ' 877' ' ' ASP . 91.7 mtp -128.71 148.31 50.82 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.481 -175.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.5 tt -129.49 148.06 33.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -111.69 146.89 17.97 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.812 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.43 ' HB3' ' SG ' ' A' ' 888' ' ' CYS . 52.8 t -70.37 155.78 40.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -86.98 -24.0 24.85 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.568 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -92.02 -45.42 8.33 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.882 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 885' ' ' CYS . 29.8 p -100.44 -178.27 3.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.485 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -112.62 14.89 20.16 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 122.712 1.244 . . . . 0.0 109.431 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.95 153.03 21.62 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.056 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 26.8 m95 -118.93 138.79 52.53 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.35 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -124.29 161.46 25.8 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.099 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.712 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 56.8 m80 -86.67 146.47 26.29 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -49.93 -53.5 42.24 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.65 -10.54 29.08 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 122.224 1.949 . . . . 0.0 113.792 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 62.4 m -87.07 -33.72 19.4 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.593 0.711 . . . . 0.0 111.023 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.5 HG23 HG12 ' A' ' 899' ' ' ILE . 19.2 m -104.75 -15.62 8.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.797 -176.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 96.0 47.36 2.46 Favored Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.855 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.5 HG12 HG23 ' A' ' 897' ' ' VAL . 48.3 mm -95.39 105.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.8 ptm -87.11 -19.5 28.44 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.234 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -170.5 151.35 3.64 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -45.56 111.53 1.39 Allowed Pre-proline 0 C--O 1.243 0.719 0 O-C-N 124.673 1.233 . . . . 0.0 110.754 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -59.86 139.13 86.73 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.903 2.402 . . . . 0.0 112.196 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.52 135.7 66.41 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.839 2.359 . . . . 0.0 111.957 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.85 -21.26 64.51 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 123.388 0.675 . . . . 0.0 111.725 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -74.98 0.21 16.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.036 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 58.0 ttp -123.99 141.82 51.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -84.6 145.9 27.79 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -117.39 128.65 55.23 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.561 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -131.23 146.32 52.27 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 20.8 p -76.65 164.88 56.75 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.39 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.59 -24.11 21.62 Favored 'Trans proline' 0 CA--C 1.551 1.366 0 C-N-CA 123.355 2.703 . . . . 0.0 112.275 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -78.54 -53.8 6.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.498 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.51 ' O ' HG12 ' A' ' 918' ' ' ILE . 85.7 m -78.54 -26.72 45.78 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.72 69.93 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -74.57 -35.54 63.05 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.053 0.93 . . . . 0.0 110.066 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -71.71 -15.62 62.21 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.005 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' A' ' 919' ' ' LYS . 44.6 mm -63.97 -26.23 40.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 123.512 0.725 . . . . 0.0 111.661 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 918' ' ' ILE . 54.8 pttt 54.69 34.23 21.14 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 126.205 1.802 . . . . 0.0 111.697 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 58.8 tttm 76.51 -57.46 0.54 Allowed 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.603 1.561 . . . . 0.0 110.667 -176.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 24.5 t70 65.8 -47.43 0.4 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 124.892 1.277 . . . . 0.0 114.125 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -77.57 121.04 23.37 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . 0.443 ' HZ3' ' HB3' ' A' ' 923' ' ' LYS . 5.9 ttpm? -59.08 -41.09 87.2 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 123.985 0.914 . . . . 0.0 112.294 -177.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 37.1 m80 . . . . . 0 C--N 1.254 -3.568 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.154 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.449 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 19.9 m 62.09 15.23 7.19 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.038 0.935 . . . . 0.0 112.488 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 64.57 85.95 0.13 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.551 1.141 . . . . 0.0 110.38 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 54.3 ttp -73.13 -25.58 60.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.102 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 58.76 36.02 24.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.516 1.126 . . . . 0.0 111.176 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 86.0 mtp -151.87 158.71 43.59 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -110.93 -108.51 0.35 Allowed 'General case' 0 C--N 1.28 -2.417 0 C-N-CA 119.105 -1.038 . . . . 0.0 112.622 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 65.85 25.31 11.24 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.927 0.891 . . . . 0.0 110.86 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.76 121.71 66.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.333 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 51.2 mt -126.85 138.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 173.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -98.59 122.15 41.43 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.182 0.992 . . . . 0.0 112.435 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.89 173.19 1.91 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 113.185 -1.825 . . . . 0.0 109.69 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.57 -28.86 70.17 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.783 0.833 . . . . 0.0 110.884 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . 0.47 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 76.3 m95 -98.24 10.68 40.06 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.076 0.465 . . . . 0.0 111.317 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.46 1.69 83.31 Favored Glycine 0 CA--C 1.508 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.144 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.47 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 45.4 m-80 -65.37 137.56 57.58 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.18 126.87 33.54 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.68 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 48.7 mm -91.49 129.13 42.68 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.622 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -77.69 145.95 36.32 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.852 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 52.6 mt -129.99 128.2 64.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.84 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.5 t -72.43 117.36 58.17 Favored Pre-proline 0 N--CA 1.419 -2.015 0 C-N-CA 125.165 1.386 . . . . 0.0 108.711 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.88 -1.13 6.35 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.565 2.176 . . . . 0.0 112.817 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.93 -48.16 10.42 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.562 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 5.8 p -113.28 -19.28 11.83 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 122.684 0.394 . . . . 0.0 111.489 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.4 t30 81.01 19.79 0.44 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.475 1.51 . . . . 0.0 109.228 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -97.73 138.81 21.06 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.918 176.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.6 Cg_endo -73.88 174.21 12.71 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.34 2.693 . . . . 0.0 110.534 173.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -59.48 119.98 8.52 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.368 0.604 . . . . 0.0 109.38 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -104.26 23.92 12.34 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 76.77 51.68 6.28 Favored Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 105.654 -2.978 . . . . 0.0 105.654 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 7.7 p -125.87 159.38 61.78 Favored Pre-proline 0 N--CA 1.42 -1.943 0 CA-C-N 113.981 -1.109 . . . . 0.0 112.888 -166.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -77.22 108.13 2.56 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 121.988 1.792 . . . . 0.0 109.563 174.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 81.9 mtp -116.24 164.76 14.02 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.839 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.5 tt -133.6 134.62 56.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.69 154.73 20.7 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 53.8 t -80.81 167.84 19.48 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.444 0.64 . . . . 0.0 110.265 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -92.86 -31.63 14.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . 0.423 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 27.5 t70 -91.45 -36.91 13.5 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.863 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 55.7 m -97.51 168.32 10.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.65 10.99 26.84 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -94.25 175.08 6.83 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.336 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -132.03 140.14 48.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.121 0.486 . . . . 0.0 112.082 -172.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -119.22 158.33 26.21 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.219 1.008 . . . . 0.0 108.285 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.658 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 73.3 m80 -84.26 149.13 26.3 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.365 176.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 33.3 m0 -53.0 -54.52 43.2 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.53 -16.44 52.31 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.274 1.983 . . . . 0.0 113.444 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 81.8 m -81.28 -27.25 35.19 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.149 0.499 . . . . 0.0 110.85 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 893' ' ' HIS . 21.1 m -115.42 14.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.109 -176.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 71.2 35.42 64.03 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.837 -1.074 . . . . 0.0 114.231 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 57.6 mt -105.61 127.58 60.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.466 0.65 . . . . 0.0 111.024 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.7 mmt -105.17 -25.12 12.61 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.231 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -152.66 154.71 35.87 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . 0.446 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -49.68 112.92 2.91 Favored Pre-proline 0 C--O 1.241 0.628 0 O-C-N 124.779 1.299 . . . . 0.0 112.366 -177.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 19.3 Cg_endo -61.48 151.85 77.06 Favored 'Trans proline' 0 C--O 1.254 1.296 0 C-N-CA 122.998 2.466 . . . . 0.0 112.202 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . 0.414 ' HB2' ' HG2' ' A' ' 906' ' ' GLU . 9.8 Cg_endo -54.08 141.97 67.32 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.525 2.817 . . . . 0.0 112.334 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -78.71 -24.0 45.2 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.847 0.832 . . . . 0.0 108.874 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 904' ' ' PRO . 11.4 pt-20 -71.62 -9.55 58.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.136 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 56.9 ttp -116.89 131.02 57.06 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -77.4 146.41 36.61 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -117.81 141.61 48.23 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 120.594 -0.443 . . . . 0.0 109.815 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -132.45 137.59 47.32 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 17.1 p -66.98 165.06 29.45 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 123.992 0.917 . . . . 0.0 110.102 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -56.01 -18.86 24.06 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.595 2.197 . . . . 0.0 112.045 174.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.575 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 74.9 mmtt -74.49 -48.49 26.92 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.542 ' O ' HG12 ' A' ' 918' ' ' ILE . 68.8 m -76.63 -29.77 56.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.99 -11.24 60.68 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 120.698 0.285 . . . . 0.0 110.931 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.04 -29.71 35.0 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 172.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.464 ' CE ' ' HA ' ' A' ' 914' ' ' CYS . 53.3 mtmt -80.52 -36.74 32.78 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.912 176.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 914' ' ' CYS . 40.1 mm -71.94 -66.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt 64.69 114.47 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 126.537 1.935 . . . . 0.0 112.187 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -68.28 82.91 0.24 Allowed 'General case' 0 C--O 1.243 0.727 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.229 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 22.8 t70 69.21 -63.63 0.36 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.843 1.657 . . . . 0.0 110.274 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -176.0 137.57 0.33 Allowed 'General case' 0 N--CA 1.425 -1.694 0 C-N-CA 126.125 1.77 . . . . 0.0 106.634 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -107.77 138.81 43.34 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 3.4 t60 . . . . . 0 C--N 1.285 -2.2 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -177.225 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.689 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 15.2 m 67.27 177.21 0.24 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.792 0.837 . . . . 0.0 111.36 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 71.25 1.51 3.86 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.816 1.247 . . . . 0.0 111.625 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 1.2 tmt? 67.75 -78.6 0.04 OUTLIER 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.678 1.591 . . . . 0.0 111.132 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 170.1 -30.51 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 126.022 1.729 . . . . 0.0 107.3 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 26.1 mmt -85.1 73.52 10.64 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.35 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -177.75 -161.14 0.05 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -90.94 11.33 23.12 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.702 0.287 . . . . 0.0 111.083 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 90.9 t -134.75 118.64 26.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 37.6 mt -122.58 166.45 17.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -108.6 131.97 54.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 119.548 1.067 . . . . 0.0 109.501 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.35 175.21 8.62 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 123.697 0.799 . . . . 0.0 108.917 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -68.09 -27.95 66.93 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 123.716 0.806 . . . . 0.0 111.013 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -81.78 -15.4 54.38 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 102.3 -8.93 55.77 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.897 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -66.76 146.82 54.03 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.53 144.88 43.88 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 121.832 0.825 . . . . 0.0 111.502 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 858' ' ' VAL . 39.3 mm -105.32 121.63 57.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -90.02 143.57 26.67 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 123.975 0.797 . . . . 0.0 109.425 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 40.8 mt -107.7 123.4 63.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 892' ' ' TYR . 41.6 t -75.2 114.46 35.57 Favored Pre-proline 0 N--CA 1.409 -2.486 0 O-C-N 124.593 1.183 . . . . 0.0 108.67 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.4 -1.72 6.99 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.147 2.565 . . . . 0.0 112.011 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -78.27 -40.74 18.98 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 6.9 p -118.38 -15.37 9.7 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 57.8 t30 71.49 32.41 2.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.417 1.087 . . . . 0.0 108.285 -175.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -116.0 140.43 26.27 Favored Pre-proline 0 C--O 1.241 0.636 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.639 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 40.2 Cg_endo -72.47 167.27 27.46 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 123.317 2.678 . . . . 0.0 112.699 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.485 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 21.7 t70 -65.84 138.42 57.88 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.239 172.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -124.52 33.41 5.25 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 74.82 47.38 14.58 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 107.487 -2.245 . . . . 0.0 107.487 -173.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 6.2 p -120.45 149.32 49.67 Favored Pre-proline 0 N--CA 1.423 -1.807 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.027 -171.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.89 126.25 16.23 Favored 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 122.037 1.825 . . . . 0.0 110.384 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.485 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 88.9 mtp -128.3 157.79 39.97 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.869 -177.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.69 138.07 52.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -105.46 155.09 17.04 Favored Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.871 ' SG ' ' HB2' ' A' ' 888' ' ' CYS . 1.7 p -74.04 135.74 43.07 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.801 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.9 -48.94 72.39 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.699 -174.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . 0.575 ' HB2' ' CE1' ' A' ' 910' ' ' PHE . 14.9 t70 -80.65 -49.41 11.27 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-O 122.704 1.24 . . . . 0.0 109.12 -175.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.871 ' HB2' ' SG ' ' A' ' 885' ' ' CYS . 0.0 OUTLIER -73.6 -103.73 0.01 OUTLIER 'General case' 0 N--CA 1.38 -3.95 0 N-CA-C 118.929 2.937 . . . . 0.0 118.929 -162.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -178.3 -25.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -166.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . 0.436 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 22.7 m-20 -90.93 173.46 7.96 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.45 0.643 . . . . 0.0 111.94 -170.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -132.81 127.39 34.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.116 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . 0.43 ' HA ' ' SG ' ' A' ' 870' ' ' CYS . 82.6 m-85 -122.67 162.51 21.82 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.672 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.597 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 54.6 m80 -84.17 151.76 24.67 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.468 ' CG ' ' HB ' ' A' ' 899' ' ' ILE . 25.9 m0 -53.12 -56.37 24.53 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.52 -13.62 40.75 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.206 1.938 . . . . 0.0 114.043 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 76.5 m -77.75 -40.86 39.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.492 0.663 . . . . 0.0 111.109 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.462 HG22 HG12 ' A' ' 899' ' ' ILE . 27.1 m -99.57 -26.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.669 -175.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 110.17 35.42 2.14 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.214 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.468 ' HB ' ' CG ' ' A' ' 894' ' ' TRP . 42.2 mm -90.16 106.73 17.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 91.3 mmm -91.93 -25.64 18.8 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.244 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -151.74 147.84 27.18 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -57.57 114.36 8.17 Favored Pre-proline 0 C--N 1.319 -0.718 0 O-C-N 124.415 1.072 . . . . 0.0 111.891 -176.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.92 146.68 48.01 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.905 2.403 . . . . 0.0 111.028 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.61 124.02 14.2 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.974 1.782 . . . . 0.0 110.793 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.34 -3.18 19.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.528 -175.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -74.99 -16.31 60.63 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.479 0.657 . . . . 0.0 109.609 173.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 16.9 tpt -98.7 152.22 19.89 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -91.36 141.99 28.17 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -127.81 125.09 39.16 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.403 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 887' ' ' ASP . 22.0 m-85 -118.16 147.04 43.73 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 885' ' ' CYS 0.254 1.8 p -80.49 164.58 51.02 Favored Pre-proline 0 C--N 1.271 -2.839 0 C-N-CA 124.478 1.111 . . . . 0.0 111.176 -174.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.56 -12.86 30.12 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.685 2.257 . . . . 0.0 112.296 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 32.4 mmtp -88.21 -62.11 1.56 Allowed 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.443 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 888' ' ' CYS . 96.3 m -74.35 -27.76 60.82 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -175.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 910' ' ' PHE . . . -72.55 -25.95 61.56 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.322 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 920' ' ' LYS . 2.3 t-20 -89.47 -4.55 57.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.754 0.788 . . . . 0.0 110.164 -177.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 913' ' ' LYS . 35.8 mmtp -83.69 -47.64 10.99 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 171.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.2 -59.42 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.227 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -98.49 71.82 2.03 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 916' ' ' ASN . 0.5 OUTLIER -67.64 -60.61 2.4 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.925 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . 0.411 ' OD1' ' HG3' ' A' ' 920' ' ' LYS . 9.2 m-20 -136.34 -0.27 2.46 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.732 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -175.89 153.72 1.4 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -100.21 147.8 25.32 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 57.4 m80 . . . . . 0 C--N 1.311 -1.104 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.388 179.181 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.758 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 18.1 m -61.36 -41.77 97.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.484 0.659 . . . . 0.0 109.928 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -134.73 158.36 44.32 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 853' ' ' MET . . . . . 0.419 ' O ' HG23 ' A' ' 859' ' ' ILE . 15.3 tpt -138.81 -79.81 0.33 Allowed 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.359 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -148.96 140.78 23.64 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.828 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 8.8 tmm? -78.28 -41.53 33.68 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -174.69 -77.54 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.088 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -112.86 12.36 19.44 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.23 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.68 128.17 74.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.17 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 46.9 mt -126.0 166.02 22.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 177.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -116.58 140.71 49.08 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.93 -168.06 1.65 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.176 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.53 -34.02 77.28 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.006 0.922 . . . . 0.0 110.714 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -87.35 -33.51 19.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.783 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 122.57 16.64 3.72 Favored Glycine 0 C--N 1.308 -1.015 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.204 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -83.52 151.18 25.54 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -79.31 135.77 36.83 Favored 'General case' 0 N--CA 1.396 -3.133 0 CA-C-O 122.02 0.914 . . . . 0.0 110.181 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 27.4 mm -103.34 129.56 55.03 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.05 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.887 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -92.67 142.71 27.07 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.898 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 39.8 mt -111.41 122.92 66.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.113 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.5 t -65.66 112.53 8.9 Favored Pre-proline 0 N--CA 1.431 -1.404 0 C-N-CA 124.769 1.228 . . . . 0.0 108.817 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.69 -5.18 8.28 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.713 2.942 . . . . 0.0 112.961 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.95 -39.2 28.64 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 121.119 -0.562 . . . . 0.0 111.967 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 9.6 p -124.44 -10.32 7.44 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 122.79 0.436 . . . . 0.0 111.629 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.336 9.5 p30 60.12 32.39 20.93 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 126.022 1.729 . . . . 0.0 112.258 -172.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -103.59 138.96 19.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.095 173.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.9 Cg_endo -74.08 171.09 18.65 Favored 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 123.38 2.72 . . . . 0.0 113.888 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.92 145.24 42.8 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.551 174.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -115.83 -0.62 12.82 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 99.92 39.54 3.32 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 107.341 -2.304 . . . . 0.0 107.341 -172.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 14.3 m -106.44 168.67 7.81 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 114.607 -0.797 . . . . 0.0 110.527 -171.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -74.51 115.62 4.36 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 121.316 1.344 . . . . 0.0 108.901 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 83.4 mtp -122.57 162.3 22.09 Favored 'General case' 0 N--CA 1.407 -2.605 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . 0.486 ' HB ' ' HE1' ' A' ' 894' ' ' TRP . 18.0 tt -122.31 133.44 68.57 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-O 120.713 0.292 . . . . 0.0 110.44 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.08 143.77 16.87 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 52.7 t -71.94 167.95 19.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.551 0.691 . . . . 0.0 110.272 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . 0.407 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 24.6 t70 -84.97 -26.29 27.23 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 174.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -95.36 -47.96 6.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.119 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 10.1 m -83.79 146.63 28.04 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.97 17.12 23.12 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.279 1.038 . . . . 0.0 108.51 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -108.77 168.4 9.37 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.383 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -115.43 150.44 36.43 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -168.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -123.37 149.68 44.65 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.68 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 44.2 m80 -75.42 142.06 43.1 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.186 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.486 ' HE1' ' HB ' ' A' ' 883' ' ' ILE . 21.1 m0 -55.85 -49.47 92.76 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 20.3 Cg_endo -61.47 -19.08 63.04 Favored 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 122.154 1.903 . . . . 0.0 113.105 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 74.0 m -83.41 -21.22 33.06 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.401 0.62 . . . . 0.0 111.519 -177.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 893' ' ' HIS . 15.9 m -118.43 12.58 7.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.877 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 62.49 48.8 79.26 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.097 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 57.7 mt -118.59 136.58 55.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 122.582 -0.364 . . . . 0.0 111.108 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 61.5 mtt -121.9 -11.6 8.52 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.229 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . 0.526 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -156.54 137.29 13.33 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -50.77 100.78 0.24 Allowed Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 125.263 1.425 . . . . 0.0 113.686 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 14.4 Cg_endo -102.93 140.0 0.15 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.715 2.943 . . . . 0.0 116.46 -177.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -95.79 154.47 1.49 Allowed 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 122.779 2.319 . . . . 0.0 107.811 163.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -87.24 -28.67 22.21 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 118.239 -1.385 . . . . 0.0 111.708 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 149.99 -15.82 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 129.464 3.106 . . . . 0.0 103.801 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 53.0 ttm -134.41 170.82 15.17 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -53.07 169.09 0.11 Allowed 'General case' 0 C--N 1.31 -1.12 0 O-C-N 124.082 0.864 . . . . 0.0 111.388 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -100.4 131.67 46.2 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.191 -173.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 84.9 m-85 -126.83 139.33 53.18 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 15.5 p -70.26 167.43 25.84 Favored Pre-proline 0 N--CA 1.426 -1.644 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.787 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.84 -20.64 18.15 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 123.08 2.52 . . . . 0.0 111.886 173.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.436 ' HA ' ' HE2' ' A' ' 913' ' ' LYS . 8.9 mmpt? -81.03 -51.47 8.46 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.21 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.484 ' O ' HG12 ' A' ' 918' ' ' ILE . 91.4 m -75.08 -29.66 60.73 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.7 66.31 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.19 0.519 . . . . 0.0 110.334 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -68.37 -28.79 67.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.354 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -79.15 -39.13 34.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.891 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 914' ' ' CYS . 47.8 mm -62.57 -46.93 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.232 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -79.57 175.38 10.66 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.397 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -119.52 120.76 37.7 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.4 -44.3 21.71 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -141.85 -42.66 0.35 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.639 -1.619 . . . . 0.0 106.65 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -150.99 -158.3 0.9 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 173.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 . . . . . 0 C--N 1.299 -1.6 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 171.789 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 857' ' ' TYR . . . . . 0.523 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 55.1 m-85 . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 122.103 0.954 . . . . 0.0 109.13 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 51.5 t -136.68 114.3 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.225 -174.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 39.5 mt -124.69 154.61 32.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -98.83 134.7 41.34 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.53 0.681 . . . . 0.0 110.076 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -71.93 172.23 10.33 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.962 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -63.12 -34.65 78.07 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 123.207 0.603 . . . . 0.0 110.468 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -88.67 -14.4 37.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.895 0.855 . . . . 0.0 108.994 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 105.31 10.51 31.48 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.077 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -68.96 164.0 23.27 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -88.36 121.06 30.32 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.632 0.73 . . . . 0.0 110.89 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 39.2 mm -91.51 112.45 25.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 173.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -88.47 130.84 35.1 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.424 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 32.8 mt -100.51 104.13 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.398 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 44.7 t -54.73 112.42 4.0 Favored Pre-proline 0 N--CA 1.429 -1.519 0 CA-C-N 113.734 -1.575 . . . . 0.0 108.997 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -71.93 3.58 3.79 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.005 1.803 . . . . 0.0 112.216 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -83.74 -36.67 13.16 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 22.3 p -114.97 -27.75 7.26 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 122.507 -0.408 . . . . 0.0 111.122 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 82.29 24.0 0.2 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.298 1.839 . . . . 0.0 110.309 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.561 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 41.2 mttm -102.86 144.43 28.6 Favored Pre-proline 0 N--CA 1.467 0.408 0 C-N-CA 123.393 0.677 . . . . 0.0 111.255 174.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.407 ' HB3' HG12 ' A' ' 869' ' ' ILE . 56.4 Cg_endo -80.42 174.09 11.66 Favored 'Trans proline' 0 C--O 1.242 0.683 0 C-N-CA 123.094 2.53 . . . . 0.0 108.479 167.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 877' ' ' ASP . . . . . 0.511 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 15.4 t70 -69.31 102.11 1.66 Allowed 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.222 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -94.97 5.06 52.99 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.438 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 119.31 55.81 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 17.7 m -134.25 163.1 53.59 Favored Pre-proline 0 N--CA 1.417 -2.108 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -75.3 137.67 21.35 Favored 'Trans proline' 0 C--O 1.264 1.777 0 C-N-CA 122.459 2.106 . . . . 0.0 108.581 172.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.511 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 58.1 mtp -117.03 152.78 33.93 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.961 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.9 tt -134.41 134.2 54.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -99.21 160.31 19.95 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.737 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.87 166.74 15.76 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.573 0.702 . . . . 0.0 110.869 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -92.88 -22.77 19.06 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.631 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -101.55 -37.64 8.31 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.246 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . 0.25 16.2 p -103.21 169.64 8.43 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.961 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.2 -21.04 19.31 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.503 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -87.1 163.59 16.91 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.897 -171.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -110.2 142.6 41.53 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.503 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -112.79 -178.05 3.29 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 125.014 1.326 . . . . 0.0 108.468 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.864 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 59.2 m80 -110.84 160.26 16.92 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -60.17 -54.1 58.55 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.24 -26.59 77.6 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 122.281 1.987 . . . . 0.0 114.071 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.864 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 5.8 m -69.31 -36.81 77.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.947 0.88 . . . . 0.0 111.772 -176.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.498 HG23 HG12 ' A' ' 899' ' ' ILE . 28.2 m -107.11 -17.87 7.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.36 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 93.3 48.94 2.7 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 121.224 -0.512 . . . . 0.0 113.139 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.498 HG12 HG23 ' A' ' 897' ' ' VAL . 44.0 mm -88.56 125.17 41.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 69.1 mtm -91.65 -37.26 13.16 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.127 0.489 . . . . 0.0 109.69 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -156.61 158.93 37.94 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 902' ' ' ALA . . . . . 0.419 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -55.2 113.81 6.1 Favored Pre-proline 0 C--N 1.32 -0.717 0 O-C-N 124.093 0.871 . . . . 0.0 111.984 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 46.3 Cg_endo . . . . . 0 CA--C 1.548 1.181 0 C-N-CA 123.346 2.698 . . . . 0.0 112.724 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 . . . . . 0 N--CA 1.418 -2.05 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -106.45 132.17 52.78 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -127.97 137.35 52.21 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 5.8 p -69.82 168.45 17.57 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 123.996 0.918 . . . . 0.0 109.695 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.24 -20.3 10.87 Favored 'Trans proline' 0 CA--C 1.552 1.409 0 C-N-CA 123.195 2.597 . . . . 0.0 112.429 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -79.29 -56.27 4.47 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.478 0.711 . . . . 0.0 109.195 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 71.5 m -79.03 -17.51 55.16 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 915' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 918' ' ' ILE . . . -67.06 -31.22 71.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.334 1.064 . . . . 0.0 108.645 172.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -73.42 -22.99 60.07 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.45 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -74.49 -36.59 63.27 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 172.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 915' ' ' ALA . 50.5 mm . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 172.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 857' ' ' TYR . . . . . 0.487 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 88.7 m-85 . . . . . 0 C--O 1.244 0.798 0 CA-C-O 120.792 0.329 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 90.9 t -132.56 116.83 29.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.855 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 35.2 mt -120.2 157.26 22.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -102.01 131.64 48.32 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.035 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.77 173.5 8.11 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.853 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.95 -37.78 80.52 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.767 0.827 . . . . 0.0 111.143 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 863' ' ' TRP . . . . . 0.498 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 75.9 m95 -91.15 1.45 57.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.557 0.694 . . . . 0.0 110.626 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.08 14.19 56.51 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.761 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 58.8 m-80 -73.84 155.65 38.57 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.73 113.17 24.01 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.678 0.751 . . . . 0.0 112.006 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 37.1 mm -80.41 118.47 28.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 175.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -92.16 138.22 31.71 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.329 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 33.5 mt -104.07 127.34 58.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.646 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 42.9 t -79.38 112.82 31.58 Favored Pre-proline 0 N--CA 1.423 -1.815 0 C-N-CA 124.348 1.059 . . . . 0.0 108.719 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 871' ' ' PRO . . . . . 0.411 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 31.9 Cg_exo -60.79 -6.06 5.43 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 123.883 3.056 . . . . 0.0 113.664 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -85.53 -23.5 46.84 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.785 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 18.9 p -123.92 -33.89 3.07 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 82.5 21.86 0.23 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.943 1.697 . . . . 0.0 109.706 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -103.66 139.52 20.19 Favored Pre-proline 0 C--O 1.25 1.107 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.934 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.408 ' HA ' HG12 ' A' ' 869' ' ' ILE . 38.0 Cg_endo -73.59 153.93 49.54 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.845 2.363 . . . . 0.0 110.644 173.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 877' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 29.2 t70 -79.53 146.17 32.79 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.139 0.495 . . . . 0.0 111.845 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -108.79 -0.62 19.82 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.247 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 879' ' ' GLY . . . . . 0.416 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 106.13 51.78 0.81 Allowed Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -172.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 1.3 m -109.02 164.35 14.91 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.04 114.92 3.36 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 121.745 1.63 . . . . 0.0 108.886 172.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 68.7 mtp -115.06 167.58 10.69 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.2 tt -132.22 143.83 38.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -101.23 147.15 17.63 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 43.7 t -80.34 170.67 16.08 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.022 0.529 . . . . 0.0 110.009 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 886' ' ' ASP . . . . . 0.441 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 26.8 t70 -88.99 -24.83 22.29 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -100.67 -31.8 11.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.323 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 22.4 m -104.71 149.09 25.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -92.45 -9.99 39.53 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.57 150.43 49.0 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.844 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -101.29 135.44 42.77 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.786 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 892' ' ' TYR . . . . . 0.411 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 45.2 m-85 -115.85 150.73 36.54 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.656 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 43.2 m80 -79.11 139.94 37.94 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.916 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 31.4 m0 -52.34 -52.03 66.84 Favored Pre-proline 0 CA--C 1.551 1.014 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.59 -9.3 22.08 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.951 1.767 . . . . 0.0 113.309 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.656 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -93.52 -17.84 22.94 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.453 0.644 . . . . 0.0 111.074 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 893' ' ' HIS . 31.5 m -118.48 7.67 6.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.927 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 70.72 37.61 66.92 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.723 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 49.0 mt -108.48 124.28 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-O 121.73 0.776 . . . . 0.0 110.848 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -105.0 -21.15 13.33 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.518 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -155.76 146.9 22.47 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -55.8 114.95 8.34 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 124.848 1.343 . . . . 0.0 112.133 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 N--CA 1.454 -0.818 0 C-N-CA 121.966 1.778 . . . . 0.0 109.784 173.883 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 92.9 t90 -134.35 138.09 44.64 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.697 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 97.5 m-85 -135.56 136.36 41.06 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 11.5 p -62.55 165.7 8.76 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 124.081 0.952 . . . . 0.0 110.24 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.424 ' CD ' HG12 ' A' ' 897' ' ' VAL . 11.5 Cg_endo -57.15 -10.26 5.83 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.014 2.476 . . . . 0.0 112.291 175.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 28.9 mmmt -83.28 -54.11 5.25 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 72.0 m -81.49 -21.37 38.72 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.32 -27.55 67.99 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -78.5 -5.39 52.46 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.635 0.731 . . . . 0.0 110.273 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -83.82 -34.97 24.57 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 68.9 mt . . . . . 0 C--N 1.308 -1.21 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.3 -179.55 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 857' ' ' TYR . . . . . 0.475 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 43.9 m-85 . . . . . 0 N--CA 1.424 -1.774 0 CA-C-O 122.296 1.046 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.32 115.57 18.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 113.902 -1.499 . . . . 0.0 107.516 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 56.5 mt -108.1 152.21 9.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -108.09 135.09 50.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.09 174.09 11.92 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.261 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.81 -24.42 63.47 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.247 0.546 . . . . 0.0 111.029 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -88.26 4.87 44.3 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.333 0.587 . . . . 0.0 110.412 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 74.73 22.06 77.66 Favored Glycine 0 CA--C 1.502 -0.738 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.598 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -86.21 154.57 21.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -86.67 130.69 34.39 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.796 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 41.6 mm -103.14 105.61 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.744 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.2 m-90 -83.95 136.86 33.91 Favored 'General case' 0 C--N 1.252 -3.639 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.609 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.494 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 53.3 mt -102.71 129.0 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.348 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.453 ' HG ' ' HD2' ' A' ' 892' ' ' TYR . 43.6 t -80.65 109.13 11.85 Favored Pre-proline 0 N--CA 1.416 -2.162 0 C-N-CA 125.612 1.565 . . . . 0.0 107.387 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 871' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 32.5 Cg_exo -62.17 -0.81 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.335 2.69 . . . . 0.0 113.624 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.81 -49.04 9.25 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 3.9 p -107.74 -20.22 13.29 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 122.593 0.357 . . . . 0.0 111.113 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 78.68 23.05 0.64 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.745 1.618 . . . . 0.0 108.786 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -101.16 141.97 23.69 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.566 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 36.3 Cg_endo -73.93 174.15 12.84 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.661 2.241 . . . . 0.0 109.226 170.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -60.8 109.78 1.14 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.835 0.826 . . . . 0.0 110.501 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -101.67 13.71 34.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.292 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 102.82 49.1 1.2 Allowed Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 21.2 m -130.03 157.01 78.28 Favored Pre-proline 0 N--CA 1.412 -2.369 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.18 135.32 16.84 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 121.973 1.782 . . . . 0.0 108.447 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 65.0 mtp -115.71 142.32 46.91 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.696 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.5 tt -123.05 136.42 59.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -119.59 152.26 17.21 Favored Glycine 0 CA--C 1.483 -1.926 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.734 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.543 ' HB3' ' O ' ' A' ' 888' ' ' CYS . 42.3 t -58.62 160.1 5.89 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.651 0.78 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -88.11 -27.25 22.04 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.54 -39.59 18.61 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.675 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 885' ' ' CYS . 8.5 p -138.17 167.12 22.49 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.031 0.444 . . . . 0.0 110.981 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -90.04 68.33 7.19 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.799 0.809 . . . . 0.0 109.755 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -112.02 97.47 6.69 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.7 -2.334 . . . . 0.0 104.7 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -96.39 128.78 43.63 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.439 -171.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 892' ' ' TYR . . . . . 0.485 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 36.5 m-85 -122.55 169.3 11.16 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.744 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.578 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.5 m80 -89.36 149.79 22.85 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.087 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -49.6 -56.33 17.4 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.44 -11.16 29.07 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.324 2.016 . . . . 0.0 113.94 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 62.8 m -89.18 -29.8 19.04 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.569 HG23 HG12 ' A' ' 899' ' ' ILE . 17.2 m -113.45 3.55 8.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -175.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.06 5.73 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.576 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.569 HG12 HG23 ' A' ' 897' ' ' VAL . 24.5 mm -105.15 114.6 45.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 90.2 mmm -95.61 -21.86 17.97 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.324 0.583 . . . . 0.0 110.204 -177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -165.52 163.07 19.52 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 902' ' ' ALA . . . . . 0.415 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -45.81 111.57 1.44 Allowed Pre-proline 0 C--O 1.241 0.609 0 O-C-N 124.579 1.174 . . . . 0.0 111.419 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 29.9 Cg_endo . . . . . 0 C--O 1.243 0.736 0 C-N-CA 122.873 2.382 . . . . 0.0 111.396 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 . . . . . 0 N--CA 1.427 -1.605 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -129.1 139.17 52.09 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -130.26 147.04 51.94 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 20.0 p -61.06 160.04 24.11 Favored Pre-proline 0 C--N 1.317 -0.806 0 O-C-N 123.871 0.732 . . . . 0.0 110.388 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.16 -15.13 13.45 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.863 2.375 . . . . 0.0 112.604 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 18.4 mtmm -82.3 -50.93 8.4 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.81 -31.52 66.64 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.74 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -65.8 -25.52 67.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.114 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.21 -37.41 57.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.48 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -60.16 -44.08 95.27 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 74.4 mt . . . . . 0 N--CA 1.447 -0.596 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.713 179.444 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 . . . . . 0 CA--C 1.505 -0.78 0 CA-C-O 121.375 0.607 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 59.1 t -111.05 106.69 21.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 34.6 mt -108.67 131.67 58.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -85.4 117.9 24.6 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -69.11 177.54 2.66 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.36 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -66.82 -30.91 71.22 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 124.686 1.194 . . . . 0.0 109.941 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 863' ' ' TRP . . . . . 0.463 ' HB3' ' OD1' ' A' ' 865' ' ' ASN . 72.5 t-105 -89.14 -3.19 58.71 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.899 0.856 . . . . 0.0 109.024 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.32 9.98 71.88 Favored Glycine 0 CA--C 1.502 -0.762 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.496 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 863' ' ' TRP . 29.2 m120 -62.2 148.89 43.23 Favored 'General case' 0 C--O 1.249 1.027 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -85.89 101.36 12.79 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.997 0.903 . . . . 0.0 109.774 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 49.8 mm -89.54 115.22 28.78 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.593 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -103.08 126.32 50.2 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.526 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.512 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 27.6 mt -87.87 124.32 40.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.36 106.5 4.69 Favored Pre-proline 0 N--CA 1.415 -2.191 0 C-N-CA 125.325 1.45 . . . . 0.0 107.412 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 871' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 21.6 Cg_exo -67.39 13.6 0.16 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.665 2.91 . . . . 0.0 113.247 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -92.25 -40.21 5.19 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 174.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 11.0 p -111.96 -25.55 9.34 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.084 0.469 . . . . 0.0 110.325 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 79.9 18.66 0.67 Allowed 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.459 1.904 . . . . 0.0 110.916 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -94.74 138.51 22.19 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.491 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 40.5 Cg_endo -72.52 148.4 47.89 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.159 2.572 . . . . 0.0 111.695 174.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.28 141.15 54.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -85.93 -34.1 21.0 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.512 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 127.83 46.46 0.19 Allowed Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 106.336 -2.706 . . . . 0.0 106.336 -171.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 20.9 p -114.11 165.41 13.7 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 114.387 -0.907 . . . . 0.0 109.697 -173.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.76 124.13 13.97 Favored 'Trans proline' 0 C--O 1.255 1.353 0 C-N-CA 122.082 1.855 . . . . 0.0 111.442 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.8 mtp -124.66 161.72 25.68 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.862 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.8 tt -130.68 138.06 54.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -108.36 152.32 16.98 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.965 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 47.4 t -77.84 167.28 21.77 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.378 0.609 . . . . 0.0 110.363 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -104.41 -23.09 13.22 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.127 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -84.94 -40.9 16.44 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.434 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.7 p -105.55 -95.06 0.35 Allowed 'General case' 0 N--CA 1.427 -1.577 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.468 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 37.3 t70 174.62 -20.46 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.022 0.929 . . . . 0.0 109.778 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -55.69 141.94 36.1 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -176.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -104.1 131.64 51.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.518 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 892' ' ' TYR . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 911' ' ' CYS . 10.6 m-85 -117.74 155.43 30.01 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.167 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.661 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 36.6 m80 -80.93 143.29 32.74 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.406 ' N ' ' HD2' ' A' ' 895' ' ' PRO . 29.2 m0 -52.59 -51.7 70.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 895' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 30.4 Cg_endo -61.2 -20.35 67.58 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.321 2.014 . . . . 0.0 113.405 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 61.6 m -80.47 -26.01 38.51 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.088 0.47 . . . . 0.0 111.641 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 11.8 m -114.0 8.25 7.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.449 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 73.04 48.79 18.83 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.7 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 58.6 mt -119.85 133.7 65.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 122.636 -0.332 . . . . 0.0 110.619 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.3 ptp -128.37 -2.88 5.57 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.265 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -164.39 130.62 2.98 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -44.64 96.35 0.11 Allowed Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 127.002 2.121 . . . . 0.0 113.83 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.556 1.58 0 C-N-CA 123.553 2.835 . . . . 0.0 116.346 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 . . . . . 0 C--O 1.242 0.669 0 CA-C-O 121.152 0.501 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -107.98 124.37 50.06 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.582 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.37 145.94 46.66 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 892' ' ' TYR . 27.3 p -66.18 163.55 37.59 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.769 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.55 -23.65 26.07 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.695 2.263 . . . . 0.0 111.904 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -79.17 -50.87 10.3 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.721 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.463 ' HA ' ' HE2' ' A' ' 917' ' ' LYS . 98.0 m -82.89 -25.2 32.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.49 65.39 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -74.36 -19.6 60.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.256 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 49.2 mtmt -86.1 -30.56 22.46 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 46.3 mm . . . . . 0 C--N 1.33 -0.274 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 176.632 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 CA--C 1.513 -0.465 0 CA-C-O 121.591 0.71 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 44.4 t -135.04 118.12 23.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.2 mt -131.92 165.39 32.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -117.91 147.93 42.64 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 861' ' ' ASP . . . . . 0.437 ' HB3' HD11 ' A' ' 867' ' ' ILE . 0.9 OUTLIER -85.42 -175.82 5.85 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.08 -27.53 67.44 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.796 0.331 . . . . 0.0 111.828 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -78.04 -48.16 16.76 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.977 0.418 . . . . 0.0 110.208 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 129.34 28.04 0.79 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.968 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -88.05 155.93 19.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -83.08 130.04 35.08 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-O 121.328 0.585 . . . . 0.0 109.455 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' A' ' 861' ' ' ASP . 50.7 mm -92.43 102.83 13.99 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 -75.51 114.34 13.96 Favored 'General case' 0 C--N 1.267 -2.997 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.436 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 50.1 mt -98.52 113.03 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.474 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 43.4 t -63.46 112.94 8.1 Favored Pre-proline 0 N--CA 1.422 -1.872 0 O-C-N 124.784 1.303 . . . . 0.0 109.068 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 871' ' ' PRO . . . . . 0.503 ' HD2' ' CE1' ' A' ' 892' ' ' TYR . 53.1 Cg_exo -58.82 -15.94 29.1 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.631 2.887 . . . . 0.0 113.098 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -70.59 -43.52 60.38 Favored Glycine 0 N--CA 1.433 -1.504 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.927 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 7.4 p -109.0 -26.51 10.15 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.952 0.406 . . . . 0.0 110.653 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 77.95 25.02 0.67 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.772 1.629 . . . . 0.0 109.507 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.76 139.51 20.94 Favored Pre-proline 0 C--O 1.247 0.936 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.324 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 37.8 Cg_endo -71.43 173.86 11.76 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 123.649 2.899 . . . . 0.0 112.931 176.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.81 112.42 1.64 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.595 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -103.22 -6.56 21.98 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.926 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 117.97 -17.82 11.67 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.07 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 64.2 m -68.17 156.27 90.31 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-N 116.674 0.237 . . . . 0.0 110.773 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.16 133.71 36.47 Favored 'Trans proline' 0 C--O 1.253 1.26 0 C-N-CA 122.785 2.323 . . . . 0.0 111.784 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.0 mtp -119.0 154.43 33.08 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.1 tt -124.61 145.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -102.98 155.21 18.2 Favored Glycine 0 C--O 1.248 0.999 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 886' ' ' ASP . 43.4 t -79.96 175.12 10.92 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.739 0.78 . . . . 0.0 110.749 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 886' ' ' ASP . . . . . 0.413 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 19.2 t70 -99.04 -24.47 14.89 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 887' ' ' ASP . . . . . 0.431 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 10.6 t70 -91.85 -39.08 11.94 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.571 0.7 . . . . 0.0 109.623 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 5.3 p -120.04 172.42 7.76 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.208 0.528 . . . . 0.0 112.371 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -104.26 11.22 35.13 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.926 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -80.17 149.86 30.36 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.226 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -110.83 134.47 52.49 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.902 0.382 . . . . 0.0 111.879 -173.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 892' ' ' TYR . . . . . 0.503 ' CE1' ' HD2' ' A' ' 871' ' ' PRO . 90.5 m-85 -123.58 147.89 46.87 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.761 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 53.6 m80 -76.47 145.01 39.5 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.413 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 35.9 m0 -54.58 -51.85 74.95 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 174.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 895' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 33.3 Cg_endo -63.36 -12.53 31.01 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.525 2.15 . . . . 0.0 113.162 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.761 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 73.6 m -85.34 -29.91 24.11 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.199 0.524 . . . . 0.0 110.834 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 16.7 m -107.89 -4.6 10.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.469 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 86.31 32.69 15.93 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.566 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 52.1 mt -98.28 123.92 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-O 121.365 0.602 . . . . 0.0 109.93 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -106.7 -19.78 13.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.073 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -151.83 150.47 30.16 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 902' ' ' ALA . . . . . 0.406 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -53.97 111.48 2.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.653 1.221 . . . . 0.0 111.385 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 40.1 Cg_endo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.489 2.126 . . . . 0.0 110.816 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 . . . . . 0 N--CA 1.439 -1.009 0 CA-C-O 121.223 0.535 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -139.76 131.84 27.97 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -125.13 140.53 52.79 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 24.8 p -71.33 164.57 56.23 Favored Pre-proline 0 N--CA 1.424 -1.745 0 O-C-N 123.855 0.722 . . . . 0.0 110.524 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -59.92 -9.97 11.12 Favored 'Trans proline' 0 CA--C 1.552 1.409 0 C-N-CA 122.895 2.397 . . . . 0.0 112.704 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 913' ' ' LYS . 72.8 mmtt -87.26 -46.32 9.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 122.252 -0.28 . . . . 0.0 110.289 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 92.2 m -76.4 -27.81 56.45 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.218 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -68.77 -24.73 64.47 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.437 0.637 . . . . 0.0 109.67 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -68.37 -37.69 80.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -60.94 -38.43 85.8 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.432 0.634 . . . . 0.0 109.845 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 50.4 mm . . . . . 0 C--N 1.317 -0.846 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.415 -178.874 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 857' ' ' TYR . . . . . 0.542 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 65.0 m-85 . . . . . 0 CA--C 1.505 -0.776 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.57 128.59 60.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 45.3 mt -137.13 162.26 34.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 860' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 860' ' ' ARG . 54.1 mtt180 -102.89 140.78 36.71 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 119.071 0.85 . . . . 0.0 110.966 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -76.71 173.67 11.35 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.681 173.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -70.66 -26.76 63.59 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 863' ' ' TRP . . . . . 0.546 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 96.2 m95 -88.61 -6.57 57.44 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.193 0.521 . . . . 0.0 109.926 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 94.32 13.71 53.27 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.942 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.546 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 51.6 m-80 -72.9 158.88 34.65 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -91.72 127.99 37.39 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 121.982 0.896 . . . . 0.0 111.726 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 46.3 mm -99.62 125.96 53.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.592 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -108.08 152.71 24.15 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.542 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 31.9 mt -112.69 133.0 59.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 O-C-N 123.579 0.55 . . . . 0.0 109.823 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 45.3 t -80.54 111.39 22.44 Favored Pre-proline 0 N--CA 1.421 -1.886 0 C-N-CA 124.911 1.284 . . . . 0.0 109.24 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 871' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 32.6 Cg_exo -63.3 2.88 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.315 0 C-N-CA 123.894 3.063 . . . . 0.0 113.498 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -90.04 -19.38 47.06 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.743 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 7.0 p -137.97 -25.29 0.98 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 17.1 t30 78.92 20.43 0.75 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.671 1.589 . . . . 0.0 109.257 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 99.3 mttt -92.43 139.12 23.83 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.731 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.403 ' CA ' HG12 ' A' ' 869' ' ' ILE . 57.8 Cg_endo -77.59 163.7 29.12 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.546 2.831 . . . . 0.0 112.487 174.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 877' ' ' ASP . . . . . 0.462 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 12.8 t70 -59.1 125.95 25.69 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.525 0.73 . . . . 0.0 111.831 175.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -99.02 19.5 15.01 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.655 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 84.11 42.5 7.53 Favored Glycine 0 CA--C 1.488 -1.639 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 -172.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 880' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 881' ' ' PRO . 9.1 p -115.48 150.79 45.2 Favored Pre-proline 0 N--CA 1.409 -2.508 0 CA-C-N 113.77 -1.215 . . . . 0.0 111.565 -170.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 880' ' ' SER . 16.3 Cg_exo -68.77 123.0 9.95 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 122.072 1.848 . . . . 0.0 108.72 171.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.462 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 92.4 mtp -120.27 157.18 29.7 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.9 tt -119.19 134.96 61.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.15 157.5 21.55 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 886' ' ' ASP . 52.3 t -80.64 170.77 15.89 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.5 0.667 . . . . 0.0 110.503 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 886' ' ' ASP . . . . . 0.409 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 22.2 t70 -93.82 -24.1 17.89 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 887' ' ' ASP . . . . . 0.416 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 16.0 t70 -99.86 -48.1 4.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.796 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.7 p -98.65 165.3 11.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.354 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -88.32 -16.19 33.71 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.158 0.983 . . . . 0.0 110.521 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.66 152.29 45.54 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.757 -174.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -105.42 133.64 49.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.512 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -115.4 146.77 41.28 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.698 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.3 m80 -76.88 141.07 40.74 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -50.31 -51.62 61.87 Favored Pre-proline 0 CA--C 1.555 1.161 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.78 -22.53 74.58 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.402 2.068 . . . . 0.0 114.176 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 60.9 m -81.02 -26.9 36.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.529 0.681 . . . . 0.0 111.652 -175.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.625 HG23 HG12 ' A' ' 899' ' ' ILE . 15.1 m -112.68 -5.47 11.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.087 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 85.65 41.81 7.12 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.365 175.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.625 HG12 HG23 ' A' ' 897' ' ' VAL . 39.9 mm -90.98 108.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.7 ptm -87.19 -23.93 24.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.735 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -162.68 149.36 12.95 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -49.66 110.6 1.65 Allowed Pre-proline 0 C--O 1.241 0.619 0 O-C-N 124.508 1.13 . . . . 0.0 111.8 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 122.979 2.452 . . . . 0.0 112.107 -179.456 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 N--CA 1.441 -0.902 0 CA-C-O 121.183 0.516 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -130.09 131.98 45.96 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -133.45 137.78 45.88 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.246 0.546 . . . . 0.0 110.132 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 7.5 p -73.48 172.12 9.01 Favored Pre-proline 0 C--N 1.296 -1.723 0 C-N-CA 124.862 1.265 . . . . 0.0 110.641 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.71 -16.17 23.86 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 123.002 2.468 . . . . 0.0 111.665 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.669 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 11.7 mmmm -80.56 -55.02 5.14 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.26 0.624 . . . . 0.0 110.849 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.435 ' O ' HG12 ' A' ' 918' ' ' ILE . 71.6 m -85.59 -22.82 27.86 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.65 -22.18 61.72 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 916' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 913' ' ' LYS . 3.4 t-20 -66.96 -36.13 81.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.741 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -66.05 -49.14 68.69 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.404 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 914' ' ' CYS . 32.5 mm . . . . . 0 C--O 1.244 0.765 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.078 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 857' ' ' TYR . . . . . 0.507 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 49.7 m-85 . . . . . 0 N--CA 1.425 -1.693 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.61 118.06 37.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.517 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 54.5 mt -117.07 162.78 14.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -96.63 134.33 40.01 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 119.313 0.96 . . . . 0.0 110.108 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -75.86 174.4 9.94 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.99 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -68.47 -30.04 68.8 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 123.666 0.786 . . . . 0.0 110.784 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -79.95 -15.58 56.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.885 0.85 . . . . 0.0 108.895 176.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 96.93 18.56 29.17 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -81.6 178.24 8.46 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -95.88 129.0 43.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.073 0.463 . . . . 0.0 110.317 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 28.2 mm -92.1 122.27 43.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -90.84 148.61 22.39 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 124.22 0.95 . . . . 0.0 111.208 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 50.7 mt -122.17 136.44 59.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.471 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.85 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 50.0 t -77.59 106.98 4.38 Favored Pre-proline 0 N--CA 1.426 -1.668 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 871' ' ' PRO . . . . . 0.485 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 57.5 Cg_endo -78.14 15.19 1.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.018 1.812 . . . . 0.0 111.977 -177.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -87.52 -32.0 14.62 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 9.4 p -115.13 -32.37 5.72 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.582 -0.309 . . . . 0.0 110.475 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 87.55 26.26 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.828 2.051 . . . . 0.0 109.864 -175.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.473 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 25.6 mtpp -110.23 139.07 21.08 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.553 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.6 Cg_endo -76.51 169.95 20.89 Favored 'Trans proline' 0 C--O 1.249 1.051 0 C-N-CA 123.426 2.751 . . . . 0.0 112.98 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -51.99 113.45 1.01 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.538 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -107.64 18.18 21.74 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.58 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 83.72 27.75 37.51 Favored Glycine 0 CA--C 1.492 -1.366 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 10.7 p -106.02 167.59 9.44 Favored Pre-proline 0 N--CA 1.42 -1.935 0 C-N-CA 123.82 0.848 . . . . 0.0 110.043 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.75 123.84 9.29 Favored 'Trans proline' 0 N--CA 1.437 -1.811 0 C-N-CA 121.368 1.379 . . . . 0.0 109.762 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 78.1 mtp -122.44 150.51 42.39 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.668 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 883' ' ' ILE . . . . . 0.528 ' HB ' ' HE1' ' A' ' 894' ' ' TRP . 19.0 tt -117.36 148.67 19.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -109.87 157.45 15.06 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.596 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.523 ' HB3' ' OD2' ' A' ' 890' ' ' ASP . 42.2 t -91.73 -170.83 2.69 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 126.037 1.735 . . . . 0.0 108.016 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -120.54 -23.34 6.11 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.965 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 887' ' ' ASP . . . . . 0.45 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 3.4 t70 -102.52 -25.09 13.72 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -167.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 890' ' ' ASP . 22.6 p -119.12 -143.93 0.36 Allowed 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -174.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -130.04 87.04 2.47 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 890' ' ' ASP . . . . . 0.523 ' OD2' ' HB3' ' A' ' 885' ' ' CYS . 1.4 p30 -128.78 157.62 40.94 Favored 'General case' 0 C--N 1.256 -3.494 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -159.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -161.09 117.3 2.22 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 127.85 2.46 . . . . 0.0 106.409 161.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 892' ' ' TYR . . . . . 0.485 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 62.8 m-85 -120.02 147.98 44.12 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.728 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 97.9 m-70 -76.69 140.2 40.79 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.899 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.528 ' HE1' ' HB ' ' A' ' 883' ' ' ILE . 24.2 m0 -53.51 -51.2 78.11 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.08 -9.42 25.01 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.039 1.826 . . . . 0.0 113.919 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.728 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 74.3 m -86.51 -39.7 15.99 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.293 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.618 HG23 HG12 ' A' ' 899' ' ' ILE . 30.5 m -104.57 -4.07 9.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.205 -175.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 87.1 53.0 2.93 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.519 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.618 HG12 HG23 ' A' ' 897' ' ' VAL . 16.7 mm -114.02 136.05 51.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.2 ptp -121.08 -15.59 8.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.605 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -162.61 135.48 5.77 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -39.21 96.7 0.12 Allowed Pre-proline 0 N--CA 1.494 1.746 0 C-N-CA 126.169 1.788 . . . . 0.0 113.833 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 CA--C 1.551 1.365 0 C-N-CA 123.553 2.835 . . . . 0.0 118.113 -176.329 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 908' ' ' GLN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 910' ' ' PHE . 38.2 mt-30 . . . . . 0 C--O 1.238 0.48 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -101.12 131.38 47.08 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 908' ' ' GLN . 92.0 m-85 -128.76 139.34 52.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 27.4 p -66.43 166.99 14.23 Favored Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 124.226 0.954 . . . . 0.0 110.944 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -48.78 -24.48 7.03 Favored 'Trans proline' 0 CA--C 1.552 1.405 0 C-N-CA 123.841 3.028 . . . . 0.0 113.075 175.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -87.01 -41.31 13.98 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.725 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 90.8 m -85.7 -17.94 34.53 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.65 74.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 122.127 0.965 . . . . 0.0 108.654 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.78 -29.19 70.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.897 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -70.4 -35.49 73.5 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.173 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.422 HD11 ' CD2' ' A' ' 910' ' ' PHE . 70.8 mt . . . . . 0 C--N 1.327 -0.397 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 . . . . . 0 CA--C 1.509 -0.611 0 CA-C-O 122.526 1.155 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 92.3 t -131.91 120.74 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 113.717 -1.583 . . . . 0.0 108.969 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 45.6 mt -119.75 152.28 22.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -102.97 137.69 40.83 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.161 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.65 172.65 10.27 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.569 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.8 -28.05 66.41 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 122.613 0.365 . . . . 0.0 110.758 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 -74.72 -23.85 58.65 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 107.62 3.82 34.69 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.164 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -69.69 149.0 48.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.977 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -84.62 127.05 33.87 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.737 0.78 . . . . 0.0 112.096 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 47.0 mm -98.75 117.55 43.97 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -94.24 135.88 35.14 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.742 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.538 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 51.1 mt -105.77 128.35 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 25.7 t -82.75 107.97 10.87 Favored Pre-proline 0 N--CA 1.414 -2.234 0 C-N-CA 125.04 1.336 . . . . 0.0 108.833 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 871' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 36.2 Cg_exo -63.17 0.25 1.81 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.459 2.772 . . . . 0.0 113.014 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.3 -33.61 35.05 Favored Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 20.3 p -119.6 -28.43 5.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.816 0.341 . . . . 0.0 110.719 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.0 t30 80.63 29.51 0.21 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.032 2.133 . . . . 0.0 109.04 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -113.05 141.4 25.55 Favored Pre-proline 0 C--O 1.243 0.732 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.038 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 39.9 Cg_endo -74.43 155.84 45.67 Favored 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 123.324 2.682 . . . . 0.0 112.691 174.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.35 145.72 37.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.81 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -133.89 5.66 3.63 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.972 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 118.73 40.66 0.65 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.723 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 37.8 m -105.07 166.08 12.07 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -69.35 123.07 9.86 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.636 1.557 . . . . 0.0 109.778 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 53.2 mtp -120.42 161.06 21.86 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.608 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.9 tt -138.26 148.15 25.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -121.14 149.16 17.4 Favored Glycine 0 C--O 1.252 1.224 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.502 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 52.2 t -64.69 160.76 19.22 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.64 1.176 . . . . 0.0 110.995 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.78 -12.34 53.89 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -106.71 -39.41 5.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.598 ' HB2' ' OD1' ' A' ' 890' ' ' ASP . 22.9 m -85.85 -160.87 0.57 Allowed 'General case' 0 CA--C 1.569 1.691 0 CA-C-O 121.849 0.833 . . . . 0.0 113.159 -174.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -133.55 29.63 3.88 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 890' ' ' ASP . . . . . 0.598 ' OD1' ' HB2' ' A' ' 888' ' ' CYS . 11.7 p-10 -89.28 176.97 6.73 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 112.068 -2.333 . . . . 0.0 112.399 -170.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -152.72 116.94 4.91 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.43 -1.714 . . . . 0.0 106.859 170.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 892' ' ' TYR . . . . . 0.444 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 26.6 m-85 -107.46 158.67 17.0 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.719 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 42.2 m80 -86.81 144.5 27.01 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.623 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 29.2 m0 -51.9 -54.11 44.09 Favored Pre-proline 0 CA--C 1.552 1.022 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.58 -23.33 64.51 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.158 1.905 . . . . 0.0 113.202 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.719 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 53.5 m -79.73 -21.89 43.96 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.252 0.549 . . . . 0.0 111.531 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 12.6 m -116.46 9.92 7.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.43 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 70.8 38.23 66.08 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 114.928 -1.033 . . . . 0.0 113.199 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.623 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 51.0 mt -111.07 127.05 68.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 120.993 0.425 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 92.7 mmm -123.54 -6.48 8.11 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.133 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -145.16 138.12 26.34 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 902' ' ' ALA . . . . . 0.418 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -59.95 112.69 5.76 Favored Pre-proline 0 C--N 1.317 -0.822 0 O-C-N 124.442 1.089 . . . . 0.0 110.992 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 42.2 Cg_endo . . . . . 0 C--O 1.25 1.108 0 C-N-CA 122.679 2.253 . . . . 0.0 111.184 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 . . . . . 0 N--CA 1.437 -1.124 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -126.99 134.52 50.34 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -124.45 140.17 53.2 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.307 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 892' ' ' TYR . 25.4 p -64.16 163.87 21.7 Favored Pre-proline 0 N--CA 1.424 -1.755 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.682 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.43 -10.54 6.83 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 122.806 2.337 . . . . 0.0 112.434 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 913' ' ' LYS . 74.4 mmtt -87.81 -57.95 2.75 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.431 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 75.1 m -69.25 -25.99 64.56 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.32 68.64 Favored 'General case' 0 C--O 1.198 -1.633 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -82.5 -5.01 58.46 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -87.77 -44.14 11.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 67.0 mt . . . . . 0 C--O 1.242 0.692 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.777 178.366 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 C--O 1.225 -0.2 0 CA-C-O 121.395 0.616 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.83 109.18 18.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 56.4 mt -102.84 148.58 7.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -96.88 122.87 40.32 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.421 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.21 165.52 11.31 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.75 -29.58 70.22 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -94.46 3.67 54.85 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.3 1.048 . . . . 0.0 109.776 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.06 22.22 46.27 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.486 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -76.71 147.73 37.22 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -80.09 113.6 18.38 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.174 0.512 . . . . 0.0 111.765 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 45.8 mm -97.92 118.67 44.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 175.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -99.98 147.0 26.06 Favored 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.334 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 37.4 mt -113.49 132.49 62.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.898 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 53.8 t -86.81 107.15 12.85 Favored Pre-proline 0 N--CA 1.405 -2.686 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 871' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 24.6 Cg_exo -65.01 1.35 1.94 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.14 2.56 . . . . 0.0 113.852 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -77.44 -50.4 6.68 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 4.4 p -102.24 -19.26 15.13 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 123.093 0.557 . . . . 0.0 110.288 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 77.56 19.39 1.21 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.557 1.543 . . . . 0.0 109.857 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -103.07 140.61 21.21 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.153 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 48.1 Cg_endo -74.85 173.02 15.16 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 123.269 2.646 . . . . 0.0 112.067 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.38 129.18 40.64 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.516 0.674 . . . . 0.0 111.101 174.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -118.06 34.36 5.21 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 73.54 44.1 34.36 Favored Glycine 0 CA--C 1.493 -1.287 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -173.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.5 p -120.23 151.04 52.71 Favored Pre-proline 0 N--CA 1.412 -2.338 0 CA-C-N 113.871 -1.164 . . . . 0.0 111.526 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.75 120.18 6.28 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 121.88 1.72 . . . . 0.0 109.995 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 76.3 mtp -115.94 150.28 37.4 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.839 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.6 tt -123.27 140.0 48.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -107.08 144.63 15.91 Favored Glycine 0 C--O 1.247 0.937 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.284 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 44.5 t -70.05 147.73 49.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.351 0.596 . . . . 0.0 112.08 -178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -81.9 -24.22 35.81 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.249 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.2 -51.79 9.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 120.989 0.424 . . . . 0.0 110.002 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 10.5 p -107.7 -92.86 0.41 Allowed 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.1 t70 179.62 -30.78 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.325 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -50.72 134.33 24.97 Favored 'General case' 0 C--O 1.247 0.947 0 O-C-N 124.703 1.252 . . . . 0.0 112.384 -172.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -101.9 133.16 47.11 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.333 -172.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -117.84 155.55 29.91 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.411 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.467 ' O ' HG22 ' A' ' 897' ' ' VAL . 41.3 m80 -77.21 143.57 38.91 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.494 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 27.7 m0 -49.8 -53.78 38.7 Favored Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.14 -19.02 65.1 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.228 1.952 . . . . 0.0 113.795 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 79.3 m -84.11 -23.7 30.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.003 0.43 . . . . 0.0 111.925 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.553 HG23 HG12 ' A' ' 899' ' ' ILE . 12.5 m -114.98 5.98 7.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.934 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 75.64 44.8 19.6 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.837 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.553 HG12 HG23 ' A' ' 897' ' ' VAL . 7.7 mm -110.32 109.7 29.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 mmt -109.61 -2.29 17.61 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.182 0.515 . . . . 0.0 110.43 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -154.32 143.62 21.32 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 902' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -58.1 116.76 15.75 Favored Pre-proline 0 N--CA 1.438 -1.058 0 O-C-N 124.225 0.953 . . . . 0.0 110.673 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 18.2 Cg_endo . . . . . 0 N--CA 1.45 -1.085 0 C-N-CA 122.262 1.975 . . . . 0.0 110.632 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -123.84 129.46 51.05 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.907 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.467 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 55.3 m-85 -120.13 142.44 48.92 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 25.7 p -63.9 160.21 48.23 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -51.53 -23.56 14.9 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.883 2.388 . . . . 0.0 112.529 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.565 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 33.3 mmtp -68.36 -55.19 12.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.37 0.668 . . . . 0.0 109.578 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.516 ' HA ' ' HE2' ' A' ' 917' ' ' LYS . 78.7 m -77.57 -22.09 51.5 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.493 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -63.56 -35.66 81.24 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.443 1.116 . . . . 0.0 108.585 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -76.72 -17.5 59.05 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.165 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 43.7 mtmt -85.76 -16.39 39.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 49.9 mm . . . . . 0 C--O 1.22 -0.467 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.052 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.965 0.888 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.05 110.61 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.864 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.537 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 58.8 mt -117.15 160.88 16.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -115.18 136.89 52.63 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.754 0.706 . . . . 0.0 110.544 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.17 176.73 7.04 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 124.831 1.252 . . . . 0.0 109.065 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.58 -26.81 62.76 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.248 0.619 . . . . 0.0 110.209 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.61 -3.34 50.04 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.317 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.69 -2.95 86.29 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 116.161 -0.472 . . . . 0.0 113.056 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -71.24 153.22 42.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 123.611 0.242 . . . . 0.0 111.019 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -71.26 146.72 48.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.557 0.694 . . . . 0.0 111.75 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.537 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 31.3 mm -120.79 126.88 75.75 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 868' ' ' TRP . . . . . 0.498 ' O ' ' HA ' ' A' ' 876' ' ' PRO . 26.1 m-90 -100.47 153.89 18.98 Favored 'General case' 0 C--N 1.285 -2.199 0 O-C-N 123.643 0.589 . . . . 0.0 111.235 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 859' ' ' ILE . 39.8 mt -118.15 117.48 54.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.745 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 38.4 t -73.81 111.65 13.15 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.28 7.97 2.74 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.984 1.79 . . . . 0.0 112.5 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.65 -27.11 43.75 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 8.4 p -121.52 -32.95 3.73 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.727 0.775 . . . . 0.0 109.411 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 80.45 39.78 0.08 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 126.745 2.018 . . . . 0.0 109.944 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -118.33 143.69 33.6 Favored Pre-proline 0 N--CA 1.446 -0.674 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.305 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 868' ' ' TRP . 50.7 Cg_endo -74.59 173.98 13.41 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 123.398 2.732 . . . . 0.0 113.018 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.42 138.93 2.21 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.071 0.949 . . . . 0.0 111.889 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -118.04 -22.97 7.6 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.144 0.974 . . . . 0.0 109.356 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 116.01 -10.49 17.97 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -171.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 11.9 p -65.05 153.0 90.04 Favored Pre-proline 0 N--CA 1.433 -1.301 0 C-N-CA 125.569 1.548 . . . . 0.0 111.193 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.54 137.37 46.17 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 122.278 1.985 . . . . 0.0 109.834 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 83.8 mtp -125.5 149.61 48.13 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.2 tt -118.84 150.75 21.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -113.76 144.92 18.33 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.418 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 49.2 t -76.72 154.69 33.88 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.58 -9.97 36.31 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.155 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.96 -64.13 1.2 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 1.6 p -94.57 -49.27 5.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.101 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 14.1 t70 80.01 79.54 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.471 1.508 . . . . 0.0 113.489 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -129.74 177.77 6.99 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -99.63 123.56 44.01 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 119.339 0.972 . . . . 0.0 112.819 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -116.82 148.69 41.0 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.756 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 49.1 m80 -76.85 144.08 39.27 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.219 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -52.77 -57.8 14.55 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.03 -11.21 30.08 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.77 1.647 . . . . 0.0 113.672 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -84.11 -37.05 22.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.285 0.564 . . . . 0.0 111.855 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.637 HG23 HG12 ' A' ' 899' ' ' ILE . 27.0 m -102.03 -8.63 9.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.772 -176.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 95.96 56.31 1.23 Allowed Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.592 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.637 HG12 HG23 ' A' ' 897' ' ' VAL . 9.0 mm -130.47 125.8 59.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 87.6 mtp -127.02 8.12 6.69 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.738 0.78 . . . . 0.0 110.411 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 901' ' ' ALA . . . . . 0.617 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -173.95 145.81 1.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -66.18 103.02 0.4 Allowed Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.7 1.2 . . . . 0.0 112.877 -174.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 25.5 Cg_endo . . . . . 0 N--CA 1.448 -1.165 0 C-N-CA 124.019 3.146 . . . . 0.0 115.998 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 . . . . . 0 C--O 1.24 0.605 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -108.85 137.5 46.68 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.464 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -126.02 138.25 53.71 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 27.4 p -69.33 163.44 58.19 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.037 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.06 -23.47 22.03 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 123.847 3.031 . . . . 0.0 112.492 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 29.9 mmmt -69.04 -44.02 73.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 73.6 m -89.01 -27.42 20.88 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.004 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.6 -24.91 61.98 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 120.777 0.322 . . . . 0.0 110.379 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -77.31 -13.84 59.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.606 0.717 . . . . 0.0 109.792 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -73.39 -29.58 62.7 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 54.4 mt . . . . . 0 N--CA 1.443 -0.794 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.382 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 857' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 871' ' ' PRO . 54.9 m-85 . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 121.576 0.703 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.35 121.08 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.749 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 59.0 mt -124.83 154.22 32.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -91.82 125.52 36.56 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.925 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -71.01 171.58 10.6 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.293 -1.322 . . . . 0.0 109.043 172.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.39 -29.15 69.25 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 122.602 0.361 . . . . 0.0 111.884 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 863' ' ' TRP . . . . . 0.501 ' HB3' ' ND2' ' A' ' 865' ' ' ASN . 44.2 t-105 -87.92 -11.93 46.18 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 97.95 15.05 37.64 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.812 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' A' ' 863' ' ' TRP . 45.9 m-80 -71.36 151.85 43.73 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -78.05 116.21 18.36 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 25.2 mm -64.15 114.59 2.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 122.172 0.987 . . . . 0.0 111.518 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.66 105.64 0.32 Allowed 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 111.478 -2.601 . . . . 0.0 110.988 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.499 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 40.4 mt -127.07 131.04 71.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 891' ' ' TRP . 52.6 t -85.81 110.23 28.57 Favored Pre-proline 0 N--CA 1.418 -2.055 0 O-C-N 124.164 0.915 . . . . 0.0 108.849 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 871' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 50.6 Cg_exo -57.0 -20.34 36.54 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.394 2.729 . . . . 0.0 113.028 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -68.97 -36.04 80.43 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.539 -0.362 . . . . 0.0 112.962 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 12.3 p -118.51 -13.54 9.71 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.806 0.303 . . . . 0.0 111.289 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 63.1 t30 72.36 24.18 3.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.25 1.42 . . . . 0.0 109.692 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -113.6 138.41 22.58 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 121.771 -0.58 . . . . 0.0 112.071 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 57.1 Cg_endo -73.22 174.03 12.74 Favored 'Trans proline' 0 C--O 1.253 1.228 0 C-N-CA 124.154 3.236 . . . . 0.0 113.328 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.09 137.09 57.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.676 176.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -122.57 25.21 8.9 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.597 1.189 . . . . 0.0 107.856 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 81.52 52.47 4.18 Favored Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 106.438 -2.665 . . . . 0.0 106.438 -171.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 3.7 p -124.0 152.57 66.94 Favored Pre-proline 0 N--CA 1.413 -2.278 0 CA-C-N 113.861 -1.17 . . . . 0.0 112.239 -170.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -72.23 112.58 3.47 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.032 1.822 . . . . 0.0 110.048 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 79.3 mtp -122.15 144.16 49.12 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.762 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 15.9 tt -117.19 152.18 19.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.779 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -110.17 156.38 15.61 Favored Glycine 0 CA--C 1.538 1.518 0 O-C-N 123.206 0.316 . . . . 0.0 113.441 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.518 ' H ' ' CG ' ' A' ' 890' ' ' ASP . 43.8 t -84.92 -170.26 3.04 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 126.31 1.844 . . . . 0.0 109.157 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -123.08 -11.54 8.04 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -107.91 -54.63 2.47 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -173.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 15.7 p -99.57 -134.79 0.28 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -165.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -128.74 89.48 2.89 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 890' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' A' ' 885' ' ' CYS . 2.6 p30 -128.06 148.69 50.56 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -158.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 891' ' ' TRP . . . . . 0.467 ' O ' ' HA ' ' A' ' 870' ' ' CYS . 68.2 m95 -161.52 117.66 2.13 Favored 'General case' 0 C--O 1.208 -1.129 0 C-N-CA 128.058 2.543 . . . . 0.0 106.929 160.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -124.54 148.73 47.59 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.462 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.68 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 57.9 m80 -80.8 144.86 31.77 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -53.53 -52.68 64.66 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.2 -11.59 32.79 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.998 1.799 . . . . 0.0 113.122 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 87.6 m -84.66 -32.14 23.79 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.648 0.737 . . . . 0.0 110.928 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 893' ' ' HIS . 20.9 m -101.52 -27.46 3.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.934 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 104.22 52.99 0.85 Allowed Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.052 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.79 136.64 58.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.026 0.441 . . . . 0.0 110.854 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.8 ptp -128.37 -1.11 5.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.849 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -150.4 141.72 23.27 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -71.91 112.34 13.96 Favored Pre-proline 0 C--N 1.311 -1.089 0 C-N-CA 123.039 0.536 . . . . 0.0 111.912 -176.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo . . . . . 0 N--CA 1.446 -1.293 0 C-N-CA 122.506 2.137 . . . . 0.0 111.029 175.79 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 . . . . . 0 N--CA 1.426 -1.675 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -118.5 140.37 49.97 Favored 'General case' 0 C--N 1.26 -3.287 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -129.53 136.41 49.81 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 9.0 p -73.85 167.25 37.02 Favored Pre-proline 0 N--CA 1.415 -2.207 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.183 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.05 -19.7 21.05 Favored 'Trans proline' 0 CA--C 1.551 1.331 0 C-N-CA 122.976 2.451 . . . . 0.0 112.41 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -81.16 -37.02 29.45 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 110.285 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 97.3 m -89.1 -30.02 18.95 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.808 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.13 68.17 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.05 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -73.05 -19.43 61.18 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.281 0.562 . . . . 0.0 111.562 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -101.05 -27.68 13.14 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.201 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 C--N 1.309 -1.186 0 CA-C-O 121.249 0.547 . . . . 0.0 109.53 174.522 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 122.179 0.99 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 858' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 8.1 p -143.42 130.36 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.684 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 44.2 mt -124.39 150.75 29.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -94.75 125.06 39.16 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.622 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.02 172.37 11.13 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.157 174.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.93 -30.39 71.48 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 123.644 0.778 . . . . 0.0 111.188 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -85.53 -0.67 55.67 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.435 0.636 . . . . 0.0 110.465 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 84.01 3.76 88.91 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.213 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -73.01 149.65 43.08 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -78.96 128.17 32.93 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.532 0.682 . . . . 0.0 111.371 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 32.4 mm -96.02 121.61 46.73 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 23.4 m-90 -99.76 139.35 35.55 Favored 'General case' 0 C--N 1.264 -3.121 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.597 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 31.6 mt -103.97 119.16 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.404 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.513 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 50.7 t -61.89 108.83 1.76 Allowed Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 125.143 1.377 . . . . 0.0 108.222 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 871' ' ' PRO . . . . . 0.432 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 52.6 Cg_exo -57.7 -16.99 27.05 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.735 2.957 . . . . 0.0 113.22 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -70.88 -46.43 45.35 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.246 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 17.0 p -106.75 -28.01 10.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 63.4 t30 81.25 27.84 0.19 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.714 1.606 . . . . 0.0 109.221 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.53 139.33 20.0 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.182 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 42.6 Cg_endo -76.17 162.73 33.77 Favored 'Trans proline' 0 C--O 1.251 1.173 0 C-N-CA 123.08 2.52 . . . . 0.0 112.583 174.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 877' ' ' ASP . . . . . 0.402 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 17.5 t70 -65.96 141.38 58.22 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.46 14.59 8.23 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 122.781 1.277 . . . . 0.0 107.965 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 85.29 52.66 3.33 Favored Glycine 0 N--CA 1.423 -2.186 0 N-CA-C 105.828 -2.909 . . . . 0.0 105.828 -170.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 11.4 p -119.69 153.54 54.44 Favored Pre-proline 0 N--CA 1.418 -2.034 0 CA-C-N 113.927 -1.137 . . . . 0.0 111.091 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.97 118.67 5.69 Favored 'Trans proline' 0 C--O 1.257 1.429 0 C-N-CA 122.24 1.96 . . . . 0.0 109.951 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.402 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 77.0 mtp -125.32 142.32 51.57 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.074 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.3 tt -110.73 144.88 17.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -110.99 163.52 12.25 Favored Glycine 0 C--N 1.301 -1.395 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.078 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.49 ' H ' ' CG ' ' A' ' 890' ' ' ASP . 51.2 t -88.99 -164.33 1.12 Allowed 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 126.027 1.731 . . . . 0.0 108.551 -177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 886' ' ' ASP . . . . . 0.406 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 30.2 t70 -131.34 -8.96 3.74 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.637 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -109.0 -46.93 3.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.4 p -104.29 -126.73 0.23 Allowed 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -166.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -136.02 88.54 2.4 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 890' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 885' ' ' CYS . 3.1 p30 -127.74 146.89 50.43 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 113.085 -1.87 . . . . 0.0 115.238 -161.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -162.39 117.62 1.88 Allowed 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 128.046 2.538 . . . . 0.0 106.349 158.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 892' ' ' TYR . . . . . 0.432 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 44.8 m-85 -123.25 148.97 45.32 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.756 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.8 m80 -77.91 145.85 35.91 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.513 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 31.6 m0 -51.95 -55.63 28.87 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 175.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.28 -12.68 34.04 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.426 2.084 . . . . 0.0 113.99 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.3 m -86.49 -21.88 26.74 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.027 0.442 . . . . 0.0 111.069 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.703 HG23 HG12 ' A' ' 899' ' ' ILE . 14.4 m -120.52 5.79 6.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.144 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 84.15 23.4 51.95 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.712 175.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.703 HG12 HG23 ' A' ' 897' ' ' VAL . 16.9 mm -91.04 121.6 41.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 18.3 ptm -118.29 -6.14 10.83 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.281 0.562 . . . . 0.0 110.568 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.1 149.81 21.57 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -60.32 112.95 6.28 Favored Pre-proline 0 C--N 1.314 -0.977 0 O-C-N 124.172 0.92 . . . . 0.0 111.004 -177.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 C--O 1.248 0.993 0 C-N-CA 123.155 2.57 . . . . 0.0 111.111 179.828 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 . . . . . 0 N--CA 1.432 -1.352 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -136.4 135.71 38.98 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -126.52 139.18 53.42 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 16.9 p -64.7 167.15 9.64 Favored Pre-proline 0 C--N 1.29 -2.003 0 O-C-N 124.2 0.937 . . . . 0.0 111.892 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 11.4 Cg_endo -56.17 -13.4 9.52 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 123.074 2.516 . . . . 0.0 112.128 175.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.489 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 31.6 mmmt -84.34 -60.57 2.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 917' ' ' LYS . 92.5 m -73.04 -27.41 61.74 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.78 78.22 Favored 'General case' 0 C--O 1.201 -1.481 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -72.42 -22.81 61.05 Favored 'General case' 0 C--O 1.211 -0.924 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 914' ' ' CYS . 92.3 mttt -72.06 -46.44 56.9 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 70.2 mt . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.465 -180.0 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 857' ' ' TYR . . . . . 0.497 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 97.0 m-85 . . . . . 0 C--O 1.24 0.571 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 14.0 p -143.62 118.89 4.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.635 0.731 . . . . 0.0 112.231 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 47.5 mt -114.84 160.87 13.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -103.78 130.65 51.34 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.233 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.83 175.29 2.5 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 125.623 1.569 . . . . 0.0 111.123 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -58.32 -40.17 81.37 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 124.937 1.295 . . . . 0.0 111.107 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 863' ' ' TRP . . . . . 0.48 ' HB3' ' ND2' ' A' ' 865' ' ' ASN . 66.9 t-105 -80.12 -25.92 39.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.369 0.604 . . . . 0.0 110.037 177.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 117.6 7.21 12.25 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.48 ' ND2' ' HB3' ' A' ' 863' ' ' TRP . 46.0 m-80 -64.25 159.9 19.8 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -85.24 117.4 24.16 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.332 0.587 . . . . 0.0 109.954 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 42.4 mm -90.76 114.02 27.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -86.13 128.07 34.82 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.847 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 33.3 mt -100.9 123.7 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.15 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.426 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 41.1 t -77.71 117.2 64.15 Favored Pre-proline 0 N--CA 1.408 -2.533 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.152 -176.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 871' ' ' PRO . . . . . 0.55 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 58.6 Cg_exo -56.5 -17.82 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.656 2.904 . . . . 0.0 113.32 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.75 -21.42 76.79 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 121.314 -0.469 . . . . 0.0 113.295 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 10.8 p -138.21 -10.6 1.48 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.301 0.551 . . . . 0.0 112.231 -177.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.257 2.3 p-10 61.15 25.44 15.44 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.299 1.84 . . . . 0.0 111.129 -173.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -106.33 140.21 21.07 Favored Pre-proline 0 N--CA 1.435 -1.222 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.3 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.73 173.65 14.15 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 123.347 2.698 . . . . 0.0 112.336 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.96 138.7 42.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.616 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -119.58 -6.1 10.22 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.895 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 89.66 21.12 41.34 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -172.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.6 t -100.89 161.32 24.13 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.36 113.62 1.76 Allowed 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.732 2.288 . . . . 0.0 111.649 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 85.6 mtp -109.92 156.83 19.92 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.02 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.6 tt -126.6 142.73 42.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.92 152.39 19.66 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.579 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 48.8 t -85.15 169.89 13.43 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.649 0.738 . . . . 0.0 110.325 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.65 -32.96 16.01 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 887' ' ' ASP . . . . . 0.487 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 14.4 t70 -100.88 -38.31 8.29 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.529 -174.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 60.5 m -89.42 158.49 17.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.148 0.499 . . . . 0.0 110.255 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.64 -0.28 43.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -86.84 159.34 19.11 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.461 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -117.0 142.4 47.0 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.156 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 892' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 64.4 m-85 -114.69 171.33 7.7 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.758 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 65.2 m80 -99.12 151.93 20.43 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -54.35 -53.29 61.04 Favored Pre-proline 0 CA--C 1.553 1.094 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.65 -29.75 90.55 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.75 1.633 . . . . 0.0 113.011 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.758 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 28.5 m -70.41 -21.68 62.81 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.859 0.837 . . . . 0.0 111.901 -175.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.25 10.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.198 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 71.79 46.61 37.15 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.243 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.14 136.37 58.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 62.3 mtt -128.19 -4.92 5.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.52 156.43 30.23 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 902' ' ' ALA . . . . . 0.506 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -44.0 114.24 1.79 Allowed Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 125.206 1.566 . . . . 0.0 112.149 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.506 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 11.4 Cg_endo . . . . . 0 CA--C 1.57 2.302 0 C-N-CA 123.913 3.075 . . . . 0.0 113.066 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 . . . . . 0 C--O 1.248 1.012 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -116.95 133.43 56.02 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.985 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -127.47 141.98 51.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 7.6 p -75.43 168.63 25.88 Favored Pre-proline 0 N--CA 1.421 -1.922 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.972 178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.72 -24.15 29.11 Favored 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 123.075 2.517 . . . . 0.0 111.803 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.594 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 0.0 OUTLIER -70.1 -58.5 3.74 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.98 176.767 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 87.2 m -72.91 -21.48 60.9 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.29 -20.2 65.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -82.51 -34.84 27.81 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.424 ' NZ ' ' SG ' ' A' ' 914' ' ' CYS . 22.5 mtmm -67.5 -43.18 81.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.508 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 72.0 mt . . . . . 0 C--O 1.241 0.647 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.49 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 . . . . . 0 N--CA 1.443 -0.788 0 CA-C-O 122.394 1.092 . . . . 0.0 108.269 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 42.5 t -130.79 101.08 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 112.672 -2.058 . . . . 0.0 105.483 172.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 40.0 mt -103.58 154.24 5.77 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -102.22 125.14 48.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.514 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 861' ' ' ASP . . . . . 0.501 ' HB3' ' H ' ' A' ' 865' ' ' ASN . 17.6 t70 -67.19 177.24 1.87 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.663 176.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -72.99 -25.11 60.87 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.357 0.599 . . . . 0.0 110.298 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -87.69 -12.64 44.77 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.157 0.98 . . . . 0.0 108.7 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 93.57 19.53 34.69 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.933 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.501 ' H ' ' HB3' ' A' ' 861' ' ' ASP . 63.8 m-20 -72.78 150.95 42.34 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -77.93 110.42 12.82 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 121.61 0.719 . . . . 0.0 110.696 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 46.3 mm -94.82 115.39 33.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -103.6 145.55 29.88 Favored 'General case' 0 C--N 1.255 -3.529 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.217 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.87 120.49 52.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.7 t -78.59 119.66 78.12 Favored Pre-proline 0 N--CA 1.404 -2.737 0 C-N-CA 125.0 1.32 . . . . 0.0 108.316 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.4 -4.58 13.17 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.63 2.22 . . . . 0.0 111.629 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -72.02 -43.5 48.64 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 5.7 p -114.49 -24.32 8.89 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.7 t30 78.75 24.66 0.55 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.824 1.65 . . . . 0.0 108.235 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -110.25 139.63 21.63 Favored Pre-proline 0 C--O 1.244 0.783 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.983 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.81 165.52 32.53 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.182 2.588 . . . . 0.0 112.361 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 877' ' ' ASP . . . . . 0.411 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 16.6 t0 -60.49 117.33 5.15 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.634 0.731 . . . . 0.0 112.375 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.81 6.42 46.87 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.661 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 105.66 40.08 2.09 Favored Glycine 0 N--CA 1.435 -1.413 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 49.1 m -123.82 159.23 56.96 Favored Pre-proline 0 N--CA 1.428 -1.549 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.14 133.62 25.3 Favored 'Trans proline' 0 C--O 1.252 1.204 0 C-N-CA 122.405 2.07 . . . . 0.0 110.896 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.411 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 64.6 mtp -123.11 163.11 21.17 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.872 -178.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 883' ' ' ILE . . . . . 0.499 ' HB ' ' HE1' ' A' ' 894' ' ' TRP . 17.6 tt -141.28 143.23 28.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.95 151.96 17.29 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.629 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 53.8 t -76.09 150.97 37.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.094 0.473 . . . . 0.0 110.481 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -82.55 -25.56 33.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.748 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 887' ' ' ASP . . . . . 0.426 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 31.3 t70 -97.33 -40.33 8.78 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.309 -0.556 . . . . 0.0 112.343 -173.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 32.0 p -98.49 -106.13 0.2 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 117.879 -1.528 . . . . 0.0 114.11 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -158.79 -41.79 0.06 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.985 -170.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.77 161.12 30.42 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -170.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -112.26 133.76 54.19 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.345 -1.752 . . . . 0.0 108.384 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -117.22 159.17 23.08 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.59 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 56.2 m80 -82.93 144.74 29.81 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.145 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.499 ' HE1' ' HB ' ' A' ' 883' ' ' ILE . 38.2 m0 -53.52 -48.95 91.17 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 177.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 895' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 28.4 Cg_endo -63.71 -13.97 40.02 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.275 1.983 . . . . 0.0 113.088 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -89.37 -26.67 20.93 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.241 0.543 . . . . 0.0 111.803 -176.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 893' ' ' HIS . 18.8 m -110.11 -4.93 10.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.443 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 83.67 48.17 5.35 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.723 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 46.1 mt -112.89 121.87 65.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.605 0.717 . . . . 0.0 111.517 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 96.2 mmm -92.7 -31.19 15.19 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.345 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.74 159.67 35.49 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 902' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -48.26 109.58 1.19 Allowed Pre-proline 0 C--N 1.323 -0.554 0 O-C-N 124.73 1.268 . . . . 0.0 111.659 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 18.8 Cg_endo . . . . . 0 C--O 1.244 0.784 0 C-N-CA 123.236 2.624 . . . . 0.0 112.406 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 . . . . . 0 N--CA 1.427 -1.607 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -104.5 124.81 49.93 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.121 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 74.2 m-85 -124.9 142.61 51.34 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.6 p -66.95 166.2 21.17 Favored Pre-proline 0 C--N 1.294 -1.817 0 O-C-N 123.609 0.568 . . . . 0.0 111.5 -176.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 5.0 Cg_endo -49.54 -27.28 14.03 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.431 2.754 . . . . 0.0 112.509 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -82.04 -47.93 12.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.341 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.504 ' HA ' ' HE2' ' A' ' 917' ' ' LYS . 92.5 m -78.38 -32.61 48.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.1 -32.03 73.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.51 -35.78 76.79 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.186 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 27.3 mtmt -70.77 -18.18 62.77 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.102 0.561 . . . . 0.0 110.656 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 51.0 mt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 121.758 0.79 . . . . 0.0 109.771 -178.054 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 858' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 64.4 t -138.73 121.09 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 113.316 -1.765 . . . . 0.0 108.267 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 869' ' ' ILE . 55.7 mt -127.48 148.92 32.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 860' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 860' ' ' ARG . 41.3 mtt180 -95.02 125.06 39.42 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 121.734 0.778 . . . . 0.0 110.891 174.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.93 171.73 3.32 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.629 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -60.86 -36.38 79.02 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 124.024 0.929 . . . . 0.0 110.6 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 863' ' ' TRP . . . . . 0.52 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 92.8 m95 -87.0 -10.15 53.84 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.376 0.608 . . . . 0.0 111.05 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 100.34 8.44 49.89 Favored Glycine 0 CA--C 1.5 -0.883 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.357 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 37.1 m-80 -71.79 160.94 31.72 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 866' ' ' GLN . . . . . 0.465 ' OE1' ' HA ' ' A' ' 866' ' ' GLN . 14.4 mm-40 -90.81 133.35 35.27 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 122.124 0.964 . . . . 0.0 112.159 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 45.8 mm -110.63 121.81 64.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 113.532 -1.667 . . . . 0.0 108.114 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -101.35 140.12 36.08 Favored 'General case' 0 C--N 1.271 -2.808 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.565 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 859' ' ' ILE . 36.4 mt -106.08 124.31 61.27 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 42.2 t -78.2 113.91 37.79 Favored Pre-proline 0 N--CA 1.404 -2.762 0 O-C-N 124.442 1.089 . . . . 0.0 108.743 -178.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 871' ' ' PRO . . . . . 0.555 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 37.6 Cg_exo -61.19 -2.47 2.38 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.282 2.655 . . . . 0.0 113.309 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.06 -39.69 19.02 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 7.5 p -114.98 -25.81 8.0 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.349 0.66 . . . . 0.0 111.554 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 76.48 26.52 0.88 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.886 1.675 . . . . 0.0 110.085 -173.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -108.03 138.82 20.21 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.466 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 44.5 Cg_endo -72.83 170.71 19.0 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.369 2.713 . . . . 0.0 113.749 176.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -64.31 133.28 52.39 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.097 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -123.44 6.73 8.97 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.903 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 93.65 22.86 25.15 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 2.7 p -96.31 155.85 37.58 Favored Pre-proline 0 C--N 1.296 -1.722 0 C-N-CA 123.35 0.66 . . . . 0.0 110.408 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.43 118.09 4.93 Favored 'Trans proline' 0 C--O 1.257 1.456 0 C-N-CA 122.069 1.846 . . . . 0.0 111.568 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.6 mtp -113.4 162.92 15.51 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.569 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.5 tt -130.64 145.29 35.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -108.95 151.02 17.14 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 42.6 t -80.74 178.85 8.1 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.513 0.673 . . . . 0.0 110.929 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 886' ' ' ASP . . . . . 0.426 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 28.9 t70 -110.48 -18.44 13.21 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.941 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 887' ' ' ASP . . . . . 0.426 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 16.4 t70 -95.93 -46.96 6.32 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 25.4 p -101.87 -179.07 3.9 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -117.81 17.64 14.23 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.349 1.071 . . . . 0.0 109.45 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -102.62 163.35 12.27 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.184 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -112.19 141.83 45.41 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.875 0.369 . . . . 0.0 111.854 -174.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 892' ' ' TYR . . . . . 0.555 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 10.9 m-85 -120.94 169.39 10.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.712 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 56.6 m80 -96.02 150.39 20.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 118.692 0.678 . . . . 0.0 111.341 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -56.1 -53.89 58.54 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.46 -19.22 67.47 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.165 1.91 . . . . 0.0 113.799 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 45.3 m -80.84 -31.21 35.57 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.34 0.59 . . . . 0.0 111.742 -176.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.592 HG23 HG12 ' A' ' 899' ' ' ILE . 24.0 m -108.86 -22.66 4.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.824 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 104.31 55.08 0.77 Allowed Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.168 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.592 HG12 HG23 ' A' ' 897' ' ' VAL . 30.5 mm -113.06 117.78 56.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 86.9 mtp -87.72 -40.34 14.2 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -144.49 154.63 43.11 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 902' ' ' ALA . . . . . 0.454 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -54.51 110.09 1.94 Allowed Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 124.799 1.312 . . . . 0.0 112.431 -176.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 25.3 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.516 2.144 . . . . 0.0 111.067 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 . . . . . 0 N--CA 1.425 -1.678 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -125.84 138.9 53.84 Favored 'General case' 0 C--N 1.248 -3.811 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 84.2 m-85 -125.55 137.36 53.93 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 18.7 p -77.26 166.6 43.14 Favored Pre-proline 0 C--N 1.28 -2.421 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.344 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -49.02 -30.99 19.38 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.228 2.619 . . . . 0.0 112.465 176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.673 ' HA ' ' HE2' ' A' ' 913' ' ' LYS . 7.8 mmpt? -81.02 -42.95 20.3 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 92.4 m -78.4 -20.18 51.69 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.084 177.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -70.22 -23.24 62.9 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -79.48 -10.89 59.89 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.964 0.411 . . . . 0.0 110.539 175.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -87.31 -57.73 2.85 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 C--O 1.239 0.546 0 CA-C-N 114.673 -1.148 . . . . 0.0 111.045 -177.052 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 857' ' ' TYR . . . . . 0.643 ' HA ' HD12 ' A' ' 869' ' ' ILE . 4.4 m-85 . . . . . 0 CA--C 1.494 -1.201 0 CA-C-O 123.124 1.44 . . . . 0.0 108.125 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.2 108.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.397 -3.108 0 CA-C-N 111.493 -2.594 . . . . 0.0 106.638 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 30.9 mt -117.73 154.41 19.63 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.724 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -100.76 137.25 39.4 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.399 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.07 179.31 6.9 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.75 176.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.29 -29.89 65.59 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.946 0.403 . . . . 0.0 110.266 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -80.04 -10.9 59.8 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.821 0.819 . . . . 0.0 109.546 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.82 18.34 40.99 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -78.72 155.15 29.53 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -85.07 118.72 24.81 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.992 0.901 . . . . 0.0 110.876 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 37.0 mm -91.14 114.4 28.4 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -100.34 147.21 26.05 Favored 'General case' 0 C--N 1.264 -3.114 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.771 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.643 HD12 ' HA ' ' A' ' 857' ' ' TYR . 26.9 mt -102.19 109.24 25.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-O 121.223 0.535 . . . . 0.0 110.626 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 49.4 t -56.29 115.43 9.88 Favored Pre-proline 0 N--CA 1.438 -1.074 0 C-N-CA 126.217 1.807 . . . . 0.0 110.32 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -59.81 -13.4 22.19 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.633 2.889 . . . . 0.0 112.869 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.46 -38.06 34.16 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.212 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 9.1 p -120.99 -15.96 8.16 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 117.218 0.509 . . . . 0.0 112.25 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 72.39 21.54 3.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.315 1.446 . . . . 0.0 108.707 -176.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -101.93 141.78 23.25 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.3 177.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -73.32 158.33 48.61 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.637 2.224 . . . . 0.0 110.931 173.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 877' ' ' ASP . . . . . 0.593 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 10.3 t0 -48.74 123.33 6.73 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.469 0.652 . . . . 0.0 111.696 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -90.47 6.1 44.86 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.473 -175.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 91.81 36.73 6.31 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 108.281 -1.927 . . . . 0.0 108.281 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 22.8 m -122.37 161.58 42.52 Favored Pre-proline 0 N--CA 1.418 -2.029 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.37 133.34 32.22 Favored 'Trans proline' 0 C--O 1.254 1.285 0 C-N-CA 121.576 1.517 . . . . 0.0 110.306 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.593 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 75.8 mtp -112.05 154.52 25.26 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.52 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.1 tt -124.75 138.23 54.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.14 158.52 16.75 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.57 169.56 17.86 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.366 0.603 . . . . 0.0 110.315 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -91.42 -26.03 19.06 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -98.54 -49.33 4.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.277 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 17.6 p -99.7 179.2 4.61 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.595 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -110.2 11.61 23.58 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.809 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -81.99 151.97 26.91 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.951 0.405 . . . . 0.0 111.236 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -114.45 139.18 49.74 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.951 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -119.23 162.42 18.72 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.294 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.607 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 65.4 m80 -83.45 144.14 29.78 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.401 ' N ' ' HD2' ' A' ' 895' ' ' PRO . 26.3 m0 -51.24 -49.49 81.37 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 175.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 895' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 893' ' ' HIS . 28.5 Cg_endo -63.93 -23.6 68.03 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.659 2.24 . . . . 0.0 114.053 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 61.2 m -76.81 -25.7 53.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.56 0.695 . . . . 0.0 111.563 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.793 HG23 HG12 ' A' ' 899' ' ' ILE . 9.0 m -114.14 -2.59 10.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.712 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 73.19 45.08 32.65 Favored Glycine 0 CA--C 1.504 -0.606 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.202 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.793 HG12 HG23 ' A' ' 897' ' ' VAL . 45.4 mm -80.02 -67.9 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.391 1.091 . . . . 0.0 110.457 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.9 mtt 66.63 -14.94 0.15 Allowed 'General case' 0 C--N 1.264 -3.117 0 C-N-CA 128.398 2.679 . . . . 0.0 114.74 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.11 147.13 19.31 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 902' ' ' ALA . . . . . 0.409 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -51.88 110.16 1.74 Allowed Pre-proline 0 C--O 1.239 0.517 0 O-C-N 124.491 1.119 . . . . 0.0 112.186 -175.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 32.6 Cg_endo . . . . . 0 N--CA 1.457 -0.676 0 C-N-CA 122.908 2.405 . . . . 0.0 112.104 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 . . . . . 0 N--CA 1.425 -1.679 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 73.0 t90 -125.42 119.95 29.68 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.525 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.47 138.63 53.7 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 30.8 p -66.39 161.84 54.54 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 123.754 0.658 . . . . 0.0 111.55 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.45 -16.12 22.22 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.207 2.605 . . . . 0.0 112.916 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.54 ' HA ' ' HE2' ' A' ' 913' ' ' LYS . 3.9 mmpt? -84.26 -48.5 9.69 Favored 'General case' 0 N--CA 1.44 -0.963 0 O-C-N 122.145 -0.347 . . . . 0.0 110.177 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.462 ' O ' HG13 ' A' ' 918' ' ' ILE . 84.7 m -68.49 -39.96 81.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.05 176.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.09 71.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.203 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -64.11 -43.65 94.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.26 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -79.62 -33.3 41.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.522 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 914' ' ' CYS . 85.4 mt . . . . . 0 C--O 1.246 0.879 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 . . . . . 0 CA--C 1.507 -0.684 0 CA-C-O 121.436 0.636 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 858' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 57.5 t -125.08 129.11 73.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.718 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 58.0 mt -125.56 144.58 35.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -92.05 117.03 29.44 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.452 175.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -71.31 176.07 4.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.72 -22.88 59.76 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.437 0.637 . . . . 0.0 109.452 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -85.99 -0.43 55.47 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.168 0.985 . . . . 0.0 108.687 173.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 75.69 16.5 80.61 Favored Glycine 0 CA--C 1.5 -0.878 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.868 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -68.35 134.01 49.61 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -82.04 81.34 8.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.51 0.672 . . . . 0.0 109.274 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 858' ' ' VAL . 46.5 mm -53.14 135.88 14.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 113.198 -1.819 . . . . 0.0 112.287 -174.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -103.07 132.63 49.18 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 124.186 0.929 . . . . 0.0 109.877 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 40.8 mt -102.43 116.96 47.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.524 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.0 111.34 3.55 Favored Pre-proline 0 N--CA 1.443 -0.806 0 C-N-CA 125.255 1.422 . . . . 0.0 110.532 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -65.31 3.73 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.851 3.034 . . . . 0.0 113.613 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -86.16 -46.03 5.44 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 14.1 p -116.4 -22.03 8.97 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.528 0.68 . . . . 0.0 110.456 -176.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.274 2.8 m-20 70.75 56.0 0.24 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 125.765 1.626 . . . . 0.0 111.563 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.3 140.01 37.13 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.151 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -74.19 173.99 13.22 Favored 'Trans proline' 0 C--O 1.257 1.427 0 C-N-CA 123.359 2.706 . . . . 0.0 112.624 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 877' ' ' ASP . . . . . 0.417 ' HA ' ' SD ' ' A' ' 882' ' ' MET . 3.4 m-20 -48.51 106.11 0.09 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.744 0.818 . . . . 0.0 108.929 172.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -102.57 -15.05 16.52 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.957 0.408 . . . . 0.0 110.868 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 127.09 -21.21 5.84 Favored Glycine 0 N--CA 1.437 -1.252 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 50.0 m -70.99 157.06 91.16 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.293 -0.454 . . . . 0.0 109.807 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -65.97 137.91 50.57 Favored 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.707 2.271 . . . . 0.0 111.468 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.417 ' SD ' ' HA ' ' A' ' 877' ' ' ASP . 91.7 mtp -128.71 148.31 50.82 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.481 -175.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.5 tt -129.49 148.06 33.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -111.69 146.89 17.97 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.812 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 888' ' ' CYS . 52.8 t -70.37 155.78 40.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -86.98 -24.0 24.85 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.568 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -92.02 -45.42 8.33 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.882 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 885' ' ' CYS . 29.8 p -100.44 -178.27 3.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.485 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -112.62 14.89 20.16 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 122.712 1.244 . . . . 0.0 109.431 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.95 153.03 21.62 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.056 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 26.8 m95 -118.93 138.79 52.53 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.35 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -124.29 161.46 25.8 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.099 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.72 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 56.8 m80 -86.67 146.47 26.29 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -49.93 -53.5 42.24 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.65 -10.54 29.08 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 122.224 1.949 . . . . 0.0 113.792 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 62.4 m -87.07 -33.72 19.4 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.593 0.711 . . . . 0.0 111.023 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.582 HG23 HG12 ' A' ' 899' ' ' ILE . 19.2 m -104.75 -15.62 8.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.797 -176.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 96.0 47.36 2.46 Favored Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.855 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.582 HG12 HG23 ' A' ' 897' ' ' VAL . 48.3 mm -95.39 105.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.8 ptm -87.11 -19.5 28.44 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.234 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -170.5 151.35 3.64 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 902' ' ' ALA . . . . . 0.413 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -45.56 111.53 1.39 Allowed Pre-proline 0 C--O 1.243 0.719 0 O-C-N 124.673 1.233 . . . . 0.0 110.754 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 12.2 Cg_endo . . . . . 0 C--O 1.244 0.822 0 C-N-CA 122.903 2.402 . . . . 0.0 112.196 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 . . . . . 0 CA--C 1.5 -0.96 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -117.39 128.65 55.23 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.561 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -131.23 146.32 52.27 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 20.8 p -76.65 164.88 56.75 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.39 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.59 -24.11 21.62 Favored 'Trans proline' 0 CA--C 1.551 1.366 0 C-N-CA 123.355 2.703 . . . . 0.0 112.275 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -78.54 -53.8 6.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.498 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.508 ' O ' HG12 ' A' ' 918' ' ' ILE . 85.7 m -78.54 -26.72 45.78 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.72 69.93 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -74.57 -35.54 63.05 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.053 0.93 . . . . 0.0 110.066 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -71.71 -15.62 62.21 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.005 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 914' ' ' CYS . 44.6 mm . . . . . 0 C--N 1.325 -0.473 0 C-N-CA 123.512 0.725 . . . . 0.0 111.661 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.46 0.043 0 CA-C-O 121.655 0.741 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.76 121.71 66.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.333 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 51.2 mt -126.85 138.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 173.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -98.59 122.15 41.43 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.182 0.992 . . . . 0.0 112.435 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.89 173.19 1.91 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 113.185 -1.825 . . . . 0.0 109.69 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.57 -28.86 70.17 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.783 0.833 . . . . 0.0 110.884 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 863' ' ' TRP . . . . . 0.483 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 76.3 m95 -98.24 10.68 40.06 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.076 0.465 . . . . 0.0 111.317 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.46 1.69 83.31 Favored Glycine 0 CA--C 1.508 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.144 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.483 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 45.4 m-80 -65.37 137.56 57.58 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.18 126.87 33.54 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.68 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 48.7 mm -91.49 129.13 42.68 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.622 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -77.69 145.95 36.32 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.852 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 52.6 mt -129.99 128.2 64.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.84 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.5 t -72.43 117.36 58.17 Favored Pre-proline 0 N--CA 1.419 -2.015 0 C-N-CA 125.165 1.386 . . . . 0.0 108.711 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.88 -1.13 6.35 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.565 2.176 . . . . 0.0 112.817 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.93 -48.16 10.42 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.562 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 5.8 p -113.28 -19.28 11.83 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 122.684 0.394 . . . . 0.0 111.489 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.4 t30 81.01 19.79 0.44 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.475 1.51 . . . . 0.0 109.228 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -97.73 138.81 21.06 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.918 176.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.6 Cg_endo -73.88 174.21 12.71 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.34 2.693 . . . . 0.0 110.534 173.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -59.48 119.98 8.52 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.368 0.604 . . . . 0.0 109.38 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -104.26 23.92 12.34 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 76.77 51.68 6.28 Favored Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 105.654 -2.978 . . . . 0.0 105.654 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 7.7 p -125.87 159.38 61.78 Favored Pre-proline 0 N--CA 1.42 -1.943 0 CA-C-N 113.981 -1.109 . . . . 0.0 112.888 -166.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -77.22 108.13 2.56 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 121.988 1.792 . . . . 0.0 109.563 174.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 81.9 mtp -116.24 164.76 14.02 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.839 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.5 tt -133.6 134.62 56.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.69 154.73 20.7 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 53.8 t -80.81 167.84 19.48 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.444 0.64 . . . . 0.0 110.265 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -92.86 -31.63 14.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 887' ' ' ASP . . . . . 0.429 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 27.5 t70 -91.45 -36.91 13.5 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.863 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 55.7 m -97.51 168.32 10.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.65 10.99 26.84 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -94.25 175.08 6.83 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.336 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -132.03 140.14 48.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.121 0.486 . . . . 0.0 112.082 -172.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -119.22 158.33 26.21 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.219 1.008 . . . . 0.0 108.285 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.669 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 73.3 m80 -84.26 149.13 26.3 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.365 176.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 33.3 m0 -53.0 -54.52 43.2 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.53 -16.44 52.31 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.274 1.983 . . . . 0.0 113.444 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 81.8 m -81.28 -27.25 35.19 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.149 0.499 . . . . 0.0 110.85 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 893' ' ' HIS . 21.1 m -115.42 14.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.109 -176.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 71.2 35.42 64.03 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.837 -1.074 . . . . 0.0 114.231 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 57.6 mt -105.61 127.58 60.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.466 0.65 . . . . 0.0 111.024 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.7 mmt -105.17 -25.12 12.61 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.231 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -152.66 154.71 35.87 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 902' ' ' ALA . . . . . 0.5 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -49.68 112.92 2.91 Favored Pre-proline 0 C--O 1.241 0.628 0 O-C-N 124.779 1.299 . . . . 0.0 112.366 -177.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 19.3 Cg_endo . . . . . 0 C--O 1.254 1.296 0 C-N-CA 122.998 2.466 . . . . 0.0 112.202 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 . . . . . 0 N--CA 1.439 -0.993 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -117.81 141.61 48.23 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 120.594 -0.443 . . . . 0.0 109.815 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -132.45 137.59 47.32 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 17.1 p -66.98 165.06 29.45 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 123.992 0.917 . . . . 0.0 110.102 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -56.01 -18.86 24.06 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.595 2.197 . . . . 0.0 112.045 174.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.58 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 74.9 mmtt -74.49 -48.49 26.92 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.554 ' O ' HG12 ' A' ' 918' ' ' ILE . 68.8 m -76.63 -29.77 56.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.99 -11.24 60.68 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 120.698 0.285 . . . . 0.0 110.931 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -81.04 -29.71 35.0 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 172.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 53.3 mtmt -80.52 -36.74 32.78 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.912 176.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 914' ' ' CYS . 40.1 mm . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.702 0.287 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 858' ' ' VAL . . . . . 0.419 HG13 ' HB2' ' A' ' 866' ' ' GLN . 90.9 t -134.75 118.64 26.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 37.6 mt -122.58 166.45 17.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -108.6 131.97 54.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 119.548 1.067 . . . . 0.0 109.501 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.35 175.21 8.62 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 123.697 0.799 . . . . 0.0 108.917 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -68.09 -27.95 66.93 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 123.716 0.806 . . . . 0.0 111.013 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -81.78 -15.4 54.38 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 102.3 -8.93 55.77 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.897 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -66.76 146.82 54.03 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 866' ' ' GLN . . . . . 0.419 ' HB2' HG13 ' A' ' 858' ' ' VAL . 14.0 pt20 -74.53 144.88 43.88 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 121.832 0.825 . . . . 0.0 111.502 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 39.3 mm -105.32 121.63 57.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -90.02 143.57 26.67 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 123.975 0.797 . . . . 0.0 109.425 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 40.8 mt -107.7 123.4 63.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 892' ' ' TYR . 41.6 t -75.2 114.46 35.57 Favored Pre-proline 0 N--CA 1.409 -2.486 0 O-C-N 124.593 1.183 . . . . 0.0 108.67 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.4 -1.72 6.99 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.147 2.565 . . . . 0.0 112.011 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -78.27 -40.74 18.98 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 6.9 p -118.38 -15.37 9.7 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 57.8 t30 71.49 32.41 2.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.417 1.087 . . . . 0.0 108.285 -175.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -116.0 140.43 26.27 Favored Pre-proline 0 C--O 1.241 0.636 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.639 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 40.2 Cg_endo -72.47 167.27 27.46 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 123.317 2.678 . . . . 0.0 112.699 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 877' ' ' ASP . . . . . 0.48 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 21.7 t70 -65.84 138.42 57.88 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.239 172.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -124.52 33.41 5.25 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 74.82 47.38 14.58 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 107.487 -2.245 . . . . 0.0 107.487 -173.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 880' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 881' ' ' PRO . 6.2 p -120.45 149.32 49.67 Favored Pre-proline 0 N--CA 1.423 -1.807 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.027 -171.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 880' ' ' SER . 22.9 Cg_exo -64.89 126.25 16.23 Favored 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 122.037 1.825 . . . . 0.0 110.384 175.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.48 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 88.9 mtp -128.3 157.79 39.97 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.869 -177.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.69 138.07 52.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -105.46 155.09 17.04 Favored Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 888' ' ' CYS . 1.7 p -74.04 135.74 43.07 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.801 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.9 -48.94 72.39 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.699 -174.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 887' ' ' ASP . . . . . 0.591 ' HB2' ' CE1' ' A' ' 910' ' ' PHE . 14.9 t70 -80.65 -49.41 11.27 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-O 122.704 1.24 . . . . 0.0 109.12 -175.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.872 ' HB2' ' SG ' ' A' ' 885' ' ' CYS . 0.0 OUTLIER -73.6 -103.73 0.01 OUTLIER 'General case' 0 N--CA 1.38 -3.95 0 N-CA-C 118.929 2.937 . . . . 0.0 118.929 -162.69 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -178.3 -25.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -166.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 890' ' ' ASP . . . . . 0.436 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 22.7 m-20 -90.93 173.46 7.96 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.45 0.643 . . . . 0.0 111.94 -170.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -132.81 127.39 34.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.116 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 892' ' ' TYR . . . . . 0.428 ' HA ' ' SG ' ' A' ' 870' ' ' CYS . 82.6 m-85 -122.67 162.51 21.82 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.672 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 54.6 m80 -84.17 151.76 24.67 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.457 ' CG ' ' HB ' ' A' ' 899' ' ' ILE . 25.9 m0 -53.12 -56.37 24.53 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.52 -13.62 40.75 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.206 1.938 . . . . 0.0 114.043 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 76.5 m -77.75 -40.86 39.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.492 0.663 . . . . 0.0 111.109 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.535 HG23 HG12 ' A' ' 899' ' ' ILE . 27.1 m -99.57 -26.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.669 -175.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 110.17 35.42 2.14 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.214 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.535 HG12 HG23 ' A' ' 897' ' ' VAL . 42.2 mm -90.16 106.73 17.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 91.3 mmm -91.93 -25.64 18.8 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.244 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -151.74 147.84 27.18 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -57.57 114.36 8.17 Favored Pre-proline 0 C--N 1.319 -0.718 0 O-C-N 124.415 1.072 . . . . 0.0 111.891 -176.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 N--CA 1.46 -0.467 0 C-N-CA 122.905 2.403 . . . . 0.0 111.028 177.033 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 . . . . . 0 N--CA 1.439 -0.988 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -127.81 125.09 39.16 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.403 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 887' ' ' ASP . 22.0 m-85 -118.16 147.04 43.73 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 914' ' ' CYS 0.254 1.8 p -80.49 164.58 51.02 Favored Pre-proline 0 C--N 1.271 -2.839 0 C-N-CA 124.478 1.111 . . . . 0.0 111.176 -174.728 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.56 -12.86 30.12 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.685 2.257 . . . . 0.0 112.296 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 32.4 mmtp -88.21 -62.11 1.56 Allowed 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.443 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.697 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 96.3 m -74.35 -27.76 60.82 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -175.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 915' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -72.55 -25.95 61.56 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.322 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -89.47 -4.55 57.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.754 0.788 . . . . 0.0 110.164 -177.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 913' ' ' LYS . 35.8 mmtp -83.69 -47.64 10.99 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 171.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 CA--C 1.519 -0.232 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.227 178.129 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 C--O 1.215 -0.719 0 CA-C-O 121.655 0.74 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.68 128.17 74.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.17 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 46.9 mt -126.0 166.02 22.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 177.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -116.58 140.71 49.08 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.93 -168.06 1.65 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.176 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.53 -34.02 77.28 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.006 0.922 . . . . 0.0 110.714 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -87.35 -33.51 19.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.783 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 122.57 16.64 3.72 Favored Glycine 0 C--N 1.308 -1.015 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.204 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -83.52 151.18 25.54 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -79.31 135.77 36.83 Favored 'General case' 0 N--CA 1.396 -3.133 0 CA-C-O 122.02 0.914 . . . . 0.0 110.181 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 27.4 mm -103.34 129.56 55.03 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.05 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.887 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -92.67 142.71 27.07 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.898 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 39.8 mt -111.41 122.92 66.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.113 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.5 t -65.66 112.53 8.9 Favored Pre-proline 0 N--CA 1.431 -1.404 0 C-N-CA 124.769 1.228 . . . . 0.0 108.817 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.69 -5.18 8.28 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.713 2.942 . . . . 0.0 112.961 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.95 -39.2 28.64 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 121.119 -0.562 . . . . 0.0 111.967 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 9.6 p -124.44 -10.32 7.44 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 122.79 0.436 . . . . 0.0 111.629 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.336 9.5 p30 60.12 32.39 20.93 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 126.022 1.729 . . . . 0.0 112.258 -172.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -103.59 138.96 19.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.095 173.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.9 Cg_endo -74.08 171.09 18.65 Favored 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 123.38 2.72 . . . . 0.0 113.888 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.92 145.24 42.8 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.551 174.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -115.83 -0.62 12.82 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 99.92 39.54 3.32 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 107.341 -2.304 . . . . 0.0 107.341 -172.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 14.3 m -106.44 168.67 7.81 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 114.607 -0.797 . . . . 0.0 110.527 -171.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -74.51 115.62 4.36 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 121.316 1.344 . . . . 0.0 108.901 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 83.4 mtp -122.57 162.3 22.09 Favored 'General case' 0 N--CA 1.407 -2.605 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 883' ' ' ILE . . . . . 0.556 ' HB ' ' HE1' ' A' ' 894' ' ' TRP . 18.0 tt -122.31 133.44 68.57 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-O 120.713 0.292 . . . . 0.0 110.44 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.08 143.77 16.87 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 52.7 t -71.94 167.95 19.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.551 0.691 . . . . 0.0 110.272 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 886' ' ' ASP . . . . . 0.421 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 24.6 t70 -84.97 -26.29 27.23 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 174.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -95.36 -47.96 6.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.119 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 10.1 m -83.79 146.63 28.04 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.97 17.12 23.12 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.279 1.038 . . . . 0.0 108.51 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -108.77 168.4 9.37 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.383 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -115.43 150.44 36.43 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -168.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -123.37 149.68 44.65 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.691 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 44.2 m80 -75.42 142.06 43.1 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.186 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.556 ' HE1' ' HB ' ' A' ' 883' ' ' ILE . 21.1 m0 -55.85 -49.47 92.76 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 895' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 20.3 Cg_endo -61.47 -19.08 63.04 Favored 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 122.154 1.903 . . . . 0.0 113.105 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.691 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 74.0 m -83.41 -21.22 33.06 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.401 0.62 . . . . 0.0 111.519 -177.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 893' ' ' HIS . 15.9 m -118.43 12.58 7.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.877 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 62.49 48.8 79.26 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.097 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 57.7 mt -118.59 136.58 55.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 122.582 -0.364 . . . . 0.0 111.108 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 61.5 mtt -121.9 -11.6 8.52 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.229 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 901' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -156.54 137.29 13.33 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -50.77 100.78 0.24 Allowed Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 125.263 1.425 . . . . 0.0 113.686 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 14.4 Cg_endo . . . . . 0 CA--C 1.544 0.985 0 C-N-CA 123.715 2.943 . . . . 0.0 116.46 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 121.499 0.666 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -100.4 131.67 46.2 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.191 -173.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 84.9 m-85 -126.83 139.33 53.18 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 15.5 p -70.26 167.43 25.84 Favored Pre-proline 0 N--CA 1.426 -1.644 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.787 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.84 -20.64 18.15 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 123.08 2.52 . . . . 0.0 111.886 173.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.519 ' HA ' ' HE2' ' A' ' 913' ' ' LYS . 8.9 mmpt? -81.03 -51.47 8.46 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.21 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.495 ' O ' HG12 ' A' ' 918' ' ' ILE . 91.4 m -75.08 -29.66 60.73 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.7 66.31 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.19 0.519 . . . . 0.0 110.334 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -68.37 -28.79 67.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.354 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -79.15 -39.13 34.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.891 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 914' ' ' CYS . 47.8 mm . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.232 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.286 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 16.2 m -75.72 113.29 13.01 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 117.16 0.48 . . . . 0.0 110.316 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -86.35 -42.03 14.02 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -93.08 171.79 8.72 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.308 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 76.53 12.31 2.56 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.858 1.263 . . . . 0.0 110.859 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 23.3 mmt -87.13 -23.96 24.68 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.896 0.855 . . . . 0.0 109.037 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 856' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 858' ' ' VAL . . . -100.28 -174.35 2.65 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.152 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 857' ' ' TYR . . . . . 0.523 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 55.1 m-85 68.22 12.34 8.72 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 122.103 0.954 . . . . 0.0 109.13 -172.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 858' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 856' ' ' ALA . 51.5 t -136.68 114.3 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.225 -174.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 39.5 mt -124.69 154.61 32.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -98.83 134.7 41.34 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.53 0.681 . . . . 0.0 110.076 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -71.93 172.23 10.33 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.962 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -63.12 -34.65 78.07 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 123.207 0.603 . . . . 0.0 110.468 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -88.67 -14.4 37.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.895 0.855 . . . . 0.0 108.994 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 105.31 10.51 31.48 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.077 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -68.96 164.0 23.27 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -88.36 121.06 30.32 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.632 0.73 . . . . 0.0 110.89 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 39.2 mm -91.51 112.45 25.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 173.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -88.47 130.84 35.1 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.424 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 32.8 mt -100.51 104.13 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.398 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 44.7 t -54.73 112.42 4.0 Favored Pre-proline 0 N--CA 1.429 -1.519 0 CA-C-N 113.734 -1.575 . . . . 0.0 108.997 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -71.93 3.58 3.79 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.005 1.803 . . . . 0.0 112.216 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -83.74 -36.67 13.16 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 22.3 p -114.97 -27.75 7.26 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 122.507 -0.408 . . . . 0.0 111.122 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 82.29 24.0 0.2 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.298 1.839 . . . . 0.0 110.309 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.561 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 41.2 mttm -102.86 144.43 28.6 Favored Pre-proline 0 N--CA 1.467 0.408 0 C-N-CA 123.393 0.677 . . . . 0.0 111.255 174.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.407 ' HB3' HG12 ' A' ' 869' ' ' ILE . 56.4 Cg_endo -80.42 174.09 11.66 Favored 'Trans proline' 0 C--O 1.242 0.683 0 C-N-CA 123.094 2.53 . . . . 0.0 108.479 167.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.597 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 15.4 t70 -69.31 102.11 1.66 Allowed 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.222 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -94.97 5.06 52.99 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.438 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 119.31 55.81 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 17.7 m -134.25 163.1 53.59 Favored Pre-proline 0 N--CA 1.417 -2.108 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -75.3 137.67 21.35 Favored 'Trans proline' 0 C--O 1.264 1.777 0 C-N-CA 122.459 2.106 . . . . 0.0 108.581 172.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.511 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 58.1 mtp -117.03 152.78 33.93 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.961 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.9 tt -134.41 134.2 54.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -99.21 160.31 19.95 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.737 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.87 166.74 15.76 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.573 0.702 . . . . 0.0 110.869 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -92.88 -22.77 19.06 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.631 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -101.55 -37.64 8.31 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.246 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . 0.25 16.2 p -103.21 169.64 8.43 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.961 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.2 -21.04 19.31 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.503 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -87.1 163.59 16.91 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.897 -171.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -110.2 142.6 41.53 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.503 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -112.79 -178.05 3.29 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 125.014 1.326 . . . . 0.0 108.468 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.864 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 59.2 m80 -110.84 160.26 16.92 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -60.17 -54.1 58.55 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.24 -26.59 77.6 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 122.281 1.987 . . . . 0.0 114.071 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.864 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 5.8 m -69.31 -36.81 77.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.947 0.88 . . . . 0.0 111.772 -176.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.498 HG23 HG12 ' A' ' 899' ' ' ILE . 28.2 m -107.11 -17.87 7.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.36 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 93.3 48.94 2.7 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 121.224 -0.512 . . . . 0.0 113.139 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.498 HG12 HG23 ' A' ' 897' ' ' VAL . 44.0 mm -88.56 125.17 41.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 69.1 mtm -91.65 -37.26 13.16 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.127 0.489 . . . . 0.0 109.69 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -156.61 158.93 37.94 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 902' ' ' ALA . . . . . 0.419 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -55.2 113.81 6.1 Favored Pre-proline 0 C--N 1.32 -0.717 0 O-C-N 124.093 0.871 . . . . 0.0 111.984 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 46.3 Cg_endo -69.19 165.93 28.64 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 123.346 2.698 . . . . 0.0 112.724 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.51 151.1 80.31 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.716 2.277 . . . . 0.0 112.267 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 905' ' ' GLU . . . . . 0.56 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 0.2 OUTLIER -85.14 -21.9 29.05 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.709 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.71 -27.08 62.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.827 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 23.1 ttt -79.33 143.94 34.7 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -97.0 121.44 38.89 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -106.45 132.17 52.78 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -127.97 137.35 52.21 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 5.8 p -69.82 168.45 17.57 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 123.996 0.918 . . . . 0.0 109.695 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.24 -20.3 10.87 Favored 'Trans proline' 0 CA--C 1.552 1.409 0 C-N-CA 123.195 2.597 . . . . 0.0 112.429 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -79.29 -56.27 4.47 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.478 0.711 . . . . 0.0 109.195 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 71.5 m -79.03 -17.51 55.16 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 915' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 918' ' ' ILE . . . -67.06 -31.22 71.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.334 1.064 . . . . 0.0 108.645 172.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -73.42 -22.99 60.07 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.45 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -74.49 -36.59 63.27 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 172.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 915' ' ' ALA . 50.5 mm -60.79 -43.02 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 172.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 80.2 tttt 71.4 -68.76 0.21 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.541 1.937 . . . . 0.0 113.581 169.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -176.91 -50.96 0.01 OUTLIER 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -92.56 91.86 7.78 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.308 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -96.51 140.65 30.83 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.531 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -115.7 10.23 15.41 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-O 121.721 0.772 . . . . 0.0 111.189 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 69.4 t60 . . . . . 0 N--CA 1.424 -1.75 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 175.41 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.651 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 22.6 t -84.57 85.15 7.45 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -125.89 168.52 13.76 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.437 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 59.9 ttp -117.6 124.15 47.93 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -138.55 128.01 24.61 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.708 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 65.8 mtt -137.4 135.35 36.87 Favored 'General case' 0 C--O 1.249 1.029 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 175.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 856' ' ' ALA . . . . . 0.481 ' O ' HD12 ' A' ' 869' ' ' ILE . . . 60.37 -150.72 0.41 Allowed 'General case' 0 N--CA 1.469 0.502 0 O-C-N 124.368 1.042 . . . . 0.0 109.765 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 857' ' ' TYR . . . . . 0.487 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 88.7 m-85 -119.58 9.65 11.55 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.016 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 90.9 t -132.56 116.83 29.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.855 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 35.2 mt -120.2 157.26 22.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -102.01 131.64 48.32 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.035 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.77 173.5 8.11 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.853 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.95 -37.78 80.52 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.767 0.827 . . . . 0.0 111.143 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 863' ' ' TRP . . . . . 0.498 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 75.9 m95 -91.15 1.45 57.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.557 0.694 . . . . 0.0 110.626 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.08 14.19 56.51 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.761 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 58.8 m-80 -73.84 155.65 38.57 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.73 113.17 24.01 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.678 0.751 . . . . 0.0 112.006 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 37.1 mm -80.41 118.47 28.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 175.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -92.16 138.22 31.71 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.329 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 33.5 mt -104.07 127.34 58.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.38 112.82 31.58 Favored Pre-proline 0 N--CA 1.423 -1.815 0 C-N-CA 124.348 1.059 . . . . 0.0 108.719 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 871' ' ' PRO . . . . . 0.411 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 31.9 Cg_exo -60.79 -6.06 5.43 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 123.883 3.056 . . . . 0.0 113.664 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -85.53 -23.5 46.84 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.785 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 18.9 p -123.92 -33.89 3.07 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -177.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 82.5 21.86 0.23 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.943 1.697 . . . . 0.0 109.706 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -103.66 139.52 20.19 Favored Pre-proline 0 C--O 1.25 1.107 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.934 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.408 ' HA ' HG12 ' A' ' 869' ' ' ILE . 38.0 Cg_endo -73.59 153.93 49.54 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.845 2.363 . . . . 0.0 110.644 173.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.625 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 29.2 t70 -79.53 146.17 32.79 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.139 0.495 . . . . 0.0 111.845 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -108.79 -0.62 19.82 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.247 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 879' ' ' GLY . . . . . 0.416 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 106.13 51.78 0.81 Allowed Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -172.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 1.3 m -109.02 164.35 14.91 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.04 114.92 3.36 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 121.745 1.63 . . . . 0.0 108.886 172.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 68.7 mtp -115.06 167.58 10.69 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.2 tt -132.22 143.83 38.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -101.23 147.15 17.63 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 43.7 t -80.34 170.67 16.08 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.022 0.529 . . . . 0.0 110.009 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 886' ' ' ASP . . . . . 0.441 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 26.8 t70 -88.99 -24.83 22.29 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -100.67 -31.8 11.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.323 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 22.4 m -104.71 149.09 25.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -92.45 -9.99 39.53 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.57 150.43 49.0 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.844 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -101.29 135.44 42.77 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.786 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 892' ' ' TYR . . . . . 0.411 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 45.2 m-85 -115.85 150.73 36.54 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.656 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 43.2 m80 -79.11 139.94 37.94 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.916 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 31.4 m0 -52.34 -52.03 66.84 Favored Pre-proline 0 CA--C 1.551 1.014 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.59 -9.3 22.08 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.951 1.767 . . . . 0.0 113.309 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.656 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -93.52 -17.84 22.94 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.453 0.644 . . . . 0.0 111.074 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 893' ' ' HIS . 31.5 m -118.48 7.67 6.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.927 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 70.72 37.61 66.92 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.723 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 49.0 mt -108.48 124.28 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-O 121.73 0.776 . . . . 0.0 110.848 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -105.0 -21.15 13.33 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.518 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -155.76 146.9 22.47 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -55.8 114.95 8.34 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 124.848 1.343 . . . . 0.0 112.133 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -68.53 155.52 68.74 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.966 1.778 . . . . 0.0 109.784 173.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.07 146.16 88.97 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.27 1.98 . . . . 0.0 112.411 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -64.59 -32.95 74.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.999 0.904 . . . . 0.0 109.667 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -78.81 1.48 23.15 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.163 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 21.0 ttt -97.85 133.19 42.69 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -81.46 137.22 35.65 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.036 -1.065 . . . . 0.0 108.484 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 92.9 t90 -134.35 138.09 44.64 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.697 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 97.5 m-85 -135.56 136.36 41.06 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 11.5 p -62.55 165.7 8.76 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 124.081 0.952 . . . . 0.0 110.24 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.424 ' CD ' HG12 ' A' ' 897' ' ' VAL . 11.5 Cg_endo -57.15 -10.26 5.83 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.014 2.476 . . . . 0.0 112.291 175.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 28.9 mmmt -83.28 -54.11 5.25 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 72.0 m -81.49 -21.37 38.72 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.32 -27.55 67.99 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 919' ' ' LYS . 2.9 t-20 -78.5 -5.39 52.46 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.635 0.731 . . . . 0.0 110.273 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -83.82 -34.97 24.57 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 68.9 mt -86.58 -50.6 13.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.3 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 919' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 916' ' ' ASN . 63.3 tttm -108.88 94.9 5.3 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -69.36 -32.55 71.69 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.695 -173.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 71.02 134.68 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.107 1.363 . . . . 0.0 111.857 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -142.5 -176.54 4.89 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.12 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -151.11 147.46 27.09 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 C--N 1.296 -1.741 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 177.41 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.071 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 21.4 t -82.69 90.34 6.84 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 117.542 0.671 . . . . 0.0 110.205 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -166.57 103.18 0.6 Allowed 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -114.6 134.27 55.18 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -87.65 149.97 23.94 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 24.4 mmt -92.71 -53.75 4.05 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -125.57 156.92 38.34 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 857' ' ' TYR . . . . . 0.475 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 43.9 m-85 -108.53 64.25 0.61 Allowed 'General case' 0 C--N 1.283 -2.316 0 CA-C-O 122.296 1.046 . . . . 0.0 111.096 -170.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.32 115.57 18.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 113.902 -1.499 . . . . 0.0 107.516 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 56.5 mt -108.1 152.21 9.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -108.09 135.09 50.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.09 174.09 11.92 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.261 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.81 -24.42 63.47 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.247 0.546 . . . . 0.0 111.029 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -88.26 4.87 44.3 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.333 0.587 . . . . 0.0 110.412 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 74.73 22.06 77.66 Favored Glycine 0 CA--C 1.502 -0.738 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.598 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -86.21 154.57 21.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -86.67 130.69 34.39 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.796 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 41.6 mm -103.14 105.61 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.744 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.2 m-90 -83.95 136.86 33.91 Favored 'General case' 0 C--N 1.252 -3.639 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.609 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.494 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 53.3 mt -102.71 129.0 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.348 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 43.6 t -80.65 109.13 11.85 Favored Pre-proline 0 N--CA 1.416 -2.162 0 C-N-CA 125.612 1.565 . . . . 0.0 107.387 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 871' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 32.5 Cg_exo -62.17 -0.81 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.335 2.69 . . . . 0.0 113.624 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.81 -49.04 9.25 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 3.9 p -107.74 -20.22 13.29 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 122.593 0.357 . . . . 0.0 111.113 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 78.68 23.05 0.64 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.745 1.618 . . . . 0.0 108.786 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -101.16 141.97 23.69 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.566 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 36.3 Cg_endo -73.93 174.15 12.84 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.661 2.241 . . . . 0.0 109.226 170.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.667 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 17.2 t0 -60.8 109.78 1.14 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.835 0.826 . . . . 0.0 110.501 174.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -101.67 13.71 34.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.292 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 102.82 49.1 1.2 Allowed Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 21.2 m -130.03 157.01 78.28 Favored Pre-proline 0 N--CA 1.412 -2.369 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.18 135.32 16.84 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 121.973 1.782 . . . . 0.0 108.447 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 65.0 mtp -115.71 142.32 46.91 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.696 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.5 tt -123.05 136.42 59.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -119.59 152.26 17.21 Favored Glycine 0 CA--C 1.483 -1.926 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.734 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.543 ' HB3' ' O ' ' A' ' 888' ' ' CYS . 42.3 t -58.62 160.1 5.89 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.651 0.78 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -88.11 -27.25 22.04 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.54 -39.59 18.61 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.675 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 885' ' ' CYS . 8.5 p -138.17 167.12 22.49 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.031 0.444 . . . . 0.0 110.981 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -90.04 68.33 7.19 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.799 0.809 . . . . 0.0 109.755 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -112.02 97.47 6.69 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.7 -2.334 . . . . 0.0 104.7 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -96.39 128.78 43.63 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.439 -171.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 892' ' ' TYR . . . . . 0.485 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 36.5 m-85 -122.55 169.3 11.16 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.744 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.667 ' HE2' ' HA ' ' A' ' 877' ' ' ASP . 41.5 m80 -89.36 149.79 22.85 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.087 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -49.6 -56.33 17.4 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.44 -11.16 29.07 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.324 2.016 . . . . 0.0 113.94 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 62.8 m -89.18 -29.8 19.04 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.569 HG23 HG12 ' A' ' 899' ' ' ILE . 17.2 m -113.45 3.55 8.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -175.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.06 5.73 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.576 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.569 HG12 HG23 ' A' ' 897' ' ' VAL . 24.5 mm -105.15 114.6 45.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 90.2 mmm -95.61 -21.86 17.97 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.324 0.583 . . . . 0.0 110.204 -177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -165.52 163.07 19.52 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 902' ' ' ALA . . . . . 0.415 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -45.81 111.57 1.44 Allowed Pre-proline 0 C--O 1.241 0.609 0 O-C-N 124.579 1.174 . . . . 0.0 111.419 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 29.9 Cg_endo -64.91 160.74 39.71 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.873 2.382 . . . . 0.0 111.396 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.43 141.62 89.62 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.25 1.967 . . . . 0.0 111.328 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -78.34 -11.97 59.97 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.105 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.66 -10.2 41.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.561 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 21.2 ttt -80.69 130.55 35.16 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.007 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -89.39 134.91 33.87 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -129.1 139.17 52.09 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -130.26 147.04 51.94 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 20.0 p -61.06 160.04 24.11 Favored Pre-proline 0 C--N 1.317 -0.806 0 O-C-N 123.871 0.732 . . . . 0.0 110.388 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.16 -15.13 13.45 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.863 2.375 . . . . 0.0 112.604 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 18.4 mtmm -82.3 -50.93 8.4 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.81 -31.52 66.64 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.74 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 915' ' ' ALA . . . . . 0.421 ' HB1' ' NZ ' ' A' ' 919' ' ' LYS . . . -65.8 -25.52 67.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.114 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.21 -37.41 57.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.48 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -60.16 -44.08 95.27 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 74.4 mt -68.93 -54.21 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.713 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 919' ' ' LYS . . . . . 0.421 ' NZ ' ' HB1' ' A' ' 915' ' ' ALA . 32.4 mtmm -100.04 84.11 2.81 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.857 0.836 . . . . 0.0 109.604 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -97.88 -40.97 8.24 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.599 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 67.75 -83.1 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.925 1.29 . . . . 0.0 110.695 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -173.63 170.55 4.04 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -86.59 123.5 31.84 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 . . . . . 0 C--O 1.256 1.395 0 C-N-CA 123.701 0.801 . . . . 0.0 109.982 -179.599 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.892 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 68.4 p 43.21 83.63 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -166.23 169.65 14.05 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 67.6 mtt -102.5 39.12 1.56 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 70.65 12.85 7.31 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.628 1.171 . . . . 0.0 112.655 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 26.2 mmt -92.33 79.19 5.03 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.135 0.493 . . . . 0.0 110.758 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -118.68 -176.22 3.05 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -95.67 -5.74 41.6 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.375 0.607 . . . . 0.0 111.261 -175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 59.1 t -111.05 106.69 21.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 34.6 mt -108.67 131.67 58.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -85.4 117.9 24.6 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -69.11 177.54 2.66 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.36 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -66.82 -30.91 71.22 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 124.686 1.194 . . . . 0.0 109.941 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 863' ' ' TRP . . . . . 0.463 ' HB3' ' OD1' ' A' ' 865' ' ' ASN . 72.5 t-105 -89.14 -3.19 58.71 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.899 0.856 . . . . 0.0 109.024 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.32 9.98 71.88 Favored Glycine 0 CA--C 1.502 -0.762 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.496 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 863' ' ' TRP . 29.2 m120 -62.2 148.89 43.23 Favored 'General case' 0 C--O 1.249 1.027 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -85.89 101.36 12.79 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.997 0.903 . . . . 0.0 109.774 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 49.8 mm -89.54 115.22 28.78 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.593 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -103.08 126.32 50.2 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.526 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.512 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 27.6 mt -87.87 124.32 40.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.36 106.5 4.69 Favored Pre-proline 0 N--CA 1.415 -2.191 0 C-N-CA 125.325 1.45 . . . . 0.0 107.412 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 871' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 21.6 Cg_exo -67.39 13.6 0.16 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.665 2.91 . . . . 0.0 113.247 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -92.25 -40.21 5.19 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 174.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 11.0 p -111.96 -25.55 9.34 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.084 0.469 . . . . 0.0 110.325 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 79.9 18.66 0.67 Allowed 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.459 1.904 . . . . 0.0 110.916 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -94.74 138.51 22.19 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.491 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 40.5 Cg_endo -72.52 148.4 47.89 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.159 2.572 . . . . 0.0 111.695 174.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.654 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 16.8 t70 -69.28 141.15 54.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -85.93 -34.1 21.0 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.512 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 127.83 46.46 0.19 Allowed Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 106.336 -2.706 . . . . 0.0 106.336 -171.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 20.9 p -114.11 165.41 13.7 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 114.387 -0.907 . . . . 0.0 109.697 -173.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.76 124.13 13.97 Favored 'Trans proline' 0 C--O 1.255 1.353 0 C-N-CA 122.082 1.855 . . . . 0.0 111.442 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.8 mtp -124.66 161.72 25.68 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.862 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.8 tt -130.68 138.06 54.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -108.36 152.32 16.98 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.965 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 47.4 t -77.84 167.28 21.77 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.378 0.609 . . . . 0.0 110.363 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -104.41 -23.09 13.22 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.127 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -84.94 -40.9 16.44 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.434 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.7 p -105.55 -95.06 0.35 Allowed 'General case' 0 N--CA 1.427 -1.577 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.468 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 37.3 t70 174.62 -20.46 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.022 0.929 . . . . 0.0 109.778 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -55.69 141.94 36.1 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -176.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -104.1 131.64 51.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.518 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 892' ' ' TYR . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 911' ' ' CYS . 10.6 m-85 -117.74 155.43 30.01 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.167 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.661 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 36.6 m80 -80.93 143.29 32.74 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.406 ' N ' ' HD2' ' A' ' 895' ' ' PRO . 29.2 m0 -52.59 -51.7 70.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 895' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 30.4 Cg_endo -61.2 -20.35 67.58 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.321 2.014 . . . . 0.0 113.405 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 61.6 m -80.47 -26.01 38.51 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.088 0.47 . . . . 0.0 111.641 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 11.8 m -114.0 8.25 7.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.449 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 73.04 48.79 18.83 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.7 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 58.6 mt -119.85 133.7 65.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 122.636 -0.332 . . . . 0.0 110.619 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.3 ptp -128.37 -2.88 5.57 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.265 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -164.39 130.62 2.98 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -44.64 96.35 0.11 Allowed Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 127.002 2.121 . . . . 0.0 113.83 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 904' ' ' PRO . 0.4 OUTLIER -114.08 156.03 0.04 OUTLIER 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 123.553 2.835 . . . . 0.0 116.346 -176.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 904' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 903' ' ' PRO . 10.2 Cg_endo -97.04 172.37 0.78 Allowed 'Trans proline' 0 N--CA 1.439 -1.681 0 N-CA-C 105.617 -2.493 . . . . 0.0 105.617 157.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 905' ' ' GLU . . . . . 0.527 ' HG3' ' H ' ' A' ' 907' ' ' MET . 8.3 pt-20 -86.43 -29.51 22.79 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 115.983 -2.287 . . . . 0.0 109.767 174.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 148.65 -20.24 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 130.518 3.527 . . . . 0.0 103.657 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 907' ' ' MET . . . . . 0.527 ' H ' ' HG3' ' A' ' 905' ' ' GLU . 56.3 ttp -126.23 170.25 12.04 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 111.544 -2.571 . . . . 0.0 105.703 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -46.98 152.52 0.51 Allowed 'General case' 0 C--O 1.242 0.669 0 O-C-N 124.537 1.148 . . . . 0.0 110.929 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -107.98 124.37 50.06 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.582 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.37 145.94 46.66 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 892' ' ' TYR . 27.3 p -66.18 163.55 37.59 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.769 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.55 -23.65 26.07 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.695 2.263 . . . . 0.0 111.904 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -79.17 -50.87 10.3 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.721 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.463 ' HA ' ' HE2' ' A' ' 917' ' ' LYS . 98.0 m -82.89 -25.2 32.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.49 65.39 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -74.36 -19.6 60.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.256 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 49.2 mtmt -86.1 -30.56 22.46 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 46.3 mm -68.61 -61.27 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -94.08 95.17 8.83 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 920' ' ' LYS . . . . . 0.441 ' HB3' ' NZ ' ' A' ' 920' ' ' LYS . 4.7 ttpm? -146.16 -45.78 0.2 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.567 -166.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.26 135.56 44.21 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -168.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -86.15 146.27 26.65 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.689 -1.596 . . . . 0.0 107.519 177.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -85.23 -0.89 56.08 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.653 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 . . . . . 0 C--N 1.29 -2.021 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 174.949 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.915 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 4.7 p -102.14 -57.77 2.0 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 116.943 0.371 . . . . 0.0 110.069 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 64.1 m80 65.41 -70.11 0.1 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.289 1.436 . . . . 0.0 113.303 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 88.8 mtp -84.63 82.65 8.32 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -167.4 -163.38 0.51 Allowed 'General case' 0 C--N 1.307 -1.283 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 95.2 mmm -113.98 17.48 17.84 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -68.15 -88.52 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -124.76 1.18 8.13 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.591 0.71 . . . . 0.0 111.026 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 44.4 t -135.04 118.12 23.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.2 mt -131.92 165.39 32.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -117.91 147.93 42.64 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 861' ' ' ASP . . . . . 0.437 ' HB3' HD11 ' A' ' 867' ' ' ILE . 0.9 OUTLIER -85.42 -175.82 5.85 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.08 -27.53 67.44 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.796 0.331 . . . . 0.0 111.828 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -78.04 -48.16 16.76 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.977 0.418 . . . . 0.0 110.208 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 129.34 28.04 0.79 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.968 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -88.05 155.93 19.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -83.08 130.04 35.08 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-O 121.328 0.585 . . . . 0.0 109.455 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' A' ' 861' ' ' ASP . 50.7 mm -92.43 102.83 13.99 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 -75.51 114.34 13.96 Favored 'General case' 0 C--N 1.267 -2.997 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.436 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 50.1 mt -98.52 113.03 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 43.4 t -63.46 112.94 8.1 Favored Pre-proline 0 N--CA 1.422 -1.872 0 O-C-N 124.784 1.303 . . . . 0.0 109.068 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 871' ' ' PRO . . . . . 0.503 ' HD2' ' CE1' ' A' ' 892' ' ' TYR . 53.1 Cg_exo -58.82 -15.94 29.1 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.631 2.887 . . . . 0.0 113.098 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -70.59 -43.52 60.38 Favored Glycine 0 N--CA 1.433 -1.504 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.927 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.4 p -109.0 -26.51 10.15 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.952 0.406 . . . . 0.0 110.653 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 77.95 25.02 0.67 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.772 1.629 . . . . 0.0 109.507 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.76 139.51 20.94 Favored Pre-proline 0 C--O 1.247 0.936 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.324 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 37.8 Cg_endo -71.43 173.86 11.76 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 123.649 2.899 . . . . 0.0 112.931 176.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.81 112.42 1.64 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.595 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -103.22 -6.56 21.98 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.926 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 117.97 -17.82 11.67 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.07 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 64.2 m -68.17 156.27 90.31 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-N 116.674 0.237 . . . . 0.0 110.773 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.16 133.71 36.47 Favored 'Trans proline' 0 C--O 1.253 1.26 0 C-N-CA 122.785 2.323 . . . . 0.0 111.784 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.0 mtp -119.0 154.43 33.08 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.1 tt -124.61 145.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -102.98 155.21 18.2 Favored Glycine 0 C--O 1.248 0.999 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 886' ' ' ASP . 43.4 t -79.96 175.12 10.92 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.739 0.78 . . . . 0.0 110.749 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 886' ' ' ASP . . . . . 0.413 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 19.2 t70 -99.04 -24.47 14.89 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 887' ' ' ASP . . . . . 0.431 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 10.6 t70 -91.85 -39.08 11.94 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.571 0.7 . . . . 0.0 109.623 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 5.3 p -120.04 172.42 7.76 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.208 0.528 . . . . 0.0 112.371 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -104.26 11.22 35.13 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.926 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -80.17 149.86 30.36 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.226 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -110.83 134.47 52.49 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.902 0.382 . . . . 0.0 111.879 -173.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 892' ' ' TYR . . . . . 0.503 ' CE1' ' HD2' ' A' ' 871' ' ' PRO . 90.5 m-85 -123.58 147.89 46.87 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.761 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 53.6 m80 -76.47 145.01 39.5 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.413 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 35.9 m0 -54.58 -51.85 74.95 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 174.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 895' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 33.3 Cg_endo -63.36 -12.53 31.01 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.525 2.15 . . . . 0.0 113.162 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.761 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 73.6 m -85.34 -29.91 24.11 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.199 0.524 . . . . 0.0 110.834 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 16.7 m -107.89 -4.6 10.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.469 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 86.31 32.69 15.93 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.566 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 52.1 mt -98.28 123.92 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-O 121.365 0.602 . . . . 0.0 109.93 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -106.7 -19.78 13.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.073 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -151.83 150.47 30.16 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 902' ' ' ALA . . . . . 0.406 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -53.97 111.48 2.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.653 1.221 . . . . 0.0 111.385 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 40.1 Cg_endo -69.6 149.19 67.6 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.489 2.126 . . . . 0.0 110.816 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.23 126.57 22.51 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.601 2.2 . . . . 0.0 111.679 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.77 -9.24 58.43 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.525 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.52 -20.22 63.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.386 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 52.1 tpp -102.72 149.77 24.13 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.278 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -85.38 149.05 25.7 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.223 0.535 . . . . 0.0 109.825 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -139.76 131.84 27.97 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -125.13 140.53 52.79 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 24.8 p -71.33 164.57 56.23 Favored Pre-proline 0 N--CA 1.424 -1.745 0 O-C-N 123.855 0.722 . . . . 0.0 110.524 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -59.92 -9.97 11.12 Favored 'Trans proline' 0 CA--C 1.552 1.409 0 C-N-CA 122.895 2.397 . . . . 0.0 112.704 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 913' ' ' LYS . 72.8 mmtt -87.26 -46.32 9.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 122.252 -0.28 . . . . 0.0 110.289 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 92.2 m -76.4 -27.81 56.45 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.218 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -68.77 -24.73 64.47 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.437 0.637 . . . . 0.0 109.67 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -68.37 -37.69 80.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -60.94 -38.43 85.8 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.432 0.634 . . . . 0.0 109.845 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 50.4 mm -63.26 -35.6 72.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.415 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -100.09 -3.52 31.72 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -173.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 920' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 923' ' ' LYS . 19.9 mtmm -86.87 97.88 10.9 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 118.141 -1.424 . . . . 0.0 109.097 176.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -86.73 -23.66 25.42 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.403 0.621 . . . . 0.0 109.854 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -73.09 -44.16 60.83 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.041 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 923' ' ' LYS . . . . . 0.407 ' O ' ' HE2' ' A' ' 920' ' ' LYS . 22.3 ttmm -154.5 158.62 40.16 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 . . . . . 0 C--N 1.311 -1.073 0 CA-C-O 118.546 -0.74 . . . . 0.0 110.294 178.561 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.771 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 16.7 m -81.42 155.14 26.04 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -152.32 177.21 10.81 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -155.59 34.96 0.36 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 174.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -72.83 125.58 27.89 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.562 -1.654 . . . . 0.0 110.456 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 26.2 ptm -134.52 134.36 41.34 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 856' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 869' ' ' ILE . . . -142.91 -178.26 5.73 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 857' ' ' TYR . . . . . 0.542 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 65.0 m-85 -121.61 7.79 10.04 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.792 -174.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.57 128.59 60.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 45.3 mt -137.13 162.26 34.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 860' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 860' ' ' ARG . 54.1 mtt180 -102.89 140.78 36.71 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 119.071 0.85 . . . . 0.0 110.966 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -76.71 173.67 11.35 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.681 173.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -70.66 -26.76 63.59 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 863' ' ' TRP . . . . . 0.546 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 96.2 m95 -88.61 -6.57 57.44 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.193 0.521 . . . . 0.0 109.926 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 94.32 13.71 53.27 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.942 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.546 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 51.6 m-80 -72.9 158.88 34.65 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -91.72 127.99 37.39 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 121.982 0.896 . . . . 0.0 111.726 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 46.3 mm -99.62 125.96 53.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.592 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -108.08 152.71 24.15 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.542 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 31.9 mt -112.69 133.0 59.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 O-C-N 123.579 0.55 . . . . 0.0 109.823 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 45.3 t -80.54 111.39 22.44 Favored Pre-proline 0 N--CA 1.421 -1.886 0 C-N-CA 124.911 1.284 . . . . 0.0 109.24 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 871' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 32.6 Cg_exo -63.3 2.88 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.315 0 C-N-CA 123.894 3.063 . . . . 0.0 113.498 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -90.04 -19.38 47.06 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.743 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 7.0 p -137.97 -25.29 0.98 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 17.1 t30 78.92 20.43 0.75 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.671 1.589 . . . . 0.0 109.257 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 99.3 mttt -92.43 139.12 23.83 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.731 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.403 ' CA ' HG12 ' A' ' 869' ' ' ILE . 57.8 Cg_endo -77.59 163.7 29.12 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.546 2.831 . . . . 0.0 112.487 174.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.462 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 12.8 t70 -59.1 125.95 25.69 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.525 0.73 . . . . 0.0 111.831 175.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -99.02 19.5 15.01 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.655 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 84.11 42.5 7.53 Favored Glycine 0 CA--C 1.488 -1.639 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 -172.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 880' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 881' ' ' PRO . 9.1 p -115.48 150.79 45.2 Favored Pre-proline 0 N--CA 1.409 -2.508 0 CA-C-N 113.77 -1.215 . . . . 0.0 111.565 -170.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 880' ' ' SER . 16.3 Cg_exo -68.77 123.0 9.95 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 122.072 1.848 . . . . 0.0 108.72 171.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.462 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 92.4 mtp -120.27 157.18 29.7 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.9 tt -119.19 134.96 61.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.15 157.5 21.55 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 886' ' ' ASP . 52.3 t -80.64 170.77 15.89 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.5 0.667 . . . . 0.0 110.503 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 886' ' ' ASP . . . . . 0.409 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 22.2 t70 -93.82 -24.1 17.89 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 887' ' ' ASP . . . . . 0.416 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 16.0 t70 -99.86 -48.1 4.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.796 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.7 p -98.65 165.3 11.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.354 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -88.32 -16.19 33.71 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.158 0.983 . . . . 0.0 110.521 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.66 152.29 45.54 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.757 -174.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -105.42 133.64 49.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.512 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -115.4 146.77 41.28 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.698 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.3 m80 -76.88 141.07 40.74 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -50.31 -51.62 61.87 Favored Pre-proline 0 CA--C 1.555 1.161 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.78 -22.53 74.58 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.402 2.068 . . . . 0.0 114.176 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 60.9 m -81.02 -26.9 36.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.529 0.681 . . . . 0.0 111.652 -175.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.625 HG23 HG12 ' A' ' 899' ' ' ILE . 15.1 m -112.68 -5.47 11.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.087 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 85.65 41.81 7.12 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.365 175.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.625 HG12 HG23 ' A' ' 897' ' ' VAL . 39.9 mm -90.98 108.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.7 ptm -87.19 -23.93 24.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.735 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -162.68 149.36 12.95 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -49.66 110.6 1.65 Allowed Pre-proline 0 C--O 1.241 0.619 0 O-C-N 124.508 1.13 . . . . 0.0 111.8 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.74 157.76 51.5 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.979 2.452 . . . . 0.0 112.107 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -68.96 130.17 19.82 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.399 2.066 . . . . 0.0 110.522 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -76.6 -5.36 47.44 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.339 0.59 . . . . 0.0 110.672 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -68.67 -21.72 64.42 Favored 'General case' 0 N--CA 1.391 -3.409 0 C-N-CA 125.729 1.612 . . . . 0.0 108.985 172.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 46.9 ttm -103.71 136.61 43.09 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -72.77 144.53 47.54 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.183 0.516 . . . . 0.0 110.435 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -130.09 131.98 45.96 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -133.45 137.78 45.88 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.246 0.546 . . . . 0.0 110.132 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 7.5 p -73.48 172.12 9.01 Favored Pre-proline 0 C--N 1.296 -1.723 0 C-N-CA 124.862 1.265 . . . . 0.0 110.641 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.71 -16.17 23.86 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 123.002 2.468 . . . . 0.0 111.665 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.669 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 11.7 mmmm -80.56 -55.02 5.14 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.26 0.624 . . . . 0.0 110.849 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.435 ' O ' HG12 ' A' ' 918' ' ' ILE . 71.6 m -85.59 -22.82 27.86 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.65 -22.18 61.72 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 913' ' ' LYS . 3.4 t-20 -66.96 -36.13 81.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.741 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.405 ' NZ ' ' SG ' ' A' ' 914' ' ' CYS . 90.2 mttt -66.05 -49.14 68.69 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.404 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 914' ' ' CYS . 32.5 mm -61.12 -39.87 83.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.078 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 919' ' ' LYS . . . . . 0.424 ' HG2' ' HB2' ' A' ' 921' ' ' ASP . 24.2 ttpp 70.09 81.47 0.17 Allowed 'General case' 0 N--CA 1.408 -2.544 0 C-N-CA 126.273 1.829 . . . . 0.0 109.829 -174.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -73.98 -38.15 64.23 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 921' ' ' ASP . . . . . 0.424 ' HB2' ' HG2' ' A' ' 919' ' ' LYS . 28.0 t70 59.98 86.86 0.09 Allowed 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 113.619 -1.628 . . . . 0.0 111.42 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.74 79.96 9.29 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.58 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -154.51 139.18 17.0 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.216 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 . . . . . 0 C--N 1.287 -2.135 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 172.285 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 850' ' ' GLY . . . . . 0.424 ' N ' ' SG ' ' A' ' 888' ' ' CYS . . . . . . . . 0 N--CA 1.464 0.536 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 851' ' ' SER . . . . . 0.79 ' HA ' ' SD ' ' A' ' 855' ' ' MET . 78.7 p -149.11 13.75 0.88 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 117.592 0.696 . . . . 0.0 111.581 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -79.03 -84.48 0.08 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.169 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 66.6 mtt -123.39 -45.76 2.07 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 122.207 1.003 . . . . 0.0 109.215 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -81.93 81.57 7.87 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.604 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 855' ' ' MET . . . . . 0.79 ' SD ' ' HA ' ' A' ' 851' ' ' SER . 25.5 ptt? -147.94 24.71 1.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 122.139 0.971 . . . . 0.0 109.856 175.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -93.04 17.05 11.43 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.842 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 857' ' ' TYR . . . . . 0.507 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 49.7 m-85 -91.73 77.92 5.53 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.61 118.06 37.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.517 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 54.5 mt -117.07 162.78 14.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -96.63 134.33 40.01 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 119.313 0.96 . . . . 0.0 110.108 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -75.86 174.4 9.94 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.99 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -68.47 -30.04 68.8 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 123.666 0.786 . . . . 0.0 110.784 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -79.95 -15.58 56.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.885 0.85 . . . . 0.0 108.895 176.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 96.93 18.56 29.17 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -81.6 178.24 8.46 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -95.88 129.0 43.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.073 0.463 . . . . 0.0 110.317 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 28.2 mm -92.1 122.27 43.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -90.84 148.61 22.39 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 124.22 0.95 . . . . 0.0 111.208 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 50.7 mt -122.17 136.44 59.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.471 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.85 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 50.0 t -77.59 106.98 4.38 Favored Pre-proline 0 N--CA 1.426 -1.668 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 871' ' ' PRO . . . . . 0.485 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 57.5 Cg_endo -78.14 15.19 1.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.018 1.812 . . . . 0.0 111.977 -177.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -87.52 -32.0 14.62 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 9.4 p -115.13 -32.37 5.72 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.582 -0.309 . . . . 0.0 110.475 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 87.55 26.26 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.828 2.051 . . . . 0.0 109.864 -175.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.473 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 25.6 mtpp -110.23 139.07 21.08 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.553 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.6 Cg_endo -76.51 169.95 20.89 Favored 'Trans proline' 0 C--O 1.249 1.051 0 C-N-CA 123.426 2.751 . . . . 0.0 112.98 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -51.99 113.45 1.01 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.538 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -107.64 18.18 21.74 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.58 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 83.72 27.75 37.51 Favored Glycine 0 CA--C 1.492 -1.366 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 10.7 p -106.02 167.59 9.44 Favored Pre-proline 0 N--CA 1.42 -1.935 0 C-N-CA 123.82 0.848 . . . . 0.0 110.043 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.75 123.84 9.29 Favored 'Trans proline' 0 N--CA 1.437 -1.811 0 C-N-CA 121.368 1.379 . . . . 0.0 109.762 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 78.1 mtp -122.44 150.51 42.39 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.668 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 883' ' ' ILE . . . . . 0.528 ' HB ' ' HE1' ' A' ' 894' ' ' TRP . 19.0 tt -117.36 148.67 19.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -109.87 157.45 15.06 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.596 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.523 ' HB3' ' OD2' ' A' ' 890' ' ' ASP . 42.2 t -91.73 -170.83 2.69 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 126.037 1.735 . . . . 0.0 108.016 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -120.54 -23.34 6.11 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.965 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 887' ' ' ASP . . . . . 0.45 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 3.4 t70 -102.52 -25.09 13.72 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -167.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 890' ' ' ASP . 22.6 p -119.12 -143.93 0.36 Allowed 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -174.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -130.04 87.04 2.47 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 890' ' ' ASP . . . . . 0.523 ' OD2' ' HB3' ' A' ' 885' ' ' CYS . 1.4 p30 -128.78 157.62 40.94 Favored 'General case' 0 C--N 1.256 -3.494 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -159.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -161.09 117.3 2.22 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 127.85 2.46 . . . . 0.0 106.409 161.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 892' ' ' TYR . . . . . 0.485 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 62.8 m-85 -120.02 147.98 44.12 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.728 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 53.4 m80 -76.69 140.2 40.79 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.899 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.528 ' HE1' ' HB ' ' A' ' 883' ' ' ILE . 24.2 m0 -53.51 -51.2 78.11 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.08 -9.42 25.01 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.039 1.826 . . . . 0.0 113.919 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.728 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 74.3 m -86.51 -39.7 15.99 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.293 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.618 HG23 HG12 ' A' ' 899' ' ' ILE . 30.5 m -104.57 -4.07 9.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.205 -175.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 87.1 53.0 2.93 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.519 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.618 HG12 HG23 ' A' ' 897' ' ' VAL . 16.7 mm -114.02 136.05 51.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.2 ptp -121.08 -15.59 8.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.605 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -162.61 135.48 5.77 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -39.21 96.7 0.12 Allowed Pre-proline 0 N--CA 1.494 1.746 0 C-N-CA 126.169 1.788 . . . . 0.0 113.833 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 904' ' ' PRO . 12.0 Cg_endo -109.92 139.55 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 123.553 2.835 . . . . 0.0 118.113 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 904' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 903' ' ' PRO . 29.8 Cg_endo -101.58 158.27 0.37 Allowed 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 123.388 2.726 . . . . 0.0 108.327 160.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -87.92 -31.0 19.66 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 117.896 -1.522 . . . . 0.0 109.803 174.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 150.92 -20.47 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 129.621 3.168 . . . . 0.0 103.555 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 25.8 ttt -117.8 166.53 12.35 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 111.708 -2.496 . . . . 0.0 106.757 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 908' ' ' GLN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 910' ' ' PHE . 38.2 mt-30 -56.42 160.02 3.35 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 124.528 1.142 . . . . 0.0 109.446 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -101.12 131.38 47.08 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 908' ' ' GLN . 92.0 m-85 -128.76 139.34 52.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 27.4 p -66.43 166.99 14.23 Favored Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 124.226 0.954 . . . . 0.0 110.944 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -48.78 -24.48 7.03 Favored 'Trans proline' 0 CA--C 1.552 1.405 0 C-N-CA 123.841 3.028 . . . . 0.0 113.075 175.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -87.01 -41.31 13.98 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.725 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 90.8 m -85.7 -17.94 34.53 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.65 74.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 122.127 0.965 . . . . 0.0 108.654 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.78 -29.19 70.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.897 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.508 ' HA ' ' CB ' ' A' ' 921' ' ' ASP . 91.1 mttt -70.4 -35.49 73.5 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.173 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.422 HD11 ' CD2' ' A' ' 910' ' ' PHE . 70.8 mt -64.28 -39.37 85.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -64.75 -75.19 0.09 Allowed 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.1 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -173.92 108.14 0.14 Allowed 'General case' 0 N--CA 1.41 -2.469 0 C-N-CA 125.464 1.505 . . . . 0.0 109.694 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 921' ' ' ASP . . . . . 0.508 ' CB ' ' HA ' ' A' ' 917' ' ' LYS . 36.6 t70 -129.48 37.51 3.99 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.673 1.225 . . . . 0.0 108.672 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -79.85 101.8 8.74 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.28 172.5 17.24 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.069 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 9.4 p80 . . . . . 0 C--N 1.309 -1.186 0 C-N-CA 125.127 1.371 . . . . 0.0 108.985 172.551 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.675 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 5.3 p -83.59 176.91 8.67 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.027 0.531 . . . . 0.0 110.93 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -76.08 -49.6 17.01 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.287 0.565 . . . . 0.0 110.25 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 21.0 mmt -123.42 160.36 27.01 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.474 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 66.02 19.58 11.21 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.035 0.934 . . . . 0.0 110.989 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -84.74 -12.9 52.78 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.645 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -159.97 -173.11 3.91 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 67.93 30.1 6.25 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.526 1.155 . . . . 0.0 108.15 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 92.3 t -131.91 120.74 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 113.717 -1.583 . . . . 0.0 108.969 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 45.6 mt -119.75 152.28 22.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -102.97 137.69 40.83 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.161 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.65 172.65 10.27 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.569 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.8 -28.05 66.41 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 122.613 0.365 . . . . 0.0 110.758 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 -74.72 -23.85 58.65 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 107.62 3.82 34.69 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.164 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -69.69 149.0 48.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.977 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -84.62 127.05 33.87 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.737 0.78 . . . . 0.0 112.096 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 47.0 mm -98.75 117.55 43.97 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -94.24 135.88 35.14 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.742 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.538 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 51.1 mt -105.77 128.35 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 25.7 t -82.75 107.97 10.87 Favored Pre-proline 0 N--CA 1.414 -2.234 0 C-N-CA 125.04 1.336 . . . . 0.0 108.833 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 871' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 36.2 Cg_exo -63.17 0.25 1.81 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.459 2.772 . . . . 0.0 113.014 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.3 -33.61 35.05 Favored Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 20.3 p -119.6 -28.43 5.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.816 0.341 . . . . 0.0 110.719 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.0 t30 80.63 29.51 0.21 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.032 2.133 . . . . 0.0 109.04 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -113.05 141.4 25.55 Favored Pre-proline 0 C--O 1.243 0.732 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.038 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 39.9 Cg_endo -74.43 155.84 45.67 Favored 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 123.324 2.682 . . . . 0.0 112.691 174.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.579 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 19.5 t70 -77.35 145.72 37.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.81 176.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -133.89 5.66 3.63 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.972 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 118.73 40.66 0.65 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.723 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 37.8 m -105.07 166.08 12.07 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -69.35 123.07 9.86 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.636 1.557 . . . . 0.0 109.778 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 53.2 mtp -120.42 161.06 21.86 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.608 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.9 tt -138.26 148.15 25.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -121.14 149.16 17.4 Favored Glycine 0 C--O 1.252 1.224 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.502 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 52.2 t -64.69 160.76 19.22 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.64 1.176 . . . . 0.0 110.995 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.78 -12.34 53.89 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -106.71 -39.41 5.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.598 ' HB2' ' OD1' ' A' ' 890' ' ' ASP . 22.9 m -85.85 -160.87 0.57 Allowed 'General case' 0 CA--C 1.569 1.691 0 CA-C-O 121.849 0.833 . . . . 0.0 113.159 -174.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -133.55 29.63 3.88 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 890' ' ' ASP . . . . . 0.598 ' OD1' ' HB2' ' A' ' 888' ' ' CYS . 11.7 p-10 -89.28 176.97 6.73 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 112.068 -2.333 . . . . 0.0 112.399 -170.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -152.72 116.94 4.91 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.43 -1.714 . . . . 0.0 106.859 170.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 892' ' ' TYR . . . . . 0.444 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 26.6 m-85 -107.46 158.67 17.0 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.719 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 42.2 m80 -86.81 144.5 27.01 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.623 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 29.2 m0 -51.9 -54.11 44.09 Favored Pre-proline 0 CA--C 1.552 1.022 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.58 -23.33 64.51 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.158 1.905 . . . . 0.0 113.202 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.719 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 53.5 m -79.73 -21.89 43.96 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.252 0.549 . . . . 0.0 111.531 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 12.6 m -116.46 9.92 7.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.43 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 70.8 38.23 66.08 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 114.928 -1.033 . . . . 0.0 113.199 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.623 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 51.0 mt -111.07 127.05 68.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 120.993 0.425 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 92.7 mmm -123.54 -6.48 8.11 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.133 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -145.16 138.12 26.34 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 902' ' ' ALA . . . . . 0.418 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -59.95 112.69 5.76 Favored Pre-proline 0 C--N 1.317 -0.822 0 O-C-N 124.442 1.089 . . . . 0.0 110.992 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 42.2 Cg_endo -69.24 164.49 33.83 Favored 'Trans proline' 0 C--O 1.25 1.108 0 C-N-CA 122.679 2.253 . . . . 0.0 111.184 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.53 126.64 22.95 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.24 1.96 . . . . 0.0 111.98 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 905' ' ' GLU . . . . . 0.538 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 0.5 OUTLIER -82.3 -6.81 59.5 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.724 -178.272 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 906' ' ' GLU . 11.5 pt-20 -92.43 8.23 39.53 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.815 -1.539 . . . . 0.0 108.882 177.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 23.0 ttt -122.52 139.62 53.68 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -75.92 137.99 40.73 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -126.99 134.52 50.34 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -124.45 140.17 53.2 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.307 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 892' ' ' TYR . 25.4 p -64.16 163.87 21.7 Favored Pre-proline 0 N--CA 1.424 -1.755 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.682 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.43 -10.54 6.83 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 122.806 2.337 . . . . 0.0 112.434 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 913' ' ' LYS . 74.4 mmtt -87.81 -57.95 2.75 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.431 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 75.1 m -69.25 -25.99 64.56 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.32 68.64 Favored 'General case' 0 C--O 1.198 -1.633 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -82.5 -5.01 58.46 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -87.77 -44.14 11.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 67.0 mt -72.41 -50.89 32.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.777 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -89.91 79.96 6.52 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -139.16 -59.33 0.59 Allowed 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 37.4 t70 48.37 82.64 0.04 OUTLIER 'General case' 0 C--O 1.243 0.757 0 O-C-N 125.191 1.557 . . . . 0.0 112.789 173.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.17 160.55 14.27 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.079 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -151.62 153.7 34.97 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 69.1 t60 . . . . . 0 C--N 1.303 -1.427 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.774 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.129 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 10.8 p -97.48 -50.08 4.65 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 116.686 0.243 . . . . 0.0 111.162 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 57.52 35.73 26.14 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 122.442 1.115 . . . . 0.0 108.638 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 853' ' ' MET . . . . . 0.481 ' HG2' ' H ' ' A' ' 855' ' ' MET . 55.3 ttp -71.69 132.21 44.24 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.575 -174.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -84.92 8.15 18.58 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.694 0.759 . . . . 0.0 112.274 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 855' ' ' MET . . . . . 0.481 ' H ' ' HG2' ' A' ' 853' ' ' MET . 97.5 mmm -91.32 80.8 5.51 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -154.51 -162.25 1.36 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.379 -175.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -85.38 10.0 13.97 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.395 0.616 . . . . 0.0 110.716 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.83 109.18 18.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 56.4 mt -102.84 148.58 7.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -96.88 122.87 40.32 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.421 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.21 165.52 11.31 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.75 -29.58 70.22 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -94.46 3.67 54.85 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.3 1.048 . . . . 0.0 109.776 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.06 22.22 46.27 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.486 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -76.71 147.73 37.22 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -80.09 113.6 18.38 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.174 0.512 . . . . 0.0 111.765 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 45.8 mm -97.92 118.67 44.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 175.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -99.98 147.0 26.06 Favored 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.334 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 37.4 mt -113.49 132.49 62.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.898 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 53.8 t -86.81 107.15 12.85 Favored Pre-proline 0 N--CA 1.405 -2.686 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 871' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 24.6 Cg_exo -65.01 1.35 1.94 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.14 2.56 . . . . 0.0 113.852 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -77.44 -50.4 6.68 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 4.4 p -102.24 -19.26 15.13 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 123.093 0.557 . . . . 0.0 110.288 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 77.56 19.39 1.21 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.557 1.543 . . . . 0.0 109.857 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -103.07 140.61 21.21 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.153 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 48.1 Cg_endo -74.85 173.02 15.16 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 123.269 2.646 . . . . 0.0 112.067 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.38 129.18 40.64 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.516 0.674 . . . . 0.0 111.101 174.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -118.06 34.36 5.21 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 73.54 44.1 34.36 Favored Glycine 0 CA--C 1.493 -1.287 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -173.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.5 p -120.23 151.04 52.71 Favored Pre-proline 0 N--CA 1.412 -2.338 0 CA-C-N 113.871 -1.164 . . . . 0.0 111.526 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.75 120.18 6.28 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 121.88 1.72 . . . . 0.0 109.995 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 76.3 mtp -115.94 150.28 37.4 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.839 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.6 tt -123.27 140.0 48.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -107.08 144.63 15.91 Favored Glycine 0 C--O 1.247 0.937 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.284 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 44.5 t -70.05 147.73 49.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.351 0.596 . . . . 0.0 112.08 -178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -81.9 -24.22 35.81 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.249 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.2 -51.79 9.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 120.989 0.424 . . . . 0.0 110.002 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 10.5 p -107.7 -92.86 0.41 Allowed 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.1 t70 179.62 -30.78 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.325 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -50.72 134.33 24.97 Favored 'General case' 0 C--O 1.247 0.947 0 O-C-N 124.703 1.252 . . . . 0.0 112.384 -172.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -101.9 133.16 47.11 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.333 -172.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -117.84 155.55 29.91 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.411 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.467 ' O ' HG22 ' A' ' 897' ' ' VAL . 41.3 m80 -77.21 143.57 38.91 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.494 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 27.7 m0 -49.8 -53.78 38.7 Favored Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.14 -19.02 65.1 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.228 1.952 . . . . 0.0 113.795 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 79.3 m -84.11 -23.7 30.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.003 0.43 . . . . 0.0 111.925 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.553 HG23 HG12 ' A' ' 899' ' ' ILE . 12.5 m -114.98 5.98 7.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.934 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 75.64 44.8 19.6 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.837 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.553 HG12 HG23 ' A' ' 897' ' ' VAL . 7.7 mm -110.32 109.7 29.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 mmt -109.61 -2.29 17.61 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.182 0.515 . . . . 0.0 110.43 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -154.32 143.62 21.32 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 902' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -58.1 116.76 15.75 Favored Pre-proline 0 N--CA 1.438 -1.058 0 O-C-N 124.225 0.953 . . . . 0.0 110.673 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 18.2 Cg_endo -68.19 140.33 48.85 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.262 1.975 . . . . 0.0 110.632 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.11 152.84 56.35 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.571 2.181 . . . . 0.0 112.261 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 905' ' ' GLU . . . . . 0.495 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 1.0 OUTLIER -73.67 -5.51 41.01 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.216 -178.064 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.37 -10.91 47.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.691 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 24.0 ttt -95.35 125.76 40.19 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.64 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -84.49 126.78 33.59 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -123.84 129.46 51.05 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.907 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.467 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 55.3 m-85 -120.13 142.44 48.92 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 25.7 p -63.9 160.21 48.23 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -51.53 -23.56 14.9 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.883 2.388 . . . . 0.0 112.529 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.565 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 33.3 mmtp -68.36 -55.19 12.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.37 0.668 . . . . 0.0 109.578 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.516 ' HA ' ' HE2' ' A' ' 917' ' ' LYS . 78.7 m -77.57 -22.09 51.5 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.493 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -63.56 -35.66 81.24 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.443 1.116 . . . . 0.0 108.585 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -76.72 -17.5 59.05 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.165 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 43.7 mtmt -85.76 -16.39 39.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 49.9 mm -67.54 -32.05 55.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp 52.76 118.77 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 127.211 2.204 . . . . 0.0 115.601 176.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -83.13 73.19 10.1 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 122.551 1.167 . . . . 0.0 108.416 173.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -93.43 -33.15 13.94 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 113.619 -1.628 . . . . 0.0 107.578 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -99.09 -174.25 2.71 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 923' ' ' LYS . . . . . 0.422 ' HB2' ' NZ ' ' A' ' 923' ' ' LYS . 3.1 ttmp? -80.01 156.76 27.0 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.264 0.554 . . . . 0.0 110.647 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 76.4 t60 . . . . . 0 C--N 1.305 -1.352 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.698 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.17 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 51.6 m 61.82 -174.2 0.14 Allowed 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.409 0.684 . . . . 0.0 111.464 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -87.9 87.24 7.29 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 60.2 mtt -94.92 84.71 4.21 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 121.709 0.766 . . . . 0.0 111.14 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -143.6 119.1 10.34 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 26.1 mmt -82.91 -31.4 27.81 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -159.17 179.0 9.41 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -108.5 11.9 26.5 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.965 0.888 . . . . 0.0 109.647 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.05 110.61 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.864 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.537 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 58.8 mt -117.15 160.88 16.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -115.18 136.89 52.63 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.754 0.706 . . . . 0.0 110.544 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.17 176.73 7.04 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 124.831 1.252 . . . . 0.0 109.065 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.58 -26.81 62.76 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.248 0.619 . . . . 0.0 110.209 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.61 -3.34 50.04 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.317 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.69 -2.95 86.29 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 116.161 -0.472 . . . . 0.0 113.056 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -71.24 153.22 42.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 123.611 0.242 . . . . 0.0 111.019 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -71.26 146.72 48.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.557 0.694 . . . . 0.0 111.75 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.537 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 31.3 mm -120.79 126.88 75.75 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.498 ' O ' ' HA ' ' A' ' 876' ' ' PRO . 26.1 m-90 -100.47 153.89 18.98 Favored 'General case' 0 C--N 1.285 -2.199 0 O-C-N 123.643 0.589 . . . . 0.0 111.235 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 859' ' ' ILE . 39.8 mt -118.15 117.48 54.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.745 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 38.4 t -73.81 111.65 13.15 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.28 7.97 2.74 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.984 1.79 . . . . 0.0 112.5 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.65 -27.11 43.75 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 8.4 p -121.52 -32.95 3.73 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.727 0.775 . . . . 0.0 109.411 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 80.45 39.78 0.08 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 126.745 2.018 . . . . 0.0 109.944 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -118.33 143.69 33.6 Favored Pre-proline 0 N--CA 1.446 -0.674 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.305 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 868' ' ' TRP . 50.7 Cg_endo -74.59 173.98 13.41 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 123.398 2.732 . . . . 0.0 113.018 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.42 138.93 2.21 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.071 0.949 . . . . 0.0 111.889 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -118.04 -22.97 7.6 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.144 0.974 . . . . 0.0 109.356 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 116.01 -10.49 17.97 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -171.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 11.9 p -65.05 153.0 90.04 Favored Pre-proline 0 N--CA 1.433 -1.301 0 C-N-CA 125.569 1.548 . . . . 0.0 111.193 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.54 137.37 46.17 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 122.278 1.985 . . . . 0.0 109.834 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 83.8 mtp -125.5 149.61 48.13 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.2 tt -118.84 150.75 21.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -113.76 144.92 18.33 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.418 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 49.2 t -76.72 154.69 33.88 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.58 -9.97 36.31 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.155 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.96 -64.13 1.2 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 1.6 p -94.57 -49.27 5.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.101 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 14.1 t70 80.01 79.54 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.471 1.508 . . . . 0.0 113.489 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -129.74 177.77 6.99 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -99.63 123.56 44.01 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 119.339 0.972 . . . . 0.0 112.819 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -116.82 148.69 41.0 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.756 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 49.1 m80 -76.85 144.08 39.27 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.219 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -52.77 -57.8 14.55 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.03 -11.21 30.08 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.77 1.647 . . . . 0.0 113.672 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -84.11 -37.05 22.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.285 0.564 . . . . 0.0 111.855 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.637 HG23 HG12 ' A' ' 899' ' ' ILE . 27.0 m -102.03 -8.63 9.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.772 -176.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 95.96 56.31 1.23 Allowed Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.592 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.637 HG12 HG23 ' A' ' 897' ' ' VAL . 9.0 mm -130.47 125.8 59.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 87.6 mtp -127.02 8.12 6.69 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.738 0.78 . . . . 0.0 110.411 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 901' ' ' ALA . . . . . 0.617 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -173.95 145.81 1.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -66.18 103.02 0.4 Allowed Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.7 1.2 . . . . 0.0 112.877 -174.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 25.5 Cg_endo -105.69 131.0 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 124.019 3.146 . . . . 0.0 115.998 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -100.01 148.78 0.45 Allowed 'Trans proline' 0 N--CA 1.43 -2.221 0 C-N-CA 122.745 2.297 . . . . 0.0 109.481 164.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -70.03 -46.98 63.89 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 149.8 -11.41 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 130.221 3.408 . . . . 0.0 103.516 -172.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 907' ' ' MET . . . . . 0.404 ' HG2' ' N ' ' A' ' 908' ' ' GLN . 23.5 ttt -135.29 169.39 17.55 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 112.309 -2.223 . . . . 0.0 105.747 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 908' ' ' GLN . . . . . 0.404 ' N ' ' HG2' ' A' ' 907' ' ' MET . 77.4 mt-30 -45.7 157.99 0.09 Allowed 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.813 1.645 . . . . 0.0 113.421 176.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -108.85 137.5 46.68 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.464 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -126.02 138.25 53.71 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 27.4 p -69.33 163.44 58.19 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.037 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.06 -23.47 22.03 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 123.847 3.031 . . . . 0.0 112.492 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 29.9 mmmt -69.04 -44.02 73.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 73.6 m -89.01 -27.42 20.88 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.004 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.6 -24.91 61.98 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 120.777 0.322 . . . . 0.0 110.379 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.31 -13.84 59.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.606 0.717 . . . . 0.0 109.792 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -73.39 -29.58 62.7 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 54.4 mt -94.72 -60.62 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.382 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -96.03 147.28 23.87 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.208 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -123.98 85.07 2.36 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.38 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -105.14 -13.67 15.64 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -141.3 159.23 42.66 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.599 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.61 8.77 0.69 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.634 0.73 . . . . 0.0 111.434 176.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 . . . . . 0 C--N 1.302 -1.461 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -178.961 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.532 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 47.0 t -166.49 158.68 13.77 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -74.28 -18.77 60.67 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 173.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 71.8 mtm 66.0 31.97 8.73 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.35 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -77.6 70.84 4.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.185 0.993 . . . . 0.0 109.325 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 53.7 mtm -138.76 20.88 2.68 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -94.56 -177.53 4.26 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.971 -174.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 857' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 871' ' ' PRO . 54.9 m-85 -86.87 19.37 3.02 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.576 0.703 . . . . 0.0 110.123 -175.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.35 121.08 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.749 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 59.0 mt -124.83 154.22 32.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -91.82 125.52 36.56 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.925 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -71.01 171.58 10.6 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.293 -1.322 . . . . 0.0 109.043 172.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.39 -29.15 69.25 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 122.602 0.361 . . . . 0.0 111.884 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 863' ' ' TRP . . . . . 0.501 ' HB3' ' ND2' ' A' ' 865' ' ' ASN . 44.2 t-105 -87.92 -11.93 46.18 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 97.95 15.05 37.64 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.812 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' A' ' 863' ' ' TRP . 45.9 m-80 -71.36 151.85 43.73 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -78.05 116.21 18.36 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 25.2 mm -64.15 114.59 2.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 122.172 0.987 . . . . 0.0 111.518 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.66 105.64 0.32 Allowed 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 111.478 -2.601 . . . . 0.0 110.988 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.499 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 40.4 mt -127.07 131.04 71.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 870' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 891' ' ' TRP . 52.6 t -85.81 110.23 28.57 Favored Pre-proline 0 N--CA 1.418 -2.055 0 O-C-N 124.164 0.915 . . . . 0.0 108.849 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 871' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 50.6 Cg_exo -57.0 -20.34 36.54 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.394 2.729 . . . . 0.0 113.028 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -68.97 -36.04 80.43 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.539 -0.362 . . . . 0.0 112.962 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 12.3 p -118.51 -13.54 9.71 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.806 0.303 . . . . 0.0 111.289 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 63.1 t30 72.36 24.18 3.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.25 1.42 . . . . 0.0 109.692 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -113.6 138.41 22.58 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 121.771 -0.58 . . . . 0.0 112.071 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 57.1 Cg_endo -73.22 174.03 12.74 Favored 'Trans proline' 0 C--O 1.253 1.228 0 C-N-CA 124.154 3.236 . . . . 0.0 113.328 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.09 137.09 57.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.676 176.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -122.57 25.21 8.9 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.597 1.189 . . . . 0.0 107.856 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 81.52 52.47 4.18 Favored Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 106.438 -2.665 . . . . 0.0 106.438 -171.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 3.7 p -124.0 152.57 66.94 Favored Pre-proline 0 N--CA 1.413 -2.278 0 CA-C-N 113.861 -1.17 . . . . 0.0 112.239 -170.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -72.23 112.58 3.47 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.032 1.822 . . . . 0.0 110.048 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 79.3 mtp -122.15 144.16 49.12 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.762 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 15.9 tt -117.19 152.18 19.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.779 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -110.17 156.38 15.61 Favored Glycine 0 CA--C 1.538 1.518 0 O-C-N 123.206 0.316 . . . . 0.0 113.441 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.518 ' H ' ' CG ' ' A' ' 890' ' ' ASP . 43.8 t -84.92 -170.26 3.04 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 126.31 1.844 . . . . 0.0 109.157 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -123.08 -11.54 8.04 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -107.91 -54.63 2.47 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -173.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 15.7 p -99.57 -134.79 0.28 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -165.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -128.74 89.48 2.89 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 890' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' A' ' 885' ' ' CYS . 2.6 p30 -128.06 148.69 50.56 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -158.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 891' ' ' TRP . . . . . 0.467 ' O ' ' HA ' ' A' ' 870' ' ' CYS . 68.2 m95 -161.52 117.66 2.13 Favored 'General case' 0 C--O 1.208 -1.129 0 C-N-CA 128.058 2.543 . . . . 0.0 106.929 160.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -124.54 148.73 47.59 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.462 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.68 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 57.9 m80 -80.8 144.86 31.77 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -53.53 -52.68 64.66 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.2 -11.59 32.79 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.998 1.799 . . . . 0.0 113.122 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 87.6 m -84.66 -32.14 23.79 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.648 0.737 . . . . 0.0 110.928 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 893' ' ' HIS . 20.9 m -101.52 -27.46 3.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.934 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 104.22 52.99 0.85 Allowed Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.052 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.79 136.64 58.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.026 0.441 . . . . 0.0 110.854 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.8 ptp -128.37 -1.11 5.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.849 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -150.4 141.72 23.27 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -71.91 112.34 13.96 Favored Pre-proline 0 C--N 1.311 -1.089 0 C-N-CA 123.039 0.536 . . . . 0.0 111.912 -176.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -75.43 129.81 12.29 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.506 2.137 . . . . 0.0 111.029 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 904' ' ' PRO . . . . . 0.567 ' HB2' ' HG2' ' A' ' 906' ' ' GLU . 35.9 Cg_exo -60.39 143.76 99.49 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.661 2.241 . . . . 0.0 111.73 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 905' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 1.3 pm0 -71.08 -2.9 17.14 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -176.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.567 ' HG2' ' HB2' ' A' ' 904' ' ' PRO . 9.1 pt-20 -69.46 -18.6 63.73 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.322 0.582 . . . . 0.0 109.488 171.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 51.3 ttm -100.41 128.82 46.37 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -77.21 128.7 34.84 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -118.5 140.37 49.97 Favored 'General case' 0 C--N 1.26 -3.287 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -129.53 136.41 49.81 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 9.0 p -73.85 167.25 37.02 Favored Pre-proline 0 N--CA 1.415 -2.207 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.183 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.05 -19.7 21.05 Favored 'Trans proline' 0 CA--C 1.551 1.331 0 C-N-CA 122.976 2.451 . . . . 0.0 112.41 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -81.16 -37.02 29.45 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 110.285 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 97.3 m -89.1 -30.02 18.95 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.808 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.13 68.17 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.05 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -73.05 -19.43 61.18 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.281 0.562 . . . . 0.0 111.562 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -101.05 -27.68 13.14 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.201 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 72.7 mt -76.57 -54.79 12.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 121.249 0.547 . . . . 0.0 109.53 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -100.04 -176.95 3.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt 54.31 -157.25 0.2 Allowed 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.393 1.077 . . . . 0.0 111.729 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -122.37 159.77 26.81 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -79.14 171.88 14.58 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 125.195 1.398 . . . . 0.0 111.522 -175.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -147.1 150.98 36.08 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 36.8 m80 . . . . . 0 C--N 1.31 -1.127 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 170.579 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.384 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 51.5 m -77.57 130.45 36.93 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.105 0.453 . . . . 0.0 109.804 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 74.28 81.0 0.12 Allowed 'General case' 0 CA--C 1.511 -0.519 0 C-N-CA 124.282 1.033 . . . . 0.0 111.486 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 95.9 mmm -98.37 115.05 27.64 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.895 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 67.61 13.3 9.23 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.407 1.083 . . . . 0.0 110.589 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 65.4 mtt -100.24 98.68 9.33 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -116.89 -159.14 0.72 Allowed 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -90.03 19.73 4.74 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 122.179 0.99 . . . . 0.0 109.261 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 858' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 8.1 p -143.42 130.36 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.684 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 44.2 mt -124.39 150.75 29.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -94.75 125.06 39.16 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.622 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.02 172.37 11.13 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.157 174.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.93 -30.39 71.48 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 123.644 0.778 . . . . 0.0 111.188 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -85.53 -0.67 55.67 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.435 0.636 . . . . 0.0 110.465 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 84.01 3.76 88.91 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.213 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -73.01 149.65 43.08 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -78.96 128.17 32.93 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.532 0.682 . . . . 0.0 111.371 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 32.4 mm -96.02 121.61 46.73 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 23.4 m-90 -99.76 139.35 35.55 Favored 'General case' 0 C--N 1.264 -3.121 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.597 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 31.6 mt -103.97 119.16 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.404 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 50.7 t -61.89 108.83 1.76 Allowed Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 125.143 1.377 . . . . 0.0 108.222 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 871' ' ' PRO . . . . . 0.432 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 52.6 Cg_exo -57.7 -16.99 27.05 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.735 2.957 . . . . 0.0 113.22 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -70.88 -46.43 45.35 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.246 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 17.0 p -106.75 -28.01 10.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -173.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 63.4 t30 81.25 27.84 0.19 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.714 1.606 . . . . 0.0 109.221 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.53 139.33 20.0 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.182 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 42.6 Cg_endo -76.17 162.73 33.77 Favored 'Trans proline' 0 C--O 1.251 1.173 0 C-N-CA 123.08 2.52 . . . . 0.0 112.583 174.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.402 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 17.5 t70 -65.96 141.38 58.22 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.46 14.59 8.23 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 122.781 1.277 . . . . 0.0 107.965 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 85.29 52.66 3.33 Favored Glycine 0 N--CA 1.423 -2.186 0 N-CA-C 105.828 -2.909 . . . . 0.0 105.828 -170.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 11.4 p -119.69 153.54 54.44 Favored Pre-proline 0 N--CA 1.418 -2.034 0 CA-C-N 113.927 -1.137 . . . . 0.0 111.091 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.97 118.67 5.69 Favored 'Trans proline' 0 C--O 1.257 1.429 0 C-N-CA 122.24 1.96 . . . . 0.0 109.951 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.402 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 77.0 mtp -125.32 142.32 51.57 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.074 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.3 tt -110.73 144.88 17.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -110.99 163.52 12.25 Favored Glycine 0 C--N 1.301 -1.395 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.078 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.49 ' H ' ' CG ' ' A' ' 890' ' ' ASP . 51.2 t -88.99 -164.33 1.12 Allowed 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 126.027 1.731 . . . . 0.0 108.551 -177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 886' ' ' ASP . . . . . 0.406 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 30.2 t70 -131.34 -8.96 3.74 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.637 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -109.0 -46.93 3.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.4 p -104.29 -126.73 0.23 Allowed 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -166.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -136.02 88.54 2.4 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 890' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 885' ' ' CYS . 3.1 p30 -127.74 146.89 50.43 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 113.085 -1.87 . . . . 0.0 115.238 -161.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -162.39 117.62 1.88 Allowed 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 128.046 2.538 . . . . 0.0 106.349 158.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 892' ' ' TYR . . . . . 0.432 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 44.8 m-85 -123.25 148.97 45.32 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.756 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.8 m80 -77.91 145.85 35.91 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.513 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 31.6 m0 -51.95 -55.63 28.87 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 175.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.28 -12.68 34.04 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.426 2.084 . . . . 0.0 113.99 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.3 m -86.49 -21.88 26.74 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.027 0.442 . . . . 0.0 111.069 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.703 HG23 HG12 ' A' ' 899' ' ' ILE . 14.4 m -120.52 5.79 6.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.144 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 84.15 23.4 51.95 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.712 175.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.703 HG12 HG23 ' A' ' 897' ' ' VAL . 16.9 mm -91.04 121.6 41.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 18.3 ptm -118.29 -6.14 10.83 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.281 0.562 . . . . 0.0 110.568 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.1 149.81 21.57 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -60.32 112.95 6.28 Favored Pre-proline 0 C--N 1.314 -0.977 0 O-C-N 124.172 0.92 . . . . 0.0 111.004 -177.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -72.8 162.5 40.97 Favored 'Trans proline' 0 C--O 1.248 0.993 0 C-N-CA 123.155 2.57 . . . . 0.0 111.111 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.77 123.3 13.53 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.568 2.179 . . . . 0.0 111.682 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.42 -17.66 63.99 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.173 -0.922 . . . . 0.0 113.281 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -87.38 -9.42 54.82 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.919 0.39 . . . . 0.0 110.757 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 48.2 ttm -80.47 133.14 35.81 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -77.02 135.42 38.66 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -136.4 135.71 38.98 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -126.52 139.18 53.42 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 16.9 p -64.7 167.15 9.64 Favored Pre-proline 0 C--N 1.29 -2.003 0 O-C-N 124.2 0.937 . . . . 0.0 111.892 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 11.4 Cg_endo -56.17 -13.4 9.52 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 123.074 2.516 . . . . 0.0 112.128 175.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.489 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 31.6 mmmt -84.34 -60.57 2.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 917' ' ' LYS . 92.5 m -73.04 -27.41 61.74 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.78 78.22 Favored 'General case' 0 C--O 1.201 -1.481 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -72.42 -22.81 61.05 Favored 'General case' 0 C--O 1.211 -0.924 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 914' ' ' CYS . 92.3 mttt -72.06 -46.44 56.9 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.42 -43.71 77.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.465 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -94.46 28.33 2.63 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 123.664 0.785 . . . . 0.0 109.787 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -66.7 -33.26 75.25 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.662 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -142.5 107.08 4.82 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.365 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -73.13 100.77 3.14 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 170.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -83.85 147.61 27.45 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.176 -169.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 61.0 m80 . . . . . 0 C--N 1.299 -1.628 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.604 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.79 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 18.9 m -105.53 24.61 11.9 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.612 0.72 . . . . 0.0 109.247 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -93.96 28.08 2.56 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.2 -65.49 0.67 Allowed 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.329 -176.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 57.61 27.09 13.69 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.642 1.177 . . . . 0.0 110.793 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 21.3 ptp -134.19 -163.27 1.34 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.598 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 856' ' ' ALA . . . . . 0.434 ' O ' HD12 ' A' ' 869' ' ' ILE . . . 70.01 -150.56 0.11 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -175.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 857' ' ' TYR . . . . . 0.497 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 97.0 m-85 -86.77 16.49 4.75 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 118.568 0.622 . . . . 0.0 112.318 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 14.0 p -143.62 118.89 4.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.635 0.731 . . . . 0.0 112.231 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 47.5 mt -114.84 160.87 13.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -103.78 130.65 51.34 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.233 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.83 175.29 2.5 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 125.623 1.569 . . . . 0.0 111.123 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -58.32 -40.17 81.37 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 124.937 1.295 . . . . 0.0 111.107 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 863' ' ' TRP . . . . . 0.48 ' HB3' ' ND2' ' A' ' 865' ' ' ASN . 66.9 t-105 -80.12 -25.92 39.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.369 0.604 . . . . 0.0 110.037 177.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 117.6 7.21 12.25 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.48 ' ND2' ' HB3' ' A' ' 863' ' ' TRP . 46.0 m-80 -64.25 159.9 19.8 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -85.24 117.4 24.16 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.332 0.587 . . . . 0.0 109.954 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 42.4 mm -90.76 114.02 27.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -86.13 128.07 34.82 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.847 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 33.3 mt -100.9 123.7 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.15 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.1 t -77.71 117.2 64.15 Favored Pre-proline 0 N--CA 1.408 -2.533 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.152 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 871' ' ' PRO . . . . . 0.55 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 58.6 Cg_exo -56.5 -17.82 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.656 2.904 . . . . 0.0 113.32 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.75 -21.42 76.79 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 121.314 -0.469 . . . . 0.0 113.295 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 10.8 p -138.21 -10.6 1.48 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.301 0.551 . . . . 0.0 112.231 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.257 2.3 p-10 61.15 25.44 15.44 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.299 1.84 . . . . 0.0 111.129 -173.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -106.33 140.21 21.07 Favored Pre-proline 0 N--CA 1.435 -1.222 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.3 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.73 173.65 14.15 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 123.347 2.698 . . . . 0.0 112.336 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.96 138.7 42.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.616 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -119.58 -6.1 10.22 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.895 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 89.66 21.12 41.34 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -172.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.6 t -100.89 161.32 24.13 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.36 113.62 1.76 Allowed 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.732 2.288 . . . . 0.0 111.649 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 85.6 mtp -109.92 156.83 19.92 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.02 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.6 tt -126.6 142.73 42.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.92 152.39 19.66 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.579 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 48.8 t -85.15 169.89 13.43 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.649 0.738 . . . . 0.0 110.325 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.65 -32.96 16.01 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 887' ' ' ASP . . . . . 0.487 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 14.4 t70 -100.88 -38.31 8.29 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.529 -174.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 60.5 m -89.42 158.49 17.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.148 0.499 . . . . 0.0 110.255 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.64 -0.28 43.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -86.84 159.34 19.11 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.461 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -117.0 142.4 47.0 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.156 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 892' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 64.4 m-85 -114.69 171.33 7.7 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.758 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 65.2 m80 -99.12 151.93 20.43 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -54.35 -53.29 61.04 Favored Pre-proline 0 CA--C 1.553 1.094 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.65 -29.75 90.55 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.75 1.633 . . . . 0.0 113.011 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.758 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 28.5 m -70.41 -21.68 62.81 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.859 0.837 . . . . 0.0 111.901 -175.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.25 10.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.198 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 71.79 46.61 37.15 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.243 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.14 136.37 58.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 62.3 mtt -128.19 -4.92 5.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.52 156.43 30.23 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 902' ' ' ALA . . . . . 0.506 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -44.0 114.24 1.79 Allowed Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 125.206 1.566 . . . . 0.0 112.149 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.506 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 11.4 Cg_endo -57.09 177.58 0.18 Allowed 'Trans proline' 0 CA--C 1.57 2.302 0 C-N-CA 123.913 3.075 . . . . 0.0 113.066 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -46.62 -165.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 125.254 3.97 . . . . 0.0 117.937 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -63.8 37.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 127.839 2.456 . . . . 0.0 113.94 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.269 2.4 pt-20 50.08 26.99 2.3 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 126.783 2.033 . . . . 0.0 112.915 -177.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.4 tpt -61.47 145.93 50.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 170.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -44.97 126.03 5.57 Favored 'General case' 0 C--O 1.248 1.012 0 O-C-N 124.477 1.111 . . . . 0.0 113.879 -170.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -116.95 133.43 56.02 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.985 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -127.47 141.98 51.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 7.6 p -75.43 168.63 25.88 Favored Pre-proline 0 N--CA 1.421 -1.922 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.972 178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.72 -24.15 29.11 Favored 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 123.075 2.517 . . . . 0.0 111.803 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.594 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 0.0 OUTLIER -70.1 -58.5 3.74 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.98 176.767 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 87.2 m -72.91 -21.48 60.9 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.29 -20.2 65.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -82.51 -34.84 27.81 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.424 ' NZ ' ' SG ' ' A' ' 914' ' ' CYS . 22.5 mtmm -67.5 -43.18 81.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.508 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 72.0 mt -66.68 -36.18 76.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt 76.55 132.28 0.05 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.914 1.686 . . . . 0.0 111.662 174.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -84.95 -24.37 28.37 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 921' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 922' ' ' LYS . 17.0 t70 61.89 -161.74 0.29 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.665 1.186 . . . . 0.0 110.277 172.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 922' ' ' LYS . . . . . 0.444 ' H ' ' CG ' ' A' ' 921' ' ' ASP . 28.2 mtpp -85.64 63.07 7.85 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -56.44 130.49 45.1 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.865 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 40.3 m80 . . . . . 0 N--CA 1.418 -2.067 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 173.904 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.644 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 22.8 t -75.29 144.59 42.4 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -77.13 75.01 3.7 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.846 0.831 . . . . 0.0 111.881 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 66.7 mtt -119.1 -53.67 2.25 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.086 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -102.31 13.1 35.53 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.257 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 86.3 mtp -121.22 108.33 13.62 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -149.21 172.8 14.25 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.734 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -107.26 0.18 23.02 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.394 1.092 . . . . 0.0 108.269 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 42.5 t -130.79 101.08 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 112.672 -2.058 . . . . 0.0 105.483 172.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 40.0 mt -103.58 154.24 5.77 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -102.22 125.14 48.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.514 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 861' ' ' ASP . . . . . 0.501 ' HB3' ' H ' ' A' ' 865' ' ' ASN . 17.6 t70 -67.19 177.24 1.87 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.663 176.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -72.99 -25.11 60.87 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.357 0.599 . . . . 0.0 110.298 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -87.69 -12.64 44.77 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.157 0.98 . . . . 0.0 108.7 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 93.57 19.53 34.69 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.933 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.501 ' H ' ' HB3' ' A' ' 861' ' ' ASP . 63.8 m-20 -72.78 150.95 42.34 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -77.93 110.42 12.82 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 121.61 0.719 . . . . 0.0 110.696 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 46.3 mm -94.82 115.39 33.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -103.6 145.55 29.88 Favored 'General case' 0 C--N 1.255 -3.529 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.217 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.87 120.49 52.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 870' ' ' CYS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.7 t -78.59 119.66 78.12 Favored Pre-proline 0 N--CA 1.404 -2.737 0 C-N-CA 125.0 1.32 . . . . 0.0 108.316 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.4 -4.58 13.17 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.63 2.22 . . . . 0.0 111.629 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -72.02 -43.5 48.64 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 5.7 p -114.49 -24.32 8.89 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.7 t30 78.75 24.66 0.55 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.824 1.65 . . . . 0.0 108.235 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -110.25 139.63 21.63 Favored Pre-proline 0 C--O 1.244 0.783 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.983 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.81 165.52 32.53 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.182 2.588 . . . . 0.0 112.361 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.715 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 16.6 t0 -60.49 117.33 5.15 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.634 0.731 . . . . 0.0 112.375 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.81 6.42 46.87 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.661 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 105.66 40.08 2.09 Favored Glycine 0 N--CA 1.435 -1.413 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 49.1 m -123.82 159.23 56.96 Favored Pre-proline 0 N--CA 1.428 -1.549 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.14 133.62 25.3 Favored 'Trans proline' 0 C--O 1.252 1.204 0 C-N-CA 122.405 2.07 . . . . 0.0 110.896 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.411 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 64.6 mtp -123.11 163.11 21.17 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.872 -178.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 883' ' ' ILE . . . . . 0.499 ' HB ' ' HE1' ' A' ' 894' ' ' TRP . 17.6 tt -141.28 143.23 28.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.95 151.96 17.29 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.629 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 53.8 t -76.09 150.97 37.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.094 0.473 . . . . 0.0 110.481 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -82.55 -25.56 33.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.748 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 887' ' ' ASP . . . . . 0.426 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 31.3 t70 -97.33 -40.33 8.78 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.309 -0.556 . . . . 0.0 112.343 -173.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 32.0 p -98.49 -106.13 0.2 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 117.879 -1.528 . . . . 0.0 114.11 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -158.79 -41.79 0.06 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.985 -170.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.77 161.12 30.42 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -170.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -112.26 133.76 54.19 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.345 -1.752 . . . . 0.0 108.384 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -117.22 159.17 23.08 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.715 ' HE2' ' HA ' ' A' ' 877' ' ' ASP . 56.2 m80 -82.93 144.74 29.81 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.145 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.499 ' HE1' ' HB ' ' A' ' 883' ' ' ILE . 38.2 m0 -53.52 -48.95 91.17 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 177.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 895' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 28.4 Cg_endo -63.71 -13.97 40.02 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.275 1.983 . . . . 0.0 113.088 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -89.37 -26.67 20.93 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.241 0.543 . . . . 0.0 111.803 -176.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 893' ' ' HIS . 18.8 m -110.11 -4.93 10.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.443 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 83.67 48.17 5.35 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.723 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 46.1 mt -112.89 121.87 65.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.605 0.717 . . . . 0.0 111.517 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 96.2 mmm -92.7 -31.19 15.19 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.345 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.74 159.67 35.49 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 902' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -48.26 109.58 1.19 Allowed Pre-proline 0 C--N 1.323 -0.554 0 O-C-N 124.73 1.268 . . . . 0.0 111.659 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 18.8 Cg_endo -60.25 147.02 95.16 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 123.236 2.624 . . . . 0.0 112.406 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 904' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 903' ' ' PRO . 25.4 Cg_exo -63.19 136.12 54.23 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.493 2.129 . . . . 0.0 110.803 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.56 1.44 16.76 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.53 -9.62 59.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.917 0.865 . . . . 0.0 108.819 173.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 36.4 ttm -113.51 121.79 45.31 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -76.28 131.15 39.07 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -104.5 124.81 49.93 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.121 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 74.2 m-85 -124.9 142.61 51.34 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.6 p -66.95 166.2 21.17 Favored Pre-proline 0 C--N 1.294 -1.817 0 O-C-N 123.609 0.568 . . . . 0.0 111.5 -176.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 5.0 Cg_endo -49.54 -27.28 14.03 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.431 2.754 . . . . 0.0 112.509 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -82.04 -47.93 12.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.341 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.504 ' HA ' ' HE2' ' A' ' 917' ' ' LYS . 92.5 m -78.38 -32.61 48.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 915' ' ' ALA . . . . . 0.504 ' O ' ' HG2' ' A' ' 919' ' ' LYS . . . -66.1 -32.03 73.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -60.51 -35.78 76.79 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.186 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 27.3 mtmt -70.77 -18.18 62.77 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.102 0.561 . . . . 0.0 110.656 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 51.0 mt -97.24 -33.18 4.3 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 CA-C-O 121.758 0.79 . . . . 0.0 109.771 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 919' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 915' ' ' ALA . 29.3 mmmt -86.4 -31.11 21.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.687 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -83.11 135.04 34.96 Favored 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.821 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 4.4 t70 68.65 -168.12 0.18 Allowed 'General case' 0 C--N 1.32 -0.686 0 O-C-N 124.647 1.217 . . . . 0.0 109.94 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.88 -8.03 12.57 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -140.37 -172.4 3.42 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 . . . . . 0 C--N 1.297 -1.695 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.054 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.216 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 4.4 p -141.31 77.17 1.58 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.863 0.84 . . . . 0.0 111.343 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -178.29 -74.17 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.693 -1.594 . . . . 0.0 107.496 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 36.7 tpp 51.07 89.7 0.02 OUTLIER 'General case' 0 C--O 1.243 0.755 0 C-N-CA 125.286 1.435 . . . . 0.0 113.193 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -84.93 127.67 34.28 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.066 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 69.9 mtm -78.32 80.72 4.71 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.398 0.618 . . . . 0.0 109.428 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -132.54 178.73 6.61 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 67.4 27.84 7.97 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -174.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 858' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 64.4 t -138.73 121.09 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 113.316 -1.765 . . . . 0.0 108.267 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 869' ' ' ILE . 55.7 mt -127.48 148.92 32.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 860' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 860' ' ' ARG . 41.3 mtt180 -95.02 125.06 39.42 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 121.734 0.778 . . . . 0.0 110.891 174.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.93 171.73 3.32 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.629 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -60.86 -36.38 79.02 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 124.024 0.929 . . . . 0.0 110.6 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 863' ' ' TRP . . . . . 0.52 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 92.8 m95 -87.0 -10.15 53.84 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.376 0.608 . . . . 0.0 111.05 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 100.34 8.44 49.89 Favored Glycine 0 CA--C 1.5 -0.883 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.357 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 37.1 m-80 -71.79 160.94 31.72 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 866' ' ' GLN . . . . . 0.465 ' OE1' ' HA ' ' A' ' 866' ' ' GLN . 14.4 mm-40 -90.81 133.35 35.27 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 122.124 0.964 . . . . 0.0 112.159 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 45.8 mm -110.63 121.81 64.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 113.532 -1.667 . . . . 0.0 108.114 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -101.35 140.12 36.08 Favored 'General case' 0 C--N 1.271 -2.808 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.565 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 859' ' ' ILE . 36.4 mt -106.08 124.31 61.27 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 42.2 t -78.2 113.91 37.79 Favored Pre-proline 0 N--CA 1.404 -2.762 0 O-C-N 124.442 1.089 . . . . 0.0 108.743 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 871' ' ' PRO . . . . . 0.555 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 37.6 Cg_exo -61.19 -2.47 2.38 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.282 2.655 . . . . 0.0 113.309 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.06 -39.69 19.02 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.5 p -114.98 -25.81 8.0 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.349 0.66 . . . . 0.0 111.554 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 76.48 26.52 0.88 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.886 1.675 . . . . 0.0 110.085 -173.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -108.03 138.82 20.21 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.466 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 44.5 Cg_endo -72.83 170.71 19.0 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.369 2.713 . . . . 0.0 113.749 176.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -64.31 133.28 52.39 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.097 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -123.44 6.73 8.97 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.903 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 93.65 22.86 25.15 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 2.7 p -96.31 155.85 37.58 Favored Pre-proline 0 C--N 1.296 -1.722 0 C-N-CA 123.35 0.66 . . . . 0.0 110.408 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.43 118.09 4.93 Favored 'Trans proline' 0 C--O 1.257 1.456 0 C-N-CA 122.069 1.846 . . . . 0.0 111.568 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.6 mtp -113.4 162.92 15.51 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.569 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.5 tt -130.64 145.29 35.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -108.95 151.02 17.14 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 42.6 t -80.74 178.85 8.1 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.513 0.673 . . . . 0.0 110.929 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 886' ' ' ASP . . . . . 0.426 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 28.9 t70 -110.48 -18.44 13.21 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.941 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 887' ' ' ASP . . . . . 0.426 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 16.4 t70 -95.93 -46.96 6.32 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 25.4 p -101.87 -179.07 3.9 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -117.81 17.64 14.23 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.349 1.071 . . . . 0.0 109.45 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -102.62 163.35 12.27 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.184 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -112.19 141.83 45.41 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.875 0.369 . . . . 0.0 111.854 -174.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 892' ' ' TYR . . . . . 0.555 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 10.9 m-85 -120.94 169.39 10.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.712 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 56.6 m80 -96.02 150.39 20.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 118.692 0.678 . . . . 0.0 111.341 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -56.1 -53.89 58.54 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.46 -19.22 67.47 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.165 1.91 . . . . 0.0 113.799 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 45.3 m -80.84 -31.21 35.57 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.34 0.59 . . . . 0.0 111.742 -176.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.592 HG23 HG12 ' A' ' 899' ' ' ILE . 24.0 m -108.86 -22.66 4.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.824 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 104.31 55.08 0.77 Allowed Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.168 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.592 HG12 HG23 ' A' ' 897' ' ' VAL . 30.5 mm -113.06 117.78 56.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 86.9 mtp -87.72 -40.34 14.2 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -144.49 154.63 43.11 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 902' ' ' ALA . . . . . 0.454 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -54.51 110.09 1.94 Allowed Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 124.799 1.312 . . . . 0.0 112.431 -176.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 25.3 Cg_endo -66.15 152.24 81.68 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 122.516 2.144 . . . . 0.0 111.067 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.65 147.8 38.31 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.706 2.271 . . . . 0.0 112.632 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -25.14 65.62 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.928 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -77.04 -14.07 59.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.706 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 25.4 ttt -82.92 121.62 27.21 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.082 0.468 . . . . 0.0 110.934 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -80.65 127.94 33.05 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -125.84 138.9 53.84 Favored 'General case' 0 C--N 1.248 -3.811 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 84.2 m-85 -125.55 137.36 53.93 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 18.7 p -77.26 166.6 43.14 Favored Pre-proline 0 C--N 1.28 -2.421 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.344 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -49.02 -30.99 19.38 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.228 2.619 . . . . 0.0 112.465 176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.673 ' HA ' ' HE2' ' A' ' 913' ' ' LYS . 7.8 mmpt? -81.02 -42.95 20.3 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 92.4 m -78.4 -20.18 51.69 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.084 177.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -70.22 -23.24 62.9 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -79.48 -10.89 59.89 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.964 0.411 . . . . 0.0 110.539 175.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -87.31 -57.73 2.85 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 68.5 mt -66.01 -53.88 32.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 114.673 -1.148 . . . . 0.0 111.045 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm 58.63 -179.01 0.07 Allowed 'General case' 0 N--CA 1.425 -1.7 0 C-N-CA 125.898 1.679 . . . . 0.0 111.197 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -114.21 -43.58 3.21 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 21.8 t70 70.43 132.9 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.404 1.482 . . . . 0.0 113.924 173.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 36.5 tttp 71.47 148.55 0.08 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.526 1.13 . . . . 0.0 111.941 173.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 923' ' ' LYS . . . . . 0.611 ' H ' ' HD3' ' A' ' 923' ' ' LYS . 0.0 OUTLIER -89.24 71.8 8.22 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.352 1.072 . . . . 0.0 110.338 176.596 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 . . . . . 0 C--N 1.293 -1.872 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -177.744 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.056 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 11.7 p -66.51 -41.7 88.44 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 173.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -105.63 158.22 16.85 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 66.1 mtt 68.81 179.04 0.24 Allowed 'General case' 0 C--O 1.244 0.811 0 O-C-N 124.195 0.934 . . . . 0.0 109.505 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -89.69 -164.23 1.12 Allowed 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 23.9 mmt -72.48 -23.15 61.0 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -169.74 -150.66 0.08 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.75 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 857' ' ' TYR . . . . . 0.643 ' HA ' HD12 ' A' ' 869' ' ' ILE . 4.4 m-85 77.39 22.28 0.96 Allowed 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 123.124 1.44 . . . . 0.0 108.125 -171.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.2 108.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.397 -3.108 0 CA-C-N 111.493 -2.594 . . . . 0.0 106.638 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 30.9 mt -117.73 154.41 19.63 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.724 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -100.76 137.25 39.4 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.399 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.07 179.31 6.9 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.75 176.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.29 -29.89 65.59 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.946 0.403 . . . . 0.0 110.266 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -80.04 -10.9 59.8 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.821 0.819 . . . . 0.0 109.546 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.82 18.34 40.99 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -78.72 155.15 29.53 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -85.07 118.72 24.81 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.992 0.901 . . . . 0.0 110.876 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 37.0 mm -91.14 114.4 28.4 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -100.34 147.21 26.05 Favored 'General case' 0 C--N 1.264 -3.114 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.771 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.643 HD12 ' HA ' ' A' ' 857' ' ' TYR . 26.9 mt -102.19 109.24 25.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-O 121.223 0.535 . . . . 0.0 110.626 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 49.4 t -56.29 115.43 9.88 Favored Pre-proline 0 N--CA 1.438 -1.074 0 C-N-CA 126.217 1.807 . . . . 0.0 110.32 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -59.81 -13.4 22.19 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.633 2.889 . . . . 0.0 112.869 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.46 -38.06 34.16 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.212 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 9.1 p -120.99 -15.96 8.16 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 117.218 0.509 . . . . 0.0 112.25 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 72.39 21.54 3.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.315 1.446 . . . . 0.0 108.707 -176.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -101.93 141.78 23.25 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.3 177.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -73.32 158.33 48.61 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.637 2.224 . . . . 0.0 110.931 173.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.593 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 10.3 t0 -48.74 123.33 6.73 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.469 0.652 . . . . 0.0 111.696 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -90.47 6.1 44.86 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.473 -175.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 91.81 36.73 6.31 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 108.281 -1.927 . . . . 0.0 108.281 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 22.8 m -122.37 161.58 42.52 Favored Pre-proline 0 N--CA 1.418 -2.029 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.37 133.34 32.22 Favored 'Trans proline' 0 C--O 1.254 1.285 0 C-N-CA 121.576 1.517 . . . . 0.0 110.306 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.593 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 75.8 mtp -112.05 154.52 25.26 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.52 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.1 tt -124.75 138.23 54.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.14 158.52 16.75 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.57 169.56 17.86 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.366 0.603 . . . . 0.0 110.315 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -91.42 -26.03 19.06 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -98.54 -49.33 4.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.277 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 17.6 p -99.7 179.2 4.61 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.595 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -110.2 11.61 23.58 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.809 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -81.99 151.97 26.91 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.951 0.405 . . . . 0.0 111.236 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -114.45 139.18 49.74 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.951 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -119.23 162.42 18.72 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.294 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.607 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 65.4 m80 -83.45 144.14 29.78 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.401 ' N ' ' HD2' ' A' ' 895' ' ' PRO . 26.3 m0 -51.24 -49.49 81.37 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 175.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 895' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 893' ' ' HIS . 28.5 Cg_endo -63.93 -23.6 68.03 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.659 2.24 . . . . 0.0 114.053 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 61.2 m -76.81 -25.7 53.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.56 0.695 . . . . 0.0 111.563 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.793 HG23 HG12 ' A' ' 899' ' ' ILE . 9.0 m -114.14 -2.59 10.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.712 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 73.19 45.08 32.65 Favored Glycine 0 CA--C 1.504 -0.606 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.202 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.793 HG12 HG23 ' A' ' 897' ' ' VAL . 45.4 mm -80.02 -67.9 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.391 1.091 . . . . 0.0 110.457 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.9 mtt 66.63 -14.94 0.15 Allowed 'General case' 0 C--N 1.264 -3.117 0 C-N-CA 128.398 2.679 . . . . 0.0 114.74 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.11 147.13 19.31 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 902' ' ' ALA . . . . . 0.409 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -51.88 110.16 1.74 Allowed Pre-proline 0 C--O 1.239 0.517 0 O-C-N 124.491 1.119 . . . . 0.0 112.186 -175.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 904' ' ' PRO . 32.6 Cg_endo -66.01 133.14 32.31 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.908 2.405 . . . . 0.0 112.104 -177.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 904' ' ' PRO . . . . . 0.485 ' HB2' ' HG2' ' A' ' 906' ' ' GLU . 33.0 Cg_exo -63.53 140.25 74.57 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.347 2.032 . . . . 0.0 110.758 176.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.92 0.73 14.71 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.485 ' HG2' ' HB2' ' A' ' 904' ' ' PRO . 10.9 pt-20 -69.16 -19.97 64.01 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 173.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 46.9 ttp -104.12 127.34 51.7 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 115.234 -0.893 . . . . 0.0 108.919 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -83.54 140.46 32.25 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 172.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 73.0 t90 -125.42 119.95 29.68 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.525 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.47 138.63 53.7 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 30.8 p -66.39 161.84 54.54 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 123.754 0.658 . . . . 0.0 111.55 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.45 -16.12 22.22 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.207 2.605 . . . . 0.0 112.916 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.54 ' HA ' ' HE2' ' A' ' 913' ' ' LYS . 3.9 mmpt? -84.26 -48.5 9.69 Favored 'General case' 0 N--CA 1.44 -0.963 0 O-C-N 122.145 -0.347 . . . . 0.0 110.177 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.462 ' O ' HG13 ' A' ' 918' ' ' ILE . 84.7 m -68.49 -39.96 81.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.05 176.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.09 71.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.203 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -64.11 -43.65 94.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.26 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -79.62 -33.3 41.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.522 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 914' ' ' CYS . 85.4 mt -62.09 -47.39 93.37 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 174.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 919' ' ' LYS . . . . . 0.502 ' HG2' ' H ' ' A' ' 920' ' ' LYS . 44.2 tttm 57.31 -151.14 0.43 Allowed 'General case' 0 N--CA 1.418 -2.051 0 C-N-CA 125.622 1.569 . . . . 0.0 110.196 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 920' ' ' LYS . . . . . 0.502 ' H ' ' HG2' ' A' ' 919' ' ' LYS . 67.0 mttm 53.73 27.04 6.47 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 124.282 1.033 . . . . 0.0 111.833 -172.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.75 117.04 21.74 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 113.85 -1.523 . . . . 0.0 107.599 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 922' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 922' ' ' LYS . 0.9 OUTLIER -136.97 -34.84 0.72 Allowed 'General case' 0 N--CA 1.405 -2.693 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.522 -178.047 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -151.16 151.49 32.0 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.258 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 84.6 t60 . . . . . 0 C--N 1.302 -1.485 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.792 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.813 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 17.2 p -93.58 -32.49 14.1 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 122.553 -0.381 . . . . 0.0 111.571 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -116.72 -24.59 7.66 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.156 0.503 . . . . 0.0 111.692 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 48.6 tpp -104.12 27.05 8.05 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.604 0.716 . . . . 0.0 109.432 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 69.39 166.13 0.27 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.005 1.322 . . . . 0.0 112.469 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 64.4 mtt -99.29 111.45 23.82 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.132 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -164.04 -179.97 6.57 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -112.43 -7.86 13.92 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.436 0.636 . . . . 0.0 110.199 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 858' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 57.5 t -125.08 129.11 73.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.718 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 58.0 mt -125.56 144.58 35.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -92.05 117.03 29.44 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.452 175.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -71.31 176.07 4.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.72 -22.88 59.76 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.437 0.637 . . . . 0.0 109.452 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -85.99 -0.43 55.47 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.168 0.985 . . . . 0.0 108.687 173.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 75.69 16.5 80.61 Favored Glycine 0 CA--C 1.5 -0.878 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.868 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -68.35 134.01 49.61 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -82.04 81.34 8.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.51 0.672 . . . . 0.0 109.274 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 858' ' ' VAL . 46.5 mm -53.14 135.88 14.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 113.198 -1.819 . . . . 0.0 112.287 -174.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -103.07 132.63 49.18 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 124.186 0.929 . . . . 0.0 109.877 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 40.8 mt -102.43 116.96 47.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.524 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.0 111.34 3.55 Favored Pre-proline 0 N--CA 1.443 -0.806 0 C-N-CA 125.255 1.422 . . . . 0.0 110.532 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -65.31 3.73 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.851 3.034 . . . . 0.0 113.613 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -86.16 -46.03 5.44 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 14.1 p -116.4 -22.03 8.97 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.528 0.68 . . . . 0.0 110.456 -176.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.274 2.8 m-20 70.75 56.0 0.24 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 125.765 1.626 . . . . 0.0 111.563 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.3 140.01 37.13 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.151 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -74.19 173.99 13.22 Favored 'Trans proline' 0 C--O 1.257 1.427 0 C-N-CA 123.359 2.706 . . . . 0.0 112.624 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.417 ' HA ' ' SD ' ' A' ' 882' ' ' MET . 3.4 m-20 -48.51 106.11 0.09 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.744 0.818 . . . . 0.0 108.929 172.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -102.57 -15.05 16.52 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.957 0.408 . . . . 0.0 110.868 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 127.09 -21.21 5.84 Favored Glycine 0 N--CA 1.437 -1.252 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 50.0 m -70.99 157.06 91.16 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.293 -0.454 . . . . 0.0 109.807 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -65.97 137.91 50.57 Favored 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.707 2.271 . . . . 0.0 111.468 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.417 ' SD ' ' HA ' ' A' ' 877' ' ' ASP . 91.7 mtp -128.71 148.31 50.82 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.481 -175.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.5 tt -129.49 148.06 33.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -111.69 146.89 17.97 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.812 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 888' ' ' CYS . 52.8 t -70.37 155.78 40.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -86.98 -24.0 24.85 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.568 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -92.02 -45.42 8.33 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.882 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 885' ' ' CYS . 29.8 p -100.44 -178.27 3.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.485 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -112.62 14.89 20.16 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 122.712 1.244 . . . . 0.0 109.431 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.95 153.03 21.62 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.056 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 26.8 m95 -118.93 138.79 52.53 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.35 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -124.29 161.46 25.8 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.099 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.72 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 56.8 m80 -86.67 146.47 26.29 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -49.93 -53.5 42.24 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.65 -10.54 29.08 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 122.224 1.949 . . . . 0.0 113.792 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 62.4 m -87.07 -33.72 19.4 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.593 0.711 . . . . 0.0 111.023 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.582 HG23 HG12 ' A' ' 899' ' ' ILE . 19.2 m -104.75 -15.62 8.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.797 -176.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 96.0 47.36 2.46 Favored Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.855 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.582 HG12 HG23 ' A' ' 897' ' ' VAL . 48.3 mm -95.39 105.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.8 ptm -87.11 -19.5 28.44 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.234 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -170.5 151.35 3.64 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 902' ' ' ALA . . . . . 0.413 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -45.56 111.53 1.39 Allowed Pre-proline 0 C--O 1.243 0.719 0 O-C-N 124.673 1.233 . . . . 0.0 110.754 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 12.2 Cg_endo -59.86 139.13 86.73 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.903 2.402 . . . . 0.0 112.196 -177.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.52 135.7 66.41 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.839 2.359 . . . . 0.0 111.957 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.85 -21.26 64.51 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 123.388 0.675 . . . . 0.0 111.725 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -74.98 0.21 16.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.036 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 58.0 ttp -123.99 141.82 51.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -84.6 145.9 27.79 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -117.39 128.65 55.23 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.561 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -131.23 146.32 52.27 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 20.8 p -76.65 164.88 56.75 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.39 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.59 -24.11 21.62 Favored 'Trans proline' 0 CA--C 1.551 1.366 0 C-N-CA 123.355 2.703 . . . . 0.0 112.275 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -78.54 -53.8 6.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.498 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.508 ' O ' HG12 ' A' ' 918' ' ' ILE . 85.7 m -78.54 -26.72 45.78 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.72 69.93 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -74.57 -35.54 63.05 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.053 0.93 . . . . 0.0 110.066 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -71.71 -15.62 62.21 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.005 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' A' ' 919' ' ' LYS . 44.6 mm -63.97 -26.23 40.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 123.512 0.725 . . . . 0.0 111.661 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 919' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 918' ' ' ILE . 54.8 pttt 54.69 34.23 21.14 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 126.205 1.802 . . . . 0.0 111.697 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 58.8 tttm 76.51 -57.46 0.54 Allowed 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.603 1.561 . . . . 0.0 110.667 -176.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 24.5 t70 65.8 -47.43 0.4 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 124.892 1.277 . . . . 0.0 114.125 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -77.57 121.04 23.37 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -59.08 -41.09 87.2 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 123.985 0.914 . . . . 0.0 112.294 -177.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 37.1 m80 . . . . . 0 C--N 1.254 -3.568 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.154 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.449 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 19.9 m 62.09 15.23 7.19 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.038 0.935 . . . . 0.0 112.488 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 64.57 85.95 0.13 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.551 1.141 . . . . 0.0 110.38 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 54.3 ttp -73.13 -25.58 60.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.102 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 58.76 36.02 24.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.516 1.126 . . . . 0.0 111.176 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 86.0 mtp -151.87 158.71 43.59 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -110.93 -108.51 0.35 Allowed 'General case' 0 C--N 1.28 -2.417 0 C-N-CA 119.105 -1.038 . . . . 0.0 112.622 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 65.85 25.31 11.24 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.927 0.891 . . . . 0.0 110.86 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.76 121.71 66.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.333 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 51.2 mt -126.85 138.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 173.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -98.59 122.15 41.43 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.182 0.992 . . . . 0.0 112.435 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.89 173.19 1.91 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 113.185 -1.825 . . . . 0.0 109.69 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.57 -28.86 70.17 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.783 0.833 . . . . 0.0 110.884 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 863' ' ' TRP . . . . . 0.483 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 76.3 m95 -98.24 10.68 40.06 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.076 0.465 . . . . 0.0 111.317 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.46 1.69 83.31 Favored Glycine 0 CA--C 1.508 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.144 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.483 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 45.4 m-80 -65.37 137.56 57.58 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.18 126.87 33.54 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.68 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 48.7 mm -91.49 129.13 42.68 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.622 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -77.69 145.95 36.32 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.852 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 52.6 mt -129.99 128.2 64.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.84 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.5 t -72.43 117.36 58.17 Favored Pre-proline 0 N--CA 1.419 -2.015 0 C-N-CA 125.165 1.386 . . . . 0.0 108.711 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.88 -1.13 6.35 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.565 2.176 . . . . 0.0 112.817 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.93 -48.16 10.42 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.562 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 5.8 p -113.28 -19.28 11.83 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 122.684 0.394 . . . . 0.0 111.489 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.4 t30 81.01 19.79 0.44 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.475 1.51 . . . . 0.0 109.228 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -97.73 138.81 21.06 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.918 176.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.6 Cg_endo -73.88 174.21 12.71 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.34 2.693 . . . . 0.0 110.534 173.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -59.48 119.98 8.52 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.368 0.604 . . . . 0.0 109.38 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -104.26 23.92 12.34 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 76.77 51.68 6.28 Favored Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 105.654 -2.978 . . . . 0.0 105.654 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 7.7 p -125.87 159.38 61.78 Favored Pre-proline 0 N--CA 1.42 -1.943 0 CA-C-N 113.981 -1.109 . . . . 0.0 112.888 -166.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -77.22 108.13 2.56 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 121.988 1.792 . . . . 0.0 109.563 174.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 81.9 mtp -116.24 164.76 14.02 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.839 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.5 tt -133.6 134.62 56.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.69 154.73 20.7 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 53.8 t -80.81 167.84 19.48 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.444 0.64 . . . . 0.0 110.265 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -92.86 -31.63 14.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 887' ' ' ASP . . . . . 0.429 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 27.5 t70 -91.45 -36.91 13.5 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.863 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 55.7 m -97.51 168.32 10.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.65 10.99 26.84 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -94.25 175.08 6.83 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.336 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -132.03 140.14 48.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.121 0.486 . . . . 0.0 112.082 -172.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -119.22 158.33 26.21 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.219 1.008 . . . . 0.0 108.285 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.669 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 73.3 m80 -84.26 149.13 26.3 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.365 176.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 33.3 m0 -53.0 -54.52 43.2 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.53 -16.44 52.31 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.274 1.983 . . . . 0.0 113.444 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 81.8 m -81.28 -27.25 35.19 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.149 0.499 . . . . 0.0 110.85 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 893' ' ' HIS . 21.1 m -115.42 14.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.109 -176.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 71.2 35.42 64.03 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.837 -1.074 . . . . 0.0 114.231 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 57.6 mt -105.61 127.58 60.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.466 0.65 . . . . 0.0 111.024 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.7 mmt -105.17 -25.12 12.61 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.231 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -152.66 154.71 35.87 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 902' ' ' ALA . . . . . 0.5 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -49.68 112.92 2.91 Favored Pre-proline 0 C--O 1.241 0.628 0 O-C-N 124.779 1.299 . . . . 0.0 112.366 -177.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 19.3 Cg_endo -61.48 151.85 77.06 Favored 'Trans proline' 0 C--O 1.254 1.296 0 C-N-CA 122.998 2.466 . . . . 0.0 112.202 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 904' ' ' PRO . . . . . 0.496 ' HB2' ' HG2' ' A' ' 906' ' ' GLU . 9.8 Cg_endo -54.08 141.97 67.32 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.525 2.817 . . . . 0.0 112.334 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -78.71 -24.0 45.2 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.847 0.832 . . . . 0.0 108.874 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.496 ' HG2' ' HB2' ' A' ' 904' ' ' PRO . 11.4 pt-20 -71.62 -9.55 58.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.136 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 56.9 ttp -116.89 131.02 57.06 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -77.4 146.41 36.61 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -117.81 141.61 48.23 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 120.594 -0.443 . . . . 0.0 109.815 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -132.45 137.59 47.32 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 17.1 p -66.98 165.06 29.45 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 123.992 0.917 . . . . 0.0 110.102 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -56.01 -18.86 24.06 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.595 2.197 . . . . 0.0 112.045 174.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.58 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 74.9 mmtt -74.49 -48.49 26.92 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.554 ' O ' HG12 ' A' ' 918' ' ' ILE . 68.8 m -76.63 -29.77 56.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.99 -11.24 60.68 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 120.698 0.285 . . . . 0.0 110.931 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -81.04 -29.71 35.0 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 172.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 53.3 mtmt -80.52 -36.74 32.78 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.912 176.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 914' ' ' CYS . 40.1 mm -71.94 -66.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt 64.69 114.47 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 126.537 1.935 . . . . 0.0 112.187 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -68.28 82.91 0.24 Allowed 'General case' 0 C--O 1.243 0.727 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.229 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 22.8 t70 69.21 -63.63 0.36 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.843 1.657 . . . . 0.0 110.274 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -176.0 137.57 0.33 Allowed 'General case' 0 N--CA 1.425 -1.694 0 C-N-CA 126.125 1.77 . . . . 0.0 106.634 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -107.77 138.81 43.34 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 3.4 t60 . . . . . 0 C--N 1.285 -2.2 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -177.225 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.689 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 15.2 m 67.27 177.21 0.24 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.792 0.837 . . . . 0.0 111.36 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 71.25 1.51 3.86 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.816 1.247 . . . . 0.0 111.625 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 1.2 tmt? 67.75 -78.6 0.04 OUTLIER 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.678 1.591 . . . . 0.0 111.132 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 170.1 -30.51 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 126.022 1.729 . . . . 0.0 107.3 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 26.1 mmt -85.1 73.52 10.64 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.35 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -177.75 -161.14 0.05 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -90.94 11.33 23.12 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.702 0.287 . . . . 0.0 111.083 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 858' ' ' VAL . . . . . 0.419 HG13 ' HB2' ' A' ' 866' ' ' GLN . 90.9 t -134.75 118.64 26.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 37.6 mt -122.58 166.45 17.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -108.6 131.97 54.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 119.548 1.067 . . . . 0.0 109.501 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.35 175.21 8.62 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 123.697 0.799 . . . . 0.0 108.917 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -68.09 -27.95 66.93 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 123.716 0.806 . . . . 0.0 111.013 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -81.78 -15.4 54.38 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 102.3 -8.93 55.77 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.897 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -66.76 146.82 54.03 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 866' ' ' GLN . . . . . 0.419 ' HB2' HG13 ' A' ' 858' ' ' VAL . 14.0 pt20 -74.53 144.88 43.88 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 121.832 0.825 . . . . 0.0 111.502 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 39.3 mm -105.32 121.63 57.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -90.02 143.57 26.67 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 123.975 0.797 . . . . 0.0 109.425 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 40.8 mt -107.7 123.4 63.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 870' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 892' ' ' TYR . 41.6 t -75.2 114.46 35.57 Favored Pre-proline 0 N--CA 1.409 -2.486 0 O-C-N 124.593 1.183 . . . . 0.0 108.67 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.4 -1.72 6.99 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.147 2.565 . . . . 0.0 112.011 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -78.27 -40.74 18.98 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 6.9 p -118.38 -15.37 9.7 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 57.8 t30 71.49 32.41 2.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.417 1.087 . . . . 0.0 108.285 -175.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -116.0 140.43 26.27 Favored Pre-proline 0 C--O 1.241 0.636 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.639 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 40.2 Cg_endo -72.47 167.27 27.46 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 123.317 2.678 . . . . 0.0 112.699 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.48 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 21.7 t70 -65.84 138.42 57.88 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.239 172.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -124.52 33.41 5.25 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 74.82 47.38 14.58 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 107.487 -2.245 . . . . 0.0 107.487 -173.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 880' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 881' ' ' PRO . 6.2 p -120.45 149.32 49.67 Favored Pre-proline 0 N--CA 1.423 -1.807 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.027 -171.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 880' ' ' SER . 22.9 Cg_exo -64.89 126.25 16.23 Favored 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 122.037 1.825 . . . . 0.0 110.384 175.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.48 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 88.9 mtp -128.3 157.79 39.97 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.869 -177.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.69 138.07 52.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -105.46 155.09 17.04 Favored Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 888' ' ' CYS . 1.7 p -74.04 135.74 43.07 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.801 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.9 -48.94 72.39 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.699 -174.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 887' ' ' ASP . . . . . 0.591 ' HB2' ' CE1' ' A' ' 910' ' ' PHE . 14.9 t70 -80.65 -49.41 11.27 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-O 122.704 1.24 . . . . 0.0 109.12 -175.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.872 ' HB2' ' SG ' ' A' ' 885' ' ' CYS . 0.0 OUTLIER -73.6 -103.73 0.01 OUTLIER 'General case' 0 N--CA 1.38 -3.95 0 N-CA-C 118.929 2.937 . . . . 0.0 118.929 -162.69 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -178.3 -25.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -166.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 890' ' ' ASP . . . . . 0.436 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 22.7 m-20 -90.93 173.46 7.96 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.45 0.643 . . . . 0.0 111.94 -170.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -132.81 127.39 34.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.116 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 892' ' ' TYR . . . . . 0.428 ' HA ' ' SG ' ' A' ' 870' ' ' CYS . 82.6 m-85 -122.67 162.51 21.82 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.672 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 54.6 m80 -84.17 151.76 24.67 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.457 ' CG ' ' HB ' ' A' ' 899' ' ' ILE . 25.9 m0 -53.12 -56.37 24.53 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.52 -13.62 40.75 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.206 1.938 . . . . 0.0 114.043 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 76.5 m -77.75 -40.86 39.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.492 0.663 . . . . 0.0 111.109 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.535 HG23 HG12 ' A' ' 899' ' ' ILE . 27.1 m -99.57 -26.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.669 -175.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 110.17 35.42 2.14 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.214 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.535 HG12 HG23 ' A' ' 897' ' ' VAL . 42.2 mm -90.16 106.73 17.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 91.3 mmm -91.93 -25.64 18.8 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.244 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -151.74 147.84 27.18 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -57.57 114.36 8.17 Favored Pre-proline 0 C--N 1.319 -0.718 0 O-C-N 124.415 1.072 . . . . 0.0 111.891 -176.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 904' ' ' PRO . 42.3 Cg_endo -71.92 146.68 48.01 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.905 2.403 . . . . 0.0 111.028 177.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 904' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 903' ' ' PRO . 32.4 Cg_exo -60.61 124.02 14.2 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.974 1.782 . . . . 0.0 110.793 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.34 -3.18 19.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.528 -175.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -74.99 -16.31 60.63 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.479 0.657 . . . . 0.0 109.609 173.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 16.9 tpt -98.7 152.22 19.89 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -91.36 141.99 28.17 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -127.81 125.09 39.16 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.403 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 887' ' ' ASP . 22.0 m-85 -118.16 147.04 43.73 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 885' ' ' CYS 0.254 1.8 p -80.49 164.58 51.02 Favored Pre-proline 0 C--N 1.271 -2.839 0 C-N-CA 124.478 1.111 . . . . 0.0 111.176 -174.728 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.56 -12.86 30.12 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.685 2.257 . . . . 0.0 112.296 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 32.4 mmtp -88.21 -62.11 1.56 Allowed 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.443 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 888' ' ' CYS . 96.3 m -74.35 -27.76 60.82 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -175.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 915' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -72.55 -25.95 61.56 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.322 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 920' ' ' LYS . 65.6 t30 -89.47 -4.55 57.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.754 0.788 . . . . 0.0 110.164 -177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 913' ' ' LYS . 35.8 mmtp -83.69 -47.64 10.99 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 171.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.2 -59.42 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.227 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -98.49 71.82 2.03 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 920' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 916' ' ' ASN . 0.5 OUTLIER -67.64 -60.61 2.4 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.925 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 921' ' ' ASP . . . . . 0.422 ' OD1' ' HG3' ' A' ' 920' ' ' LYS . 9.2 m-20 -136.34 -0.27 2.46 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.732 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -175.89 153.72 1.4 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -100.21 147.8 25.32 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 57.4 m80 . . . . . 0 C--N 1.311 -1.104 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.388 179.181 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.758 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 18.1 m -61.36 -41.77 97.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.484 0.659 . . . . 0.0 109.928 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -134.73 158.36 44.32 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 853' ' ' MET . . . . . 0.427 ' O ' HG23 ' A' ' 859' ' ' ILE . 15.3 tpt -138.81 -79.81 0.33 Allowed 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.359 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -148.96 140.78 23.64 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.828 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 8.8 tmm? -78.28 -41.53 33.68 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -174.69 -77.54 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.088 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -112.86 12.36 19.44 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.23 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.68 128.17 74.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.17 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 46.9 mt -126.0 166.02 22.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 177.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -116.58 140.71 49.08 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.93 -168.06 1.65 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.176 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.53 -34.02 77.28 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.006 0.922 . . . . 0.0 110.714 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -87.35 -33.51 19.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.783 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 122.57 16.64 3.72 Favored Glycine 0 C--N 1.308 -1.015 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.204 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -83.52 151.18 25.54 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -79.31 135.77 36.83 Favored 'General case' 0 N--CA 1.396 -3.133 0 CA-C-O 122.02 0.914 . . . . 0.0 110.181 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 27.4 mm -103.34 129.56 55.03 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.05 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.887 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -92.67 142.71 27.07 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.898 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 39.8 mt -111.41 122.92 66.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.113 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.5 t -65.66 112.53 8.9 Favored Pre-proline 0 N--CA 1.431 -1.404 0 C-N-CA 124.769 1.228 . . . . 0.0 108.817 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.69 -5.18 8.28 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.713 2.942 . . . . 0.0 112.961 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.95 -39.2 28.64 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 121.119 -0.562 . . . . 0.0 111.967 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 9.6 p -124.44 -10.32 7.44 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 122.79 0.436 . . . . 0.0 111.629 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.336 9.5 p30 60.12 32.39 20.93 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 126.022 1.729 . . . . 0.0 112.258 -172.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -103.59 138.96 19.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.095 173.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.9 Cg_endo -74.08 171.09 18.65 Favored 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 123.38 2.72 . . . . 0.0 113.888 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.92 145.24 42.8 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.551 174.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -115.83 -0.62 12.82 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 99.92 39.54 3.32 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 107.341 -2.304 . . . . 0.0 107.341 -172.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 14.3 m -106.44 168.67 7.81 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 114.607 -0.797 . . . . 0.0 110.527 -171.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -74.51 115.62 4.36 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 121.316 1.344 . . . . 0.0 108.901 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 83.4 mtp -122.57 162.3 22.09 Favored 'General case' 0 N--CA 1.407 -2.605 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 883' ' ' ILE . . . . . 0.556 ' HB ' ' HE1' ' A' ' 894' ' ' TRP . 18.0 tt -122.31 133.44 68.57 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-O 120.713 0.292 . . . . 0.0 110.44 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.08 143.77 16.87 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 52.7 t -71.94 167.95 19.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.551 0.691 . . . . 0.0 110.272 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 886' ' ' ASP . . . . . 0.421 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 24.6 t70 -84.97 -26.29 27.23 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 174.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -95.36 -47.96 6.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.119 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 10.1 m -83.79 146.63 28.04 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.97 17.12 23.12 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.279 1.038 . . . . 0.0 108.51 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -108.77 168.4 9.37 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.383 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -115.43 150.44 36.43 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -168.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -123.37 149.68 44.65 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.691 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 44.2 m80 -75.42 142.06 43.1 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.186 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.556 ' HE1' ' HB ' ' A' ' 883' ' ' ILE . 21.1 m0 -55.85 -49.47 92.76 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 895' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 20.3 Cg_endo -61.47 -19.08 63.04 Favored 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 122.154 1.903 . . . . 0.0 113.105 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.691 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 74.0 m -83.41 -21.22 33.06 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.401 0.62 . . . . 0.0 111.519 -177.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 893' ' ' HIS . 15.9 m -118.43 12.58 7.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.877 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 62.49 48.8 79.26 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.097 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 57.7 mt -118.59 136.58 55.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 122.582 -0.364 . . . . 0.0 111.108 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 61.5 mtt -121.9 -11.6 8.52 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.229 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 901' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -156.54 137.29 13.33 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -50.77 100.78 0.24 Allowed Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 125.263 1.425 . . . . 0.0 113.686 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 14.4 Cg_endo -102.93 140.0 0.15 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.715 2.943 . . . . 0.0 116.46 -177.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -95.79 154.47 1.49 Allowed 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 122.779 2.319 . . . . 0.0 107.811 163.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -87.24 -28.67 22.21 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 118.239 -1.385 . . . . 0.0 111.708 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 149.99 -15.82 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 129.464 3.106 . . . . 0.0 103.801 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 53.0 ttm -134.41 170.82 15.17 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -53.07 169.09 0.11 Allowed 'General case' 0 C--N 1.31 -1.12 0 O-C-N 124.082 0.864 . . . . 0.0 111.388 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -100.4 131.67 46.2 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.191 -173.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 84.9 m-85 -126.83 139.33 53.18 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 15.5 p -70.26 167.43 25.84 Favored Pre-proline 0 N--CA 1.426 -1.644 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.787 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.84 -20.64 18.15 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 123.08 2.52 . . . . 0.0 111.886 173.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.519 ' HA ' ' HE2' ' A' ' 913' ' ' LYS . 8.9 mmpt? -81.03 -51.47 8.46 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.21 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.495 ' O ' HG12 ' A' ' 918' ' ' ILE . 91.4 m -75.08 -29.66 60.73 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.7 66.31 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.19 0.519 . . . . 0.0 110.334 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -68.37 -28.79 67.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.354 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -79.15 -39.13 34.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.891 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 914' ' ' CYS . 47.8 mm -62.57 -46.93 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.232 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -79.57 175.38 10.66 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.397 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -119.52 120.76 37.7 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.4 -44.3 21.71 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -141.85 -42.66 0.35 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.639 -1.619 . . . . 0.0 106.65 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -150.99 -158.3 0.9 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 173.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 . . . . . 0 C--N 1.299 -1.6 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 171.789 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . 0.523 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 55.1 m-85 . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 122.103 0.954 . . . . 0.0 109.13 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 51.5 t -136.68 114.3 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.225 -174.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 39.5 mt -124.69 154.61 32.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -98.83 134.7 41.34 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.53 0.681 . . . . 0.0 110.076 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -71.93 172.23 10.33 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.962 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -63.12 -34.65 78.07 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 123.207 0.603 . . . . 0.0 110.468 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -88.67 -14.4 37.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.895 0.855 . . . . 0.0 108.994 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 105.31 10.51 31.48 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.077 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -68.96 164.0 23.27 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -88.36 121.06 30.32 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.632 0.73 . . . . 0.0 110.89 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 39.2 mm -91.51 112.45 25.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 173.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -88.47 130.84 35.1 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.424 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 32.8 mt -100.51 104.13 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.398 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 44.7 t -54.73 112.42 4.0 Favored Pre-proline 0 N--CA 1.429 -1.519 0 CA-C-N 113.734 -1.575 . . . . 0.0 108.997 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -71.93 3.58 3.79 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.005 1.803 . . . . 0.0 112.216 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -83.74 -36.67 13.16 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 22.3 p -114.97 -27.75 7.26 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 122.507 -0.408 . . . . 0.0 111.122 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 82.29 24.0 0.2 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.298 1.839 . . . . 0.0 110.309 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.561 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 41.2 mttm -102.86 144.43 28.6 Favored Pre-proline 0 N--CA 1.467 0.408 0 C-N-CA 123.393 0.677 . . . . 0.0 111.255 174.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.407 ' HB3' HG12 ' A' ' 869' ' ' ILE . 56.4 Cg_endo -80.42 174.09 11.66 Favored 'Trans proline' 0 C--O 1.242 0.683 0 C-N-CA 123.094 2.53 . . . . 0.0 108.479 167.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . 0.511 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 15.4 t70 -69.31 102.11 1.66 Allowed 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.222 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -94.97 5.06 52.99 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.438 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 119.31 55.81 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 17.7 m -134.25 163.1 53.59 Favored Pre-proline 0 N--CA 1.417 -2.108 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -75.3 137.67 21.35 Favored 'Trans proline' 0 C--O 1.264 1.777 0 C-N-CA 122.459 2.106 . . . . 0.0 108.581 172.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.511 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 58.1 mtp -117.03 152.78 33.93 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.961 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.9 tt -134.41 134.2 54.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -99.21 160.31 19.95 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.737 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.87 166.74 15.76 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.573 0.702 . . . . 0.0 110.869 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -92.88 -22.77 19.06 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.631 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -101.55 -37.64 8.31 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.246 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . 0.25 16.2 p -103.21 169.64 8.43 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.961 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.2 -21.04 19.31 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.503 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -87.1 163.59 16.91 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.897 -171.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -110.2 142.6 41.53 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.503 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -112.79 -178.05 3.29 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 125.014 1.326 . . . . 0.0 108.468 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.864 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 59.2 m80 -110.84 160.26 16.92 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -60.17 -54.1 58.55 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.24 -26.59 77.6 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 122.281 1.987 . . . . 0.0 114.071 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.864 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 5.8 m -69.31 -36.81 77.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.947 0.88 . . . . 0.0 111.772 -176.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.498 HG23 HG12 ' A' ' 899' ' ' ILE . 28.2 m -107.11 -17.87 7.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.36 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 93.3 48.94 2.7 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 121.224 -0.512 . . . . 0.0 113.139 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.498 HG12 HG23 ' A' ' 897' ' ' VAL . 44.0 mm -88.56 125.17 41.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 69.1 mtm -91.65 -37.26 13.16 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.127 0.489 . . . . 0.0 109.69 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -156.61 158.93 37.94 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . 0.419 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -55.2 113.81 6.1 Favored Pre-proline 0 C--N 1.32 -0.717 0 O-C-N 124.093 0.871 . . . . 0.0 111.984 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 46.3 Cg_endo . . . . . 0 CA--C 1.548 1.181 0 C-N-CA 123.346 2.698 . . . . 0.0 112.724 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 . . . . . 0 N--CA 1.418 -2.05 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -106.45 132.17 52.78 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -127.97 137.35 52.21 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 5.8 p -69.82 168.45 17.57 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 123.996 0.918 . . . . 0.0 109.695 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.24 -20.3 10.87 Favored 'Trans proline' 0 CA--C 1.552 1.409 0 C-N-CA 123.195 2.597 . . . . 0.0 112.429 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -79.29 -56.27 4.47 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.478 0.711 . . . . 0.0 109.195 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 71.5 m -79.03 -17.51 55.16 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 918' ' ' ILE . . . -67.06 -31.22 71.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.334 1.064 . . . . 0.0 108.645 172.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -73.42 -22.99 60.07 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.45 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -74.49 -36.59 63.27 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 172.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 915' ' ' ALA . 50.5 mm . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 172.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . 0.487 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 88.7 m-85 . . . . . 0 C--O 1.244 0.798 0 CA-C-O 120.792 0.329 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 90.9 t -132.56 116.83 29.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.855 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 35.2 mt -120.2 157.26 22.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -102.01 131.64 48.32 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.035 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.77 173.5 8.11 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.853 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.95 -37.78 80.52 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.767 0.827 . . . . 0.0 111.143 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.498 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 75.9 m95 -91.15 1.45 57.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.557 0.694 . . . . 0.0 110.626 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.08 14.19 56.51 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.761 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 58.8 m-80 -73.84 155.65 38.57 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.73 113.17 24.01 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.678 0.751 . . . . 0.0 112.006 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 37.1 mm -80.41 118.47 28.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 175.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -92.16 138.22 31.71 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.329 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 33.5 mt -104.07 127.34 58.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.646 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 42.9 t -79.38 112.82 31.58 Favored Pre-proline 0 N--CA 1.423 -1.815 0 C-N-CA 124.348 1.059 . . . . 0.0 108.719 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . 0.411 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 31.9 Cg_exo -60.79 -6.06 5.43 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 123.883 3.056 . . . . 0.0 113.664 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -85.53 -23.5 46.84 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.785 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 18.9 p -123.92 -33.89 3.07 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 82.5 21.86 0.23 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.943 1.697 . . . . 0.0 109.706 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -103.66 139.52 20.19 Favored Pre-proline 0 C--O 1.25 1.107 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.934 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.408 ' HA ' HG12 ' A' ' 869' ' ' ILE . 38.0 Cg_endo -73.59 153.93 49.54 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.845 2.363 . . . . 0.0 110.644 173.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 29.2 t70 -79.53 146.17 32.79 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.139 0.495 . . . . 0.0 111.845 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -108.79 -0.62 19.82 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.247 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . 0.416 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 106.13 51.78 0.81 Allowed Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -172.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 1.3 m -109.02 164.35 14.91 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.04 114.92 3.36 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 121.745 1.63 . . . . 0.0 108.886 172.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 68.7 mtp -115.06 167.58 10.69 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.2 tt -132.22 143.83 38.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -101.23 147.15 17.63 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 43.7 t -80.34 170.67 16.08 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.022 0.529 . . . . 0.0 110.009 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . 0.441 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 26.8 t70 -88.99 -24.83 22.29 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -100.67 -31.8 11.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.323 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 22.4 m -104.71 149.09 25.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -92.45 -9.99 39.53 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.57 150.43 49.0 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.844 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -101.29 135.44 42.77 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.786 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . 0.411 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 45.2 m-85 -115.85 150.73 36.54 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.656 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 43.2 m80 -79.11 139.94 37.94 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.916 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 31.4 m0 -52.34 -52.03 66.84 Favored Pre-proline 0 CA--C 1.551 1.014 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.59 -9.3 22.08 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.951 1.767 . . . . 0.0 113.309 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.656 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -93.52 -17.84 22.94 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.453 0.644 . . . . 0.0 111.074 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 893' ' ' HIS . 31.5 m -118.48 7.67 6.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.927 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 70.72 37.61 66.92 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.723 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 49.0 mt -108.48 124.28 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-O 121.73 0.776 . . . . 0.0 110.848 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -105.0 -21.15 13.33 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.518 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -155.76 146.9 22.47 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -55.8 114.95 8.34 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 124.848 1.343 . . . . 0.0 112.133 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 N--CA 1.454 -0.818 0 C-N-CA 121.966 1.778 . . . . 0.0 109.784 173.883 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 92.9 t90 -134.35 138.09 44.64 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.697 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 97.5 m-85 -135.56 136.36 41.06 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 11.5 p -62.55 165.7 8.76 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 124.081 0.952 . . . . 0.0 110.24 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.424 ' CD ' HG12 ' A' ' 897' ' ' VAL . 11.5 Cg_endo -57.15 -10.26 5.83 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.014 2.476 . . . . 0.0 112.291 175.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 28.9 mmmt -83.28 -54.11 5.25 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 72.0 m -81.49 -21.37 38.72 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.32 -27.55 67.99 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -78.5 -5.39 52.46 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.635 0.731 . . . . 0.0 110.273 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -83.82 -34.97 24.57 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 68.9 mt . . . . . 0 C--N 1.308 -1.21 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.3 -179.55 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . 0.475 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 43.9 m-85 . . . . . 0 N--CA 1.424 -1.774 0 CA-C-O 122.296 1.046 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.32 115.57 18.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 113.902 -1.499 . . . . 0.0 107.516 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 56.5 mt -108.1 152.21 9.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -108.09 135.09 50.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.09 174.09 11.92 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.261 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.81 -24.42 63.47 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.247 0.546 . . . . 0.0 111.029 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -88.26 4.87 44.3 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.333 0.587 . . . . 0.0 110.412 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 74.73 22.06 77.66 Favored Glycine 0 CA--C 1.502 -0.738 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.598 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -86.21 154.57 21.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -86.67 130.69 34.39 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.796 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 41.6 mm -103.14 105.61 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.744 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.2 m-90 -83.95 136.86 33.91 Favored 'General case' 0 C--N 1.252 -3.639 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.609 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.494 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 53.3 mt -102.71 129.0 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.348 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.453 ' HG ' ' HD2' ' A' ' 892' ' ' TYR . 43.6 t -80.65 109.13 11.85 Favored Pre-proline 0 N--CA 1.416 -2.162 0 C-N-CA 125.612 1.565 . . . . 0.0 107.387 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 32.5 Cg_exo -62.17 -0.81 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.335 2.69 . . . . 0.0 113.624 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.81 -49.04 9.25 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 3.9 p -107.74 -20.22 13.29 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 122.593 0.357 . . . . 0.0 111.113 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 78.68 23.05 0.64 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.745 1.618 . . . . 0.0 108.786 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -101.16 141.97 23.69 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.566 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 36.3 Cg_endo -73.93 174.15 12.84 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.661 2.241 . . . . 0.0 109.226 170.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -60.8 109.78 1.14 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.835 0.826 . . . . 0.0 110.501 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -101.67 13.71 34.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.292 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 102.82 49.1 1.2 Allowed Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 21.2 m -130.03 157.01 78.28 Favored Pre-proline 0 N--CA 1.412 -2.369 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.18 135.32 16.84 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 121.973 1.782 . . . . 0.0 108.447 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 65.0 mtp -115.71 142.32 46.91 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.696 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.5 tt -123.05 136.42 59.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -119.59 152.26 17.21 Favored Glycine 0 CA--C 1.483 -1.926 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.734 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.543 ' HB3' ' O ' ' A' ' 888' ' ' CYS . 42.3 t -58.62 160.1 5.89 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.651 0.78 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -88.11 -27.25 22.04 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.54 -39.59 18.61 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.675 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 885' ' ' CYS . 8.5 p -138.17 167.12 22.49 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.031 0.444 . . . . 0.0 110.981 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -90.04 68.33 7.19 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.799 0.809 . . . . 0.0 109.755 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -112.02 97.47 6.69 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.7 -2.334 . . . . 0.0 104.7 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -96.39 128.78 43.63 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.439 -171.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . 0.485 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 36.5 m-85 -122.55 169.3 11.16 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.744 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.578 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.5 m80 -89.36 149.79 22.85 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.087 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -49.6 -56.33 17.4 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.44 -11.16 29.07 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.324 2.016 . . . . 0.0 113.94 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 62.8 m -89.18 -29.8 19.04 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.569 HG23 HG12 ' A' ' 899' ' ' ILE . 17.2 m -113.45 3.55 8.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -175.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.06 5.73 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.576 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.569 HG12 HG23 ' A' ' 897' ' ' VAL . 24.5 mm -105.15 114.6 45.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 90.2 mmm -95.61 -21.86 17.97 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.324 0.583 . . . . 0.0 110.204 -177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -165.52 163.07 19.52 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . 0.415 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -45.81 111.57 1.44 Allowed Pre-proline 0 C--O 1.241 0.609 0 O-C-N 124.579 1.174 . . . . 0.0 111.419 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 29.9 Cg_endo . . . . . 0 C--O 1.243 0.736 0 C-N-CA 122.873 2.382 . . . . 0.0 111.396 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 . . . . . 0 N--CA 1.427 -1.605 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -129.1 139.17 52.09 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -130.26 147.04 51.94 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 20.0 p -61.06 160.04 24.11 Favored Pre-proline 0 C--N 1.317 -0.806 0 O-C-N 123.871 0.732 . . . . 0.0 110.388 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.16 -15.13 13.45 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.863 2.375 . . . . 0.0 112.604 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 18.4 mtmm -82.3 -50.93 8.4 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.81 -31.52 66.64 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.74 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -65.8 -25.52 67.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.114 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.21 -37.41 57.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.48 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -60.16 -44.08 95.27 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 74.4 mt . . . . . 0 N--CA 1.447 -0.596 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.713 179.444 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 . . . . . 0 CA--C 1.505 -0.78 0 CA-C-O 121.375 0.607 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 59.1 t -111.05 106.69 21.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 34.6 mt -108.67 131.67 58.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -85.4 117.9 24.6 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -69.11 177.54 2.66 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.36 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -66.82 -30.91 71.22 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 124.686 1.194 . . . . 0.0 109.941 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.613 ' HB3' ' ND2' ' A' ' 865' ' ' ASN . 72.5 t-105 -89.14 -3.19 58.71 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.899 0.856 . . . . 0.0 109.024 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.32 9.98 71.88 Favored Glycine 0 CA--C 1.502 -0.762 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.496 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.613 ' ND2' ' HB3' ' A' ' 863' ' ' TRP . 47.9 m-80 -62.2 148.89 43.23 Favored 'General case' 0 C--O 1.249 1.027 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -85.89 101.36 12.79 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.997 0.903 . . . . 0.0 109.774 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 49.8 mm -89.54 115.22 28.78 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.593 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -103.08 126.32 50.2 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.526 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.512 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 27.6 mt -87.87 124.32 40.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.36 106.5 4.69 Favored Pre-proline 0 N--CA 1.415 -2.191 0 C-N-CA 125.325 1.45 . . . . 0.0 107.412 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 21.6 Cg_exo -67.39 13.6 0.16 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.665 2.91 . . . . 0.0 113.247 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -92.25 -40.21 5.19 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 174.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 11.0 p -111.96 -25.55 9.34 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.084 0.469 . . . . 0.0 110.325 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 79.9 18.66 0.67 Allowed 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.459 1.904 . . . . 0.0 110.916 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -94.74 138.51 22.19 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.491 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 40.5 Cg_endo -72.52 148.4 47.89 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.159 2.572 . . . . 0.0 111.695 174.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.28 141.15 54.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -85.93 -34.1 21.0 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.512 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 127.83 46.46 0.19 Allowed Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 106.336 -2.706 . . . . 0.0 106.336 -171.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 20.9 p -114.11 165.41 13.7 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 114.387 -0.907 . . . . 0.0 109.697 -173.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.76 124.13 13.97 Favored 'Trans proline' 0 C--O 1.255 1.353 0 C-N-CA 122.082 1.855 . . . . 0.0 111.442 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.8 mtp -124.66 161.72 25.68 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.862 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.8 tt -130.68 138.06 54.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -108.36 152.32 16.98 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.965 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 47.4 t -77.84 167.28 21.77 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.378 0.609 . . . . 0.0 110.363 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -104.41 -23.09 13.22 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.127 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -84.94 -40.9 16.44 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.434 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.7 p -105.55 -95.06 0.35 Allowed 'General case' 0 N--CA 1.427 -1.577 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.468 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 37.3 t70 174.62 -20.46 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.022 0.929 . . . . 0.0 109.778 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -55.69 141.94 36.1 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -176.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -104.1 131.64 51.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.518 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 911' ' ' CYS . 10.6 m-85 -117.74 155.43 30.01 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.167 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.661 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 36.6 m80 -80.93 143.29 32.74 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.406 ' N ' ' HD2' ' A' ' 895' ' ' PRO . 29.2 m0 -52.59 -51.7 70.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 30.4 Cg_endo -61.2 -20.35 67.58 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.321 2.014 . . . . 0.0 113.405 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 61.6 m -80.47 -26.01 38.51 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.088 0.47 . . . . 0.0 111.641 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 11.8 m -114.0 8.25 7.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.449 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 73.04 48.79 18.83 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.7 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 58.6 mt -119.85 133.7 65.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 122.636 -0.332 . . . . 0.0 110.619 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.3 ptp -128.37 -2.88 5.57 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.265 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -164.39 130.62 2.98 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -44.64 96.35 0.11 Allowed Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 127.002 2.121 . . . . 0.0 113.83 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.556 1.58 0 C-N-CA 123.553 2.835 . . . . 0.0 116.346 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 . . . . . 0 C--O 1.242 0.669 0 CA-C-O 121.152 0.501 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -107.98 124.37 50.06 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.582 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.37 145.94 46.66 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 892' ' ' TYR . 27.3 p -66.18 163.55 37.59 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.769 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.55 -23.65 26.07 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.695 2.263 . . . . 0.0 111.904 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -79.17 -50.87 10.3 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.721 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.463 ' HA ' ' HE2' ' A' ' 917' ' ' LYS . 98.0 m -82.89 -25.2 32.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.49 65.39 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -74.36 -19.6 60.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.256 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 49.2 mtmt -86.1 -30.56 22.46 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 46.3 mm . . . . . 0 C--N 1.33 -0.274 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 176.632 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 CA--C 1.513 -0.465 0 CA-C-O 121.591 0.71 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 44.4 t -135.04 118.12 23.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.2 mt -131.92 165.39 32.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -117.91 147.93 42.64 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . 0.437 ' HB3' HD11 ' A' ' 867' ' ' ILE . 0.9 OUTLIER -85.42 -175.82 5.85 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.08 -27.53 67.44 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.796 0.331 . . . . 0.0 111.828 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -78.04 -48.16 16.76 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.977 0.418 . . . . 0.0 110.208 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 129.34 28.04 0.79 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.968 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -88.05 155.93 19.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -83.08 130.04 35.08 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-O 121.328 0.585 . . . . 0.0 109.455 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' A' ' 861' ' ' ASP . 50.7 mm -92.43 102.83 13.99 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 -75.51 114.34 13.96 Favored 'General case' 0 C--N 1.267 -2.997 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.436 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 50.1 mt -98.52 113.03 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.474 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 43.4 t -63.46 112.94 8.1 Favored Pre-proline 0 N--CA 1.422 -1.872 0 O-C-N 124.784 1.303 . . . . 0.0 109.068 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . 0.503 ' HD2' ' CE1' ' A' ' 892' ' ' TYR . 53.1 Cg_exo -58.82 -15.94 29.1 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.631 2.887 . . . . 0.0 113.098 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -70.59 -43.52 60.38 Favored Glycine 0 N--CA 1.433 -1.504 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.927 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 7.4 p -109.0 -26.51 10.15 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.952 0.406 . . . . 0.0 110.653 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 13.9 m120 77.95 25.02 0.67 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.772 1.629 . . . . 0.0 109.507 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.76 139.51 20.94 Favored Pre-proline 0 C--O 1.247 0.936 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.324 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 37.8 Cg_endo -71.43 173.86 11.76 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 123.649 2.899 . . . . 0.0 112.931 176.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.81 112.42 1.64 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.595 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -103.22 -6.56 21.98 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.926 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 117.97 -17.82 11.67 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.07 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 64.2 m -68.17 156.27 90.31 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-N 116.674 0.237 . . . . 0.0 110.773 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.16 133.71 36.47 Favored 'Trans proline' 0 C--O 1.253 1.26 0 C-N-CA 122.785 2.323 . . . . 0.0 111.784 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.0 mtp -119.0 154.43 33.08 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.1 tt -124.61 145.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -102.98 155.21 18.2 Favored Glycine 0 C--O 1.248 0.999 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 886' ' ' ASP . 43.4 t -79.96 175.12 10.92 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.739 0.78 . . . . 0.0 110.749 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . 0.413 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 19.2 t70 -99.04 -24.47 14.89 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . 0.431 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 10.6 t70 -91.85 -39.08 11.94 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.571 0.7 . . . . 0.0 109.623 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 5.3 p -120.04 172.42 7.76 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.208 0.528 . . . . 0.0 112.371 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -104.26 11.22 35.13 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.926 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -80.17 149.86 30.36 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.226 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -110.83 134.47 52.49 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.902 0.382 . . . . 0.0 111.879 -173.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . 0.503 ' CE1' ' HD2' ' A' ' 871' ' ' PRO . 90.5 m-85 -123.58 147.89 46.87 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.761 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 53.6 m80 -76.47 145.01 39.5 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.413 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 35.9 m0 -54.58 -51.85 74.95 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 174.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 33.3 Cg_endo -63.36 -12.53 31.01 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.525 2.15 . . . . 0.0 113.162 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.761 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 73.6 m -85.34 -29.91 24.11 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.199 0.524 . . . . 0.0 110.834 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 16.7 m -107.89 -4.6 10.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.469 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 86.31 32.69 15.93 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.566 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 52.1 mt -98.28 123.92 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-O 121.365 0.602 . . . . 0.0 109.93 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -106.7 -19.78 13.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.073 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -151.83 150.47 30.16 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . 0.406 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -53.97 111.48 2.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.653 1.221 . . . . 0.0 111.385 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 40.1 Cg_endo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.489 2.126 . . . . 0.0 110.816 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 . . . . . 0 N--CA 1.439 -1.009 0 CA-C-O 121.223 0.535 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -139.76 131.84 27.97 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -125.13 140.53 52.79 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 24.8 p -71.33 164.57 56.23 Favored Pre-proline 0 N--CA 1.424 -1.745 0 O-C-N 123.855 0.722 . . . . 0.0 110.524 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -59.92 -9.97 11.12 Favored 'Trans proline' 0 CA--C 1.552 1.409 0 C-N-CA 122.895 2.397 . . . . 0.0 112.704 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 913' ' ' LYS . 72.8 mmtt -87.26 -46.32 9.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 122.252 -0.28 . . . . 0.0 110.289 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 92.2 m -76.4 -27.81 56.45 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.218 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -68.77 -24.73 64.47 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.437 0.637 . . . . 0.0 109.67 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -68.37 -37.69 80.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -60.94 -38.43 85.8 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.432 0.634 . . . . 0.0 109.845 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 50.4 mm . . . . . 0 C--N 1.317 -0.846 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.415 -178.874 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . 0.542 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 65.0 m-85 . . . . . 0 CA--C 1.505 -0.776 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.57 128.59 60.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 45.3 mt -137.13 162.26 34.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 860' ' ' ARG . 54.1 mtt180 -102.89 140.78 36.71 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 119.071 0.85 . . . . 0.0 110.966 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -76.71 173.67 11.35 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.681 173.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -70.66 -26.76 63.59 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.546 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 96.2 m95 -88.61 -6.57 57.44 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.193 0.521 . . . . 0.0 109.926 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 94.32 13.71 53.27 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.942 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.546 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 51.6 m-80 -72.9 158.88 34.65 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -91.72 127.99 37.39 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 121.982 0.896 . . . . 0.0 111.726 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 46.3 mm -99.62 125.96 53.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.592 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -108.08 152.71 24.15 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.542 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 31.9 mt -112.69 133.0 59.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 O-C-N 123.579 0.55 . . . . 0.0 109.823 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 45.3 t -80.54 111.39 22.44 Favored Pre-proline 0 N--CA 1.421 -1.886 0 C-N-CA 124.911 1.284 . . . . 0.0 109.24 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 32.6 Cg_exo -63.3 2.88 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.315 0 C-N-CA 123.894 3.063 . . . . 0.0 113.498 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -90.04 -19.38 47.06 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.743 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 7.0 p -137.97 -25.29 0.98 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 17.1 t30 78.92 20.43 0.75 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.671 1.589 . . . . 0.0 109.257 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 99.3 mttt -92.43 139.12 23.83 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.731 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.403 ' CA ' HG12 ' A' ' 869' ' ' ILE . 57.8 Cg_endo -77.59 163.7 29.12 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.546 2.831 . . . . 0.0 112.487 174.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . 0.462 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 12.8 t70 -59.1 125.95 25.69 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.525 0.73 . . . . 0.0 111.831 175.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -99.02 19.5 15.01 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.655 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 84.11 42.5 7.53 Favored Glycine 0 CA--C 1.488 -1.639 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 -172.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 881' ' ' PRO . 9.1 p -115.48 150.79 45.2 Favored Pre-proline 0 N--CA 1.409 -2.508 0 CA-C-N 113.77 -1.215 . . . . 0.0 111.565 -170.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 880' ' ' SER . 16.3 Cg_exo -68.77 123.0 9.95 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 122.072 1.848 . . . . 0.0 108.72 171.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.462 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 92.4 mtp -120.27 157.18 29.7 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.9 tt -119.19 134.96 61.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.15 157.5 21.55 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 886' ' ' ASP . 52.3 t -80.64 170.77 15.89 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.5 0.667 . . . . 0.0 110.503 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . 0.409 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 22.2 t70 -93.82 -24.1 17.89 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . 0.416 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 16.0 t70 -99.86 -48.1 4.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.796 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.7 p -98.65 165.3 11.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.354 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -88.32 -16.19 33.71 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.158 0.983 . . . . 0.0 110.521 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.66 152.29 45.54 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.757 -174.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -105.42 133.64 49.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.512 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -115.4 146.77 41.28 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.698 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.3 m80 -76.88 141.07 40.74 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -50.31 -51.62 61.87 Favored Pre-proline 0 CA--C 1.555 1.161 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.78 -22.53 74.58 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.402 2.068 . . . . 0.0 114.176 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 60.9 m -81.02 -26.9 36.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.529 0.681 . . . . 0.0 111.652 -175.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.625 HG23 HG12 ' A' ' 899' ' ' ILE . 15.1 m -112.68 -5.47 11.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.087 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 85.65 41.81 7.12 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.365 175.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.625 HG12 HG23 ' A' ' 897' ' ' VAL . 39.9 mm -90.98 108.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.7 ptm -87.19 -23.93 24.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.735 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -162.68 149.36 12.95 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -49.66 110.6 1.65 Allowed Pre-proline 0 C--O 1.241 0.619 0 O-C-N 124.508 1.13 . . . . 0.0 111.8 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 122.979 2.452 . . . . 0.0 112.107 -179.456 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 N--CA 1.441 -0.902 0 CA-C-O 121.183 0.516 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -130.09 131.98 45.96 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -133.45 137.78 45.88 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.246 0.546 . . . . 0.0 110.132 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 7.5 p -73.48 172.12 9.01 Favored Pre-proline 0 C--N 1.296 -1.723 0 C-N-CA 124.862 1.265 . . . . 0.0 110.641 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.71 -16.17 23.86 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 123.002 2.468 . . . . 0.0 111.665 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.669 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 11.7 mmmm -80.56 -55.02 5.14 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.26 0.624 . . . . 0.0 110.849 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.435 ' O ' HG12 ' A' ' 918' ' ' ILE . 71.6 m -85.59 -22.82 27.86 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.65 -22.18 61.72 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 913' ' ' LYS . 3.4 t-20 -66.96 -36.13 81.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.741 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -66.05 -49.14 68.69 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.404 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 914' ' ' CYS . 32.5 mm . . . . . 0 C--O 1.244 0.765 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.078 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . 0.507 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 49.7 m-85 . . . . . 0 N--CA 1.425 -1.693 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.61 118.06 37.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.517 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 54.5 mt -117.07 162.78 14.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -96.63 134.33 40.01 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 119.313 0.96 . . . . 0.0 110.108 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -75.86 174.4 9.94 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.99 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -68.47 -30.04 68.8 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 123.666 0.786 . . . . 0.0 110.784 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -79.95 -15.58 56.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.885 0.85 . . . . 0.0 108.895 176.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 96.93 18.56 29.17 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -81.6 178.24 8.46 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -95.88 129.0 43.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.073 0.463 . . . . 0.0 110.317 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 28.2 mm -92.1 122.27 43.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -90.84 148.61 22.39 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 124.22 0.95 . . . . 0.0 111.208 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 50.7 mt -122.17 136.44 59.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.471 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.85 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 50.0 t -77.59 106.98 4.38 Favored Pre-proline 0 N--CA 1.426 -1.668 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . 0.485 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 57.5 Cg_endo -78.14 15.19 1.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.018 1.812 . . . . 0.0 111.977 -177.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -87.52 -32.0 14.62 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 9.4 p -115.13 -32.37 5.72 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.582 -0.309 . . . . 0.0 110.475 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 87.55 26.26 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.828 2.051 . . . . 0.0 109.864 -175.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.473 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 25.6 mtpp -110.23 139.07 21.08 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.553 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.6 Cg_endo -76.51 169.95 20.89 Favored 'Trans proline' 0 C--O 1.249 1.051 0 C-N-CA 123.426 2.751 . . . . 0.0 112.98 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -51.99 113.45 1.01 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.538 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -107.64 18.18 21.74 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.58 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 83.72 27.75 37.51 Favored Glycine 0 CA--C 1.492 -1.366 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 10.7 p -106.02 167.59 9.44 Favored Pre-proline 0 N--CA 1.42 -1.935 0 C-N-CA 123.82 0.848 . . . . 0.0 110.043 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.75 123.84 9.29 Favored 'Trans proline' 0 N--CA 1.437 -1.811 0 C-N-CA 121.368 1.379 . . . . 0.0 109.762 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 78.1 mtp -122.44 150.51 42.39 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.668 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . 0.528 ' HB ' ' HE1' ' A' ' 894' ' ' TRP . 19.0 tt -117.36 148.67 19.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -109.87 157.45 15.06 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.596 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.523 ' HB3' ' OD2' ' A' ' 890' ' ' ASP . 42.2 t -91.73 -170.83 2.69 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 126.037 1.735 . . . . 0.0 108.016 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -120.54 -23.34 6.11 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.965 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . 0.45 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 3.4 t70 -102.52 -25.09 13.72 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -167.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 890' ' ' ASP . 22.6 p -119.12 -143.93 0.36 Allowed 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -174.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -130.04 87.04 2.47 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . 0.523 ' OD2' ' HB3' ' A' ' 885' ' ' CYS . 1.4 p30 -128.78 157.62 40.94 Favored 'General case' 0 C--N 1.256 -3.494 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -159.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -161.09 117.3 2.22 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 127.85 2.46 . . . . 0.0 106.409 161.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . 0.485 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 62.8 m-85 -120.02 147.98 44.12 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.728 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 53.4 m80 -76.69 140.2 40.79 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.899 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.528 ' HE1' ' HB ' ' A' ' 883' ' ' ILE . 24.2 m0 -53.51 -51.2 78.11 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.08 -9.42 25.01 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.039 1.826 . . . . 0.0 113.919 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.728 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 74.3 m -86.51 -39.7 15.99 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.293 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.618 HG23 HG12 ' A' ' 899' ' ' ILE . 30.5 m -104.57 -4.07 9.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.205 -175.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 87.1 53.0 2.93 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.519 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.618 HG12 HG23 ' A' ' 897' ' ' VAL . 16.7 mm -114.02 136.05 51.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.2 ptp -121.08 -15.59 8.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.605 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -162.61 135.48 5.77 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -39.21 96.7 0.12 Allowed Pre-proline 0 N--CA 1.494 1.746 0 C-N-CA 126.169 1.788 . . . . 0.0 113.833 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 CA--C 1.551 1.365 0 C-N-CA 123.553 2.835 . . . . 0.0 118.113 -176.329 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 910' ' ' PHE . 38.2 mt-30 . . . . . 0 C--O 1.238 0.48 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -101.12 131.38 47.08 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 908' ' ' GLN . 92.0 m-85 -128.76 139.34 52.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 27.4 p -66.43 166.99 14.23 Favored Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 124.226 0.954 . . . . 0.0 110.944 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -48.78 -24.48 7.03 Favored 'Trans proline' 0 CA--C 1.552 1.405 0 C-N-CA 123.841 3.028 . . . . 0.0 113.075 175.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -87.01 -41.31 13.98 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.725 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 90.8 m -85.7 -17.94 34.53 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.65 74.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 122.127 0.965 . . . . 0.0 108.654 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.78 -29.19 70.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.897 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -70.4 -35.49 73.5 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.173 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.422 HD11 ' CD2' ' A' ' 910' ' ' PHE . 70.8 mt . . . . . 0 C--N 1.327 -0.397 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 . . . . . 0 CA--C 1.509 -0.611 0 CA-C-O 122.526 1.155 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 92.3 t -131.91 120.74 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 113.717 -1.583 . . . . 0.0 108.969 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 45.6 mt -119.75 152.28 22.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -102.97 137.69 40.83 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.161 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.65 172.65 10.27 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.569 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.8 -28.05 66.41 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 122.613 0.365 . . . . 0.0 110.758 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 -74.72 -23.85 58.65 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 107.62 3.82 34.69 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.164 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -69.69 149.0 48.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.977 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -84.62 127.05 33.87 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.737 0.78 . . . . 0.0 112.096 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 47.0 mm -98.75 117.55 43.97 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -94.24 135.88 35.14 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.742 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.538 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 51.1 mt -105.77 128.35 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 25.7 t -82.75 107.97 10.87 Favored Pre-proline 0 N--CA 1.414 -2.234 0 C-N-CA 125.04 1.336 . . . . 0.0 108.833 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 36.2 Cg_exo -63.17 0.25 1.81 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.459 2.772 . . . . 0.0 113.014 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.3 -33.61 35.05 Favored Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 20.3 p -119.6 -28.43 5.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.816 0.341 . . . . 0.0 110.719 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.0 t30 80.63 29.51 0.21 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.032 2.133 . . . . 0.0 109.04 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -113.05 141.4 25.55 Favored Pre-proline 0 C--O 1.243 0.732 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.038 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 39.9 Cg_endo -74.43 155.84 45.67 Favored 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 123.324 2.682 . . . . 0.0 112.691 174.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.35 145.72 37.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.81 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -133.89 5.66 3.63 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.972 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 118.73 40.66 0.65 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.723 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 37.8 m -105.07 166.08 12.07 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -69.35 123.07 9.86 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.636 1.557 . . . . 0.0 109.778 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 53.2 mtp -120.42 161.06 21.86 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.608 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.9 tt -138.26 148.15 25.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -121.14 149.16 17.4 Favored Glycine 0 C--O 1.252 1.224 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.502 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 52.2 t -64.69 160.76 19.22 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.64 1.176 . . . . 0.0 110.995 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.78 -12.34 53.89 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -106.71 -39.41 5.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.598 ' HB2' ' OD1' ' A' ' 890' ' ' ASP . 22.9 m -85.85 -160.87 0.57 Allowed 'General case' 0 CA--C 1.569 1.691 0 CA-C-O 121.849 0.833 . . . . 0.0 113.159 -174.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -133.55 29.63 3.88 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . 0.598 ' OD1' ' HB2' ' A' ' 888' ' ' CYS . 11.7 p-10 -89.28 176.97 6.73 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 112.068 -2.333 . . . . 0.0 112.399 -170.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -152.72 116.94 4.91 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.43 -1.714 . . . . 0.0 106.859 170.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . 0.444 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 26.6 m-85 -107.46 158.67 17.0 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.719 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 42.2 m80 -86.81 144.5 27.01 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.623 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 29.2 m0 -51.9 -54.11 44.09 Favored Pre-proline 0 CA--C 1.552 1.022 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.58 -23.33 64.51 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.158 1.905 . . . . 0.0 113.202 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.719 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 53.5 m -79.73 -21.89 43.96 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.252 0.549 . . . . 0.0 111.531 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 12.6 m -116.46 9.92 7.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.43 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 70.8 38.23 66.08 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 114.928 -1.033 . . . . 0.0 113.199 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.623 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 51.0 mt -111.07 127.05 68.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 120.993 0.425 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 92.7 mmm -123.54 -6.48 8.11 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.133 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -145.16 138.12 26.34 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . 0.418 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -59.95 112.69 5.76 Favored Pre-proline 0 C--N 1.317 -0.822 0 O-C-N 124.442 1.089 . . . . 0.0 110.992 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 42.2 Cg_endo . . . . . 0 C--O 1.25 1.108 0 C-N-CA 122.679 2.253 . . . . 0.0 111.184 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 . . . . . 0 N--CA 1.437 -1.124 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -126.99 134.52 50.34 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -124.45 140.17 53.2 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.307 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 892' ' ' TYR . 25.4 p -64.16 163.87 21.7 Favored Pre-proline 0 N--CA 1.424 -1.755 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.682 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.43 -10.54 6.83 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 122.806 2.337 . . . . 0.0 112.434 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 913' ' ' LYS . 74.4 mmtt -87.81 -57.95 2.75 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.431 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 75.1 m -69.25 -25.99 64.56 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.32 68.64 Favored 'General case' 0 C--O 1.198 -1.633 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.5 -5.01 58.46 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -87.77 -44.14 11.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 67.0 mt . . . . . 0 C--O 1.242 0.692 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.777 178.366 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 C--O 1.225 -0.2 0 CA-C-O 121.395 0.616 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.83 109.18 18.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 56.4 mt -102.84 148.58 7.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -96.88 122.87 40.32 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.421 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.21 165.52 11.31 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.75 -29.58 70.22 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -94.46 3.67 54.85 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.3 1.048 . . . . 0.0 109.776 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.06 22.22 46.27 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.486 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -76.71 147.73 37.22 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -80.09 113.6 18.38 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.174 0.512 . . . . 0.0 111.765 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 45.8 mm -97.92 118.67 44.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 175.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -99.98 147.0 26.06 Favored 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.334 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 37.4 mt -113.49 132.49 62.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.898 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 53.8 t -86.81 107.15 12.85 Favored Pre-proline 0 N--CA 1.405 -2.686 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 24.6 Cg_exo -65.01 1.35 1.94 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.14 2.56 . . . . 0.0 113.852 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -77.44 -50.4 6.68 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 4.4 p -102.24 -19.26 15.13 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 123.093 0.557 . . . . 0.0 110.288 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 77.56 19.39 1.21 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.557 1.543 . . . . 0.0 109.857 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -103.07 140.61 21.21 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.153 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 48.1 Cg_endo -74.85 173.02 15.16 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 123.269 2.646 . . . . 0.0 112.067 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.38 129.18 40.64 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.516 0.674 . . . . 0.0 111.101 174.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -118.06 34.36 5.21 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 73.54 44.1 34.36 Favored Glycine 0 CA--C 1.493 -1.287 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -173.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.5 p -120.23 151.04 52.71 Favored Pre-proline 0 N--CA 1.412 -2.338 0 CA-C-N 113.871 -1.164 . . . . 0.0 111.526 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.75 120.18 6.28 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 121.88 1.72 . . . . 0.0 109.995 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 76.3 mtp -115.94 150.28 37.4 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.839 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.6 tt -123.27 140.0 48.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -107.08 144.63 15.91 Favored Glycine 0 C--O 1.247 0.937 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.284 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 44.5 t -70.05 147.73 49.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.351 0.596 . . . . 0.0 112.08 -178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -81.9 -24.22 35.81 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.249 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.2 -51.79 9.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 120.989 0.424 . . . . 0.0 110.002 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 10.5 p -107.7 -92.86 0.41 Allowed 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.1 t70 179.62 -30.78 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.325 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -50.72 134.33 24.97 Favored 'General case' 0 C--O 1.247 0.947 0 O-C-N 124.703 1.252 . . . . 0.0 112.384 -172.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -101.9 133.16 47.11 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.333 -172.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -117.84 155.55 29.91 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.411 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.467 ' O ' HG22 ' A' ' 897' ' ' VAL . 41.3 m80 -77.21 143.57 38.91 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.494 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 27.7 m0 -49.8 -53.78 38.7 Favored Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.14 -19.02 65.1 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.228 1.952 . . . . 0.0 113.795 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 79.3 m -84.11 -23.7 30.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.003 0.43 . . . . 0.0 111.925 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.553 HG23 HG12 ' A' ' 899' ' ' ILE . 12.5 m -114.98 5.98 7.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.934 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 75.64 44.8 19.6 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.837 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.553 HG12 HG23 ' A' ' 897' ' ' VAL . 7.7 mm -110.32 109.7 29.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 mmt -109.61 -2.29 17.61 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.182 0.515 . . . . 0.0 110.43 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -154.32 143.62 21.32 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -58.1 116.76 15.75 Favored Pre-proline 0 N--CA 1.438 -1.058 0 O-C-N 124.225 0.953 . . . . 0.0 110.673 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 18.2 Cg_endo . . . . . 0 N--CA 1.45 -1.085 0 C-N-CA 122.262 1.975 . . . . 0.0 110.632 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -123.84 129.46 51.05 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.907 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.467 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 55.3 m-85 -120.13 142.44 48.92 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 25.7 p -63.9 160.21 48.23 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -51.53 -23.56 14.9 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.883 2.388 . . . . 0.0 112.529 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.565 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 33.3 mmtp -68.36 -55.19 12.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.37 0.668 . . . . 0.0 109.578 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.516 ' HA ' ' HE2' ' A' ' 917' ' ' LYS . 78.7 m -77.57 -22.09 51.5 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.493 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -63.56 -35.66 81.24 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.443 1.116 . . . . 0.0 108.585 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -76.72 -17.5 59.05 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.165 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 43.7 mtmt -85.76 -16.39 39.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 49.9 mm . . . . . 0 C--O 1.22 -0.467 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.052 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.965 0.888 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.05 110.61 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.864 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.537 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 58.8 mt -117.15 160.88 16.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -115.18 136.89 52.63 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.754 0.706 . . . . 0.0 110.544 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.17 176.73 7.04 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 124.831 1.252 . . . . 0.0 109.065 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.58 -26.81 62.76 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.248 0.619 . . . . 0.0 110.209 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.61 -3.34 50.04 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.317 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.69 -2.95 86.29 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 116.161 -0.472 . . . . 0.0 113.056 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -71.24 153.22 42.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 123.611 0.242 . . . . 0.0 111.019 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -71.26 146.72 48.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.557 0.694 . . . . 0.0 111.75 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.537 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 31.3 mm -120.79 126.88 75.75 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . 0.498 ' O ' ' HA ' ' A' ' 876' ' ' PRO . 26.1 m-90 -100.47 153.89 18.98 Favored 'General case' 0 C--N 1.285 -2.199 0 O-C-N 123.643 0.589 . . . . 0.0 111.235 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 859' ' ' ILE . 39.8 mt -118.15 117.48 54.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.745 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 38.4 t -73.81 111.65 13.15 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.28 7.97 2.74 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.984 1.79 . . . . 0.0 112.5 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.65 -27.11 43.75 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 8.4 p -121.52 -32.95 3.73 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.727 0.775 . . . . 0.0 109.411 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 80.45 39.78 0.08 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 126.745 2.018 . . . . 0.0 109.944 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -118.33 143.69 33.6 Favored Pre-proline 0 N--CA 1.446 -0.674 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.305 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 868' ' ' TRP . 50.7 Cg_endo -74.59 173.98 13.41 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 123.398 2.732 . . . . 0.0 113.018 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.42 138.93 2.21 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.071 0.949 . . . . 0.0 111.889 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -118.04 -22.97 7.6 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.144 0.974 . . . . 0.0 109.356 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 116.01 -10.49 17.97 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -171.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 11.9 p -65.05 153.0 90.04 Favored Pre-proline 0 N--CA 1.433 -1.301 0 C-N-CA 125.569 1.548 . . . . 0.0 111.193 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.54 137.37 46.17 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 122.278 1.985 . . . . 0.0 109.834 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 83.8 mtp -125.5 149.61 48.13 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.2 tt -118.84 150.75 21.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -113.76 144.92 18.33 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.418 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 49.2 t -76.72 154.69 33.88 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.58 -9.97 36.31 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.155 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.96 -64.13 1.2 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 1.6 p -94.57 -49.27 5.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.101 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 14.1 t70 80.01 79.54 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.471 1.508 . . . . 0.0 113.489 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -129.74 177.77 6.99 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -99.63 123.56 44.01 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 119.339 0.972 . . . . 0.0 112.819 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -116.82 148.69 41.0 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.756 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 49.1 m80 -76.85 144.08 39.27 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.219 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -52.77 -57.8 14.55 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.03 -11.21 30.08 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.77 1.647 . . . . 0.0 113.672 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -84.11 -37.05 22.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.285 0.564 . . . . 0.0 111.855 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.637 HG23 HG12 ' A' ' 899' ' ' ILE . 27.0 m -102.03 -8.63 9.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.772 -176.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 95.96 56.31 1.23 Allowed Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.592 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.637 HG12 HG23 ' A' ' 897' ' ' VAL . 9.0 mm -130.47 125.8 59.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 87.6 mtp -127.02 8.12 6.69 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.738 0.78 . . . . 0.0 110.411 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . 0.617 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -173.95 145.81 1.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -66.18 103.02 0.4 Allowed Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.7 1.2 . . . . 0.0 112.877 -174.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 25.5 Cg_endo . . . . . 0 N--CA 1.448 -1.165 0 C-N-CA 124.019 3.146 . . . . 0.0 115.998 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 . . . . . 0 C--O 1.24 0.605 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -108.85 137.5 46.68 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.464 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -126.02 138.25 53.71 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 27.4 p -69.33 163.44 58.19 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.037 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.06 -23.47 22.03 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 123.847 3.031 . . . . 0.0 112.492 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 29.9 mmmt -69.04 -44.02 73.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 73.6 m -89.01 -27.42 20.88 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.004 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.6 -24.91 61.98 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 120.777 0.322 . . . . 0.0 110.379 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.31 -13.84 59.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.606 0.717 . . . . 0.0 109.792 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -73.39 -29.58 62.7 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 54.4 mt . . . . . 0 N--CA 1.443 -0.794 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.382 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 871' ' ' PRO . 54.9 m-85 . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 121.576 0.703 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.35 121.08 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.749 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 59.0 mt -124.83 154.22 32.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -91.82 125.52 36.56 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.925 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -71.01 171.58 10.6 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.293 -1.322 . . . . 0.0 109.043 172.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.39 -29.15 69.25 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 122.602 0.361 . . . . 0.0 111.884 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.501 ' HB3' ' ND2' ' A' ' 865' ' ' ASN . 44.2 t-105 -87.92 -11.93 46.18 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 97.95 15.05 37.64 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.812 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' A' ' 863' ' ' TRP . 45.9 m-80 -71.36 151.85 43.73 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -78.05 116.21 18.36 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 25.2 mm -64.15 114.59 2.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 122.172 0.987 . . . . 0.0 111.518 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.66 105.64 0.32 Allowed 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 111.478 -2.601 . . . . 0.0 110.988 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.499 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 40.4 mt -127.07 131.04 71.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 891' ' ' TRP . 52.6 t -85.81 110.23 28.57 Favored Pre-proline 0 N--CA 1.418 -2.055 0 O-C-N 124.164 0.915 . . . . 0.0 108.849 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 50.6 Cg_exo -57.0 -20.34 36.54 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.394 2.729 . . . . 0.0 113.028 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -68.97 -36.04 80.43 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.539 -0.362 . . . . 0.0 112.962 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 12.3 p -118.51 -13.54 9.71 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.806 0.303 . . . . 0.0 111.289 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 72.36 24.18 3.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.25 1.42 . . . . 0.0 109.692 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -113.6 138.41 22.58 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 121.771 -0.58 . . . . 0.0 112.071 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 57.1 Cg_endo -73.22 174.03 12.74 Favored 'Trans proline' 0 C--O 1.253 1.228 0 C-N-CA 124.154 3.236 . . . . 0.0 113.328 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.09 137.09 57.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.676 176.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -122.57 25.21 8.9 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.597 1.189 . . . . 0.0 107.856 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 81.52 52.47 4.18 Favored Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 106.438 -2.665 . . . . 0.0 106.438 -171.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 3.7 p -124.0 152.57 66.94 Favored Pre-proline 0 N--CA 1.413 -2.278 0 CA-C-N 113.861 -1.17 . . . . 0.0 112.239 -170.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -72.23 112.58 3.47 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.032 1.822 . . . . 0.0 110.048 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 79.3 mtp -122.15 144.16 49.12 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.762 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 15.9 tt -117.19 152.18 19.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.779 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -110.17 156.38 15.61 Favored Glycine 0 CA--C 1.538 1.518 0 O-C-N 123.206 0.316 . . . . 0.0 113.441 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.518 ' H ' ' CG ' ' A' ' 890' ' ' ASP . 43.8 t -84.92 -170.26 3.04 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 126.31 1.844 . . . . 0.0 109.157 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -123.08 -11.54 8.04 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -107.91 -54.63 2.47 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -173.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 15.7 p -99.57 -134.79 0.28 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -165.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -128.74 89.48 2.89 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' A' ' 885' ' ' CYS . 2.6 p30 -128.06 148.69 50.56 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -158.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . 0.467 ' O ' ' HA ' ' A' ' 870' ' ' CYS . 68.2 m95 -161.52 117.66 2.13 Favored 'General case' 0 C--O 1.208 -1.129 0 C-N-CA 128.058 2.543 . . . . 0.0 106.929 160.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -124.54 148.73 47.59 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.462 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.68 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 57.9 m80 -80.8 144.86 31.77 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -53.53 -52.68 64.66 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.2 -11.59 32.79 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.998 1.799 . . . . 0.0 113.122 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 87.6 m -84.66 -32.14 23.79 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.648 0.737 . . . . 0.0 110.928 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 893' ' ' HIS . 20.9 m -101.52 -27.46 3.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.934 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 104.22 52.99 0.85 Allowed Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.052 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.79 136.64 58.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.026 0.441 . . . . 0.0 110.854 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.8 ptp -128.37 -1.11 5.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.849 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -150.4 141.72 23.27 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -71.91 112.34 13.96 Favored Pre-proline 0 C--N 1.311 -1.089 0 C-N-CA 123.039 0.536 . . . . 0.0 111.912 -176.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo . . . . . 0 N--CA 1.446 -1.293 0 C-N-CA 122.506 2.137 . . . . 0.0 111.029 175.79 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 . . . . . 0 N--CA 1.426 -1.675 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -118.5 140.37 49.97 Favored 'General case' 0 C--N 1.26 -3.287 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -129.53 136.41 49.81 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 9.0 p -73.85 167.25 37.02 Favored Pre-proline 0 N--CA 1.415 -2.207 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.183 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.05 -19.7 21.05 Favored 'Trans proline' 0 CA--C 1.551 1.331 0 C-N-CA 122.976 2.451 . . . . 0.0 112.41 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -81.16 -37.02 29.45 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 110.285 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 97.3 m -89.1 -30.02 18.95 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.808 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.13 68.17 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.05 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -73.05 -19.43 61.18 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.281 0.562 . . . . 0.0 111.562 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -101.05 -27.68 13.14 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.201 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 C--N 1.309 -1.186 0 CA-C-O 121.249 0.547 . . . . 0.0 109.53 174.522 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 122.179 0.99 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 8.1 p -143.42 130.36 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.684 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 44.2 mt -124.39 150.75 29.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -94.75 125.06 39.16 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.622 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.02 172.37 11.13 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.157 174.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.93 -30.39 71.48 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 123.644 0.778 . . . . 0.0 111.188 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -85.53 -0.67 55.67 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.435 0.636 . . . . 0.0 110.465 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 84.01 3.76 88.91 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.213 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -73.01 149.65 43.08 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -78.96 128.17 32.93 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.532 0.682 . . . . 0.0 111.371 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 32.4 mm -96.02 121.61 46.73 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 23.4 m-90 -99.76 139.35 35.55 Favored 'General case' 0 C--N 1.264 -3.121 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.597 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 31.6 mt -103.97 119.16 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.404 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.513 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 50.7 t -61.89 108.83 1.76 Allowed Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 125.143 1.377 . . . . 0.0 108.222 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . 0.432 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 52.6 Cg_exo -57.7 -16.99 27.05 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.735 2.957 . . . . 0.0 113.22 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -70.88 -46.43 45.35 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.246 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 17.0 p -106.75 -28.01 10.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 63.4 t30 81.25 27.84 0.19 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.714 1.606 . . . . 0.0 109.221 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.53 139.33 20.0 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.182 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 42.6 Cg_endo -76.17 162.73 33.77 Favored 'Trans proline' 0 C--O 1.251 1.173 0 C-N-CA 123.08 2.52 . . . . 0.0 112.583 174.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . 0.402 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 17.5 t70 -65.96 141.38 58.22 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.46 14.59 8.23 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 122.781 1.277 . . . . 0.0 107.965 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 85.29 52.66 3.33 Favored Glycine 0 N--CA 1.423 -2.186 0 N-CA-C 105.828 -2.909 . . . . 0.0 105.828 -170.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 11.4 p -119.69 153.54 54.44 Favored Pre-proline 0 N--CA 1.418 -2.034 0 CA-C-N 113.927 -1.137 . . . . 0.0 111.091 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.97 118.67 5.69 Favored 'Trans proline' 0 C--O 1.257 1.429 0 C-N-CA 122.24 1.96 . . . . 0.0 109.951 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.402 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 77.0 mtp -125.32 142.32 51.57 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.074 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.3 tt -110.73 144.88 17.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -110.99 163.52 12.25 Favored Glycine 0 C--N 1.301 -1.395 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.078 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.49 ' H ' ' CG ' ' A' ' 890' ' ' ASP . 51.2 t -88.99 -164.33 1.12 Allowed 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 126.027 1.731 . . . . 0.0 108.551 -177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . 0.406 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 30.2 t70 -131.34 -8.96 3.74 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.637 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -109.0 -46.93 3.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.4 p -104.29 -126.73 0.23 Allowed 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -166.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -136.02 88.54 2.4 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 885' ' ' CYS . 3.1 p30 -127.74 146.89 50.43 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 113.085 -1.87 . . . . 0.0 115.238 -161.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -162.39 117.62 1.88 Allowed 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 128.046 2.538 . . . . 0.0 106.349 158.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . 0.432 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 44.8 m-85 -123.25 148.97 45.32 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.756 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.8 m80 -77.91 145.85 35.91 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.513 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 31.6 m0 -51.95 -55.63 28.87 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 175.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.28 -12.68 34.04 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.426 2.084 . . . . 0.0 113.99 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.3 m -86.49 -21.88 26.74 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.027 0.442 . . . . 0.0 111.069 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.703 HG23 HG12 ' A' ' 899' ' ' ILE . 14.4 m -120.52 5.79 6.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.144 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 84.15 23.4 51.95 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.712 175.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.703 HG12 HG23 ' A' ' 897' ' ' VAL . 16.9 mm -91.04 121.6 41.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 18.3 ptm -118.29 -6.14 10.83 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.281 0.562 . . . . 0.0 110.568 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.1 149.81 21.57 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -60.32 112.95 6.28 Favored Pre-proline 0 C--N 1.314 -0.977 0 O-C-N 124.172 0.92 . . . . 0.0 111.004 -177.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 C--O 1.248 0.993 0 C-N-CA 123.155 2.57 . . . . 0.0 111.111 179.828 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 . . . . . 0 N--CA 1.432 -1.352 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -136.4 135.71 38.98 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -126.52 139.18 53.42 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 16.9 p -64.7 167.15 9.64 Favored Pre-proline 0 C--N 1.29 -2.003 0 O-C-N 124.2 0.937 . . . . 0.0 111.892 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 11.4 Cg_endo -56.17 -13.4 9.52 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 123.074 2.516 . . . . 0.0 112.128 175.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.489 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 31.6 mmmt -84.34 -60.57 2.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 917' ' ' LYS . 92.5 m -73.04 -27.41 61.74 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.78 78.22 Favored 'General case' 0 C--O 1.201 -1.481 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -72.42 -22.81 61.05 Favored 'General case' 0 C--O 1.211 -0.924 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 914' ' ' CYS . 92.3 mttt -72.06 -46.44 56.9 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 70.2 mt . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.465 -180.0 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . 0.497 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 97.0 m-85 . . . . . 0 C--O 1.24 0.571 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 14.0 p -143.62 118.89 4.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.635 0.731 . . . . 0.0 112.231 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 47.5 mt -114.84 160.87 13.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -103.78 130.65 51.34 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.233 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.83 175.29 2.5 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 125.623 1.569 . . . . 0.0 111.123 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -58.32 -40.17 81.37 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 124.937 1.295 . . . . 0.0 111.107 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.48 ' HB3' ' ND2' ' A' ' 865' ' ' ASN . 66.9 t-105 -80.12 -25.92 39.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.369 0.604 . . . . 0.0 110.037 177.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 117.6 7.21 12.25 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.48 ' ND2' ' HB3' ' A' ' 863' ' ' TRP . 46.0 m-80 -64.25 159.9 19.8 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -85.24 117.4 24.16 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.332 0.587 . . . . 0.0 109.954 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 42.4 mm -90.76 114.02 27.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -86.13 128.07 34.82 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.847 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 33.3 mt -100.9 123.7 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.15 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.426 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 41.1 t -77.71 117.2 64.15 Favored Pre-proline 0 N--CA 1.408 -2.533 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.152 -176.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . 0.55 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 58.6 Cg_exo -56.5 -17.82 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.656 2.904 . . . . 0.0 113.32 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.75 -21.42 76.79 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 121.314 -0.469 . . . . 0.0 113.295 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 10.8 p -138.21 -10.6 1.48 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.301 0.551 . . . . 0.0 112.231 -177.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.257 2.3 p-10 61.15 25.44 15.44 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.299 1.84 . . . . 0.0 111.129 -173.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -106.33 140.21 21.07 Favored Pre-proline 0 N--CA 1.435 -1.222 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.3 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.73 173.65 14.15 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 123.347 2.698 . . . . 0.0 112.336 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.96 138.7 42.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.616 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -119.58 -6.1 10.22 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.895 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 89.66 21.12 41.34 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -172.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.6 t -100.89 161.32 24.13 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.36 113.62 1.76 Allowed 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.732 2.288 . . . . 0.0 111.649 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 85.6 mtp -109.92 156.83 19.92 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.02 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.6 tt -126.6 142.73 42.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.92 152.39 19.66 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.579 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 48.8 t -85.15 169.89 13.43 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.649 0.738 . . . . 0.0 110.325 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.65 -32.96 16.01 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . 0.487 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 14.4 t70 -100.88 -38.31 8.29 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.529 -174.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 60.5 m -89.42 158.49 17.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.148 0.499 . . . . 0.0 110.255 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.64 -0.28 43.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -86.84 159.34 19.11 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.461 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -117.0 142.4 47.0 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.156 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 64.4 m-85 -114.69 171.33 7.7 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.758 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 65.2 m80 -99.12 151.93 20.43 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -54.35 -53.29 61.04 Favored Pre-proline 0 CA--C 1.553 1.094 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.65 -29.75 90.55 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.75 1.633 . . . . 0.0 113.011 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.758 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 28.5 m -70.41 -21.68 62.81 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.859 0.837 . . . . 0.0 111.901 -175.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.25 10.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.198 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 71.79 46.61 37.15 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.243 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.14 136.37 58.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 62.3 mtt -128.19 -4.92 5.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.52 156.43 30.23 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . 0.506 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -44.0 114.24 1.79 Allowed Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 125.206 1.566 . . . . 0.0 112.149 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.506 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 11.4 Cg_endo . . . . . 0 CA--C 1.57 2.302 0 C-N-CA 123.913 3.075 . . . . 0.0 113.066 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 . . . . . 0 C--O 1.248 1.012 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -116.95 133.43 56.02 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.985 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -127.47 141.98 51.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 7.6 p -75.43 168.63 25.88 Favored Pre-proline 0 N--CA 1.421 -1.922 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.972 178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.72 -24.15 29.11 Favored 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 123.075 2.517 . . . . 0.0 111.803 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.594 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 0.0 OUTLIER -70.1 -58.5 3.74 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.98 176.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 87.2 m -72.91 -21.48 60.9 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.29 -20.2 65.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.51 -34.84 27.81 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.424 ' NZ ' ' SG ' ' A' ' 914' ' ' CYS . 22.5 mtmm -67.5 -43.18 81.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.508 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 72.0 mt . . . . . 0 C--O 1.241 0.647 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.49 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 . . . . . 0 N--CA 1.443 -0.788 0 CA-C-O 122.394 1.092 . . . . 0.0 108.269 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 42.5 t -130.79 101.08 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 112.672 -2.058 . . . . 0.0 105.483 172.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 40.0 mt -103.58 154.24 5.77 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -102.22 125.14 48.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.514 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . 0.501 ' HB3' ' H ' ' A' ' 865' ' ' ASN . 17.6 t70 -67.19 177.24 1.87 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.663 176.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -72.99 -25.11 60.87 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.357 0.599 . . . . 0.0 110.298 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -87.69 -12.64 44.77 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.157 0.98 . . . . 0.0 108.7 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 93.57 19.53 34.69 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.933 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.501 ' H ' ' HB3' ' A' ' 861' ' ' ASP . 63.8 m-20 -72.78 150.95 42.34 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -77.93 110.42 12.82 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 121.61 0.719 . . . . 0.0 110.696 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 46.3 mm -94.82 115.39 33.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -103.6 145.55 29.88 Favored 'General case' 0 C--N 1.255 -3.529 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.217 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.87 120.49 52.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.7 t -78.59 119.66 78.12 Favored Pre-proline 0 N--CA 1.404 -2.737 0 C-N-CA 125.0 1.32 . . . . 0.0 108.316 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.4 -4.58 13.17 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.63 2.22 . . . . 0.0 111.629 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -72.02 -43.5 48.64 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 5.7 p -114.49 -24.32 8.89 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.7 t30 78.75 24.66 0.55 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.824 1.65 . . . . 0.0 108.235 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -110.25 139.63 21.63 Favored Pre-proline 0 C--O 1.244 0.783 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.983 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.81 165.52 32.53 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.182 2.588 . . . . 0.0 112.361 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . 0.411 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 16.6 t0 -60.49 117.33 5.15 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.634 0.731 . . . . 0.0 112.375 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.81 6.42 46.87 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.661 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 105.66 40.08 2.09 Favored Glycine 0 N--CA 1.435 -1.413 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 49.1 m -123.82 159.23 56.96 Favored Pre-proline 0 N--CA 1.428 -1.549 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.14 133.62 25.3 Favored 'Trans proline' 0 C--O 1.252 1.204 0 C-N-CA 122.405 2.07 . . . . 0.0 110.896 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.411 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 64.6 mtp -123.11 163.11 21.17 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.872 -178.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . 0.499 ' HB ' ' HE1' ' A' ' 894' ' ' TRP . 17.6 tt -141.28 143.23 28.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.95 151.96 17.29 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.629 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 53.8 t -76.09 150.97 37.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.094 0.473 . . . . 0.0 110.481 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -82.55 -25.56 33.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.748 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . 0.426 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 31.3 t70 -97.33 -40.33 8.78 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.309 -0.556 . . . . 0.0 112.343 -173.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 32.0 p -98.49 -106.13 0.2 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 117.879 -1.528 . . . . 0.0 114.11 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -158.79 -41.79 0.06 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.985 -170.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.77 161.12 30.42 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -170.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -112.26 133.76 54.19 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.345 -1.752 . . . . 0.0 108.384 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -117.22 159.17 23.08 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.59 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 56.2 m80 -82.93 144.74 29.81 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.145 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.499 ' HE1' ' HB ' ' A' ' 883' ' ' ILE . 38.2 m0 -53.52 -48.95 91.17 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 177.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 28.4 Cg_endo -63.71 -13.97 40.02 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.275 1.983 . . . . 0.0 113.088 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -89.37 -26.67 20.93 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.241 0.543 . . . . 0.0 111.803 -176.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 893' ' ' HIS . 18.8 m -110.11 -4.93 10.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.443 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 83.67 48.17 5.35 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.723 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 46.1 mt -112.89 121.87 65.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.605 0.717 . . . . 0.0 111.517 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 96.2 mmm -92.7 -31.19 15.19 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.345 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.74 159.67 35.49 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -48.26 109.58 1.19 Allowed Pre-proline 0 C--N 1.323 -0.554 0 O-C-N 124.73 1.268 . . . . 0.0 111.659 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 18.8 Cg_endo . . . . . 0 C--O 1.244 0.784 0 C-N-CA 123.236 2.624 . . . . 0.0 112.406 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 . . . . . 0 N--CA 1.427 -1.607 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -104.5 124.81 49.93 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.121 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 74.2 m-85 -124.9 142.61 51.34 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.6 p -66.95 166.2 21.17 Favored Pre-proline 0 C--N 1.294 -1.817 0 O-C-N 123.609 0.568 . . . . 0.0 111.5 -176.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 5.0 Cg_endo -49.54 -27.28 14.03 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.431 2.754 . . . . 0.0 112.509 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -82.04 -47.93 12.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.341 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.504 ' HA ' ' HE2' ' A' ' 917' ' ' LYS . 92.5 m -78.38 -32.61 48.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.1 -32.03 73.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.51 -35.78 76.79 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.186 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 27.3 mtmt -70.77 -18.18 62.77 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.102 0.561 . . . . 0.0 110.656 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 51.0 mt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 121.758 0.79 . . . . 0.0 109.771 -178.054 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 64.4 t -138.73 121.09 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 113.316 -1.765 . . . . 0.0 108.267 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 869' ' ' ILE . 55.7 mt -127.48 148.92 32.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 860' ' ' ARG . 41.3 mtt180 -95.02 125.06 39.42 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 121.734 0.778 . . . . 0.0 110.891 174.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.93 171.73 3.32 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.629 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -60.86 -36.38 79.02 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 124.024 0.929 . . . . 0.0 110.6 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.52 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 92.8 m95 -87.0 -10.15 53.84 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.376 0.608 . . . . 0.0 111.05 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 100.34 8.44 49.89 Favored Glycine 0 CA--C 1.5 -0.883 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.357 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 37.1 m-80 -71.79 160.94 31.72 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 866' ' ' GLN . 14.4 mm-40 -90.81 133.35 35.27 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 122.124 0.964 . . . . 0.0 112.159 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 45.8 mm -110.63 121.81 64.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 113.532 -1.667 . . . . 0.0 108.114 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -101.35 140.12 36.08 Favored 'General case' 0 C--N 1.271 -2.808 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.565 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 859' ' ' ILE . 36.4 mt -106.08 124.31 61.27 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 42.2 t -78.2 113.91 37.79 Favored Pre-proline 0 N--CA 1.404 -2.762 0 O-C-N 124.442 1.089 . . . . 0.0 108.743 -178.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . 0.555 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 37.6 Cg_exo -61.19 -2.47 2.38 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.282 2.655 . . . . 0.0 113.309 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.06 -39.69 19.02 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 7.5 p -114.98 -25.81 8.0 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.349 0.66 . . . . 0.0 111.554 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 76.48 26.52 0.88 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.886 1.675 . . . . 0.0 110.085 -173.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -108.03 138.82 20.21 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.466 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 44.5 Cg_endo -72.83 170.71 19.0 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.369 2.713 . . . . 0.0 113.749 176.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -64.31 133.28 52.39 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.097 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -123.44 6.73 8.97 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.903 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 93.65 22.86 25.15 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 2.7 p -96.31 155.85 37.58 Favored Pre-proline 0 C--N 1.296 -1.722 0 C-N-CA 123.35 0.66 . . . . 0.0 110.408 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.43 118.09 4.93 Favored 'Trans proline' 0 C--O 1.257 1.456 0 C-N-CA 122.069 1.846 . . . . 0.0 111.568 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.6 mtp -113.4 162.92 15.51 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.569 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.5 tt -130.64 145.29 35.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -108.95 151.02 17.14 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 42.6 t -80.74 178.85 8.1 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.513 0.673 . . . . 0.0 110.929 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . 0.426 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 28.9 t70 -110.48 -18.44 13.21 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.941 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . 0.426 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 16.4 t70 -95.93 -46.96 6.32 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 25.4 p -101.87 -179.07 3.9 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -117.81 17.64 14.23 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.349 1.071 . . . . 0.0 109.45 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -102.62 163.35 12.27 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.184 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -112.19 141.83 45.41 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.875 0.369 . . . . 0.0 111.854 -174.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . 0.555 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 10.9 m-85 -120.94 169.39 10.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.712 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 56.6 m80 -96.02 150.39 20.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 118.692 0.678 . . . . 0.0 111.341 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -56.1 -53.89 58.54 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.46 -19.22 67.47 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.165 1.91 . . . . 0.0 113.799 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 45.3 m -80.84 -31.21 35.57 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.34 0.59 . . . . 0.0 111.742 -176.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.592 HG23 HG12 ' A' ' 899' ' ' ILE . 24.0 m -108.86 -22.66 4.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.824 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 104.31 55.08 0.77 Allowed Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.168 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.592 HG12 HG23 ' A' ' 897' ' ' VAL . 30.5 mm -113.06 117.78 56.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 86.9 mtp -87.72 -40.34 14.2 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -144.49 154.63 43.11 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . 0.454 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -54.51 110.09 1.94 Allowed Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 124.799 1.312 . . . . 0.0 112.431 -176.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 25.3 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.516 2.144 . . . . 0.0 111.067 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 . . . . . 0 N--CA 1.425 -1.678 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -125.84 138.9 53.84 Favored 'General case' 0 C--N 1.248 -3.811 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 84.2 m-85 -125.55 137.36 53.93 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 18.7 p -77.26 166.6 43.14 Favored Pre-proline 0 C--N 1.28 -2.421 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.344 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -49.02 -30.99 19.38 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.228 2.619 . . . . 0.0 112.465 176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.673 ' HA ' ' HE2' ' A' ' 913' ' ' LYS . 7.8 mmpt? -81.02 -42.95 20.3 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 92.4 m -78.4 -20.18 51.69 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.084 177.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -70.22 -23.24 62.9 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -79.48 -10.89 59.89 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.964 0.411 . . . . 0.0 110.539 175.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -87.31 -57.73 2.85 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 C--O 1.239 0.546 0 CA-C-N 114.673 -1.148 . . . . 0.0 111.045 -177.052 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . 0.643 ' HA ' HD12 ' A' ' 869' ' ' ILE . 4.4 m-85 . . . . . 0 CA--C 1.494 -1.201 0 CA-C-O 123.124 1.44 . . . . 0.0 108.125 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.2 108.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.397 -3.108 0 CA-C-N 111.493 -2.594 . . . . 0.0 106.638 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 30.9 mt -117.73 154.41 19.63 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.724 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -100.76 137.25 39.4 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.399 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.07 179.31 6.9 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.75 176.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.29 -29.89 65.59 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.946 0.403 . . . . 0.0 110.266 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -80.04 -10.9 59.8 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.821 0.819 . . . . 0.0 109.546 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.82 18.34 40.99 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -78.72 155.15 29.53 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -85.07 118.72 24.81 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.992 0.901 . . . . 0.0 110.876 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 37.0 mm -91.14 114.4 28.4 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -100.34 147.21 26.05 Favored 'General case' 0 C--N 1.264 -3.114 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.771 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.643 HD12 ' HA ' ' A' ' 857' ' ' TYR . 26.9 mt -102.19 109.24 25.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-O 121.223 0.535 . . . . 0.0 110.626 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 49.4 t -56.29 115.43 9.88 Favored Pre-proline 0 N--CA 1.438 -1.074 0 C-N-CA 126.217 1.807 . . . . 0.0 110.32 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -59.81 -13.4 22.19 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.633 2.889 . . . . 0.0 112.869 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.46 -38.06 34.16 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.212 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 9.1 p -120.99 -15.96 8.16 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 117.218 0.509 . . . . 0.0 112.25 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 72.39 21.54 3.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.315 1.446 . . . . 0.0 108.707 -176.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -101.93 141.78 23.25 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.3 177.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -73.32 158.33 48.61 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.637 2.224 . . . . 0.0 110.931 173.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . 0.593 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 10.3 t0 -48.74 123.33 6.73 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.469 0.652 . . . . 0.0 111.696 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -90.47 6.1 44.86 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.473 -175.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 91.81 36.73 6.31 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 108.281 -1.927 . . . . 0.0 108.281 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 22.8 m -122.37 161.58 42.52 Favored Pre-proline 0 N--CA 1.418 -2.029 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.37 133.34 32.22 Favored 'Trans proline' 0 C--O 1.254 1.285 0 C-N-CA 121.576 1.517 . . . . 0.0 110.306 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.593 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 75.8 mtp -112.05 154.52 25.26 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.52 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.1 tt -124.75 138.23 54.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.14 158.52 16.75 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.57 169.56 17.86 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.366 0.603 . . . . 0.0 110.315 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -91.42 -26.03 19.06 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -98.54 -49.33 4.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.277 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 17.6 p -99.7 179.2 4.61 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.595 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -110.2 11.61 23.58 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.809 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -81.99 151.97 26.91 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.951 0.405 . . . . 0.0 111.236 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -114.45 139.18 49.74 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.951 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -119.23 162.42 18.72 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.294 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.607 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 65.4 m80 -83.45 144.14 29.78 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.401 ' N ' ' HD2' ' A' ' 895' ' ' PRO . 26.3 m0 -51.24 -49.49 81.37 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 175.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 893' ' ' HIS . 28.5 Cg_endo -63.93 -23.6 68.03 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.659 2.24 . . . . 0.0 114.053 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 61.2 m -76.81 -25.7 53.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.56 0.695 . . . . 0.0 111.563 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.793 HG23 HG12 ' A' ' 899' ' ' ILE . 9.0 m -114.14 -2.59 10.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.712 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 73.19 45.08 32.65 Favored Glycine 0 CA--C 1.504 -0.606 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.202 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.793 HG12 HG23 ' A' ' 897' ' ' VAL . 45.4 mm -80.02 -67.9 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.391 1.091 . . . . 0.0 110.457 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.9 mtt 66.63 -14.94 0.15 Allowed 'General case' 0 C--N 1.264 -3.117 0 C-N-CA 128.398 2.679 . . . . 0.0 114.74 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.11 147.13 19.31 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . 0.409 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -51.88 110.16 1.74 Allowed Pre-proline 0 C--O 1.239 0.517 0 O-C-N 124.491 1.119 . . . . 0.0 112.186 -175.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 32.6 Cg_endo . . . . . 0 N--CA 1.457 -0.676 0 C-N-CA 122.908 2.405 . . . . 0.0 112.104 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 . . . . . 0 N--CA 1.425 -1.679 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 73.0 t90 -125.42 119.95 29.68 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.525 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.47 138.63 53.7 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 30.8 p -66.39 161.84 54.54 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 123.754 0.658 . . . . 0.0 111.55 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.45 -16.12 22.22 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.207 2.605 . . . . 0.0 112.916 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.54 ' HA ' ' HE2' ' A' ' 913' ' ' LYS . 3.9 mmpt? -84.26 -48.5 9.69 Favored 'General case' 0 N--CA 1.44 -0.963 0 O-C-N 122.145 -0.347 . . . . 0.0 110.177 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.462 ' O ' HG13 ' A' ' 918' ' ' ILE . 84.7 m -68.49 -39.96 81.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.05 176.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.09 71.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.203 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -64.11 -43.65 94.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.26 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -79.62 -33.3 41.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.522 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 914' ' ' CYS . 85.4 mt . . . . . 0 C--O 1.246 0.879 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 . . . . . 0 CA--C 1.507 -0.684 0 CA-C-O 121.436 0.636 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 57.5 t -125.08 129.11 73.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.718 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 58.0 mt -125.56 144.58 35.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -92.05 117.03 29.44 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.452 175.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -71.31 176.07 4.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.72 -22.88 59.76 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.437 0.637 . . . . 0.0 109.452 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -85.99 -0.43 55.47 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.168 0.985 . . . . 0.0 108.687 173.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 75.69 16.5 80.61 Favored Glycine 0 CA--C 1.5 -0.878 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.868 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -68.35 134.01 49.61 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -82.04 81.34 8.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.51 0.672 . . . . 0.0 109.274 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 858' ' ' VAL . 46.5 mm -53.14 135.88 14.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 113.198 -1.819 . . . . 0.0 112.287 -174.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -103.07 132.63 49.18 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 124.186 0.929 . . . . 0.0 109.877 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 40.8 mt -102.43 116.96 47.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.524 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.0 111.34 3.55 Favored Pre-proline 0 N--CA 1.443 -0.806 0 C-N-CA 125.255 1.422 . . . . 0.0 110.532 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -65.31 3.73 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.851 3.034 . . . . 0.0 113.613 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -86.16 -46.03 5.44 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 14.1 p -116.4 -22.03 8.97 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.528 0.68 . . . . 0.0 110.456 -176.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.274 2.8 m-20 70.75 56.0 0.24 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 125.765 1.626 . . . . 0.0 111.563 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.3 140.01 37.13 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.151 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -74.19 173.99 13.22 Favored 'Trans proline' 0 C--O 1.257 1.427 0 C-N-CA 123.359 2.706 . . . . 0.0 112.624 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . 0.417 ' HA ' ' SD ' ' A' ' 882' ' ' MET . 3.4 m-20 -48.51 106.11 0.09 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.744 0.818 . . . . 0.0 108.929 172.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -102.57 -15.05 16.52 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.957 0.408 . . . . 0.0 110.868 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 127.09 -21.21 5.84 Favored Glycine 0 N--CA 1.437 -1.252 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 50.0 m -70.99 157.06 91.16 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.293 -0.454 . . . . 0.0 109.807 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -65.97 137.91 50.57 Favored 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.707 2.271 . . . . 0.0 111.468 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.417 ' SD ' ' HA ' ' A' ' 877' ' ' ASP . 91.7 mtp -128.71 148.31 50.82 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.481 -175.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.5 tt -129.49 148.06 33.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -111.69 146.89 17.97 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.812 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 888' ' ' CYS . 52.8 t -70.37 155.78 40.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -86.98 -24.0 24.85 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.568 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -92.02 -45.42 8.33 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.882 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 885' ' ' CYS . 29.8 p -100.44 -178.27 3.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.485 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -112.62 14.89 20.16 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 122.712 1.244 . . . . 0.0 109.431 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.95 153.03 21.62 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.056 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 26.8 m95 -118.93 138.79 52.53 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.35 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -124.29 161.46 25.8 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.099 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.72 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 56.8 m80 -86.67 146.47 26.29 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -49.93 -53.5 42.24 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.65 -10.54 29.08 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 122.224 1.949 . . . . 0.0 113.792 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 62.4 m -87.07 -33.72 19.4 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.593 0.711 . . . . 0.0 111.023 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.582 HG23 HG12 ' A' ' 899' ' ' ILE . 19.2 m -104.75 -15.62 8.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.797 -176.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 96.0 47.36 2.46 Favored Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.855 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.582 HG12 HG23 ' A' ' 897' ' ' VAL . 48.3 mm -95.39 105.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.8 ptm -87.11 -19.5 28.44 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.234 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -170.5 151.35 3.64 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . 0.413 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -45.56 111.53 1.39 Allowed Pre-proline 0 C--O 1.243 0.719 0 O-C-N 124.673 1.233 . . . . 0.0 110.754 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 12.2 Cg_endo . . . . . 0 C--O 1.244 0.822 0 C-N-CA 122.903 2.402 . . . . 0.0 112.196 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 . . . . . 0 CA--C 1.5 -0.96 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -117.39 128.65 55.23 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.561 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -131.23 146.32 52.27 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 20.8 p -76.65 164.88 56.75 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.39 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.59 -24.11 21.62 Favored 'Trans proline' 0 CA--C 1.551 1.366 0 C-N-CA 123.355 2.703 . . . . 0.0 112.275 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -78.54 -53.8 6.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.498 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.508 ' O ' HG12 ' A' ' 918' ' ' ILE . 85.7 m -78.54 -26.72 45.78 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.72 69.93 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -74.57 -35.54 63.05 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.053 0.93 . . . . 0.0 110.066 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -71.71 -15.62 62.21 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.005 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 914' ' ' CYS . 44.6 mm . . . . . 0 C--N 1.325 -0.473 0 C-N-CA 123.512 0.725 . . . . 0.0 111.661 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.46 0.043 0 CA-C-O 121.655 0.741 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.76 121.71 66.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.333 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 51.2 mt -126.85 138.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 173.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -98.59 122.15 41.43 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.182 0.992 . . . . 0.0 112.435 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.89 173.19 1.91 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 113.185 -1.825 . . . . 0.0 109.69 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.57 -28.86 70.17 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.783 0.833 . . . . 0.0 110.884 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.483 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 76.3 m95 -98.24 10.68 40.06 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.076 0.465 . . . . 0.0 111.317 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.46 1.69 83.31 Favored Glycine 0 CA--C 1.508 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.144 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.483 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 45.4 m-80 -65.37 137.56 57.58 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.18 126.87 33.54 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.68 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 48.7 mm -91.49 129.13 42.68 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.622 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -77.69 145.95 36.32 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.852 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 52.6 mt -129.99 128.2 64.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.84 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.5 t -72.43 117.36 58.17 Favored Pre-proline 0 N--CA 1.419 -2.015 0 C-N-CA 125.165 1.386 . . . . 0.0 108.711 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.88 -1.13 6.35 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.565 2.176 . . . . 0.0 112.817 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.93 -48.16 10.42 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.562 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 5.8 p -113.28 -19.28 11.83 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 122.684 0.394 . . . . 0.0 111.489 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.4 t30 81.01 19.79 0.44 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.475 1.51 . . . . 0.0 109.228 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -97.73 138.81 21.06 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.918 176.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.6 Cg_endo -73.88 174.21 12.71 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.34 2.693 . . . . 0.0 110.534 173.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -59.48 119.98 8.52 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.368 0.604 . . . . 0.0 109.38 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -104.26 23.92 12.34 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 76.77 51.68 6.28 Favored Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 105.654 -2.978 . . . . 0.0 105.654 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 7.7 p -125.87 159.38 61.78 Favored Pre-proline 0 N--CA 1.42 -1.943 0 CA-C-N 113.981 -1.109 . . . . 0.0 112.888 -166.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -77.22 108.13 2.56 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 121.988 1.792 . . . . 0.0 109.563 174.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 81.9 mtp -116.24 164.76 14.02 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.839 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.5 tt -133.6 134.62 56.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.69 154.73 20.7 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 53.8 t -80.81 167.84 19.48 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.444 0.64 . . . . 0.0 110.265 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -92.86 -31.63 14.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . 0.429 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 27.5 t70 -91.45 -36.91 13.5 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.863 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 55.7 m -97.51 168.32 10.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.65 10.99 26.84 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -94.25 175.08 6.83 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.336 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -132.03 140.14 48.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.121 0.486 . . . . 0.0 112.082 -172.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -119.22 158.33 26.21 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.219 1.008 . . . . 0.0 108.285 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.669 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 73.3 m80 -84.26 149.13 26.3 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.365 176.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 33.3 m0 -53.0 -54.52 43.2 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.53 -16.44 52.31 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.274 1.983 . . . . 0.0 113.444 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 81.8 m -81.28 -27.25 35.19 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.149 0.499 . . . . 0.0 110.85 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 893' ' ' HIS . 21.1 m -115.42 14.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.109 -176.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 71.2 35.42 64.03 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.837 -1.074 . . . . 0.0 114.231 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 57.6 mt -105.61 127.58 60.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.466 0.65 . . . . 0.0 111.024 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.7 mmt -105.17 -25.12 12.61 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.231 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -152.66 154.71 35.87 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . 0.5 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -49.68 112.92 2.91 Favored Pre-proline 0 C--O 1.241 0.628 0 O-C-N 124.779 1.299 . . . . 0.0 112.366 -177.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 19.3 Cg_endo . . . . . 0 C--O 1.254 1.296 0 C-N-CA 122.998 2.466 . . . . 0.0 112.202 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 . . . . . 0 N--CA 1.439 -0.993 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -117.81 141.61 48.23 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 120.594 -0.443 . . . . 0.0 109.815 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -132.45 137.59 47.32 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 17.1 p -66.98 165.06 29.45 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 123.992 0.917 . . . . 0.0 110.102 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -56.01 -18.86 24.06 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.595 2.197 . . . . 0.0 112.045 174.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.58 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 74.9 mmtt -74.49 -48.49 26.92 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.554 ' O ' HG12 ' A' ' 918' ' ' ILE . 68.8 m -76.63 -29.77 56.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.99 -11.24 60.68 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 120.698 0.285 . . . . 0.0 110.931 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.04 -29.71 35.0 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 172.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 53.3 mtmt -80.52 -36.74 32.78 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.912 176.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 914' ' ' CYS . 40.1 mm . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.702 0.287 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.419 HG13 ' HB2' ' A' ' 866' ' ' GLN . 90.9 t -134.75 118.64 26.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 37.6 mt -122.58 166.45 17.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -108.6 131.97 54.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 119.548 1.067 . . . . 0.0 109.501 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.35 175.21 8.62 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 123.697 0.799 . . . . 0.0 108.917 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -68.09 -27.95 66.93 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 123.716 0.806 . . . . 0.0 111.013 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -81.78 -15.4 54.38 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 102.3 -8.93 55.77 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.897 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -66.76 146.82 54.03 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . 0.419 ' HB2' HG13 ' A' ' 858' ' ' VAL . 14.0 pt20 -74.53 144.88 43.88 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 121.832 0.825 . . . . 0.0 111.502 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 39.3 mm -105.32 121.63 57.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -90.02 143.57 26.67 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 123.975 0.797 . . . . 0.0 109.425 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 40.8 mt -107.7 123.4 63.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 892' ' ' TYR . 41.6 t -75.2 114.46 35.57 Favored Pre-proline 0 N--CA 1.409 -2.486 0 O-C-N 124.593 1.183 . . . . 0.0 108.67 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.4 -1.72 6.99 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.147 2.565 . . . . 0.0 112.011 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -78.27 -40.74 18.98 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 6.9 p -118.38 -15.37 9.7 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 57.8 t30 71.49 32.41 2.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.417 1.087 . . . . 0.0 108.285 -175.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -116.0 140.43 26.27 Favored Pre-proline 0 C--O 1.241 0.636 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.639 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 40.2 Cg_endo -72.47 167.27 27.46 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 123.317 2.678 . . . . 0.0 112.699 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . 0.48 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 21.7 t70 -65.84 138.42 57.88 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.239 172.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -124.52 33.41 5.25 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 74.82 47.38 14.58 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 107.487 -2.245 . . . . 0.0 107.487 -173.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 881' ' ' PRO . 6.2 p -120.45 149.32 49.67 Favored Pre-proline 0 N--CA 1.423 -1.807 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.027 -171.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 880' ' ' SER . 22.9 Cg_exo -64.89 126.25 16.23 Favored 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 122.037 1.825 . . . . 0.0 110.384 175.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.48 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 88.9 mtp -128.3 157.79 39.97 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.869 -177.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.69 138.07 52.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -105.46 155.09 17.04 Favored Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 888' ' ' CYS . 1.7 p -74.04 135.74 43.07 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.801 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.9 -48.94 72.39 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.699 -174.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . 0.591 ' HB2' ' CE1' ' A' ' 910' ' ' PHE . 14.9 t70 -80.65 -49.41 11.27 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-O 122.704 1.24 . . . . 0.0 109.12 -175.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.872 ' HB2' ' SG ' ' A' ' 885' ' ' CYS . 0.0 OUTLIER -73.6 -103.73 0.01 OUTLIER 'General case' 0 N--CA 1.38 -3.95 0 N-CA-C 118.929 2.937 . . . . 0.0 118.929 -162.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -178.3 -25.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -166.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . 0.436 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 22.7 m-20 -90.93 173.46 7.96 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.45 0.643 . . . . 0.0 111.94 -170.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -132.81 127.39 34.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.116 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . 0.428 ' HA ' ' SG ' ' A' ' 870' ' ' CYS . 82.6 m-85 -122.67 162.51 21.82 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.672 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 54.6 m80 -84.17 151.76 24.67 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.457 ' CG ' ' HB ' ' A' ' 899' ' ' ILE . 25.9 m0 -53.12 -56.37 24.53 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.52 -13.62 40.75 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.206 1.938 . . . . 0.0 114.043 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 76.5 m -77.75 -40.86 39.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.492 0.663 . . . . 0.0 111.109 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.535 HG23 HG12 ' A' ' 899' ' ' ILE . 27.1 m -99.57 -26.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.669 -175.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 110.17 35.42 2.14 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.214 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.535 HG12 HG23 ' A' ' 897' ' ' VAL . 42.2 mm -90.16 106.73 17.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 91.3 mmm -91.93 -25.64 18.8 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.244 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -151.74 147.84 27.18 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -57.57 114.36 8.17 Favored Pre-proline 0 C--N 1.319 -0.718 0 O-C-N 124.415 1.072 . . . . 0.0 111.891 -176.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 N--CA 1.46 -0.467 0 C-N-CA 122.905 2.403 . . . . 0.0 111.028 177.033 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 . . . . . 0 N--CA 1.439 -0.988 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -127.81 125.09 39.16 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.403 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 887' ' ' ASP . 22.0 m-85 -118.16 147.04 43.73 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 914' ' ' CYS 0.254 1.8 p -80.49 164.58 51.02 Favored Pre-proline 0 C--N 1.271 -2.839 0 C-N-CA 124.478 1.111 . . . . 0.0 111.176 -174.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.56 -12.86 30.12 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.685 2.257 . . . . 0.0 112.296 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 32.4 mmtp -88.21 -62.11 1.56 Allowed 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.443 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.697 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 96.3 m -74.35 -27.76 60.82 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -175.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -72.55 -25.95 61.56 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.322 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -89.47 -4.55 57.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.754 0.788 . . . . 0.0 110.164 -177.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 913' ' ' LYS . 35.8 mmtp -83.69 -47.64 10.99 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 171.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 CA--C 1.519 -0.232 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.227 178.129 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 C--O 1.215 -0.719 0 CA-C-O 121.655 0.74 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.68 128.17 74.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.17 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 46.9 mt -126.0 166.02 22.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 177.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -116.58 140.71 49.08 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.93 -168.06 1.65 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.176 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.53 -34.02 77.28 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.006 0.922 . . . . 0.0 110.714 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -87.35 -33.51 19.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.783 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 122.57 16.64 3.72 Favored Glycine 0 C--N 1.308 -1.015 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.204 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -83.52 151.18 25.54 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -79.31 135.77 36.83 Favored 'General case' 0 N--CA 1.396 -3.133 0 CA-C-O 122.02 0.914 . . . . 0.0 110.181 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 27.4 mm -103.34 129.56 55.03 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.05 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.887 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -92.67 142.71 27.07 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.898 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 39.8 mt -111.41 122.92 66.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.113 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.5 t -65.66 112.53 8.9 Favored Pre-proline 0 N--CA 1.431 -1.404 0 C-N-CA 124.769 1.228 . . . . 0.0 108.817 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.69 -5.18 8.28 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.713 2.942 . . . . 0.0 112.961 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.95 -39.2 28.64 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 121.119 -0.562 . . . . 0.0 111.967 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 9.6 p -124.44 -10.32 7.44 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 122.79 0.436 . . . . 0.0 111.629 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.336 9.5 p30 60.12 32.39 20.93 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 126.022 1.729 . . . . 0.0 112.258 -172.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -103.59 138.96 19.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.095 173.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.9 Cg_endo -74.08 171.09 18.65 Favored 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 123.38 2.72 . . . . 0.0 113.888 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.92 145.24 42.8 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.551 174.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -115.83 -0.62 12.82 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 99.92 39.54 3.32 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 107.341 -2.304 . . . . 0.0 107.341 -172.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 14.3 m -106.44 168.67 7.81 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 114.607 -0.797 . . . . 0.0 110.527 -171.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -74.51 115.62 4.36 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 121.316 1.344 . . . . 0.0 108.901 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 83.4 mtp -122.57 162.3 22.09 Favored 'General case' 0 N--CA 1.407 -2.605 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . 0.556 ' HB ' ' HE1' ' A' ' 894' ' ' TRP . 18.0 tt -122.31 133.44 68.57 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-O 120.713 0.292 . . . . 0.0 110.44 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.08 143.77 16.87 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 52.7 t -71.94 167.95 19.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.551 0.691 . . . . 0.0 110.272 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . 0.421 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 24.6 t70 -84.97 -26.29 27.23 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 174.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -95.36 -47.96 6.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.119 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 10.1 m -83.79 146.63 28.04 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.97 17.12 23.12 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.279 1.038 . . . . 0.0 108.51 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -108.77 168.4 9.37 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.383 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -115.43 150.44 36.43 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -168.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -123.37 149.68 44.65 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.691 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 44.2 m80 -75.42 142.06 43.1 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.186 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.556 ' HE1' ' HB ' ' A' ' 883' ' ' ILE . 21.1 m0 -55.85 -49.47 92.76 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 20.3 Cg_endo -61.47 -19.08 63.04 Favored 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 122.154 1.903 . . . . 0.0 113.105 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.691 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 74.0 m -83.41 -21.22 33.06 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.401 0.62 . . . . 0.0 111.519 -177.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 893' ' ' HIS . 15.9 m -118.43 12.58 7.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.877 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 62.49 48.8 79.26 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.097 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 57.7 mt -118.59 136.58 55.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 122.582 -0.364 . . . . 0.0 111.108 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 61.5 mtt -121.9 -11.6 8.52 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.229 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -156.54 137.29 13.33 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -50.77 100.78 0.24 Allowed Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 125.263 1.425 . . . . 0.0 113.686 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 14.4 Cg_endo . . . . . 0 CA--C 1.544 0.985 0 C-N-CA 123.715 2.943 . . . . 0.0 116.46 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 121.499 0.666 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -100.4 131.67 46.2 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.191 -173.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 84.9 m-85 -126.83 139.33 53.18 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 15.5 p -70.26 167.43 25.84 Favored Pre-proline 0 N--CA 1.426 -1.644 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.787 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.84 -20.64 18.15 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 123.08 2.52 . . . . 0.0 111.886 173.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.519 ' HA ' ' HE2' ' A' ' 913' ' ' LYS . 8.9 mmpt? -81.03 -51.47 8.46 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.21 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.495 ' O ' HG12 ' A' ' 918' ' ' ILE . 91.4 m -75.08 -29.66 60.73 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.7 66.31 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.19 0.519 . . . . 0.0 110.334 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -68.37 -28.79 67.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.354 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -79.15 -39.13 34.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.891 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 914' ' ' CYS . 47.8 mm . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.232 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.286 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 16.2 m -75.72 113.29 13.01 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 117.16 0.48 . . . . 0.0 110.316 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -86.35 -42.03 14.02 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -93.08 171.79 8.72 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.308 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 76.53 12.31 2.56 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.858 1.263 . . . . 0.0 110.859 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 23.3 mmt -87.13 -23.96 24.68 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.896 0.855 . . . . 0.0 109.037 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 858' ' ' VAL . . . -100.28 -174.35 2.65 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.152 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . 0.523 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 55.1 m-85 68.22 12.34 8.72 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 122.103 0.954 . . . . 0.0 109.13 -172.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 856' ' ' ALA . 51.5 t -136.68 114.3 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.225 -174.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 39.5 mt -124.69 154.61 32.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -98.83 134.7 41.34 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.53 0.681 . . . . 0.0 110.076 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -71.93 172.23 10.33 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.962 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -63.12 -34.65 78.07 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 123.207 0.603 . . . . 0.0 110.468 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -88.67 -14.4 37.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.895 0.855 . . . . 0.0 108.994 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 105.31 10.51 31.48 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.077 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -68.96 164.0 23.27 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -88.36 121.06 30.32 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.632 0.73 . . . . 0.0 110.89 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 39.2 mm -91.51 112.45 25.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 173.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -88.47 130.84 35.1 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.424 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 32.8 mt -100.51 104.13 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.398 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 44.7 t -54.73 112.42 4.0 Favored Pre-proline 0 N--CA 1.429 -1.519 0 CA-C-N 113.734 -1.575 . . . . 0.0 108.997 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -71.93 3.58 3.79 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.005 1.803 . . . . 0.0 112.216 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -83.74 -36.67 13.16 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 22.3 p -114.97 -27.75 7.26 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 122.507 -0.408 . . . . 0.0 111.122 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 82.29 24.0 0.2 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.298 1.839 . . . . 0.0 110.309 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.561 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 41.2 mttm -102.86 144.43 28.6 Favored Pre-proline 0 N--CA 1.467 0.408 0 C-N-CA 123.393 0.677 . . . . 0.0 111.255 174.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.407 ' HB3' HG12 ' A' ' 869' ' ' ILE . 56.4 Cg_endo -80.42 174.09 11.66 Favored 'Trans proline' 0 C--O 1.242 0.683 0 C-N-CA 123.094 2.53 . . . . 0.0 108.479 167.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.597 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 15.4 t70 -69.31 102.11 1.66 Allowed 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.222 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -94.97 5.06 52.99 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.438 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 119.31 55.81 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 17.7 m -134.25 163.1 53.59 Favored Pre-proline 0 N--CA 1.417 -2.108 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -75.3 137.67 21.35 Favored 'Trans proline' 0 C--O 1.264 1.777 0 C-N-CA 122.459 2.106 . . . . 0.0 108.581 172.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.511 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 58.1 mtp -117.03 152.78 33.93 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.961 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.9 tt -134.41 134.2 54.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -99.21 160.31 19.95 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.737 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.87 166.74 15.76 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.573 0.702 . . . . 0.0 110.869 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -92.88 -22.77 19.06 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.631 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -101.55 -37.64 8.31 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.246 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . 0.25 16.2 p -103.21 169.64 8.43 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.961 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.2 -21.04 19.31 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.503 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -87.1 163.59 16.91 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.897 -171.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -110.2 142.6 41.53 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.503 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -112.79 -178.05 3.29 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 125.014 1.326 . . . . 0.0 108.468 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.864 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 59.2 m80 -110.84 160.26 16.92 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -60.17 -54.1 58.55 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.24 -26.59 77.6 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 122.281 1.987 . . . . 0.0 114.071 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.864 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 5.8 m -69.31 -36.81 77.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.947 0.88 . . . . 0.0 111.772 -176.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.498 HG23 HG12 ' A' ' 899' ' ' ILE . 28.2 m -107.11 -17.87 7.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.36 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 93.3 48.94 2.7 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 121.224 -0.512 . . . . 0.0 113.139 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.498 HG12 HG23 ' A' ' 897' ' ' VAL . 44.0 mm -88.56 125.17 41.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 69.1 mtm -91.65 -37.26 13.16 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.127 0.489 . . . . 0.0 109.69 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -156.61 158.93 37.94 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . 0.419 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -55.2 113.81 6.1 Favored Pre-proline 0 C--N 1.32 -0.717 0 O-C-N 124.093 0.871 . . . . 0.0 111.984 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 46.3 Cg_endo -69.19 165.93 28.64 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 123.346 2.698 . . . . 0.0 112.724 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.51 151.1 80.31 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.716 2.277 . . . . 0.0 112.267 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . 0.56 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 0.2 OUTLIER -85.14 -21.9 29.05 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.709 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.71 -27.08 62.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.827 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 23.1 ttt -79.33 143.94 34.7 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -97.0 121.44 38.89 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -106.45 132.17 52.78 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -127.97 137.35 52.21 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 5.8 p -69.82 168.45 17.57 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 123.996 0.918 . . . . 0.0 109.695 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.24 -20.3 10.87 Favored 'Trans proline' 0 CA--C 1.552 1.409 0 C-N-CA 123.195 2.597 . . . . 0.0 112.429 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -79.29 -56.27 4.47 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.478 0.711 . . . . 0.0 109.195 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 71.5 m -79.03 -17.51 55.16 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 918' ' ' ILE . . . -67.06 -31.22 71.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.334 1.064 . . . . 0.0 108.645 172.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -73.42 -22.99 60.07 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.45 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -74.49 -36.59 63.27 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 172.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 915' ' ' ALA . 50.5 mm -60.79 -43.02 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 172.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 80.2 tttt 71.4 -68.76 0.21 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.541 1.937 . . . . 0.0 113.581 169.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -176.91 -50.96 0.01 OUTLIER 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -92.56 91.86 7.78 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.308 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -96.51 140.65 30.83 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.531 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -115.7 10.23 15.41 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-O 121.721 0.772 . . . . 0.0 111.189 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 69.4 t60 . . . . . 0 N--CA 1.424 -1.75 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 175.41 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.651 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 22.6 t -84.57 85.15 7.45 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -125.89 168.52 13.76 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.437 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 59.9 ttp -117.6 124.15 47.93 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -138.55 128.01 24.61 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.708 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 65.8 mtt -137.4 135.35 36.87 Favored 'General case' 0 C--O 1.249 1.029 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 175.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . 0.481 ' O ' HD12 ' A' ' 869' ' ' ILE . . . 60.37 -150.72 0.41 Allowed 'General case' 0 N--CA 1.469 0.502 0 O-C-N 124.368 1.042 . . . . 0.0 109.765 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . 0.487 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 88.7 m-85 -119.58 9.65 11.55 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.016 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 90.9 t -132.56 116.83 29.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.855 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 35.2 mt -120.2 157.26 22.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -102.01 131.64 48.32 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.035 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.77 173.5 8.11 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.853 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.95 -37.78 80.52 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.767 0.827 . . . . 0.0 111.143 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.498 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 75.9 m95 -91.15 1.45 57.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.557 0.694 . . . . 0.0 110.626 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.08 14.19 56.51 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.761 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 58.8 m-80 -73.84 155.65 38.57 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.73 113.17 24.01 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.678 0.751 . . . . 0.0 112.006 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 37.1 mm -80.41 118.47 28.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 175.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -92.16 138.22 31.71 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.329 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 33.5 mt -104.07 127.34 58.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.38 112.82 31.58 Favored Pre-proline 0 N--CA 1.423 -1.815 0 C-N-CA 124.348 1.059 . . . . 0.0 108.719 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . 0.411 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 31.9 Cg_exo -60.79 -6.06 5.43 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 123.883 3.056 . . . . 0.0 113.664 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -85.53 -23.5 46.84 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.785 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 18.9 p -123.92 -33.89 3.07 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -177.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 82.5 21.86 0.23 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.943 1.697 . . . . 0.0 109.706 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -103.66 139.52 20.19 Favored Pre-proline 0 C--O 1.25 1.107 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.934 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.408 ' HA ' HG12 ' A' ' 869' ' ' ILE . 38.0 Cg_endo -73.59 153.93 49.54 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.845 2.363 . . . . 0.0 110.644 173.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.625 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 29.2 t70 -79.53 146.17 32.79 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.139 0.495 . . . . 0.0 111.845 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -108.79 -0.62 19.82 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.247 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . 0.416 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 106.13 51.78 0.81 Allowed Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -172.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 1.3 m -109.02 164.35 14.91 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.04 114.92 3.36 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 121.745 1.63 . . . . 0.0 108.886 172.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 68.7 mtp -115.06 167.58 10.69 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.2 tt -132.22 143.83 38.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -101.23 147.15 17.63 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 43.7 t -80.34 170.67 16.08 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.022 0.529 . . . . 0.0 110.009 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . 0.441 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 26.8 t70 -88.99 -24.83 22.29 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -100.67 -31.8 11.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.323 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 22.4 m -104.71 149.09 25.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -92.45 -9.99 39.53 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.57 150.43 49.0 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.844 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -101.29 135.44 42.77 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.786 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . 0.411 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 45.2 m-85 -115.85 150.73 36.54 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.656 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 43.2 m80 -79.11 139.94 37.94 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.916 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 31.4 m0 -52.34 -52.03 66.84 Favored Pre-proline 0 CA--C 1.551 1.014 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.59 -9.3 22.08 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.951 1.767 . . . . 0.0 113.309 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.656 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -93.52 -17.84 22.94 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.453 0.644 . . . . 0.0 111.074 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 893' ' ' HIS . 31.5 m -118.48 7.67 6.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.927 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 70.72 37.61 66.92 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.723 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 49.0 mt -108.48 124.28 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-O 121.73 0.776 . . . . 0.0 110.848 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -105.0 -21.15 13.33 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.518 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -155.76 146.9 22.47 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -55.8 114.95 8.34 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 124.848 1.343 . . . . 0.0 112.133 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -68.53 155.52 68.74 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.966 1.778 . . . . 0.0 109.784 173.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.07 146.16 88.97 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.27 1.98 . . . . 0.0 112.411 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -64.59 -32.95 74.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.999 0.904 . . . . 0.0 109.667 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -78.81 1.48 23.15 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.163 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 21.0 ttt -97.85 133.19 42.69 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -81.46 137.22 35.65 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.036 -1.065 . . . . 0.0 108.484 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 92.9 t90 -134.35 138.09 44.64 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.697 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 97.5 m-85 -135.56 136.36 41.06 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 11.5 p -62.55 165.7 8.76 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 124.081 0.952 . . . . 0.0 110.24 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.424 ' CD ' HG12 ' A' ' 897' ' ' VAL . 11.5 Cg_endo -57.15 -10.26 5.83 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.014 2.476 . . . . 0.0 112.291 175.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 28.9 mmmt -83.28 -54.11 5.25 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 72.0 m -81.49 -21.37 38.72 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.32 -27.55 67.99 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 919' ' ' LYS . 2.9 t-20 -78.5 -5.39 52.46 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.635 0.731 . . . . 0.0 110.273 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -83.82 -34.97 24.57 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 68.9 mt -86.58 -50.6 13.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.3 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 916' ' ' ASN . 63.3 tttm -108.88 94.9 5.3 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -69.36 -32.55 71.69 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.695 -173.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 71.02 134.68 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.107 1.363 . . . . 0.0 111.857 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -142.5 -176.54 4.89 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.12 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -151.11 147.46 27.09 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 C--N 1.296 -1.741 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 177.41 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.071 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 21.4 t -82.69 90.34 6.84 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 117.542 0.671 . . . . 0.0 110.205 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -166.57 103.18 0.6 Allowed 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -114.6 134.27 55.18 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -87.65 149.97 23.94 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 24.4 mmt -92.71 -53.75 4.05 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -125.57 156.92 38.34 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . 0.475 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 43.9 m-85 -108.53 64.25 0.61 Allowed 'General case' 0 C--N 1.283 -2.316 0 CA-C-O 122.296 1.046 . . . . 0.0 111.096 -170.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.32 115.57 18.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 113.902 -1.499 . . . . 0.0 107.516 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 56.5 mt -108.1 152.21 9.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -108.09 135.09 50.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.09 174.09 11.92 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.261 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.81 -24.42 63.47 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.247 0.546 . . . . 0.0 111.029 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -88.26 4.87 44.3 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.333 0.587 . . . . 0.0 110.412 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 74.73 22.06 77.66 Favored Glycine 0 CA--C 1.502 -0.738 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.598 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -86.21 154.57 21.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -86.67 130.69 34.39 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.796 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 41.6 mm -103.14 105.61 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.744 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.2 m-90 -83.95 136.86 33.91 Favored 'General case' 0 C--N 1.252 -3.639 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.609 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.494 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 53.3 mt -102.71 129.0 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.348 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 43.6 t -80.65 109.13 11.85 Favored Pre-proline 0 N--CA 1.416 -2.162 0 C-N-CA 125.612 1.565 . . . . 0.0 107.387 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 32.5 Cg_exo -62.17 -0.81 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.335 2.69 . . . . 0.0 113.624 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.81 -49.04 9.25 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 3.9 p -107.74 -20.22 13.29 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 122.593 0.357 . . . . 0.0 111.113 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 78.68 23.05 0.64 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.745 1.618 . . . . 0.0 108.786 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -101.16 141.97 23.69 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.566 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 36.3 Cg_endo -73.93 174.15 12.84 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.661 2.241 . . . . 0.0 109.226 170.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.667 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 17.2 t0 -60.8 109.78 1.14 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.835 0.826 . . . . 0.0 110.501 174.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -101.67 13.71 34.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.292 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 102.82 49.1 1.2 Allowed Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 21.2 m -130.03 157.01 78.28 Favored Pre-proline 0 N--CA 1.412 -2.369 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.18 135.32 16.84 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 121.973 1.782 . . . . 0.0 108.447 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 65.0 mtp -115.71 142.32 46.91 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.696 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.5 tt -123.05 136.42 59.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -119.59 152.26 17.21 Favored Glycine 0 CA--C 1.483 -1.926 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.734 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.543 ' HB3' ' O ' ' A' ' 888' ' ' CYS . 42.3 t -58.62 160.1 5.89 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.651 0.78 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -88.11 -27.25 22.04 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.54 -39.59 18.61 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.675 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 885' ' ' CYS . 8.5 p -138.17 167.12 22.49 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.031 0.444 . . . . 0.0 110.981 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -90.04 68.33 7.19 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.799 0.809 . . . . 0.0 109.755 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -112.02 97.47 6.69 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.7 -2.334 . . . . 0.0 104.7 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -96.39 128.78 43.63 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.439 -171.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . 0.485 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 36.5 m-85 -122.55 169.3 11.16 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.744 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.667 ' HE2' ' HA ' ' A' ' 877' ' ' ASP . 41.5 m80 -89.36 149.79 22.85 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.087 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -49.6 -56.33 17.4 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.44 -11.16 29.07 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.324 2.016 . . . . 0.0 113.94 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 62.8 m -89.18 -29.8 19.04 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.569 HG23 HG12 ' A' ' 899' ' ' ILE . 17.2 m -113.45 3.55 8.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -175.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.06 5.73 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.576 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.569 HG12 HG23 ' A' ' 897' ' ' VAL . 24.5 mm -105.15 114.6 45.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 90.2 mmm -95.61 -21.86 17.97 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.324 0.583 . . . . 0.0 110.204 -177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -165.52 163.07 19.52 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . 0.415 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -45.81 111.57 1.44 Allowed Pre-proline 0 C--O 1.241 0.609 0 O-C-N 124.579 1.174 . . . . 0.0 111.419 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 29.9 Cg_endo -64.91 160.74 39.71 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.873 2.382 . . . . 0.0 111.396 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.43 141.62 89.62 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.25 1.967 . . . . 0.0 111.328 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -78.34 -11.97 59.97 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.105 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.66 -10.2 41.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.561 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 21.2 ttt -80.69 130.55 35.16 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.007 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -89.39 134.91 33.87 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -129.1 139.17 52.09 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -130.26 147.04 51.94 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 20.0 p -61.06 160.04 24.11 Favored Pre-proline 0 C--N 1.317 -0.806 0 O-C-N 123.871 0.732 . . . . 0.0 110.388 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.16 -15.13 13.45 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.863 2.375 . . . . 0.0 112.604 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 18.4 mtmm -82.3 -50.93 8.4 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.81 -31.52 66.64 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.74 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . 0.421 ' HB1' ' NZ ' ' A' ' 919' ' ' LYS . . . -65.8 -25.52 67.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.114 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.21 -37.41 57.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.48 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -60.16 -44.08 95.27 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 74.4 mt -68.93 -54.21 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.713 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . 0.421 ' NZ ' ' HB1' ' A' ' 915' ' ' ALA . 32.4 mtmm -100.04 84.11 2.81 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.857 0.836 . . . . 0.0 109.604 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -97.88 -40.97 8.24 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.599 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 67.75 -83.1 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.925 1.29 . . . . 0.0 110.695 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -173.63 170.55 4.04 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -86.59 123.5 31.84 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 . . . . . 0 C--O 1.256 1.395 0 C-N-CA 123.701 0.801 . . . . 0.0 109.982 -179.599 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.892 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 68.4 p 43.21 83.63 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -166.23 169.65 14.05 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 67.6 mtt -102.5 39.12 1.56 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 70.65 12.85 7.31 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.628 1.171 . . . . 0.0 112.655 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 26.2 mmt -92.33 79.19 5.03 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.135 0.493 . . . . 0.0 110.758 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -118.68 -176.22 3.05 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -95.67 -5.74 41.6 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.375 0.607 . . . . 0.0 111.261 -175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 59.1 t -111.05 106.69 21.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 34.6 mt -108.67 131.67 58.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -85.4 117.9 24.6 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -69.11 177.54 2.66 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.36 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -66.82 -30.91 71.22 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 124.686 1.194 . . . . 0.0 109.941 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.613 ' HB3' ' ND2' ' A' ' 865' ' ' ASN . 72.5 t-105 -89.14 -3.19 58.71 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.899 0.856 . . . . 0.0 109.024 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.32 9.98 71.88 Favored Glycine 0 CA--C 1.502 -0.762 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.496 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.613 ' ND2' ' HB3' ' A' ' 863' ' ' TRP . 47.9 m-80 -62.2 148.89 43.23 Favored 'General case' 0 C--O 1.249 1.027 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -85.89 101.36 12.79 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.997 0.903 . . . . 0.0 109.774 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 49.8 mm -89.54 115.22 28.78 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.593 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -103.08 126.32 50.2 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.526 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.512 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 27.6 mt -87.87 124.32 40.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.36 106.5 4.69 Favored Pre-proline 0 N--CA 1.415 -2.191 0 C-N-CA 125.325 1.45 . . . . 0.0 107.412 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 21.6 Cg_exo -67.39 13.6 0.16 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.665 2.91 . . . . 0.0 113.247 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -92.25 -40.21 5.19 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 174.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 11.0 p -111.96 -25.55 9.34 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.084 0.469 . . . . 0.0 110.325 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 79.9 18.66 0.67 Allowed 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.459 1.904 . . . . 0.0 110.916 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -94.74 138.51 22.19 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.491 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 40.5 Cg_endo -72.52 148.4 47.89 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.159 2.572 . . . . 0.0 111.695 174.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.654 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 16.8 t70 -69.28 141.15 54.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -85.93 -34.1 21.0 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.512 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 127.83 46.46 0.19 Allowed Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 106.336 -2.706 . . . . 0.0 106.336 -171.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 20.9 p -114.11 165.41 13.7 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 114.387 -0.907 . . . . 0.0 109.697 -173.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.76 124.13 13.97 Favored 'Trans proline' 0 C--O 1.255 1.353 0 C-N-CA 122.082 1.855 . . . . 0.0 111.442 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.8 mtp -124.66 161.72 25.68 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.862 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.8 tt -130.68 138.06 54.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -108.36 152.32 16.98 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.965 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 47.4 t -77.84 167.28 21.77 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.378 0.609 . . . . 0.0 110.363 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -104.41 -23.09 13.22 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.127 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -84.94 -40.9 16.44 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.434 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.7 p -105.55 -95.06 0.35 Allowed 'General case' 0 N--CA 1.427 -1.577 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.468 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 37.3 t70 174.62 -20.46 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.022 0.929 . . . . 0.0 109.778 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -55.69 141.94 36.1 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -176.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -104.1 131.64 51.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.518 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 911' ' ' CYS . 10.6 m-85 -117.74 155.43 30.01 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.167 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.661 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 36.6 m80 -80.93 143.29 32.74 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.406 ' N ' ' HD2' ' A' ' 895' ' ' PRO . 29.2 m0 -52.59 -51.7 70.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 30.4 Cg_endo -61.2 -20.35 67.58 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.321 2.014 . . . . 0.0 113.405 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 61.6 m -80.47 -26.01 38.51 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.088 0.47 . . . . 0.0 111.641 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 11.8 m -114.0 8.25 7.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.449 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 73.04 48.79 18.83 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.7 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 58.6 mt -119.85 133.7 65.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 122.636 -0.332 . . . . 0.0 110.619 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.3 ptp -128.37 -2.88 5.57 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.265 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -164.39 130.62 2.98 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -44.64 96.35 0.11 Allowed Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 127.002 2.121 . . . . 0.0 113.83 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 904' ' ' PRO . 0.4 OUTLIER -114.08 156.03 0.04 OUTLIER 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 123.553 2.835 . . . . 0.0 116.346 -176.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 903' ' ' PRO . 10.2 Cg_endo -97.04 172.37 0.78 Allowed 'Trans proline' 0 N--CA 1.439 -1.681 0 N-CA-C 105.617 -2.493 . . . . 0.0 105.617 157.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . 0.527 ' HG3' ' H ' ' A' ' 907' ' ' MET . 8.3 pt-20 -86.43 -29.51 22.79 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 115.983 -2.287 . . . . 0.0 109.767 174.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 148.65 -20.24 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 130.518 3.527 . . . . 0.0 103.657 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . 0.527 ' H ' ' HG3' ' A' ' 905' ' ' GLU . 56.3 ttp -126.23 170.25 12.04 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 111.544 -2.571 . . . . 0.0 105.703 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -46.98 152.52 0.51 Allowed 'General case' 0 C--O 1.242 0.669 0 O-C-N 124.537 1.148 . . . . 0.0 110.929 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -107.98 124.37 50.06 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.582 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.37 145.94 46.66 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 892' ' ' TYR . 27.3 p -66.18 163.55 37.59 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.769 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.55 -23.65 26.07 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.695 2.263 . . . . 0.0 111.904 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -79.17 -50.87 10.3 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.721 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.463 ' HA ' ' HE2' ' A' ' 917' ' ' LYS . 98.0 m -82.89 -25.2 32.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.49 65.39 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -74.36 -19.6 60.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.256 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 49.2 mtmt -86.1 -30.56 22.46 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 46.3 mm -68.61 -61.27 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -94.08 95.17 8.83 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . 0.441 ' HB3' ' NZ ' ' A' ' 920' ' ' LYS . 4.7 ttpm? -146.16 -45.78 0.2 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.567 -166.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.26 135.56 44.21 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -168.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -86.15 146.27 26.65 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.689 -1.596 . . . . 0.0 107.519 177.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -85.23 -0.89 56.08 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.653 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 . . . . . 0 C--N 1.29 -2.021 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 174.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.915 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 4.7 p -102.14 -57.77 2.0 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 116.943 0.371 . . . . 0.0 110.069 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 64.1 m80 65.41 -70.11 0.1 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.289 1.436 . . . . 0.0 113.303 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 88.8 mtp -84.63 82.65 8.32 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -167.4 -163.38 0.51 Allowed 'General case' 0 C--N 1.307 -1.283 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 95.2 mmm -113.98 17.48 17.84 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -68.15 -88.52 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -124.76 1.18 8.13 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.591 0.71 . . . . 0.0 111.026 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 44.4 t -135.04 118.12 23.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.2 mt -131.92 165.39 32.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -117.91 147.93 42.64 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . 0.437 ' HB3' HD11 ' A' ' 867' ' ' ILE . 0.9 OUTLIER -85.42 -175.82 5.85 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.08 -27.53 67.44 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.796 0.331 . . . . 0.0 111.828 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -78.04 -48.16 16.76 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.977 0.418 . . . . 0.0 110.208 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 129.34 28.04 0.79 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.968 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -88.05 155.93 19.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -83.08 130.04 35.08 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-O 121.328 0.585 . . . . 0.0 109.455 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' A' ' 861' ' ' ASP . 50.7 mm -92.43 102.83 13.99 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 -75.51 114.34 13.96 Favored 'General case' 0 C--N 1.267 -2.997 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.436 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 50.1 mt -98.52 113.03 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 43.4 t -63.46 112.94 8.1 Favored Pre-proline 0 N--CA 1.422 -1.872 0 O-C-N 124.784 1.303 . . . . 0.0 109.068 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . 0.503 ' HD2' ' CE1' ' A' ' 892' ' ' TYR . 53.1 Cg_exo -58.82 -15.94 29.1 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.631 2.887 . . . . 0.0 113.098 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -70.59 -43.52 60.38 Favored Glycine 0 N--CA 1.433 -1.504 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.927 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.4 p -109.0 -26.51 10.15 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.952 0.406 . . . . 0.0 110.653 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 13.9 m120 77.95 25.02 0.67 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.772 1.629 . . . . 0.0 109.507 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.76 139.51 20.94 Favored Pre-proline 0 C--O 1.247 0.936 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.324 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 37.8 Cg_endo -71.43 173.86 11.76 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 123.649 2.899 . . . . 0.0 112.931 176.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.81 112.42 1.64 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.595 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -103.22 -6.56 21.98 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.926 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 117.97 -17.82 11.67 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.07 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 64.2 m -68.17 156.27 90.31 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-N 116.674 0.237 . . . . 0.0 110.773 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.16 133.71 36.47 Favored 'Trans proline' 0 C--O 1.253 1.26 0 C-N-CA 122.785 2.323 . . . . 0.0 111.784 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.0 mtp -119.0 154.43 33.08 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.1 tt -124.61 145.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -102.98 155.21 18.2 Favored Glycine 0 C--O 1.248 0.999 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 886' ' ' ASP . 43.4 t -79.96 175.12 10.92 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.739 0.78 . . . . 0.0 110.749 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . 0.413 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 19.2 t70 -99.04 -24.47 14.89 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . 0.431 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 10.6 t70 -91.85 -39.08 11.94 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.571 0.7 . . . . 0.0 109.623 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 5.3 p -120.04 172.42 7.76 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.208 0.528 . . . . 0.0 112.371 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -104.26 11.22 35.13 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.926 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -80.17 149.86 30.36 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.226 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -110.83 134.47 52.49 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.902 0.382 . . . . 0.0 111.879 -173.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . 0.503 ' CE1' ' HD2' ' A' ' 871' ' ' PRO . 90.5 m-85 -123.58 147.89 46.87 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.761 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 53.6 m80 -76.47 145.01 39.5 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.413 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 35.9 m0 -54.58 -51.85 74.95 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 174.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 33.3 Cg_endo -63.36 -12.53 31.01 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.525 2.15 . . . . 0.0 113.162 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.761 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 73.6 m -85.34 -29.91 24.11 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.199 0.524 . . . . 0.0 110.834 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 16.7 m -107.89 -4.6 10.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.469 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 86.31 32.69 15.93 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.566 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 52.1 mt -98.28 123.92 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-O 121.365 0.602 . . . . 0.0 109.93 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -106.7 -19.78 13.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.073 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -151.83 150.47 30.16 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . 0.406 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -53.97 111.48 2.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.653 1.221 . . . . 0.0 111.385 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 40.1 Cg_endo -69.6 149.19 67.6 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.489 2.126 . . . . 0.0 110.816 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.23 126.57 22.51 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.601 2.2 . . . . 0.0 111.679 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.77 -9.24 58.43 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.525 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.52 -20.22 63.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.386 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 52.1 tpp -102.72 149.77 24.13 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.278 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -85.38 149.05 25.7 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.223 0.535 . . . . 0.0 109.825 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -139.76 131.84 27.97 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -125.13 140.53 52.79 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 24.8 p -71.33 164.57 56.23 Favored Pre-proline 0 N--CA 1.424 -1.745 0 O-C-N 123.855 0.722 . . . . 0.0 110.524 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -59.92 -9.97 11.12 Favored 'Trans proline' 0 CA--C 1.552 1.409 0 C-N-CA 122.895 2.397 . . . . 0.0 112.704 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 913' ' ' LYS . 72.8 mmtt -87.26 -46.32 9.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 122.252 -0.28 . . . . 0.0 110.289 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 92.2 m -76.4 -27.81 56.45 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.218 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -68.77 -24.73 64.47 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.437 0.637 . . . . 0.0 109.67 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -68.37 -37.69 80.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -60.94 -38.43 85.8 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.432 0.634 . . . . 0.0 109.845 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 50.4 mm -63.26 -35.6 72.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.415 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -100.09 -3.52 31.72 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -173.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 923' ' ' LYS . 19.9 mtmm -86.87 97.88 10.9 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 118.141 -1.424 . . . . 0.0 109.097 176.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -86.73 -23.66 25.42 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.403 0.621 . . . . 0.0 109.854 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -73.09 -44.16 60.83 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.041 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . 0.407 ' O ' ' HE2' ' A' ' 920' ' ' LYS . 22.3 ttmm -154.5 158.62 40.16 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 . . . . . 0 C--N 1.311 -1.073 0 CA-C-O 118.546 -0.74 . . . . 0.0 110.294 178.561 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.771 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 16.7 m -81.42 155.14 26.04 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -152.32 177.21 10.81 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -155.59 34.96 0.36 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 174.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -72.83 125.58 27.89 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.562 -1.654 . . . . 0.0 110.456 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 26.2 ptm -134.52 134.36 41.34 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 869' ' ' ILE . . . -142.91 -178.26 5.73 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . 0.542 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 65.0 m-85 -121.61 7.79 10.04 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.792 -174.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.57 128.59 60.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 45.3 mt -137.13 162.26 34.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 860' ' ' ARG . 54.1 mtt180 -102.89 140.78 36.71 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 119.071 0.85 . . . . 0.0 110.966 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -76.71 173.67 11.35 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.681 173.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -70.66 -26.76 63.59 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.546 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 96.2 m95 -88.61 -6.57 57.44 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.193 0.521 . . . . 0.0 109.926 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 94.32 13.71 53.27 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.942 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.546 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 51.6 m-80 -72.9 158.88 34.65 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -91.72 127.99 37.39 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 121.982 0.896 . . . . 0.0 111.726 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 46.3 mm -99.62 125.96 53.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.592 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -108.08 152.71 24.15 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.542 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 31.9 mt -112.69 133.0 59.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 O-C-N 123.579 0.55 . . . . 0.0 109.823 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 45.3 t -80.54 111.39 22.44 Favored Pre-proline 0 N--CA 1.421 -1.886 0 C-N-CA 124.911 1.284 . . . . 0.0 109.24 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 32.6 Cg_exo -63.3 2.88 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.315 0 C-N-CA 123.894 3.063 . . . . 0.0 113.498 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -90.04 -19.38 47.06 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.743 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 7.0 p -137.97 -25.29 0.98 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 17.1 t30 78.92 20.43 0.75 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.671 1.589 . . . . 0.0 109.257 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 99.3 mttt -92.43 139.12 23.83 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.731 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.403 ' CA ' HG12 ' A' ' 869' ' ' ILE . 57.8 Cg_endo -77.59 163.7 29.12 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.546 2.831 . . . . 0.0 112.487 174.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.462 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 12.8 t70 -59.1 125.95 25.69 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.525 0.73 . . . . 0.0 111.831 175.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -99.02 19.5 15.01 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.655 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 84.11 42.5 7.53 Favored Glycine 0 CA--C 1.488 -1.639 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 -172.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 881' ' ' PRO . 9.1 p -115.48 150.79 45.2 Favored Pre-proline 0 N--CA 1.409 -2.508 0 CA-C-N 113.77 -1.215 . . . . 0.0 111.565 -170.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 880' ' ' SER . 16.3 Cg_exo -68.77 123.0 9.95 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 122.072 1.848 . . . . 0.0 108.72 171.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.462 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 92.4 mtp -120.27 157.18 29.7 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.9 tt -119.19 134.96 61.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.15 157.5 21.55 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 886' ' ' ASP . 52.3 t -80.64 170.77 15.89 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.5 0.667 . . . . 0.0 110.503 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . 0.409 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 22.2 t70 -93.82 -24.1 17.89 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . 0.416 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 16.0 t70 -99.86 -48.1 4.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.796 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.7 p -98.65 165.3 11.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.354 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -88.32 -16.19 33.71 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.158 0.983 . . . . 0.0 110.521 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.66 152.29 45.54 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.757 -174.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -105.42 133.64 49.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.512 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -115.4 146.77 41.28 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.698 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.3 m80 -76.88 141.07 40.74 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -50.31 -51.62 61.87 Favored Pre-proline 0 CA--C 1.555 1.161 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.78 -22.53 74.58 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.402 2.068 . . . . 0.0 114.176 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 60.9 m -81.02 -26.9 36.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.529 0.681 . . . . 0.0 111.652 -175.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.625 HG23 HG12 ' A' ' 899' ' ' ILE . 15.1 m -112.68 -5.47 11.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.087 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 85.65 41.81 7.12 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.365 175.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.625 HG12 HG23 ' A' ' 897' ' ' VAL . 39.9 mm -90.98 108.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.7 ptm -87.19 -23.93 24.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.735 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -162.68 149.36 12.95 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -49.66 110.6 1.65 Allowed Pre-proline 0 C--O 1.241 0.619 0 O-C-N 124.508 1.13 . . . . 0.0 111.8 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.74 157.76 51.5 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.979 2.452 . . . . 0.0 112.107 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -68.96 130.17 19.82 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.399 2.066 . . . . 0.0 110.522 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -76.6 -5.36 47.44 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.339 0.59 . . . . 0.0 110.672 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -68.67 -21.72 64.42 Favored 'General case' 0 N--CA 1.391 -3.409 0 C-N-CA 125.729 1.612 . . . . 0.0 108.985 172.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 46.9 ttm -103.71 136.61 43.09 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.77 144.53 47.54 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.183 0.516 . . . . 0.0 110.435 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -130.09 131.98 45.96 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -133.45 137.78 45.88 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.246 0.546 . . . . 0.0 110.132 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 7.5 p -73.48 172.12 9.01 Favored Pre-proline 0 C--N 1.296 -1.723 0 C-N-CA 124.862 1.265 . . . . 0.0 110.641 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.71 -16.17 23.86 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 123.002 2.468 . . . . 0.0 111.665 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.669 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 11.7 mmmm -80.56 -55.02 5.14 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.26 0.624 . . . . 0.0 110.849 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.435 ' O ' HG12 ' A' ' 918' ' ' ILE . 71.6 m -85.59 -22.82 27.86 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.65 -22.18 61.72 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 913' ' ' LYS . 3.4 t-20 -66.96 -36.13 81.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.741 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.405 ' NZ ' ' SG ' ' A' ' 914' ' ' CYS . 90.2 mttt -66.05 -49.14 68.69 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.404 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 914' ' ' CYS . 32.5 mm -61.12 -39.87 83.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.078 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . 0.424 ' HG2' ' HB2' ' A' ' 921' ' ' ASP . 24.2 ttpp 70.09 81.47 0.17 Allowed 'General case' 0 N--CA 1.408 -2.544 0 C-N-CA 126.273 1.829 . . . . 0.0 109.829 -174.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -73.98 -38.15 64.23 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . 0.424 ' HB2' ' HG2' ' A' ' 919' ' ' LYS . 28.0 t70 59.98 86.86 0.09 Allowed 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 113.619 -1.628 . . . . 0.0 111.42 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.74 79.96 9.29 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.58 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -154.51 139.18 17.0 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.216 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 . . . . . 0 C--N 1.287 -2.135 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 172.285 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . 0.424 ' N ' ' SG ' ' A' ' 888' ' ' CYS . . . . . . . . 0 N--CA 1.464 0.536 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . 0.79 ' HA ' ' SD ' ' A' ' 855' ' ' MET . 78.7 p -149.11 13.75 0.88 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 117.592 0.696 . . . . 0.0 111.581 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -79.03 -84.48 0.08 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.169 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 66.6 mtt -123.39 -45.76 2.07 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 122.207 1.003 . . . . 0.0 109.215 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -81.93 81.57 7.87 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.604 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . 0.79 ' SD ' ' HA ' ' A' ' 851' ' ' SER . 25.5 ptt? -147.94 24.71 1.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 122.139 0.971 . . . . 0.0 109.856 175.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -93.04 17.05 11.43 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.842 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . 0.507 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 49.7 m-85 -91.73 77.92 5.53 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.61 118.06 37.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.517 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 54.5 mt -117.07 162.78 14.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -96.63 134.33 40.01 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 119.313 0.96 . . . . 0.0 110.108 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -75.86 174.4 9.94 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.99 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -68.47 -30.04 68.8 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 123.666 0.786 . . . . 0.0 110.784 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -79.95 -15.58 56.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.885 0.85 . . . . 0.0 108.895 176.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 96.93 18.56 29.17 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -81.6 178.24 8.46 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -95.88 129.0 43.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.073 0.463 . . . . 0.0 110.317 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 28.2 mm -92.1 122.27 43.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -90.84 148.61 22.39 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 124.22 0.95 . . . . 0.0 111.208 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 50.7 mt -122.17 136.44 59.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.471 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.85 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 50.0 t -77.59 106.98 4.38 Favored Pre-proline 0 N--CA 1.426 -1.668 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . 0.485 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 57.5 Cg_endo -78.14 15.19 1.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.018 1.812 . . . . 0.0 111.977 -177.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -87.52 -32.0 14.62 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 9.4 p -115.13 -32.37 5.72 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.582 -0.309 . . . . 0.0 110.475 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 87.55 26.26 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.828 2.051 . . . . 0.0 109.864 -175.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.473 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 25.6 mtpp -110.23 139.07 21.08 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.553 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.6 Cg_endo -76.51 169.95 20.89 Favored 'Trans proline' 0 C--O 1.249 1.051 0 C-N-CA 123.426 2.751 . . . . 0.0 112.98 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -51.99 113.45 1.01 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.538 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -107.64 18.18 21.74 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.58 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 83.72 27.75 37.51 Favored Glycine 0 CA--C 1.492 -1.366 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 10.7 p -106.02 167.59 9.44 Favored Pre-proline 0 N--CA 1.42 -1.935 0 C-N-CA 123.82 0.848 . . . . 0.0 110.043 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.75 123.84 9.29 Favored 'Trans proline' 0 N--CA 1.437 -1.811 0 C-N-CA 121.368 1.379 . . . . 0.0 109.762 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 78.1 mtp -122.44 150.51 42.39 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.668 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . 0.528 ' HB ' ' HE1' ' A' ' 894' ' ' TRP . 19.0 tt -117.36 148.67 19.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -109.87 157.45 15.06 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.596 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.523 ' HB3' ' OD2' ' A' ' 890' ' ' ASP . 42.2 t -91.73 -170.83 2.69 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 126.037 1.735 . . . . 0.0 108.016 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -120.54 -23.34 6.11 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.965 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . 0.45 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 3.4 t70 -102.52 -25.09 13.72 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -167.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 890' ' ' ASP . 22.6 p -119.12 -143.93 0.36 Allowed 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -174.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -130.04 87.04 2.47 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . 0.523 ' OD2' ' HB3' ' A' ' 885' ' ' CYS . 1.4 p30 -128.78 157.62 40.94 Favored 'General case' 0 C--N 1.256 -3.494 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -159.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -161.09 117.3 2.22 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 127.85 2.46 . . . . 0.0 106.409 161.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . 0.485 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 62.8 m-85 -120.02 147.98 44.12 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.728 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 53.4 m80 -76.69 140.2 40.79 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.899 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.528 ' HE1' ' HB ' ' A' ' 883' ' ' ILE . 24.2 m0 -53.51 -51.2 78.11 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.08 -9.42 25.01 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.039 1.826 . . . . 0.0 113.919 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.728 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 74.3 m -86.51 -39.7 15.99 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.293 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.618 HG23 HG12 ' A' ' 899' ' ' ILE . 30.5 m -104.57 -4.07 9.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.205 -175.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 87.1 53.0 2.93 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.519 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.618 HG12 HG23 ' A' ' 897' ' ' VAL . 16.7 mm -114.02 136.05 51.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.2 ptp -121.08 -15.59 8.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.605 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -162.61 135.48 5.77 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -39.21 96.7 0.12 Allowed Pre-proline 0 N--CA 1.494 1.746 0 C-N-CA 126.169 1.788 . . . . 0.0 113.833 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 904' ' ' PRO . 12.0 Cg_endo -109.92 139.55 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 123.553 2.835 . . . . 0.0 118.113 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 903' ' ' PRO . 29.8 Cg_endo -101.58 158.27 0.37 Allowed 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 123.388 2.726 . . . . 0.0 108.327 160.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -87.92 -31.0 19.66 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 117.896 -1.522 . . . . 0.0 109.803 174.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 150.92 -20.47 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 129.621 3.168 . . . . 0.0 103.555 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 25.8 ttt -117.8 166.53 12.35 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 111.708 -2.496 . . . . 0.0 106.757 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 910' ' ' PHE . 38.2 mt-30 -56.42 160.02 3.35 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 124.528 1.142 . . . . 0.0 109.446 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -101.12 131.38 47.08 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 908' ' ' GLN . 92.0 m-85 -128.76 139.34 52.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 27.4 p -66.43 166.99 14.23 Favored Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 124.226 0.954 . . . . 0.0 110.944 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -48.78 -24.48 7.03 Favored 'Trans proline' 0 CA--C 1.552 1.405 0 C-N-CA 123.841 3.028 . . . . 0.0 113.075 175.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -87.01 -41.31 13.98 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.725 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 90.8 m -85.7 -17.94 34.53 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.65 74.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 122.127 0.965 . . . . 0.0 108.654 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.78 -29.19 70.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.897 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.508 ' HA ' ' CB ' ' A' ' 921' ' ' ASP . 91.1 mttt -70.4 -35.49 73.5 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.173 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.422 HD11 ' CD2' ' A' ' 910' ' ' PHE . 70.8 mt -64.28 -39.37 85.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -64.75 -75.19 0.09 Allowed 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.1 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -173.92 108.14 0.14 Allowed 'General case' 0 N--CA 1.41 -2.469 0 C-N-CA 125.464 1.505 . . . . 0.0 109.694 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . 0.508 ' CB ' ' HA ' ' A' ' 917' ' ' LYS . 36.6 t70 -129.48 37.51 3.99 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.673 1.225 . . . . 0.0 108.672 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -79.85 101.8 8.74 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.28 172.5 17.24 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.069 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 9.4 p80 . . . . . 0 C--N 1.309 -1.186 0 C-N-CA 125.127 1.371 . . . . 0.0 108.985 172.551 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.675 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 5.3 p -83.59 176.91 8.67 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.027 0.531 . . . . 0.0 110.93 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -76.08 -49.6 17.01 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.287 0.565 . . . . 0.0 110.25 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 21.0 mmt -123.42 160.36 27.01 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.474 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 66.02 19.58 11.21 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.035 0.934 . . . . 0.0 110.989 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -84.74 -12.9 52.78 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.645 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -159.97 -173.11 3.91 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 67.93 30.1 6.25 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.526 1.155 . . . . 0.0 108.15 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 92.3 t -131.91 120.74 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 113.717 -1.583 . . . . 0.0 108.969 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 45.6 mt -119.75 152.28 22.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -102.97 137.69 40.83 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.161 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.65 172.65 10.27 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.569 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.8 -28.05 66.41 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 122.613 0.365 . . . . 0.0 110.758 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 -74.72 -23.85 58.65 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 107.62 3.82 34.69 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.164 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -69.69 149.0 48.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.977 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -84.62 127.05 33.87 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.737 0.78 . . . . 0.0 112.096 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 47.0 mm -98.75 117.55 43.97 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -94.24 135.88 35.14 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.742 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.538 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 51.1 mt -105.77 128.35 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 25.7 t -82.75 107.97 10.87 Favored Pre-proline 0 N--CA 1.414 -2.234 0 C-N-CA 125.04 1.336 . . . . 0.0 108.833 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 36.2 Cg_exo -63.17 0.25 1.81 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.459 2.772 . . . . 0.0 113.014 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.3 -33.61 35.05 Favored Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 20.3 p -119.6 -28.43 5.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.816 0.341 . . . . 0.0 110.719 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.0 t30 80.63 29.51 0.21 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.032 2.133 . . . . 0.0 109.04 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -113.05 141.4 25.55 Favored Pre-proline 0 C--O 1.243 0.732 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.038 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 39.9 Cg_endo -74.43 155.84 45.67 Favored 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 123.324 2.682 . . . . 0.0 112.691 174.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.579 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 19.5 t70 -77.35 145.72 37.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.81 176.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -133.89 5.66 3.63 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.972 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 118.73 40.66 0.65 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.723 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 37.8 m -105.07 166.08 12.07 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -69.35 123.07 9.86 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.636 1.557 . . . . 0.0 109.778 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 53.2 mtp -120.42 161.06 21.86 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.608 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.9 tt -138.26 148.15 25.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -121.14 149.16 17.4 Favored Glycine 0 C--O 1.252 1.224 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.502 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 52.2 t -64.69 160.76 19.22 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.64 1.176 . . . . 0.0 110.995 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.78 -12.34 53.89 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -106.71 -39.41 5.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.598 ' HB2' ' OD1' ' A' ' 890' ' ' ASP . 22.9 m -85.85 -160.87 0.57 Allowed 'General case' 0 CA--C 1.569 1.691 0 CA-C-O 121.849 0.833 . . . . 0.0 113.159 -174.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -133.55 29.63 3.88 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . 0.598 ' OD1' ' HB2' ' A' ' 888' ' ' CYS . 11.7 p-10 -89.28 176.97 6.73 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 112.068 -2.333 . . . . 0.0 112.399 -170.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -152.72 116.94 4.91 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.43 -1.714 . . . . 0.0 106.859 170.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . 0.444 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 26.6 m-85 -107.46 158.67 17.0 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.719 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 42.2 m80 -86.81 144.5 27.01 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.623 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 29.2 m0 -51.9 -54.11 44.09 Favored Pre-proline 0 CA--C 1.552 1.022 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.58 -23.33 64.51 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.158 1.905 . . . . 0.0 113.202 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.719 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 53.5 m -79.73 -21.89 43.96 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.252 0.549 . . . . 0.0 111.531 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 12.6 m -116.46 9.92 7.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.43 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 70.8 38.23 66.08 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 114.928 -1.033 . . . . 0.0 113.199 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.623 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 51.0 mt -111.07 127.05 68.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 120.993 0.425 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 92.7 mmm -123.54 -6.48 8.11 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.133 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -145.16 138.12 26.34 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . 0.418 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -59.95 112.69 5.76 Favored Pre-proline 0 C--N 1.317 -0.822 0 O-C-N 124.442 1.089 . . . . 0.0 110.992 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 42.2 Cg_endo -69.24 164.49 33.83 Favored 'Trans proline' 0 C--O 1.25 1.108 0 C-N-CA 122.679 2.253 . . . . 0.0 111.184 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.53 126.64 22.95 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.24 1.96 . . . . 0.0 111.98 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . 0.538 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 0.5 OUTLIER -82.3 -6.81 59.5 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.724 -178.272 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 906' ' ' GLU . 11.5 pt-20 -92.43 8.23 39.53 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.815 -1.539 . . . . 0.0 108.882 177.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 23.0 ttt -122.52 139.62 53.68 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -75.92 137.99 40.73 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -126.99 134.52 50.34 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -124.45 140.17 53.2 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.307 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 892' ' ' TYR . 25.4 p -64.16 163.87 21.7 Favored Pre-proline 0 N--CA 1.424 -1.755 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.682 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.43 -10.54 6.83 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 122.806 2.337 . . . . 0.0 112.434 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 913' ' ' LYS . 74.4 mmtt -87.81 -57.95 2.75 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.431 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 75.1 m -69.25 -25.99 64.56 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.32 68.64 Favored 'General case' 0 C--O 1.198 -1.633 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.5 -5.01 58.46 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -87.77 -44.14 11.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 67.0 mt -72.41 -50.89 32.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.777 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -89.91 79.96 6.52 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -139.16 -59.33 0.59 Allowed 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 37.4 t70 48.37 82.64 0.04 OUTLIER 'General case' 0 C--O 1.243 0.757 0 O-C-N 125.191 1.557 . . . . 0.0 112.789 173.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.17 160.55 14.27 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.079 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -151.62 153.7 34.97 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 69.1 t60 . . . . . 0 C--N 1.303 -1.427 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.774 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.129 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 10.8 p -97.48 -50.08 4.65 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 116.686 0.243 . . . . 0.0 111.162 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 57.52 35.73 26.14 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 122.442 1.115 . . . . 0.0 108.638 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . 0.481 ' HG2' ' H ' ' A' ' 855' ' ' MET . 55.3 ttp -71.69 132.21 44.24 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.575 -174.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -84.92 8.15 18.58 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.694 0.759 . . . . 0.0 112.274 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . 0.481 ' H ' ' HG2' ' A' ' 853' ' ' MET . 97.5 mmm -91.32 80.8 5.51 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -154.51 -162.25 1.36 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.379 -175.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -85.38 10.0 13.97 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.395 0.616 . . . . 0.0 110.716 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.83 109.18 18.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 56.4 mt -102.84 148.58 7.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -96.88 122.87 40.32 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.421 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.21 165.52 11.31 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.75 -29.58 70.22 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -94.46 3.67 54.85 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.3 1.048 . . . . 0.0 109.776 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.06 22.22 46.27 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.486 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -76.71 147.73 37.22 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -80.09 113.6 18.38 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.174 0.512 . . . . 0.0 111.765 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 45.8 mm -97.92 118.67 44.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 175.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -99.98 147.0 26.06 Favored 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.334 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 37.4 mt -113.49 132.49 62.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.898 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 53.8 t -86.81 107.15 12.85 Favored Pre-proline 0 N--CA 1.405 -2.686 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 24.6 Cg_exo -65.01 1.35 1.94 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.14 2.56 . . . . 0.0 113.852 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -77.44 -50.4 6.68 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 4.4 p -102.24 -19.26 15.13 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 123.093 0.557 . . . . 0.0 110.288 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 77.56 19.39 1.21 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.557 1.543 . . . . 0.0 109.857 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -103.07 140.61 21.21 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.153 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 48.1 Cg_endo -74.85 173.02 15.16 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 123.269 2.646 . . . . 0.0 112.067 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.38 129.18 40.64 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.516 0.674 . . . . 0.0 111.101 174.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -118.06 34.36 5.21 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 73.54 44.1 34.36 Favored Glycine 0 CA--C 1.493 -1.287 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -173.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.5 p -120.23 151.04 52.71 Favored Pre-proline 0 N--CA 1.412 -2.338 0 CA-C-N 113.871 -1.164 . . . . 0.0 111.526 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.75 120.18 6.28 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 121.88 1.72 . . . . 0.0 109.995 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 76.3 mtp -115.94 150.28 37.4 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.839 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.6 tt -123.27 140.0 48.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -107.08 144.63 15.91 Favored Glycine 0 C--O 1.247 0.937 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.284 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 44.5 t -70.05 147.73 49.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.351 0.596 . . . . 0.0 112.08 -178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -81.9 -24.22 35.81 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.249 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.2 -51.79 9.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 120.989 0.424 . . . . 0.0 110.002 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 10.5 p -107.7 -92.86 0.41 Allowed 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.1 t70 179.62 -30.78 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.325 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -50.72 134.33 24.97 Favored 'General case' 0 C--O 1.247 0.947 0 O-C-N 124.703 1.252 . . . . 0.0 112.384 -172.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -101.9 133.16 47.11 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.333 -172.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -117.84 155.55 29.91 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.411 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.467 ' O ' HG22 ' A' ' 897' ' ' VAL . 41.3 m80 -77.21 143.57 38.91 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.494 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 27.7 m0 -49.8 -53.78 38.7 Favored Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.14 -19.02 65.1 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.228 1.952 . . . . 0.0 113.795 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 79.3 m -84.11 -23.7 30.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.003 0.43 . . . . 0.0 111.925 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.553 HG23 HG12 ' A' ' 899' ' ' ILE . 12.5 m -114.98 5.98 7.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.934 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 75.64 44.8 19.6 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.837 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.553 HG12 HG23 ' A' ' 897' ' ' VAL . 7.7 mm -110.32 109.7 29.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 mmt -109.61 -2.29 17.61 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.182 0.515 . . . . 0.0 110.43 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -154.32 143.62 21.32 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -58.1 116.76 15.75 Favored Pre-proline 0 N--CA 1.438 -1.058 0 O-C-N 124.225 0.953 . . . . 0.0 110.673 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 18.2 Cg_endo -68.19 140.33 48.85 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.262 1.975 . . . . 0.0 110.632 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.11 152.84 56.35 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.571 2.181 . . . . 0.0 112.261 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . 0.495 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 1.0 OUTLIER -73.67 -5.51 41.01 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.216 -178.064 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.37 -10.91 47.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.691 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 24.0 ttt -95.35 125.76 40.19 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.64 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -84.49 126.78 33.59 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -123.84 129.46 51.05 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.907 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.467 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 55.3 m-85 -120.13 142.44 48.92 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 25.7 p -63.9 160.21 48.23 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -51.53 -23.56 14.9 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.883 2.388 . . . . 0.0 112.529 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.565 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 33.3 mmtp -68.36 -55.19 12.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.37 0.668 . . . . 0.0 109.578 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.516 ' HA ' ' HE2' ' A' ' 917' ' ' LYS . 78.7 m -77.57 -22.09 51.5 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.493 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -63.56 -35.66 81.24 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.443 1.116 . . . . 0.0 108.585 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -76.72 -17.5 59.05 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.165 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 43.7 mtmt -85.76 -16.39 39.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 49.9 mm -67.54 -32.05 55.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp 52.76 118.77 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 127.211 2.204 . . . . 0.0 115.601 176.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -83.13 73.19 10.1 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 122.551 1.167 . . . . 0.0 108.416 173.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -93.43 -33.15 13.94 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 113.619 -1.628 . . . . 0.0 107.578 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -99.09 -174.25 2.71 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . 0.422 ' NZ ' ' HB2' ' A' ' 923' ' ' LYS . 3.1 ttmp? -80.01 156.76 27.0 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.264 0.554 . . . . 0.0 110.647 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 76.4 t60 . . . . . 0 C--N 1.305 -1.352 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.698 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.17 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 51.6 m 61.82 -174.2 0.14 Allowed 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.409 0.684 . . . . 0.0 111.464 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . 0.434 ' HE1' ' OD1' ' A' ' 874' ' ' ASN . 60.7 t60 -87.9 87.24 7.29 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 60.2 mtt -94.92 84.71 4.21 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 121.709 0.766 . . . . 0.0 111.14 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -143.6 119.1 10.34 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 26.1 mmt -82.91 -31.4 27.81 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -159.17 179.0 9.41 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -108.5 11.9 26.5 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.965 0.888 . . . . 0.0 109.647 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.05 110.61 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.864 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.537 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 58.8 mt -117.15 160.88 16.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -115.18 136.89 52.63 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.754 0.706 . . . . 0.0 110.544 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.17 176.73 7.04 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 124.831 1.252 . . . . 0.0 109.065 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.58 -26.81 62.76 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.248 0.619 . . . . 0.0 110.209 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.61 -3.34 50.04 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.317 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.69 -2.95 86.29 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 116.161 -0.472 . . . . 0.0 113.056 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -71.24 153.22 42.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 123.611 0.242 . . . . 0.0 111.019 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -71.26 146.72 48.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.557 0.694 . . . . 0.0 111.75 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.537 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 31.3 mm -120.79 126.88 75.75 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.498 ' O ' ' HA ' ' A' ' 876' ' ' PRO . 26.1 m-90 -100.47 153.89 18.98 Favored 'General case' 0 C--N 1.285 -2.199 0 O-C-N 123.643 0.589 . . . . 0.0 111.235 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 859' ' ' ILE . 39.8 mt -118.15 117.48 54.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.745 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 38.4 t -73.81 111.65 13.15 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.28 7.97 2.74 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.984 1.79 . . . . 0.0 112.5 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.65 -27.11 43.75 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 8.4 p -121.52 -32.95 3.73 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.727 0.775 . . . . 0.0 109.411 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.434 ' OD1' ' HE1' ' A' ' 852' ' ' HIS . 55.8 m-80 80.45 39.78 0.08 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 126.745 2.018 . . . . 0.0 109.944 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -118.33 143.69 33.6 Favored Pre-proline 0 N--CA 1.446 -0.674 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.305 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 868' ' ' TRP . 50.7 Cg_endo -74.59 173.98 13.41 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 123.398 2.732 . . . . 0.0 113.018 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.42 138.93 2.21 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.071 0.949 . . . . 0.0 111.889 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -118.04 -22.97 7.6 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.144 0.974 . . . . 0.0 109.356 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 116.01 -10.49 17.97 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -171.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 11.9 p -65.05 153.0 90.04 Favored Pre-proline 0 N--CA 1.433 -1.301 0 C-N-CA 125.569 1.548 . . . . 0.0 111.193 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.54 137.37 46.17 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 122.278 1.985 . . . . 0.0 109.834 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 83.8 mtp -125.5 149.61 48.13 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.2 tt -118.84 150.75 21.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -113.76 144.92 18.33 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.418 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 49.2 t -76.72 154.69 33.88 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.58 -9.97 36.31 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.155 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.96 -64.13 1.2 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 1.6 p -94.57 -49.27 5.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.101 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 14.1 t70 80.01 79.54 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.471 1.508 . . . . 0.0 113.489 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -129.74 177.77 6.99 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -99.63 123.56 44.01 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 119.339 0.972 . . . . 0.0 112.819 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -116.82 148.69 41.0 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.756 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 49.1 m80 -76.85 144.08 39.27 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.219 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -52.77 -57.8 14.55 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.03 -11.21 30.08 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.77 1.647 . . . . 0.0 113.672 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -84.11 -37.05 22.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.285 0.564 . . . . 0.0 111.855 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.637 HG23 HG12 ' A' ' 899' ' ' ILE . 27.0 m -102.03 -8.63 9.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.772 -176.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 95.96 56.31 1.23 Allowed Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.592 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.637 HG12 HG23 ' A' ' 897' ' ' VAL . 9.0 mm -130.47 125.8 59.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 87.6 mtp -127.02 8.12 6.69 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.738 0.78 . . . . 0.0 110.411 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . 0.617 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -173.95 145.81 1.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -66.18 103.02 0.4 Allowed Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.7 1.2 . . . . 0.0 112.877 -174.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 25.5 Cg_endo -105.69 131.0 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 124.019 3.146 . . . . 0.0 115.998 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -100.01 148.78 0.45 Allowed 'Trans proline' 0 N--CA 1.43 -2.221 0 C-N-CA 122.745 2.297 . . . . 0.0 109.481 164.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -70.03 -46.98 63.89 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 149.8 -11.41 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 130.221 3.408 . . . . 0.0 103.516 -172.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . 0.404 ' HG2' ' N ' ' A' ' 908' ' ' GLN . 23.5 ttt -135.29 169.39 17.55 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 112.309 -2.223 . . . . 0.0 105.747 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . 0.404 ' N ' ' HG2' ' A' ' 907' ' ' MET . 28.5 mt-30 -45.7 157.99 0.09 Allowed 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.813 1.645 . . . . 0.0 113.421 176.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -108.85 137.5 46.68 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.464 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -126.02 138.25 53.71 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 27.4 p -69.33 163.44 58.19 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.037 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.06 -23.47 22.03 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 123.847 3.031 . . . . 0.0 112.492 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 29.9 mmmt -69.04 -44.02 73.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 73.6 m -89.01 -27.42 20.88 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.004 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.6 -24.91 61.98 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 120.777 0.322 . . . . 0.0 110.379 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.31 -13.84 59.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.606 0.717 . . . . 0.0 109.792 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -73.39 -29.58 62.7 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 54.4 mt -94.72 -60.62 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.382 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -96.03 147.28 23.87 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.208 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -123.98 85.07 2.36 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.38 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -105.14 -13.67 15.64 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -141.3 159.23 42.66 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.599 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.61 8.77 0.69 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.634 0.73 . . . . 0.0 111.434 176.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 . . . . . 0 C--N 1.302 -1.461 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -178.961 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.532 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 47.0 t -166.49 158.68 13.77 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -74.28 -18.77 60.67 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 173.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 71.8 mtm 66.0 31.97 8.73 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.35 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -77.6 70.84 4.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.185 0.993 . . . . 0.0 109.325 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 53.7 mtm -138.76 20.88 2.68 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -94.56 -177.53 4.26 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.971 -174.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 871' ' ' PRO . 54.9 m-85 -86.87 19.37 3.02 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.576 0.703 . . . . 0.0 110.123 -175.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.35 121.08 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.749 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 59.0 mt -124.83 154.22 32.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -91.82 125.52 36.56 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.925 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -71.01 171.58 10.6 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.293 -1.322 . . . . 0.0 109.043 172.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.39 -29.15 69.25 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 122.602 0.361 . . . . 0.0 111.884 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.501 ' HB3' ' ND2' ' A' ' 865' ' ' ASN . 44.2 t-105 -87.92 -11.93 46.18 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 97.95 15.05 37.64 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.812 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' A' ' 863' ' ' TRP . 45.9 m-80 -71.36 151.85 43.73 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -78.05 116.21 18.36 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 25.2 mm -64.15 114.59 2.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 122.172 0.987 . . . . 0.0 111.518 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.66 105.64 0.32 Allowed 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 111.478 -2.601 . . . . 0.0 110.988 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.499 ' O ' ' HD3' ' A' ' 871' ' ' PRO . 40.4 mt -127.07 131.04 71.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 891' ' ' TRP . 52.6 t -85.81 110.23 28.57 Favored Pre-proline 0 N--CA 1.418 -2.055 0 O-C-N 124.164 0.915 . . . . 0.0 108.849 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 869' ' ' ILE . 50.6 Cg_exo -57.0 -20.34 36.54 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.394 2.729 . . . . 0.0 113.028 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -68.97 -36.04 80.43 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.539 -0.362 . . . . 0.0 112.962 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 12.3 p -118.51 -13.54 9.71 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.806 0.303 . . . . 0.0 111.289 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 72.36 24.18 3.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.25 1.42 . . . . 0.0 109.692 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -113.6 138.41 22.58 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 121.771 -0.58 . . . . 0.0 112.071 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 57.1 Cg_endo -73.22 174.03 12.74 Favored 'Trans proline' 0 C--O 1.253 1.228 0 C-N-CA 124.154 3.236 . . . . 0.0 113.328 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.09 137.09 57.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.676 176.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -122.57 25.21 8.9 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.597 1.189 . . . . 0.0 107.856 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 81.52 52.47 4.18 Favored Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 106.438 -2.665 . . . . 0.0 106.438 -171.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 3.7 p -124.0 152.57 66.94 Favored Pre-proline 0 N--CA 1.413 -2.278 0 CA-C-N 113.861 -1.17 . . . . 0.0 112.239 -170.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -72.23 112.58 3.47 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.032 1.822 . . . . 0.0 110.048 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 79.3 mtp -122.15 144.16 49.12 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.762 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 15.9 tt -117.19 152.18 19.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.779 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -110.17 156.38 15.61 Favored Glycine 0 CA--C 1.538 1.518 0 O-C-N 123.206 0.316 . . . . 0.0 113.441 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.518 ' H ' ' CG ' ' A' ' 890' ' ' ASP . 43.8 t -84.92 -170.26 3.04 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 126.31 1.844 . . . . 0.0 109.157 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -123.08 -11.54 8.04 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -107.91 -54.63 2.47 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -173.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 15.7 p -99.57 -134.79 0.28 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -165.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -128.74 89.48 2.89 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' A' ' 885' ' ' CYS . 2.6 p30 -128.06 148.69 50.56 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -158.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . 0.467 ' O ' ' HA ' ' A' ' 870' ' ' CYS . 68.2 m95 -161.52 117.66 2.13 Favored 'General case' 0 C--O 1.208 -1.129 0 C-N-CA 128.058 2.543 . . . . 0.0 106.929 160.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -124.54 148.73 47.59 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.462 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.68 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 57.9 m80 -80.8 144.86 31.77 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -53.53 -52.68 64.66 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.2 -11.59 32.79 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.998 1.799 . . . . 0.0 113.122 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 87.6 m -84.66 -32.14 23.79 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.648 0.737 . . . . 0.0 110.928 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 893' ' ' HIS . 20.9 m -101.52 -27.46 3.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.934 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 104.22 52.99 0.85 Allowed Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.052 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.79 136.64 58.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.026 0.441 . . . . 0.0 110.854 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.8 ptp -128.37 -1.11 5.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.849 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -150.4 141.72 23.27 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -71.91 112.34 13.96 Favored Pre-proline 0 C--N 1.311 -1.089 0 C-N-CA 123.039 0.536 . . . . 0.0 111.912 -176.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -75.43 129.81 12.29 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.506 2.137 . . . . 0.0 111.029 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . 0.567 ' HB2' ' HG2' ' A' ' 906' ' ' GLU . 35.9 Cg_exo -60.39 143.76 99.49 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.661 2.241 . . . . 0.0 111.73 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 1.3 pm0 -71.08 -2.9 17.14 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -176.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.567 ' HG2' ' HB2' ' A' ' 904' ' ' PRO . 9.1 pt-20 -69.46 -18.6 63.73 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.322 0.582 . . . . 0.0 109.488 171.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 51.3 ttm -100.41 128.82 46.37 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -77.21 128.7 34.84 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -118.5 140.37 49.97 Favored 'General case' 0 C--N 1.26 -3.287 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -129.53 136.41 49.81 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 9.0 p -73.85 167.25 37.02 Favored Pre-proline 0 N--CA 1.415 -2.207 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.183 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.05 -19.7 21.05 Favored 'Trans proline' 0 CA--C 1.551 1.331 0 C-N-CA 122.976 2.451 . . . . 0.0 112.41 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -81.16 -37.02 29.45 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 110.285 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 97.3 m -89.1 -30.02 18.95 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.808 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.13 68.17 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.05 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -73.05 -19.43 61.18 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.281 0.562 . . . . 0.0 111.562 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -101.05 -27.68 13.14 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.201 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 72.7 mt -76.57 -54.79 12.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 121.249 0.547 . . . . 0.0 109.53 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -100.04 -176.95 3.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt 54.31 -157.25 0.2 Allowed 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.393 1.077 . . . . 0.0 111.729 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -122.37 159.77 26.81 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -79.14 171.88 14.58 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 125.195 1.398 . . . . 0.0 111.522 -175.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -147.1 150.98 36.08 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 36.8 m80 . . . . . 0 C--N 1.31 -1.127 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 170.579 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.384 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 51.5 m -77.57 130.45 36.93 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.105 0.453 . . . . 0.0 109.804 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 74.28 81.0 0.12 Allowed 'General case' 0 CA--C 1.511 -0.519 0 C-N-CA 124.282 1.033 . . . . 0.0 111.486 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 95.9 mmm -98.37 115.05 27.64 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.895 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 67.61 13.3 9.23 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.407 1.083 . . . . 0.0 110.589 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 65.4 mtt -100.24 98.68 9.33 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -116.89 -159.14 0.72 Allowed 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -90.03 19.73 4.74 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 122.179 0.99 . . . . 0.0 109.261 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 8.1 p -143.42 130.36 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.684 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 44.2 mt -124.39 150.75 29.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -94.75 125.06 39.16 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.622 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.02 172.37 11.13 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.157 174.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.93 -30.39 71.48 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 123.644 0.778 . . . . 0.0 111.188 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -85.53 -0.67 55.67 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.435 0.636 . . . . 0.0 110.465 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 84.01 3.76 88.91 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.213 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -73.01 149.65 43.08 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -78.96 128.17 32.93 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.532 0.682 . . . . 0.0 111.371 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 32.4 mm -96.02 121.61 46.73 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 23.4 m-90 -99.76 139.35 35.55 Favored 'General case' 0 C--N 1.264 -3.121 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.597 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 31.6 mt -103.97 119.16 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.404 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 50.7 t -61.89 108.83 1.76 Allowed Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 125.143 1.377 . . . . 0.0 108.222 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . 0.432 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 52.6 Cg_exo -57.7 -16.99 27.05 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.735 2.957 . . . . 0.0 113.22 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -70.88 -46.43 45.35 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.246 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 17.0 p -106.75 -28.01 10.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -173.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 63.4 t30 81.25 27.84 0.19 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.714 1.606 . . . . 0.0 109.221 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.53 139.33 20.0 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.182 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 42.6 Cg_endo -76.17 162.73 33.77 Favored 'Trans proline' 0 C--O 1.251 1.173 0 C-N-CA 123.08 2.52 . . . . 0.0 112.583 174.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.402 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 17.5 t70 -65.96 141.38 58.22 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.46 14.59 8.23 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 122.781 1.277 . . . . 0.0 107.965 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 85.29 52.66 3.33 Favored Glycine 0 N--CA 1.423 -2.186 0 N-CA-C 105.828 -2.909 . . . . 0.0 105.828 -170.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 11.4 p -119.69 153.54 54.44 Favored Pre-proline 0 N--CA 1.418 -2.034 0 CA-C-N 113.927 -1.137 . . . . 0.0 111.091 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.97 118.67 5.69 Favored 'Trans proline' 0 C--O 1.257 1.429 0 C-N-CA 122.24 1.96 . . . . 0.0 109.951 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.402 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 77.0 mtp -125.32 142.32 51.57 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.074 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.3 tt -110.73 144.88 17.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -110.99 163.52 12.25 Favored Glycine 0 C--N 1.301 -1.395 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.078 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.49 ' H ' ' CG ' ' A' ' 890' ' ' ASP . 51.2 t -88.99 -164.33 1.12 Allowed 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 126.027 1.731 . . . . 0.0 108.551 -177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . 0.406 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 30.2 t70 -131.34 -8.96 3.74 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.637 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -109.0 -46.93 3.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.4 p -104.29 -126.73 0.23 Allowed 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -166.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -136.02 88.54 2.4 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 885' ' ' CYS . 3.1 p30 -127.74 146.89 50.43 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 113.085 -1.87 . . . . 0.0 115.238 -161.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -162.39 117.62 1.88 Allowed 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 128.046 2.538 . . . . 0.0 106.349 158.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . 0.432 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 44.8 m-85 -123.25 148.97 45.32 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.756 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.8 m80 -77.91 145.85 35.91 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.513 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 31.6 m0 -51.95 -55.63 28.87 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 175.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.28 -12.68 34.04 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.426 2.084 . . . . 0.0 113.99 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.3 m -86.49 -21.88 26.74 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.027 0.442 . . . . 0.0 111.069 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.703 HG23 HG12 ' A' ' 899' ' ' ILE . 14.4 m -120.52 5.79 6.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.144 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 84.15 23.4 51.95 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.712 175.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.703 HG12 HG23 ' A' ' 897' ' ' VAL . 16.9 mm -91.04 121.6 41.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 18.3 ptm -118.29 -6.14 10.83 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.281 0.562 . . . . 0.0 110.568 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.1 149.81 21.57 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -60.32 112.95 6.28 Favored Pre-proline 0 C--N 1.314 -0.977 0 O-C-N 124.172 0.92 . . . . 0.0 111.004 -177.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -72.8 162.5 40.97 Favored 'Trans proline' 0 C--O 1.248 0.993 0 C-N-CA 123.155 2.57 . . . . 0.0 111.111 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.77 123.3 13.53 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.568 2.179 . . . . 0.0 111.682 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.42 -17.66 63.99 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.173 -0.922 . . . . 0.0 113.281 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -87.38 -9.42 54.82 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.919 0.39 . . . . 0.0 110.757 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 48.2 ttm -80.47 133.14 35.81 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -77.02 135.42 38.66 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -136.4 135.71 38.98 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -126.52 139.18 53.42 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 16.9 p -64.7 167.15 9.64 Favored Pre-proline 0 C--N 1.29 -2.003 0 O-C-N 124.2 0.937 . . . . 0.0 111.892 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 11.4 Cg_endo -56.17 -13.4 9.52 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 123.074 2.516 . . . . 0.0 112.128 175.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.489 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 31.6 mmmt -84.34 -60.57 2.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 917' ' ' LYS . 92.5 m -73.04 -27.41 61.74 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.78 78.22 Favored 'General case' 0 C--O 1.201 -1.481 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -72.42 -22.81 61.05 Favored 'General case' 0 C--O 1.211 -0.924 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 914' ' ' CYS . 92.3 mttt -72.06 -46.44 56.9 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.42 -43.71 77.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.465 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -94.46 28.33 2.63 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 123.664 0.785 . . . . 0.0 109.787 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -66.7 -33.26 75.25 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.662 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -142.5 107.08 4.82 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.365 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -73.13 100.77 3.14 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 170.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -83.85 147.61 27.45 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.176 -169.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 61.0 m80 . . . . . 0 C--N 1.299 -1.628 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.604 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.79 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 18.9 m -105.53 24.61 11.9 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.612 0.72 . . . . 0.0 109.247 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -93.96 28.08 2.56 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.2 -65.49 0.67 Allowed 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.329 -176.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 57.61 27.09 13.69 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.642 1.177 . . . . 0.0 110.793 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 21.3 ptp -134.19 -163.27 1.34 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.598 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . 0.434 ' O ' HD12 ' A' ' 869' ' ' ILE . . . 70.01 -150.56 0.11 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -175.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . 0.497 ' HA ' ' HB ' ' A' ' 869' ' ' ILE . 97.0 m-85 -86.77 16.49 4.75 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 118.568 0.622 . . . . 0.0 112.318 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 14.0 p -143.62 118.89 4.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.635 0.731 . . . . 0.0 112.231 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 47.5 mt -114.84 160.87 13.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -103.78 130.65 51.34 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.233 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.83 175.29 2.5 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 125.623 1.569 . . . . 0.0 111.123 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -58.32 -40.17 81.37 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 124.937 1.295 . . . . 0.0 111.107 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.48 ' HB3' ' ND2' ' A' ' 865' ' ' ASN . 66.9 t-105 -80.12 -25.92 39.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.369 0.604 . . . . 0.0 110.037 177.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 117.6 7.21 12.25 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.48 ' ND2' ' HB3' ' A' ' 863' ' ' TRP . 46.0 m-80 -64.25 159.9 19.8 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -85.24 117.4 24.16 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.332 0.587 . . . . 0.0 109.954 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 42.4 mm -90.76 114.02 27.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -86.13 128.07 34.82 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.847 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 857' ' ' TYR . 33.3 mt -100.9 123.7 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.15 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.1 t -77.71 117.2 64.15 Favored Pre-proline 0 N--CA 1.408 -2.533 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.152 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . 0.55 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 58.6 Cg_exo -56.5 -17.82 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.656 2.904 . . . . 0.0 113.32 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.75 -21.42 76.79 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 121.314 -0.469 . . . . 0.0 113.295 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 10.8 p -138.21 -10.6 1.48 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.301 0.551 . . . . 0.0 112.231 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.257 2.3 p-10 61.15 25.44 15.44 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.299 1.84 . . . . 0.0 111.129 -173.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -106.33 140.21 21.07 Favored Pre-proline 0 N--CA 1.435 -1.222 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.3 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.73 173.65 14.15 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 123.347 2.698 . . . . 0.0 112.336 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.96 138.7 42.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.616 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -119.58 -6.1 10.22 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.895 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 89.66 21.12 41.34 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -172.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.6 t -100.89 161.32 24.13 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.36 113.62 1.76 Allowed 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.732 2.288 . . . . 0.0 111.649 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 85.6 mtp -109.92 156.83 19.92 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.02 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.6 tt -126.6 142.73 42.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.92 152.39 19.66 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.579 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 48.8 t -85.15 169.89 13.43 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.649 0.738 . . . . 0.0 110.325 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.65 -32.96 16.01 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . 0.487 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 14.4 t70 -100.88 -38.31 8.29 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.529 -174.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 60.5 m -89.42 158.49 17.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.148 0.499 . . . . 0.0 110.255 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.64 -0.28 43.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -86.84 159.34 19.11 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.461 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -117.0 142.4 47.0 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.156 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 64.4 m-85 -114.69 171.33 7.7 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.758 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 65.2 m80 -99.12 151.93 20.43 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -54.35 -53.29 61.04 Favored Pre-proline 0 CA--C 1.553 1.094 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.65 -29.75 90.55 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.75 1.633 . . . . 0.0 113.011 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.758 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 28.5 m -70.41 -21.68 62.81 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.859 0.837 . . . . 0.0 111.901 -175.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.25 10.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.198 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 71.79 46.61 37.15 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.243 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.14 136.37 58.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 62.3 mtt -128.19 -4.92 5.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.52 156.43 30.23 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . 0.506 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -44.0 114.24 1.79 Allowed Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 125.206 1.566 . . . . 0.0 112.149 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.506 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 11.4 Cg_endo -57.09 177.58 0.18 Allowed 'Trans proline' 0 CA--C 1.57 2.302 0 C-N-CA 123.913 3.075 . . . . 0.0 113.066 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -46.62 -165.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 125.254 3.97 . . . . 0.0 117.937 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -63.8 37.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 127.839 2.456 . . . . 0.0 113.94 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.269 2.4 pt-20 50.08 26.99 2.3 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 126.783 2.033 . . . . 0.0 112.915 -177.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.4 tpt -61.47 145.93 50.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 170.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -44.97 126.03 5.57 Favored 'General case' 0 C--O 1.248 1.012 0 O-C-N 124.477 1.111 . . . . 0.0 113.879 -170.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -116.95 133.43 56.02 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.985 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -127.47 141.98 51.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 7.6 p -75.43 168.63 25.88 Favored Pre-proline 0 N--CA 1.421 -1.922 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.972 178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.72 -24.15 29.11 Favored 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 123.075 2.517 . . . . 0.0 111.803 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.594 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 0.0 OUTLIER -70.1 -58.5 3.74 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.98 176.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 87.2 m -72.91 -21.48 60.9 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.29 -20.2 65.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.51 -34.84 27.81 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.424 ' NZ ' ' SG ' ' A' ' 914' ' ' CYS . 22.5 mtmm -67.5 -43.18 81.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.508 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 72.0 mt -66.68 -36.18 76.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt 76.55 132.28 0.05 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.914 1.686 . . . . 0.0 111.662 174.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -84.95 -24.37 28.37 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 922' ' ' LYS . 17.0 t70 61.89 -161.74 0.29 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.665 1.186 . . . . 0.0 110.277 172.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . 0.444 ' H ' ' CG ' ' A' ' 921' ' ' ASP . 28.2 mtpp -85.64 63.07 7.85 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -56.44 130.49 45.1 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.865 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 40.3 m80 . . . . . 0 N--CA 1.418 -2.067 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 173.904 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.644 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 22.8 t -75.29 144.59 42.4 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -77.13 75.01 3.7 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.846 0.831 . . . . 0.0 111.881 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 66.7 mtt -119.1 -53.67 2.25 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.086 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -102.31 13.1 35.53 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.257 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 86.3 mtp -121.22 108.33 13.62 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -149.21 172.8 14.25 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.734 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -107.26 0.18 23.02 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.394 1.092 . . . . 0.0 108.269 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 42.5 t -130.79 101.08 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 112.672 -2.058 . . . . 0.0 105.483 172.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 40.0 mt -103.58 154.24 5.77 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -102.22 125.14 48.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.514 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . 0.501 ' HB3' ' H ' ' A' ' 865' ' ' ASN . 17.6 t70 -67.19 177.24 1.87 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.663 176.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -72.99 -25.11 60.87 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.357 0.599 . . . . 0.0 110.298 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -87.69 -12.64 44.77 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.157 0.98 . . . . 0.0 108.7 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 93.57 19.53 34.69 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.933 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.501 ' H ' ' HB3' ' A' ' 861' ' ' ASP . 63.8 m-20 -72.78 150.95 42.34 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -77.93 110.42 12.82 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 121.61 0.719 . . . . 0.0 110.696 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 46.3 mm -94.82 115.39 33.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -103.6 145.55 29.88 Favored 'General case' 0 C--N 1.255 -3.529 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.217 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.87 120.49 52.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.7 t -78.59 119.66 78.12 Favored Pre-proline 0 N--CA 1.404 -2.737 0 C-N-CA 125.0 1.32 . . . . 0.0 108.316 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.4 -4.58 13.17 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.63 2.22 . . . . 0.0 111.629 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -72.02 -43.5 48.64 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 5.7 p -114.49 -24.32 8.89 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.7 t30 78.75 24.66 0.55 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.824 1.65 . . . . 0.0 108.235 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -110.25 139.63 21.63 Favored Pre-proline 0 C--O 1.244 0.783 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.983 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.81 165.52 32.53 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.182 2.588 . . . . 0.0 112.361 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.715 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 16.6 t0 -60.49 117.33 5.15 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.634 0.731 . . . . 0.0 112.375 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.81 6.42 46.87 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.661 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 105.66 40.08 2.09 Favored Glycine 0 N--CA 1.435 -1.413 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 49.1 m -123.82 159.23 56.96 Favored Pre-proline 0 N--CA 1.428 -1.549 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.14 133.62 25.3 Favored 'Trans proline' 0 C--O 1.252 1.204 0 C-N-CA 122.405 2.07 . . . . 0.0 110.896 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.411 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 64.6 mtp -123.11 163.11 21.17 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.872 -178.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . 0.499 ' HB ' ' HE1' ' A' ' 894' ' ' TRP . 17.6 tt -141.28 143.23 28.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.95 151.96 17.29 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.629 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 53.8 t -76.09 150.97 37.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.094 0.473 . . . . 0.0 110.481 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -82.55 -25.56 33.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.748 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . 0.426 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 31.3 t70 -97.33 -40.33 8.78 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.309 -0.556 . . . . 0.0 112.343 -173.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 32.0 p -98.49 -106.13 0.2 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 117.879 -1.528 . . . . 0.0 114.11 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -158.79 -41.79 0.06 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.985 -170.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.77 161.12 30.42 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -170.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -112.26 133.76 54.19 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.345 -1.752 . . . . 0.0 108.384 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -117.22 159.17 23.08 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.715 ' HE2' ' HA ' ' A' ' 877' ' ' ASP . 56.2 m80 -82.93 144.74 29.81 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.145 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.499 ' HE1' ' HB ' ' A' ' 883' ' ' ILE . 38.2 m0 -53.52 -48.95 91.17 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 177.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 28.4 Cg_endo -63.71 -13.97 40.02 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.275 1.983 . . . . 0.0 113.088 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 75.0 m -89.37 -26.67 20.93 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.241 0.543 . . . . 0.0 111.803 -176.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 893' ' ' HIS . 18.8 m -110.11 -4.93 10.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.443 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 83.67 48.17 5.35 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.723 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 46.1 mt -112.89 121.87 65.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.605 0.717 . . . . 0.0 111.517 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 96.2 mmm -92.7 -31.19 15.19 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.345 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.74 159.67 35.49 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -48.26 109.58 1.19 Allowed Pre-proline 0 C--N 1.323 -0.554 0 O-C-N 124.73 1.268 . . . . 0.0 111.659 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 18.8 Cg_endo -60.25 147.02 95.16 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 123.236 2.624 . . . . 0.0 112.406 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 903' ' ' PRO . 25.4 Cg_exo -63.19 136.12 54.23 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.493 2.129 . . . . 0.0 110.803 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.56 1.44 16.76 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.53 -9.62 59.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.917 0.865 . . . . 0.0 108.819 173.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 36.4 ttm -113.51 121.79 45.31 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -76.28 131.15 39.07 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -104.5 124.81 49.93 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.121 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 74.2 m-85 -124.9 142.61 51.34 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.6 p -66.95 166.2 21.17 Favored Pre-proline 0 C--N 1.294 -1.817 0 O-C-N 123.609 0.568 . . . . 0.0 111.5 -176.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 5.0 Cg_endo -49.54 -27.28 14.03 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.431 2.754 . . . . 0.0 112.509 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -82.04 -47.93 12.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.341 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.504 ' HA ' ' HE2' ' A' ' 917' ' ' LYS . 92.5 m -78.38 -32.61 48.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . 0.504 ' O ' ' HG2' ' A' ' 919' ' ' LYS . . . -66.1 -32.03 73.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.51 -35.78 76.79 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.186 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 27.3 mtmt -70.77 -18.18 62.77 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.102 0.561 . . . . 0.0 110.656 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 51.0 mt -97.24 -33.18 4.3 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 CA-C-O 121.758 0.79 . . . . 0.0 109.771 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 915' ' ' ALA . 29.3 mmmt -86.4 -31.11 21.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.687 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -83.11 135.04 34.96 Favored 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.821 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 4.4 t70 68.65 -168.12 0.18 Allowed 'General case' 0 C--N 1.32 -0.686 0 O-C-N 124.647 1.217 . . . . 0.0 109.94 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.88 -8.03 12.57 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -140.37 -172.4 3.42 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 . . . . . 0 C--N 1.297 -1.695 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.054 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.216 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 4.4 p -141.31 77.17 1.58 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.863 0.84 . . . . 0.0 111.343 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -178.29 -74.17 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.693 -1.594 . . . . 0.0 107.496 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 36.7 tpp 51.07 89.7 0.02 OUTLIER 'General case' 0 C--O 1.243 0.755 0 C-N-CA 125.286 1.435 . . . . 0.0 113.193 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -84.93 127.67 34.28 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.066 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 69.9 mtm -78.32 80.72 4.71 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.398 0.618 . . . . 0.0 109.428 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -132.54 178.73 6.61 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 67.4 27.84 7.97 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -174.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 64.4 t -138.73 121.09 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 113.316 -1.765 . . . . 0.0 108.267 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 869' ' ' ILE . 55.7 mt -127.48 148.92 32.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 860' ' ' ARG . 41.3 mtt180 -95.02 125.06 39.42 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 121.734 0.778 . . . . 0.0 110.891 174.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.93 171.73 3.32 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.629 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -60.86 -36.38 79.02 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 124.024 0.929 . . . . 0.0 110.6 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.52 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 92.8 m95 -87.0 -10.15 53.84 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.376 0.608 . . . . 0.0 111.05 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 100.34 8.44 49.89 Favored Glycine 0 CA--C 1.5 -0.883 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.357 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 37.1 m-80 -71.79 160.94 31.72 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 866' ' ' GLN . 14.4 mm-40 -90.81 133.35 35.27 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 122.124 0.964 . . . . 0.0 112.159 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 45.8 mm -110.63 121.81 64.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 113.532 -1.667 . . . . 0.0 108.114 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -101.35 140.12 36.08 Favored 'General case' 0 C--N 1.271 -2.808 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.565 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 859' ' ' ILE . 36.4 mt -106.08 124.31 61.27 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 42.2 t -78.2 113.91 37.79 Favored Pre-proline 0 N--CA 1.404 -2.762 0 O-C-N 124.442 1.089 . . . . 0.0 108.743 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . 0.555 ' HD2' ' CE2' ' A' ' 892' ' ' TYR . 37.6 Cg_exo -61.19 -2.47 2.38 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.282 2.655 . . . . 0.0 113.309 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.06 -39.69 19.02 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.5 p -114.98 -25.81 8.0 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.349 0.66 . . . . 0.0 111.554 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 76.48 26.52 0.88 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.886 1.675 . . . . 0.0 110.085 -173.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -108.03 138.82 20.21 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.466 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 44.5 Cg_endo -72.83 170.71 19.0 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.369 2.713 . . . . 0.0 113.749 176.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -64.31 133.28 52.39 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.097 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -123.44 6.73 8.97 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.903 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 93.65 22.86 25.15 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 2.7 p -96.31 155.85 37.58 Favored Pre-proline 0 C--N 1.296 -1.722 0 C-N-CA 123.35 0.66 . . . . 0.0 110.408 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.43 118.09 4.93 Favored 'Trans proline' 0 C--O 1.257 1.456 0 C-N-CA 122.069 1.846 . . . . 0.0 111.568 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 77.6 mtp -113.4 162.92 15.51 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.569 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.5 tt -130.64 145.29 35.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -108.95 151.02 17.14 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 42.6 t -80.74 178.85 8.1 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.513 0.673 . . . . 0.0 110.929 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . 0.426 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 28.9 t70 -110.48 -18.44 13.21 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.941 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . 0.426 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 16.4 t70 -95.93 -46.96 6.32 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 25.4 p -101.87 -179.07 3.9 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -117.81 17.64 14.23 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.349 1.071 . . . . 0.0 109.45 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -102.62 163.35 12.27 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.184 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -112.19 141.83 45.41 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.875 0.369 . . . . 0.0 111.854 -174.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . 0.555 ' CE2' ' HD2' ' A' ' 871' ' ' PRO . 10.9 m-85 -120.94 169.39 10.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.712 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 56.6 m80 -96.02 150.39 20.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 118.692 0.678 . . . . 0.0 111.341 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -56.1 -53.89 58.54 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.46 -19.22 67.47 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.165 1.91 . . . . 0.0 113.799 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 45.3 m -80.84 -31.21 35.57 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.34 0.59 . . . . 0.0 111.742 -176.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.592 HG23 HG12 ' A' ' 899' ' ' ILE . 24.0 m -108.86 -22.66 4.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.824 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 104.31 55.08 0.77 Allowed Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.168 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.592 HG12 HG23 ' A' ' 897' ' ' VAL . 30.5 mm -113.06 117.78 56.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 86.9 mtp -87.72 -40.34 14.2 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -144.49 154.63 43.11 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . 0.454 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -54.51 110.09 1.94 Allowed Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 124.799 1.312 . . . . 0.0 112.431 -176.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 25.3 Cg_endo -66.15 152.24 81.68 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 122.516 2.144 . . . . 0.0 111.067 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.65 147.8 38.31 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.706 2.271 . . . . 0.0 112.632 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -25.14 65.62 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.928 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -77.04 -14.07 59.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.706 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 25.4 ttt -82.92 121.62 27.21 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.082 0.468 . . . . 0.0 110.934 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -80.65 127.94 33.05 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -125.84 138.9 53.84 Favored 'General case' 0 C--N 1.248 -3.811 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 84.2 m-85 -125.55 137.36 53.93 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 18.7 p -77.26 166.6 43.14 Favored Pre-proline 0 C--N 1.28 -2.421 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.344 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -49.02 -30.99 19.38 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.228 2.619 . . . . 0.0 112.465 176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.673 ' HA ' ' HE2' ' A' ' 913' ' ' LYS . 7.8 mmpt? -81.02 -42.95 20.3 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 887' ' ' ASP . 92.4 m -78.4 -20.18 51.69 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.084 177.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -70.22 -23.24 62.9 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -79.48 -10.89 59.89 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.964 0.411 . . . . 0.0 110.539 175.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -87.31 -57.73 2.85 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 68.5 mt -66.01 -53.88 32.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 114.673 -1.148 . . . . 0.0 111.045 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm 58.63 -179.01 0.07 Allowed 'General case' 0 N--CA 1.425 -1.7 0 C-N-CA 125.898 1.679 . . . . 0.0 111.197 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -114.21 -43.58 3.21 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 21.8 t70 70.43 132.9 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.404 1.482 . . . . 0.0 113.924 173.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 36.5 tttp 71.47 148.55 0.08 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.526 1.13 . . . . 0.0 111.941 173.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . 0.611 ' H ' ' HD3' ' A' ' 923' ' ' LYS . 0.0 OUTLIER -89.24 71.8 8.22 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.352 1.072 . . . . 0.0 110.338 176.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 . . . . . 0 C--N 1.293 -1.872 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -177.744 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.056 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 11.7 p -66.51 -41.7 88.44 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 173.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -105.63 158.22 16.85 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 66.1 mtt 68.81 179.04 0.24 Allowed 'General case' 0 C--O 1.244 0.811 0 O-C-N 124.195 0.934 . . . . 0.0 109.505 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -89.69 -164.23 1.12 Allowed 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 23.9 mmt -72.48 -23.15 61.0 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -169.74 -150.66 0.08 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.75 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . 0.643 ' HA ' HD12 ' A' ' 869' ' ' ILE . 4.4 m-85 77.39 22.28 0.96 Allowed 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 123.124 1.44 . . . . 0.0 108.125 -171.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.2 108.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.397 -3.108 0 CA-C-N 111.493 -2.594 . . . . 0.0 106.638 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 30.9 mt -117.73 154.41 19.63 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.724 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -100.76 137.25 39.4 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.399 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.07 179.31 6.9 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.75 176.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.29 -29.89 65.59 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.946 0.403 . . . . 0.0 110.266 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -80.04 -10.9 59.8 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.821 0.819 . . . . 0.0 109.546 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.82 18.34 40.99 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -78.72 155.15 29.53 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -85.07 118.72 24.81 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.992 0.901 . . . . 0.0 110.876 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 37.0 mm -91.14 114.4 28.4 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -100.34 147.21 26.05 Favored 'General case' 0 C--N 1.264 -3.114 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.771 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.643 HD12 ' HA ' ' A' ' 857' ' ' TYR . 26.9 mt -102.19 109.24 25.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-O 121.223 0.535 . . . . 0.0 110.626 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 49.4 t -56.29 115.43 9.88 Favored Pre-proline 0 N--CA 1.438 -1.074 0 C-N-CA 126.217 1.807 . . . . 0.0 110.32 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -59.81 -13.4 22.19 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.633 2.889 . . . . 0.0 112.869 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.46 -38.06 34.16 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.212 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 9.1 p -120.99 -15.96 8.16 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 117.218 0.509 . . . . 0.0 112.25 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 72.39 21.54 3.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.315 1.446 . . . . 0.0 108.707 -176.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -101.93 141.78 23.25 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.3 177.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -73.32 158.33 48.61 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.637 2.224 . . . . 0.0 110.931 173.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.593 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 10.3 t0 -48.74 123.33 6.73 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.469 0.652 . . . . 0.0 111.696 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -90.47 6.1 44.86 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.473 -175.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 91.81 36.73 6.31 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 108.281 -1.927 . . . . 0.0 108.281 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 22.8 m -122.37 161.58 42.52 Favored Pre-proline 0 N--CA 1.418 -2.029 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.37 133.34 32.22 Favored 'Trans proline' 0 C--O 1.254 1.285 0 C-N-CA 121.576 1.517 . . . . 0.0 110.306 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.593 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 75.8 mtp -112.05 154.52 25.26 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.52 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.1 tt -124.75 138.23 54.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.14 158.52 16.75 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.57 169.56 17.86 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.366 0.603 . . . . 0.0 110.315 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -91.42 -26.03 19.06 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -98.54 -49.33 4.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.277 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 17.6 p -99.7 179.2 4.61 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.595 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -110.2 11.61 23.58 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.809 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -81.99 151.97 26.91 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.951 0.405 . . . . 0.0 111.236 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -114.45 139.18 49.74 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.951 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -119.23 162.42 18.72 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.294 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.607 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 65.4 m80 -83.45 144.14 29.78 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.401 ' N ' ' HD2' ' A' ' 895' ' ' PRO . 26.3 m0 -51.24 -49.49 81.37 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 175.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 893' ' ' HIS . 28.5 Cg_endo -63.93 -23.6 68.03 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.659 2.24 . . . . 0.0 114.053 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 61.2 m -76.81 -25.7 53.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.56 0.695 . . . . 0.0 111.563 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.793 HG23 HG12 ' A' ' 899' ' ' ILE . 9.0 m -114.14 -2.59 10.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.712 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 73.19 45.08 32.65 Favored Glycine 0 CA--C 1.504 -0.606 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.202 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.793 HG12 HG23 ' A' ' 897' ' ' VAL . 45.4 mm -80.02 -67.9 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.391 1.091 . . . . 0.0 110.457 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.9 mtt 66.63 -14.94 0.15 Allowed 'General case' 0 C--N 1.264 -3.117 0 C-N-CA 128.398 2.679 . . . . 0.0 114.74 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -158.11 147.13 19.31 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . 0.409 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -51.88 110.16 1.74 Allowed Pre-proline 0 C--O 1.239 0.517 0 O-C-N 124.491 1.119 . . . . 0.0 112.186 -175.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 904' ' ' PRO . 32.6 Cg_endo -66.01 133.14 32.31 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.908 2.405 . . . . 0.0 112.104 -177.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . 0.485 ' HB2' ' HG2' ' A' ' 906' ' ' GLU . 33.0 Cg_exo -63.53 140.25 74.57 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.347 2.032 . . . . 0.0 110.758 176.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.92 0.73 14.71 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.485 ' HG2' ' HB2' ' A' ' 904' ' ' PRO . 10.9 pt-20 -69.16 -19.97 64.01 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 173.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 46.9 ttp -104.12 127.34 51.7 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 115.234 -0.893 . . . . 0.0 108.919 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -83.54 140.46 32.25 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 172.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 73.0 t90 -125.42 119.95 29.68 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.525 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.47 138.63 53.7 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 30.8 p -66.39 161.84 54.54 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 123.754 0.658 . . . . 0.0 111.55 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.45 -16.12 22.22 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.207 2.605 . . . . 0.0 112.916 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.54 ' HA ' ' HE2' ' A' ' 913' ' ' LYS . 3.9 mmpt? -84.26 -48.5 9.69 Favored 'General case' 0 N--CA 1.44 -0.963 0 O-C-N 122.145 -0.347 . . . . 0.0 110.177 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.462 ' O ' HG13 ' A' ' 918' ' ' ILE . 84.7 m -68.49 -39.96 81.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.05 176.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.09 71.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.203 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -64.11 -43.65 94.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.26 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -79.62 -33.3 41.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.522 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 914' ' ' CYS . 85.4 mt -62.09 -47.39 93.37 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 174.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . 0.502 ' HG2' ' H ' ' A' ' 920' ' ' LYS . 44.2 tttm 57.31 -151.14 0.43 Allowed 'General case' 0 N--CA 1.418 -2.051 0 C-N-CA 125.622 1.569 . . . . 0.0 110.196 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . 0.502 ' H ' ' HG2' ' A' ' 919' ' ' LYS . 67.0 mttm 53.73 27.04 6.47 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 124.282 1.033 . . . . 0.0 111.833 -172.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.75 117.04 21.74 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 113.85 -1.523 . . . . 0.0 107.599 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 922' ' ' LYS . 0.9 OUTLIER -136.97 -34.84 0.72 Allowed 'General case' 0 N--CA 1.405 -2.693 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.522 -178.047 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -151.16 151.49 32.0 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.258 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 84.6 t60 . . . . . 0 C--N 1.302 -1.485 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.792 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.813 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 17.2 p -93.58 -32.49 14.1 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 122.553 -0.381 . . . . 0.0 111.571 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -116.72 -24.59 7.66 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.156 0.503 . . . . 0.0 111.692 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 48.6 tpp -104.12 27.05 8.05 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.604 0.716 . . . . 0.0 109.432 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 69.39 166.13 0.27 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.005 1.322 . . . . 0.0 112.469 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 64.4 mtt -99.29 111.45 23.82 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.132 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -164.04 -179.97 6.57 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -112.43 -7.86 13.92 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.436 0.636 . . . . 0.0 110.199 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 867' ' ' ILE . 57.5 t -125.08 129.11 73.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.718 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 58.0 mt -125.56 144.58 35.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -92.05 117.03 29.44 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.452 175.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -71.31 176.07 4.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.72 -22.88 59.76 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.437 0.637 . . . . 0.0 109.452 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -85.99 -0.43 55.47 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.168 0.985 . . . . 0.0 108.687 173.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 75.69 16.5 80.61 Favored Glycine 0 CA--C 1.5 -0.878 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.868 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -68.35 134.01 49.61 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -82.04 81.34 8.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.51 0.672 . . . . 0.0 109.274 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 858' ' ' VAL . 46.5 mm -53.14 135.88 14.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 113.198 -1.819 . . . . 0.0 112.287 -174.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -103.07 132.63 49.18 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 124.186 0.929 . . . . 0.0 109.877 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 40.8 mt -102.43 116.96 47.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.524 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.0 111.34 3.55 Favored Pre-proline 0 N--CA 1.443 -0.806 0 C-N-CA 125.255 1.422 . . . . 0.0 110.532 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -65.31 3.73 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.851 3.034 . . . . 0.0 113.613 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -86.16 -46.03 5.44 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 14.1 p -116.4 -22.03 8.97 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.528 0.68 . . . . 0.0 110.456 -176.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.274 2.8 m-20 70.75 56.0 0.24 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 125.765 1.626 . . . . 0.0 111.563 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.3 140.01 37.13 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.151 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -74.19 173.99 13.22 Favored 'Trans proline' 0 C--O 1.257 1.427 0 C-N-CA 123.359 2.706 . . . . 0.0 112.624 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.417 ' HA ' ' SD ' ' A' ' 882' ' ' MET . 3.4 m-20 -48.51 106.11 0.09 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.744 0.818 . . . . 0.0 108.929 172.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -102.57 -15.05 16.52 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.957 0.408 . . . . 0.0 110.868 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 127.09 -21.21 5.84 Favored Glycine 0 N--CA 1.437 -1.252 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 50.0 m -70.99 157.06 91.16 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.293 -0.454 . . . . 0.0 109.807 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -65.97 137.91 50.57 Favored 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.707 2.271 . . . . 0.0 111.468 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.417 ' SD ' ' HA ' ' A' ' 877' ' ' ASP . 91.7 mtp -128.71 148.31 50.82 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.481 -175.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 17.5 tt -129.49 148.06 33.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -111.69 146.89 17.97 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.812 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 888' ' ' CYS . 52.8 t -70.37 155.78 40.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -86.98 -24.0 24.85 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.568 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -92.02 -45.42 8.33 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.882 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 885' ' ' CYS . 29.8 p -100.44 -178.27 3.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.485 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -112.62 14.89 20.16 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 122.712 1.244 . . . . 0.0 109.431 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.95 153.03 21.62 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.056 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 26.8 m95 -118.93 138.79 52.53 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.35 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -124.29 161.46 25.8 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.099 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.72 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 56.8 m80 -86.67 146.47 26.29 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -49.93 -53.5 42.24 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.65 -10.54 29.08 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 122.224 1.949 . . . . 0.0 113.792 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 62.4 m -87.07 -33.72 19.4 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.593 0.711 . . . . 0.0 111.023 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.582 HG23 HG12 ' A' ' 899' ' ' ILE . 19.2 m -104.75 -15.62 8.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.797 -176.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 96.0 47.36 2.46 Favored Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.855 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.582 HG12 HG23 ' A' ' 897' ' ' VAL . 48.3 mm -95.39 105.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 22.8 ptm -87.11 -19.5 28.44 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.234 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -170.5 151.35 3.64 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . 0.413 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -45.56 111.53 1.39 Allowed Pre-proline 0 C--O 1.243 0.719 0 O-C-N 124.673 1.233 . . . . 0.0 110.754 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 12.2 Cg_endo -59.86 139.13 86.73 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.903 2.402 . . . . 0.0 112.196 -177.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.52 135.7 66.41 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.839 2.359 . . . . 0.0 111.957 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.85 -21.26 64.51 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 123.388 0.675 . . . . 0.0 111.725 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -74.98 0.21 16.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.036 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 58.0 ttp -123.99 141.82 51.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -84.6 145.9 27.79 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -117.39 128.65 55.23 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.561 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -131.23 146.32 52.27 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 20.8 p -76.65 164.88 56.75 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.39 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.59 -24.11 21.62 Favored 'Trans proline' 0 CA--C 1.551 1.366 0 C-N-CA 123.355 2.703 . . . . 0.0 112.275 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -78.54 -53.8 6.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.498 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.508 ' O ' HG12 ' A' ' 918' ' ' ILE . 85.7 m -78.54 -26.72 45.78 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.72 69.93 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -74.57 -35.54 63.05 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.053 0.93 . . . . 0.0 110.066 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -71.71 -15.62 62.21 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.005 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' A' ' 919' ' ' LYS . 44.6 mm -63.97 -26.23 40.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 123.512 0.725 . . . . 0.0 111.661 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 918' ' ' ILE . 54.8 pttt 54.69 34.23 21.14 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 126.205 1.802 . . . . 0.0 111.697 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 58.8 tttm 76.51 -57.46 0.54 Allowed 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.603 1.561 . . . . 0.0 110.667 -176.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 24.5 t70 65.8 -47.43 0.4 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 124.892 1.277 . . . . 0.0 114.125 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -77.57 121.04 23.37 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -59.08 -41.09 87.2 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 123.985 0.914 . . . . 0.0 112.294 -177.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 37.1 m80 . . . . . 0 C--N 1.254 -3.568 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.154 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.449 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 19.9 m 62.09 15.23 7.19 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.038 0.935 . . . . 0.0 112.488 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 64.57 85.95 0.13 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.551 1.141 . . . . 0.0 110.38 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 54.3 ttp -73.13 -25.58 60.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.102 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 58.76 36.02 24.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.516 1.126 . . . . 0.0 111.176 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 86.0 mtp -151.87 158.71 43.59 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -110.93 -108.51 0.35 Allowed 'General case' 0 C--N 1.28 -2.417 0 C-N-CA 119.105 -1.038 . . . . 0.0 112.622 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 65.85 25.31 11.24 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.927 0.891 . . . . 0.0 110.86 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.76 121.71 66.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.333 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 51.2 mt -126.85 138.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 173.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -98.59 122.15 41.43 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.182 0.992 . . . . 0.0 112.435 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.89 173.19 1.91 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 113.185 -1.825 . . . . 0.0 109.69 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.57 -28.86 70.17 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.783 0.833 . . . . 0.0 110.884 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.483 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 76.3 m95 -98.24 10.68 40.06 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.076 0.465 . . . . 0.0 111.317 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 87.46 1.69 83.31 Favored Glycine 0 CA--C 1.508 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.144 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.483 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 45.4 m-80 -65.37 137.56 57.58 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.18 126.87 33.54 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.68 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 48.7 mm -91.49 129.13 42.68 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.622 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -77.69 145.95 36.32 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.852 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 52.6 mt -129.99 128.2 64.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.84 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.5 t -72.43 117.36 58.17 Favored Pre-proline 0 N--CA 1.419 -2.015 0 C-N-CA 125.165 1.386 . . . . 0.0 108.711 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.88 -1.13 6.35 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.565 2.176 . . . . 0.0 112.817 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.93 -48.16 10.42 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.562 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 5.8 p -113.28 -19.28 11.83 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 122.684 0.394 . . . . 0.0 111.489 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.4 t30 81.01 19.79 0.44 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.475 1.51 . . . . 0.0 109.228 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -97.73 138.81 21.06 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.918 176.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.6 Cg_endo -73.88 174.21 12.71 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.34 2.693 . . . . 0.0 110.534 173.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -59.48 119.98 8.52 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.368 0.604 . . . . 0.0 109.38 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -104.26 23.92 12.34 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 76.77 51.68 6.28 Favored Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 105.654 -2.978 . . . . 0.0 105.654 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 7.7 p -125.87 159.38 61.78 Favored Pre-proline 0 N--CA 1.42 -1.943 0 CA-C-N 113.981 -1.109 . . . . 0.0 112.888 -166.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -77.22 108.13 2.56 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 121.988 1.792 . . . . 0.0 109.563 174.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 81.9 mtp -116.24 164.76 14.02 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.839 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.5 tt -133.6 134.62 56.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.69 154.73 20.7 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 53.8 t -80.81 167.84 19.48 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.444 0.64 . . . . 0.0 110.265 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -92.86 -31.63 14.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . 0.429 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 27.5 t70 -91.45 -36.91 13.5 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.863 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 55.7 m -97.51 168.32 10.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.65 10.99 26.84 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -94.25 175.08 6.83 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.336 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -132.03 140.14 48.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.121 0.486 . . . . 0.0 112.082 -172.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -119.22 158.33 26.21 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.219 1.008 . . . . 0.0 108.285 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.669 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 73.3 m80 -84.26 149.13 26.3 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.365 176.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . . . . . . . . . 33.3 m0 -53.0 -54.52 43.2 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.53 -16.44 52.31 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.274 1.983 . . . . 0.0 113.444 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 81.8 m -81.28 -27.25 35.19 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.149 0.499 . . . . 0.0 110.85 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 893' ' ' HIS . 21.1 m -115.42 14.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.109 -176.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 71.2 35.42 64.03 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.837 -1.074 . . . . 0.0 114.231 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 57.6 mt -105.61 127.58 60.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.466 0.65 . . . . 0.0 111.024 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.7 mmt -105.17 -25.12 12.61 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.231 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -152.66 154.71 35.87 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . 0.5 ' HA ' ' HD2' ' A' ' 903' ' ' PRO . . . -49.68 112.92 2.91 Favored Pre-proline 0 C--O 1.241 0.628 0 O-C-N 124.779 1.299 . . . . 0.0 112.366 -177.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 902' ' ' ALA . 19.3 Cg_endo -61.48 151.85 77.06 Favored 'Trans proline' 0 C--O 1.254 1.296 0 C-N-CA 122.998 2.466 . . . . 0.0 112.202 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . 0.496 ' HB2' ' HG2' ' A' ' 906' ' ' GLU . 9.8 Cg_endo -54.08 141.97 67.32 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.525 2.817 . . . . 0.0 112.334 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -78.71 -24.0 45.2 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.847 0.832 . . . . 0.0 108.874 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.496 ' HG2' ' HB2' ' A' ' 904' ' ' PRO . 11.4 pt-20 -71.62 -9.55 58.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.136 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 56.9 ttp -116.89 131.02 57.06 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -77.4 146.41 36.61 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -117.81 141.61 48.23 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 120.594 -0.443 . . . . 0.0 109.815 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -132.45 137.59 47.32 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 17.1 p -66.98 165.06 29.45 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 123.992 0.917 . . . . 0.0 110.102 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -56.01 -18.86 24.06 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.595 2.197 . . . . 0.0 112.045 174.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.58 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 74.9 mmtt -74.49 -48.49 26.92 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.554 ' O ' HG12 ' A' ' 918' ' ' ILE . 68.8 m -76.63 -29.77 56.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.99 -11.24 60.68 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 120.698 0.285 . . . . 0.0 110.931 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.04 -29.71 35.0 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 172.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 53.3 mtmt -80.52 -36.74 32.78 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.912 176.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 914' ' ' CYS . 40.1 mm -71.94 -66.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt 64.69 114.47 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 126.537 1.935 . . . . 0.0 112.187 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -68.28 82.91 0.24 Allowed 'General case' 0 C--O 1.243 0.727 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.229 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 22.8 t70 69.21 -63.63 0.36 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.843 1.657 . . . . 0.0 110.274 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -176.0 137.57 0.33 Allowed 'General case' 0 N--CA 1.425 -1.694 0 C-N-CA 126.125 1.77 . . . . 0.0 106.634 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -107.77 138.81 43.34 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 3.4 t60 . . . . . 0 C--N 1.285 -2.2 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -177.225 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.689 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 15.2 m 67.27 177.21 0.24 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.792 0.837 . . . . 0.0 111.36 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 71.25 1.51 3.86 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.816 1.247 . . . . 0.0 111.625 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 1.2 tmt? 67.75 -78.6 0.04 OUTLIER 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.678 1.591 . . . . 0.0 111.132 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 170.1 -30.51 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 126.022 1.729 . . . . 0.0 107.3 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 26.1 mmt -85.1 73.52 10.64 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.35 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -177.75 -161.14 0.05 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -90.94 11.33 23.12 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.702 0.287 . . . . 0.0 111.083 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.419 HG13 ' HB2' ' A' ' 866' ' ' GLN . 90.9 t -134.75 118.64 26.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 37.6 mt -122.58 166.45 17.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -108.6 131.97 54.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 119.548 1.067 . . . . 0.0 109.501 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.35 175.21 8.62 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 123.697 0.799 . . . . 0.0 108.917 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -68.09 -27.95 66.93 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 123.716 0.806 . . . . 0.0 111.013 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -81.78 -15.4 54.38 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 102.3 -8.93 55.77 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.897 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -66.76 146.82 54.03 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . 0.419 ' HB2' HG13 ' A' ' 858' ' ' VAL . 14.0 pt20 -74.53 144.88 43.88 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 121.832 0.825 . . . . 0.0 111.502 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 39.3 mm -105.32 121.63 57.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -90.02 143.57 26.67 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 123.975 0.797 . . . . 0.0 109.425 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 40.8 mt -107.7 123.4 63.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 892' ' ' TYR . 41.6 t -75.2 114.46 35.57 Favored Pre-proline 0 N--CA 1.409 -2.486 0 O-C-N 124.593 1.183 . . . . 0.0 108.67 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.4 -1.72 6.99 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.147 2.565 . . . . 0.0 112.011 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -78.27 -40.74 18.98 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 6.9 p -118.38 -15.37 9.7 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 57.8 t30 71.49 32.41 2.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.417 1.087 . . . . 0.0 108.285 -175.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -116.0 140.43 26.27 Favored Pre-proline 0 C--O 1.241 0.636 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.639 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 40.2 Cg_endo -72.47 167.27 27.46 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 123.317 2.678 . . . . 0.0 112.699 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.48 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 21.7 t70 -65.84 138.42 57.88 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.239 172.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -124.52 33.41 5.25 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 74.82 47.38 14.58 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 107.487 -2.245 . . . . 0.0 107.487 -173.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 881' ' ' PRO . 6.2 p -120.45 149.32 49.67 Favored Pre-proline 0 N--CA 1.423 -1.807 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.027 -171.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 880' ' ' SER . 22.9 Cg_exo -64.89 126.25 16.23 Favored 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 122.037 1.825 . . . . 0.0 110.384 175.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.48 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 88.9 mtp -128.3 157.79 39.97 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.869 -177.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.69 138.07 52.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -105.46 155.09 17.04 Favored Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 888' ' ' CYS . 1.7 p -74.04 135.74 43.07 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.801 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.9 -48.94 72.39 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.699 -174.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . 0.591 ' HB2' ' CE1' ' A' ' 910' ' ' PHE . 14.9 t70 -80.65 -49.41 11.27 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-O 122.704 1.24 . . . . 0.0 109.12 -175.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.872 ' HB2' ' SG ' ' A' ' 885' ' ' CYS . 0.0 OUTLIER -73.6 -103.73 0.01 OUTLIER 'General case' 0 N--CA 1.38 -3.95 0 N-CA-C 118.929 2.937 . . . . 0.0 118.929 -162.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -178.3 -25.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -166.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . 0.436 ' N ' ' SG ' ' A' ' 885' ' ' CYS . 22.7 m-20 -90.93 173.46 7.96 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.45 0.643 . . . . 0.0 111.94 -170.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -132.81 127.39 34.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.116 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . 0.428 ' HA ' ' SG ' ' A' ' 870' ' ' CYS . 82.6 m-85 -122.67 162.51 21.82 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.672 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 54.6 m80 -84.17 151.76 24.67 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.457 ' CG ' ' HB ' ' A' ' 899' ' ' ILE . 25.9 m0 -53.12 -56.37 24.53 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.52 -13.62 40.75 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.206 1.938 . . . . 0.0 114.043 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 76.5 m -77.75 -40.86 39.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.492 0.663 . . . . 0.0 111.109 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.535 HG23 HG12 ' A' ' 899' ' ' ILE . 27.1 m -99.57 -26.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.669 -175.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 110.17 35.42 2.14 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.214 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.535 HG12 HG23 ' A' ' 897' ' ' VAL . 42.2 mm -90.16 106.73 17.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 91.3 mmm -91.93 -25.64 18.8 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.244 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -151.74 147.84 27.18 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -57.57 114.36 8.17 Favored Pre-proline 0 C--N 1.319 -0.718 0 O-C-N 124.415 1.072 . . . . 0.0 111.891 -176.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 904' ' ' PRO . 42.3 Cg_endo -71.92 146.68 48.01 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.905 2.403 . . . . 0.0 111.028 177.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 903' ' ' PRO . 32.4 Cg_exo -60.61 124.02 14.2 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.974 1.782 . . . . 0.0 110.793 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.34 -3.18 19.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.528 -175.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -74.99 -16.31 60.63 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.479 0.657 . . . . 0.0 109.609 173.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 16.9 tpt -98.7 152.22 19.89 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -91.36 141.99 28.17 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -127.81 125.09 39.16 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.403 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 887' ' ' ASP . 22.0 m-85 -118.16 147.04 43.73 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 885' ' ' CYS 0.254 1.8 p -80.49 164.58 51.02 Favored Pre-proline 0 C--N 1.271 -2.839 0 C-N-CA 124.478 1.111 . . . . 0.0 111.176 -174.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.56 -12.86 30.12 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.685 2.257 . . . . 0.0 112.296 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 32.4 mmtp -88.21 -62.11 1.56 Allowed 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.443 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 888' ' ' CYS . 96.3 m -74.35 -27.76 60.82 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -175.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -72.55 -25.95 61.56 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.322 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 920' ' ' LYS . 2.3 t-20 -89.47 -4.55 57.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.754 0.788 . . . . 0.0 110.164 -177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 913' ' ' LYS . 35.8 mmtp -83.69 -47.64 10.99 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 171.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.2 -59.42 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.227 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -98.49 71.82 2.03 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 916' ' ' ASN . 0.5 OUTLIER -67.64 -60.61 2.4 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.925 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . 0.422 ' OD1' ' HG3' ' A' ' 920' ' ' LYS . 9.2 m-20 -136.34 -0.27 2.46 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.732 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -175.89 153.72 1.4 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -100.21 147.8 25.32 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 57.4 m80 . . . . . 0 C--N 1.311 -1.104 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.388 179.181 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.758 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 18.1 m -61.36 -41.77 97.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.484 0.659 . . . . 0.0 109.928 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -134.73 158.36 44.32 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . 0.427 ' O ' HG23 ' A' ' 859' ' ' ILE . 15.3 tpt -138.81 -79.81 0.33 Allowed 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.359 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -148.96 140.78 23.64 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.828 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 8.8 tmm? -78.28 -41.53 33.68 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -174.69 -77.54 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.088 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -112.86 12.36 19.44 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.23 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.68 128.17 74.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.17 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 867' ' ' ILE . 46.9 mt -126.0 166.02 22.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 177.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -116.58 140.71 49.08 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.93 -168.06 1.65 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.176 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.53 -34.02 77.28 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.006 0.922 . . . . 0.0 110.714 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -87.35 -33.51 19.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.783 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 122.57 16.64 3.72 Favored Glycine 0 C--N 1.308 -1.015 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.204 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -83.52 151.18 25.54 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -79.31 135.77 36.83 Favored 'General case' 0 N--CA 1.396 -3.133 0 CA-C-O 122.02 0.914 . . . . 0.0 110.181 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 859' ' ' ILE . 27.4 mm -103.34 129.56 55.03 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.05 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.887 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -92.67 142.71 27.07 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.898 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 39.8 mt -111.41 122.92 66.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.113 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.5 t -65.66 112.53 8.9 Favored Pre-proline 0 N--CA 1.431 -1.404 0 C-N-CA 124.769 1.228 . . . . 0.0 108.817 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.69 -5.18 8.28 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.713 2.942 . . . . 0.0 112.961 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.95 -39.2 28.64 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 121.119 -0.562 . . . . 0.0 111.967 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 9.6 p -124.44 -10.32 7.44 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 122.79 0.436 . . . . 0.0 111.629 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.336 9.5 p30 60.12 32.39 20.93 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 126.022 1.729 . . . . 0.0 112.258 -172.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -103.59 138.96 19.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.095 173.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 38.9 Cg_endo -74.08 171.09 18.65 Favored 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 123.38 2.72 . . . . 0.0 113.888 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.92 145.24 42.8 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.551 174.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -115.83 -0.62 12.82 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 99.92 39.54 3.32 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 107.341 -2.304 . . . . 0.0 107.341 -172.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 14.3 m -106.44 168.67 7.81 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 114.607 -0.797 . . . . 0.0 110.527 -171.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -74.51 115.62 4.36 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 121.316 1.344 . . . . 0.0 108.901 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 83.4 mtp -122.57 162.3 22.09 Favored 'General case' 0 N--CA 1.407 -2.605 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . 0.556 ' HB ' ' HE1' ' A' ' 894' ' ' TRP . 18.0 tt -122.31 133.44 68.57 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-O 120.713 0.292 . . . . 0.0 110.44 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.08 143.77 16.87 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 52.7 t -71.94 167.95 19.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.551 0.691 . . . . 0.0 110.272 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . 0.421 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 24.6 t70 -84.97 -26.29 27.23 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 174.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -95.36 -47.96 6.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.119 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 10.1 m -83.79 146.63 28.04 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.97 17.12 23.12 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.279 1.038 . . . . 0.0 108.51 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -108.77 168.4 9.37 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.383 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -115.43 150.44 36.43 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -168.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -123.37 149.68 44.65 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.691 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 44.2 m80 -75.42 142.06 43.1 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.186 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.556 ' HE1' ' HB ' ' A' ' 883' ' ' ILE . 21.1 m0 -55.85 -49.47 92.76 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 894' ' ' TRP . 20.3 Cg_endo -61.47 -19.08 63.04 Favored 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 122.154 1.903 . . . . 0.0 113.105 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.691 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 74.0 m -83.41 -21.22 33.06 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.401 0.62 . . . . 0.0 111.519 -177.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 893' ' ' HIS . 15.9 m -118.43 12.58 7.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.877 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 62.49 48.8 79.26 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.097 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 57.7 mt -118.59 136.58 55.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 122.582 -0.364 . . . . 0.0 111.108 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 61.5 mtt -121.9 -11.6 8.52 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.229 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 903' ' ' PRO . . . -156.54 137.29 13.33 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -50.77 100.78 0.24 Allowed Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 125.263 1.425 . . . . 0.0 113.686 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 901' ' ' ALA . 14.4 Cg_endo -102.93 140.0 0.15 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.715 2.943 . . . . 0.0 116.46 -177.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -95.79 154.47 1.49 Allowed 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 122.779 2.319 . . . . 0.0 107.811 163.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -87.24 -28.67 22.21 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 118.239 -1.385 . . . . 0.0 111.708 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 149.99 -15.82 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 129.464 3.106 . . . . 0.0 103.801 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 53.0 ttm -134.41 170.82 15.17 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -53.07 169.09 0.11 Allowed 'General case' 0 C--N 1.31 -1.12 0 O-C-N 124.082 0.864 . . . . 0.0 111.388 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -100.4 131.67 46.2 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.191 -173.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 84.9 m-85 -126.83 139.33 53.18 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 15.5 p -70.26 167.43 25.84 Favored Pre-proline 0 N--CA 1.426 -1.644 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.787 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.84 -20.64 18.15 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 123.08 2.52 . . . . 0.0 111.886 173.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.519 ' HA ' ' HE2' ' A' ' 913' ' ' LYS . 8.9 mmpt? -81.03 -51.47 8.46 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.21 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.495 ' O ' HG12 ' A' ' 918' ' ' ILE . 91.4 m -75.08 -29.66 60.73 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.7 66.31 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.19 0.519 . . . . 0.0 110.334 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -68.37 -28.79 67.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.354 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -79.15 -39.13 34.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.891 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 914' ' ' CYS . 47.8 mm -62.57 -46.93 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.232 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -79.57 175.38 10.66 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.397 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -119.52 120.76 37.7 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.4 -44.3 21.71 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -141.85 -42.66 0.35 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.639 -1.619 . . . . 0.0 106.65 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -150.99 -158.3 0.9 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 173.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 . . . . . 0 C--N 1.299 -1.6 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 171.789 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_